-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (Drugs)))) (SBAR (WHNP (WDT (that))) (S (VP (VP (VBP (Inhibit))) (CC (or)) (VP (VBP (Induce)) (NP (NP (NE-Type-2-drug (NP (NN (Cytochrome)) (NN (P450)) (NN (3A4))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (Drugs)))) (SBAR (WHNP (WDT (that))) (S (VP (VP (VBP (Inhibit))) (CC (or)) (VP (VBP (Induce)) (NP (NP (drug_ENTITY (NP (NN (Cytochrome)) (NN (P450)) (NN (3A4)))) (NNS (Enzymes))) (S (S (NP (NN (Lapatinib))) (VP (VBZ (undergoes)) (NP (JJ (extensive)) (NN (metabolism))) (PP (IN (by)) (NE-Type-2-drug (NP (NN (CYP3A4)))))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (Drugs)))) (SBAR (WHNP (WDT (that))) (S (VP (VP (VBP (Inhibit))) (CC (or)) (VP (VBP (Induce)) (NP (NP (drug_ENTITY (NP (NN (Cytochrome)) (NN (P450)) (NN (3A4)))) (NNS (Enzymes))) (S (S (NP (NN (Lapatinib))) (VP (VBZ (undergoes)) (NP (JJ (extensive)) (NN (metabolism))) (PP (IN (by)) (drug_ENTITY (NP (NN (CYP3A4))))))) (, (,)) (CC (and)) (S (NP (NP (JJ (concomitant)) (NN (administration))) (PP (IN (of)) (NP (NP (JJ (strong)) (NNS (inhibitors))) (CC (or)) (NP (NP (NNS (inducers))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (CYP3A4))))))))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (Drugs)))) (SBAR (WHNP (WDT (that))) (S (VP (VP (VBP (Inhibit))) (CC (or)) (VP (VBP (Induce)) (NP (NP (drug_ENTITY (NP (NN (Cytochrome)) (NN (P450)) (NN (3A4)))) (NNS (Enzymes))) (S (S (NP (NN (Lapatinib))) (VP (VBZ (undergoes)) (NP (JJ (extensive)) (NN (metabolism))) (PP (IN (by)) (drug_ENTITY (NP (NN (CYP3A4))))))) (, (,)) (CC (and)) (S (NP (NP (JJ (concomitant)) (NN (administration))) (PP (IN (of)) (NP (NP (JJ (strong)) (NNS (inhibitors))) (CC (or)) (NP (NP (NNS (inducers))) (PP (IN (of)) (drug_ENTITY (NP (NN (CYP3A4))))))))) (VP (VB (alter)) (NE-Type-2-drug (NP (NN (lapatinib))))))))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (Cytochrome)) (NN (P450)) (NN (3A4)))) (NNS (Enzymes))) (S (S (NP (NN (Lapatinib))) (VP (VBZ (undergoes)) (NP (JJ (extensive)) (NN (metabolism))) (PP (IN (by)) (NE-Type-2-drug (NP (NN (CYP3A4))))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (Cytochrome)) (NN (P450)) (NN (3A4)))) (NNS (Enzymes))) (S (S (NP (NN (Lapatinib))) (VP (VBZ (undergoes)) (NP (JJ (extensive)) (NN (metabolism))) (PP (IN (by)) (drug_ENTITY (NP (NN (CYP3A4))))))) (, (,)) (CC (and)) (S (NP (NP (JJ (concomitant)) (NN (administration))) (PP (IN (of)) (NP (NP (JJ (strong)) (NNS (inhibitors))) (CC (or)) (NP (NP (NNS (inducers))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (CYP3A4)))))))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (Cytochrome)) (NN (P450)) (NN (3A4)))) (NNS (Enzymes))) (S (S (NP (NN (Lapatinib))) (VP (VBZ (undergoes)) (NP (JJ (extensive)) (NN (metabolism))) (PP (IN (by)) (drug_ENTITY (NP (NN (CYP3A4))))))) (, (,)) (CC (and)) (S (NP (NP (JJ (concomitant)) (NN (administration))) (PP (IN (of)) (NP (NP (JJ (strong)) (NNS (inhibitors))) (CC (or)) (NP (NP (NNS (inducers))) (PP (IN (of)) (drug_ENTITY (NP (NN (CYP3A4))))))))) (VP (VB (alter)) (NE-Type-2-drug (NP (NN (lapatinib)))))))) |ET|
-1  |BT|  (S (S (VP (PP (NE-Type-1-drug (NP (NN (CYP3A4))))))) (, (,)) (CC (and)) (S (NP (NP (JJ (concomitant)) (NN (administration))) (PP (IN (of)) (NP (NP (JJ (strong)) (NNS (inhibitors))) (CC (or)) (NP (NP (NNS (inducers))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (CYP3A4))))))))))) |ET|
-1  |BT|  (S (S (VP (PP (NE-Type-1-drug (NP (NN (CYP3A4))))))) (, (,)) (CC (and)) (S (NP (NP (JJ (concomitant)) (NN (administration))) (PP (IN (of)) (NP (NP (JJ (strong)) (NNS (inhibitors))) (CC (or)) (NP (NP (NNS (inducers))) (PP (IN (of)) (drug_ENTITY (NP (NN (CYP3A4))))))))) (VP (VB (alter)) (NE-Type-2-drug (NP (NN (lapatinib))))))) |ET|
1  |BT|  (S (NP (PP (NP (NP (PP (NE-Type-1-drug (NP (NN (CYP3A4))))))))) (VP (VB (alter)) (NE-Type-2-drug (NP (NN (lapatinib)))))) |ET|
1  |BT|  (S (NP (PP (NE-Type-1-drug (NP (NN (lapatinib)))))) (VP (MD (should)) (VP (VB (be)) (VP (VBN (considered)) (PP (IN (for)) (NP (NP (NNS (patients))) (SBAR (WHNP (WP (who))) (S (VP (MD (must)) (VP (VBP (receive)) (NP (NP (NP (JJ (concomitant)) (JJ (strong)) (NNS (inhibitors))) (CC (or)) (NP (JJ (concomitant)) (JJ (strong)) (NNS (inducers)))) (PP (IN (of)) (NE-Type-2-drug (NP (JJ (CYP3A4)))))))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Ketoconazole)))) (: (:)) (S (PP (IN (In)) (NP (NP (JJ (healthy)) (NNS (subjects))) (VP (VBG (receiving)) (NP (NE-Type-2-drug (NP (NN (ketoconazole)))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Ketoconazole)))) (: (:)) (S (PP (IN (In)) (NP (NP (JJ (healthy)) (NNS (subjects))) (VP (VBG (receiving)) (NP (drug_ENTITY (NP (NN (ketoconazole)))) (, (,)) (NE-Type-2-drug (NP (DT (a)) (NN (CYP3A4)))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Ketoconazole)))) (: (:)) (S (PP (IN (In)) (NP (NP (JJ (healthy)) (NNS (subjects))) (VP (VBG (receiving)) (NP (drug_ENTITY (NP (NN (ketoconazole)))) (, (,)) (drug_ENTITY (NP (DT (a)) (NN (CYP3A4)) (NN (inhibitor)))) (, (,))) (PP (IN (at)) (NP (NP (CD (200)) (NN (mg))) (ADVP (RB (twice)) (RB (daily)) (PP (IN (for)) (NP (CD (7)) (NNS (days)))))))))) (, (,)) (NP (NP (NP (JJ (systemic)) (NN (exposure))) (PRN (-LRB- (<LB>)) (NP (NN (AUC))) (-RRB- (<RB>)))) (PP (TO (to)) (NE-Type-2-drug (NP (NN (lapatinib)))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (ketoconazole)))) (, (,)) (NE-Type-2-drug (NP (DT (a)) (NN (CYP3A4))))) |ET|
1  |BT|  (S (PP (NP (VP (NP (NE-Type-1-drug (NP (NN (ketoconazole)))) (, (,)) (drug_ENTITY (NP (DT (a)) (NN (CYP3A4)) (NN (inhibitor)))) (, (,))) (PP (IN (at)) (NP (NP (CD (200)) (NN (mg))) (ADVP (RB (twice)) (RB (daily)) (PP (IN (for)) (NP (CD (7)) (NNS (days)))))))))) (, (,)) (NP (NP (NP (JJ (systemic)) (NN (exposure))) (PRN (-LRB- (<LB>)) (NP (NN (AUC))) (-RRB- (<RB>)))) (PP (TO (to)) (NE-Type-2-drug (NP (NN (lapatinib))))))) |ET|
-1  |BT|  (S (PP (NP (VP (NP (NE-Type-1-drug (NP (NN (CYP3A4)) (NN (inhibitor)))) (, (,))) (PP (IN (at)) (NP (NP (CD (200)) (NN (mg))) (ADVP (RB (twice)) (RB (daily)) (PP (IN (for)) (NP (CD (7)) (NNS (days)))))))))) (, (,)) (NP (NP (NP (JJ (systemic)) (NN (exposure))) (PRN (-LRB- (<LB>)) (NP (NN (AUC))) (-RRB- (<RB>)))) (PP (TO (to)) (NE-Type-2-drug (NP (NN (lapatinib))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Carbamazepine)))) (: (:)) (S (PP (IN (In)) (NP (NP (JJ (healthy)) (NNS (subjects))) (VP (VBG (receiving)) (NP (NE-Type-2-drug (NP (DT (the)) (NN (CYP3A4)))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Carbamazepine)))) (: (:)) (S (PP (IN (In)) (NP (NP (JJ (healthy)) (NNS (subjects))) (VP (VBG (receiving)) (NP (drug_ENTITY (NP (DT (the)) (NN (CYP3A4)) (NN (inducer)))) (, (,)) (NE-Type-2-drug (NP (NN (carbamazepine)))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Carbamazepine)))) (: (:)) (S (PP (IN (In)) (NP (NP (JJ (healthy)) (NNS (subjects))) (VP (VBG (receiving)) (NP (drug_ENTITY (NP (DT (the)) (NN (CYP3A4)) (NN (inducer)))) (, (,)) (drug_ENTITY (NP (NN (carbamazepine)))) (, (,))) (PP (IN (at)) (NP (NP (NP (CD (100)) (NN (mg))) (ADJP (RB (twice)) (JJ (daily)) (PP (IN (for)) (NP (CD (3)) (NNS (days)))))) (CC (and)) (NP (NP (CD (200)) (NN (mg))) (ADJP (RB (twice)) (JJ (daily)) (PP (IN (for)) (NP (CD (17)) (NNS (days))))))))))) (, (,)) (NP (NP (NP (JJ (systemic)) (NN (exposure))) (PRN (-LRB- (<LB>)) (NP (NN (AUC))) (-RRB- (<RB>)))) (PP (TO (to)) (NE-Type-2-drug (NP (NN (lapatinib)))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (CYP3A4)) (NN (inducer)))) (, (,)) (NE-Type-2-drug (NP (NN (carbamazepine))))) |ET|
-1  |BT|  (S (PP (NP (VP (NP (NE-Type-1-drug (NP (NN (CYP3A4)) (NN (inducer)))) (, (,)) (drug_ENTITY (NP (NN (carbamazepine)))) (, (,))) (PP (IN (at)) (NP (NP (NP (CD (100)) (NN (mg))) (ADJP (RB (twice)) (JJ (daily)) (PP (IN (for)) (NP (CD (3)) (NNS (days)))))) (CC (and)) (NP (NP (CD (200)) (NN (mg))) (ADJP (RB (twice)) (JJ (daily)) (PP (IN (for)) (NP (CD (17)) (NNS (days))))))))))) (, (,)) (NP (NP (NP (JJ (systemic)) (NN (exposure))) (PRN (-LRB- (<LB>)) (NP (NN (AUC))) (-RRB- (<RB>)))) (PP (TO (to)) (NE-Type-2-drug (NP (NN (lapatinib))))))) |ET|
1  |BT|  (S (PP (NP (VP (NP (NE-Type-1-drug (NP (NN (carbamazepine)))) (, (,))) (PP (IN (at)) (NP (NP (NP (CD (100)) (NN (mg))) (ADJP (RB (twice)) (JJ (daily)) (PP (IN (for)) (NP (CD (3)) (NNS (days)))))) (CC (and)) (NP (NP (CD (200)) (NN (mg))) (ADJP (RB (twice)) (JJ (daily)) (PP (IN (for)) (NP (CD (17)) (NNS (days))))))))))) (, (,)) (NP (NP (NP (JJ (systemic)) (NN (exposure))) (PRN (-LRB- (<LB>)) (NP (NN (AUC))) (-RRB- (<RB>)))) (PP (TO (to)) (NE-Type-2-drug (NP (NN (lapatinib))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (Drugs)))) (SBAR (WHNP (WDT (that))) (S (VP (VBP (Inhibit)) (NE-Type-2-drug (NP (NP (NN (Drug)) (NN (Transport)) (NNS (Systems))) (NN (Lapatinib)))))))) |ET|
-1  |BT|  (S (NP (NE-Type-1-drug (NP (NNS (Drugs)))) (SBAR (WHNP (WDT (that))) (S (VP (VBP (Inhibit)) (drug_ENTITY (NP (NP (NN (Drug)) (NN (Transport)) (NNS (Systems))) (NN (Lapatinib)))))))) (VP (VBZ (is)) (NP (NP (DT (a)) (NN (substrate))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (DT (the)) (NN (efflux)) (NN (transporter))))))))) |ET|
-1  |BT|  (S (NP (NE-Type-1-drug (NP (NNS (Drugs)))) (SBAR (WHNP (WDT (that))) (S (VP (VBP (Inhibit)) (drug_ENTITY (NP (NP (NN (Drug)) (NN (Transport)) (NNS (Systems))) (NN (Lapatinib)))))))) (VP (VBZ (is)) (NP (NP (DT (a)) (NN (substrate))) (PP (IN (of)) (NP (drug_ENTITY (NP (DT (the)) (NN (efflux)) (NN (transporter)) (NN (P-glycoprotein)))) (PRN (-LRB- (<LB>)) (NP (NP (NN (Pgp))) (, (,)) (NE-Type-2-drug (NP (NN (ABCB1))))))))))) |ET|
-1  |BT|  (S (NP (SBAR (S (VP (NE-Type-1-drug (NP (NN (Lapatinib)))))))) (VP (VBZ (is)) (NP (NP (DT (a)) (NN (substrate))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (DT (the)) (NN (efflux)) (NN (transporter))))))))) |ET|
-1  |BT|  (S (NP (SBAR (S (VP (NE-Type-1-drug (NP (NN (Lapatinib)))))))) (VP (VBZ (is)) (NP (NP (DT (a)) (NN (substrate))) (PP (IN (of)) (NP (drug_ENTITY (NP (DT (the)) (NN (efflux)) (NN (transporter)) (NN (P-glycoprotein)))) (PRN (-LRB- (<LB>)) (NP (NP (NN (Pgp))) (, (,)) (NE-Type-2-drug (NP (NN (ABCB1))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (transporter)) (NN (P-glycoprotein)))) (PRN (-LRB- (<LB>)) (NP (NP (NN (Pgp))) (, (,)) (NE-Type-2-drug (NP (NN (ABCB1))))))) |ET|
-1  |BT|  (S (SBAR (S (VP (VP (PP (NP (NE-Type-1-drug (NP (NNS (drugs)))) (SBAR (WHNP (WDT (that))) (S (VP (VBP (inhibit)) (NP (NN (Pgp)))))))))))) (, (,)) (S (S (NP (NP (VBN (increased)) (NNS (concentrations))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (lapatinib))))))))) |ET|
-1  |BT|  (NP (PP (NE-Type-1-drug (NP (NN (lapatinib))))) (PP (IN (with)) (NE-Type-2-drug (NP (NN (capecitabine)))))) |ET|
-1  |BT|  (S (NP (PP (NE-Type-1-drug (NP (NN (lapatinib))))) (PP (IN (with)) (drug_ENTITY (NP (NN (capecitabine)))))) (VP (VBD (did)) (RB (not)) (ADVP (RB (meaningfully))) (VP (VB (alter)) (NP (NP (DT (the)) (NNS (pharmacokinetics))) (PP (IN (of)) (NP (DT (either)) (NN (agent))))) (PRN (-LRB- (<LB>)) (CC (or)) (NP (NE-Type-2-drug (NP (DT (the)) (NNS (metabolites))))))))) |ET|
-1  |BT|  (S (NP (PP (NE-Type-1-drug (NP (NN (lapatinib))))) (PP (IN (with)) (drug_ENTITY (NP (NN (capecitabine)))))) (VP (VBD (did)) (RB (not)) (ADVP (RB (meaningfully))) (VP (VB (alter)) (NP (NP (DT (the)) (NNS (pharmacokinetics))) (PP (IN (of)) (NP (DT (either)) (NN (agent))))) (PRN (-LRB- (<LB>)) (CC (or)) (NP (drug_ENTITY (NP (DT (the)) (NNS (metabolites)))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (capecitabine)))))))))) |ET|
-1  |BT|  (S (NP (PP (NE-Type-1-drug (NP (NN (capecitabine)))))) (VP (VBD (did)) (RB (not)) (ADVP (RB (meaningfully))) (VP (VB (alter)) (NP (NP (DT (the)) (NNS (pharmacokinetics))) (PP (IN (of)) (NP (DT (either)) (NN (agent))))) (PRN (-LRB- (<LB>)) (CC (or)) (NP (NE-Type-2-drug (NP (DT (the)) (NNS (metabolites))))))))) |ET|
-1  |BT|  (S (NP (PP (NE-Type-1-drug (NP (NN (capecitabine)))))) (VP (VBD (did)) (RB (not)) (ADVP (RB (meaningfully))) (VP (VB (alter)) (NP (NP (DT (the)) (NNS (pharmacokinetics))) (PP (IN (of)) (NP (DT (either)) (NN (agent))))) (PRN (-LRB- (<LB>)) (CC (or)) (NP (drug_ENTITY (NP (DT (the)) (NNS (metabolites)))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (capecitabine)))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (metabolites)))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (capecitabine)))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Cholestyramine)))) (CC (and)) (NE-Type-2-drug (NP (NN (Charcoal))))) |ET|
1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (Cholestyramine)))) (CC (and)) (drug_ENTITY (NP (NN (Charcoal)) (NN (Administration))))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (NN (cholestyramine))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (Cholestyramine)))) (CC (and)) (drug_ENTITY (NP (NN (Charcoal)) (NN (Administration))))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (cholestyramine)))) (CC (or)) (NE-Type-2-drug (NP (VBN (activated)) (NN (charcoal))))))) |ET|
-1  |BT|  (S (NP (NP (NE-Type-1-drug (NP (NN (Cholestyramine)))) (CC (and)) (drug_ENTITY (NP (NN (Charcoal)) (NN (Administration))))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (cholestyramine)))) (CC (or)) (drug_ENTITY (NP (VBN (activated)) (NN (charcoal)))))) (PP (IN (in)) (NP (NP (NP (NNS (patients))) (PRN (-LRB- (<LB>)) (NP (NN (n=13))) (-RRB- (<RB>)))) (CC (and)) (NP (NP (NNS (volunteers))) (PRN (-LRB- (<LB>)) (NP (CD (n=96))) (-RRB- (<RB>))))))) (VP (VBD (resulted)) (PP (IN (in)) (NP (NP (DT (a)) (ADJP (ADJP (JJ (rapid))) (CC (and)) (ADJP (JJ (significant)))) (NN (decrease))) (PP (IN (in)) (NP (NN (plasma)) (NP (NP (NN (M1))) (PRN (-LRB- (<LB>)) (NP (NE-Type-2-drug (NP (DT (the)) (JJ (active)) (NN (metabolite))))))))))))) |ET|
-1  |BT|  (S (NP (NP (NE-Type-1-drug (NP (NN (Cholestyramine)))) (CC (and)) (drug_ENTITY (NP (NN (Charcoal)) (NN (Administration))))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (cholestyramine)))) (CC (or)) (drug_ENTITY (NP (VBN (activated)) (NN (charcoal)))))) (PP (IN (in)) (NP (NP (NP (NNS (patients))) (PRN (-LRB- (<LB>)) (NP (NN (n=13))) (-RRB- (<RB>)))) (CC (and)) (NP (NP (NNS (volunteers))) (PRN (-LRB- (<LB>)) (NP (CD (n=96))) (-RRB- (<RB>))))))) (VP (VBD (resulted)) (PP (IN (in)) (NP (NP (DT (a)) (ADJP (ADJP (JJ (rapid))) (CC (and)) (ADJP (JJ (significant)))) (NN (decrease))) (PP (IN (in)) (NP (NN (plasma)) (NP (NP (NN (M1))) (PRN (-LRB- (<LB>)) (NP (drug_ENTITY (NP (DT (the)) (JJ (active)) (NN (metabolite)))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (leflunomide)))))))))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (Charcoal)) (NN (Administration))))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (NN (cholestyramine))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (Charcoal)) (NN (Administration))))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (cholestyramine)))) (CC (or)) (NE-Type-2-drug (NP (VBN (activated)) (NN (charcoal))))))) |ET|
-1  |BT|  (S (NP (NP (NE-Type-1-drug (NP (NN (Charcoal)) (NN (Administration))))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (cholestyramine)))) (CC (or)) (drug_ENTITY (NP (VBN (activated)) (NN (charcoal)))))) (PP (IN (in)) (NP (NP (NP (NNS (patients))) (PRN (-LRB- (<LB>)) (NP (NN (n=13))) (-RRB- (<RB>)))) (CC (and)) (NP (NP (NNS (volunteers))) (PRN (-LRB- (<LB>)) (NP (CD (n=96))) (-RRB- (<RB>))))))) (VP (VBD (resulted)) (PP (IN (in)) (NP (NP (DT (a)) (ADJP (ADJP (JJ (rapid))) (CC (and)) (ADJP (JJ (significant)))) (NN (decrease))) (PP (IN (in)) (NP (NN (plasma)) (NP (NP (NN (M1))) (PRN (-LRB- (<LB>)) (NP (NE-Type-2-drug (NP (DT (the)) (JJ (active)) (NN (metabolite))))))))))))) |ET|
-1  |BT|  (S (NP (NP (NE-Type-1-drug (NP (NN (Charcoal)) (NN (Administration))))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (cholestyramine)))) (CC (or)) (drug_ENTITY (NP (VBN (activated)) (NN (charcoal)))))) (PP (IN (in)) (NP (NP (NP (NNS (patients))) (PRN (-LRB- (<LB>)) (NP (NN (n=13))) (-RRB- (<RB>)))) (CC (and)) (NP (NP (NNS (volunteers))) (PRN (-LRB- (<LB>)) (NP (CD (n=96))) (-RRB- (<RB>))))))) (VP (VBD (resulted)) (PP (IN (in)) (NP (NP (DT (a)) (ADJP (ADJP (JJ (rapid))) (CC (and)) (ADJP (JJ (significant)))) (NN (decrease))) (PP (IN (in)) (NP (NN (plasma)) (NP (NP (NN (M1))) (PRN (-LRB- (<LB>)) (NP (drug_ENTITY (NP (DT (the)) (JJ (active)) (NN (metabolite)))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (leflunomide)))))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (cholestyramine)))) (CC (or)) (NE-Type-2-drug (NP (VBN (activated)) (NN (charcoal))))) |ET|
-1  |BT|  (S (NP (PP (NP (NE-Type-1-drug (NP (NN (cholestyramine)))) (CC (or)) (drug_ENTITY (NP (VBN (activated)) (NN (charcoal)))))) (PP (IN (in)) (NP (NP (NP (NNS (patients))) (PRN (-LRB- (<LB>)) (NP (NN (n=13))) (-RRB- (<RB>)))) (CC (and)) (NP (NP (NNS (volunteers))) (PRN (-LRB- (<LB>)) (NP (CD (n=96))) (-RRB- (<RB>))))))) (VP (VBD (resulted)) (PP (IN (in)) (NP (NP (DT (a)) (ADJP (ADJP (JJ (rapid))) (CC (and)) (ADJP (JJ (significant)))) (NN (decrease))) (PP (IN (in)) (NP (NN (plasma)) (NP (NP (NN (M1))) (PRN (-LRB- (<LB>)) (NP (NE-Type-2-drug (NP (DT (the)) (JJ (active)) (NN (metabolite))))))))))))) |ET|
-1  |BT|  (S (NP (PP (NP (NE-Type-1-drug (NP (NN (cholestyramine)))) (CC (or)) (drug_ENTITY (NP (VBN (activated)) (NN (charcoal)))))) (PP (IN (in)) (NP (NP (NP (NNS (patients))) (PRN (-LRB- (<LB>)) (NP (NN (n=13))) (-RRB- (<RB>)))) (CC (and)) (NP (NP (NNS (volunteers))) (PRN (-LRB- (<LB>)) (NP (CD (n=96))) (-RRB- (<RB>))))))) (VP (VBD (resulted)) (PP (IN (in)) (NP (NP (DT (a)) (ADJP (ADJP (JJ (rapid))) (CC (and)) (ADJP (JJ (significant)))) (NN (decrease))) (PP (IN (in)) (NP (NN (plasma)) (NP (NP (NN (M1))) (PRN (-LRB- (<LB>)) (NP (drug_ENTITY (NP (DT (the)) (JJ (active)) (NN (metabolite)))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (leflunomide)))))))))))))) |ET|
-1  |BT|  (S (NP (PP (NP (NE-Type-1-drug (NP (VBN (activated)) (NN (charcoal)))))) (PP (IN (in)) (NP (NP (NP (NNS (patients))) (PRN (-LRB- (<LB>)) (NP (NN (n=13))) (-RRB- (<RB>)))) (CC (and)) (NP (NP (NNS (volunteers))) (PRN (-LRB- (<LB>)) (NP (CD (n=96))) (-RRB- (<RB>))))))) (VP (VBD (resulted)) (PP (IN (in)) (NP (NP (DT (a)) (ADJP (ADJP (JJ (rapid))) (CC (and)) (ADJP (JJ (significant)))) (NN (decrease))) (PP (IN (in)) (NP (NN (plasma)) (NP (NP (NN (M1))) (PRN (-LRB- (<LB>)) (NP (NE-Type-2-drug (NP (DT (the)) (JJ (active)) (NN (metabolite))))))))))))) |ET|
-1  |BT|  (S (NP (PP (NP (NE-Type-1-drug (NP (VBN (activated)) (NN (charcoal)))))) (PP (IN (in)) (NP (NP (NP (NNS (patients))) (PRN (-LRB- (<LB>)) (NP (NN (n=13))) (-RRB- (<RB>)))) (CC (and)) (NP (NP (NNS (volunteers))) (PRN (-LRB- (<LB>)) (NP (CD (n=96))) (-RRB- (<RB>))))))) (VP (VBD (resulted)) (PP (IN (in)) (NP (NP (DT (a)) (ADJP (ADJP (JJ (rapid))) (CC (and)) (ADJP (JJ (significant)))) (NN (decrease))) (PP (IN (in)) (NP (NN (plasma)) (NP (NP (NN (M1))) (PRN (-LRB- (<LB>)) (NP (drug_ENTITY (NP (DT (the)) (JJ (active)) (NN (metabolite)))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (leflunomide)))))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (JJ (active)) (NN (metabolite)))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (leflunomide)))))) |ET|
1  |BT|  (S (NP (NE-Type-1-drug (NP (NNS (Drugs)))) (VBN (Increased)) (NN (side)) (NNS (effects))) (VP (MD (may)) (VP (VB (occur)) (SBAR (WHADVP (WRB (when))) (S (NE-Type-2-drug (NP (NN (leflunomide))))))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NN (leflunomide)) (NN (treatment)))) (VP (VBZ (is)) (VP (VBN (followed)) (PP (IN (by)) (NE-Type-2-drug (NP (JJ (such)) (NNS (drugs)))))))) |ET|
1  |BT|  (NP (PP (NE-Type-1-drug (NP (NN (ARAVA))))) (PP (IN (with)) (NE-Type-2-drug (NP (NN (methotrexate)))))) |ET|
-1  |BT|  (S (PP (NP (PP (NE-Type-1-drug (NP (NN (ARAVA))))) (PP (IN (with)) (drug_ENTITY (NP (NN (methotrexate))))))) (, (,)) (NP (NP (DT (a)) (ADJP (CD (2-)) (TO (to)) (JJ (3-fold))) (NN (elevation))) (PP (IN (in)) (NE-Type-2-drug (NP (NN (liver)) (NNS (enzymes))))))) |ET|
-1  |BT|  (S (PP (NP (PP (NE-Type-1-drug (NP (NN (methotrexate))))))) (, (,)) (NP (NP (DT (a)) (ADJP (CD (2-)) (TO (to)) (JJ (3-fold))) (NN (elevation))) (PP (IN (in)) (NE-Type-2-drug (NP (NN (liver)) (NNS (enzymes))))))) |ET|
-1  |BT|  (NP (NP (PP (NP (PP (NE-Type-1-drug (NP (NNS (drugs)))))))) (CC (and)) (NP (NP (CD (3))) (PP (IN (after)) (NP (NP (NN (discontinuation))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (leflunomide))))))))) |ET|
-1  |BT|  (NP (NP (PP (NP (PP (NE-Type-1-drug (NP (NNS (drugs)))))))) (CC (and)) (NP (NP (CD (3))) (PP (IN (after)) (NP (NP (NN (discontinuation))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (leflunomide))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (NSAIDs)))) (: (:)) (S (PP (IN (In)) (NP (ADJP (FW (in)) (FW (vitro))) (NNS (studies)))) (, (,)) (NP (NN (M1))) (VP (VBD (was)) (VP (VBN (shown)) (S (VP (TO (to)) (VP (VB (cause)) (NP (NP (NNS (increases))) (VP (VBG (ranging)) (PP (IN (from)) (NP (QP (CD (13)) (CC (-)) (CD (50))) (NN (%)))) (PP (IN (in)) (NP (NP (DT (the)) (JJ (free)) (NN (fraction))) (PP (IN (of)) (NP (NP (NE-Type-2-drug (NP (NN (diclofenac)))))))))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (NSAIDs)))) (: (:)) (S (PP (IN (In)) (NP (ADJP (FW (in)) (FW (vitro))) (NNS (studies)))) (, (,)) (NP (NN (M1))) (VP (VBD (was)) (VP (VBN (shown)) (S (VP (TO (to)) (VP (VB (cause)) (NP (NP (NNS (increases))) (VP (VBG (ranging)) (PP (IN (from)) (NP (QP (CD (13)) (CC (-)) (CD (50))) (NN (%)))) (PP (IN (in)) (NP (NP (DT (the)) (JJ (free)) (NN (fraction))) (PP (IN (of)) (NP (NP (drug_ENTITY (NP (NN (diclofenac)))) (CC (and)) (NE-Type-2-drug (NP (NN (ibuprofen)))))))))))))))))) |ET|
1  |BT|  (NP (NE-Type-1-drug (NP (NN (diclofenac)))) (CC (and)) (NE-Type-2-drug (NP (NN (ibuprofen))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Tolbutamide)))) (: (:)) (S (PP (IN (In)) (NP (ADJP (FW (in)) (FW (vitro))) (NNS (studies)))) (, (,)) (NP (NN (M1))) (VP (VBD (was)) (VP (VBN (shown)) (S (VP (TO (to)) (VP (VB (cause)) (NP (NP (NNS (increases))) (VP (VBG (ranging)) (PP (IN (from)) (NP (QP (CD (13)) (CC (-)) (CD (50))) (NN (%)))) (PP (IN (in)) (NP (NP (DT (the)) (JJ (free)) (NN (fraction))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (tolbutamide)))))))))))))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NN (Rifampin)))) (VP (VBG (Following)) (NP (NP (JJ (concomitant)) (NN (administration))) (PP (IN (of)) (NP (NP (DT (a)) (JJ (single)) (NN (dose))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (ARAVA)))))))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NN (Rifampin)))) (VP (VBG (Following)) (NP (NP (JJ (concomitant)) (NN (administration))) (PP (IN (of)) (NP (NP (DT (a)) (JJ (single)) (NN (dose))) (PP (IN (of)) (drug_ENTITY (NP (NN (ARAVA)))))))) (PP (TO (to)) (NP (NP (NNS (subjects))) (VP (VBG (receiving)) (NP (NP (JJ (multiple)) (NNS (doses))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (rifampin))))))))))) |ET|
-1  |BT|  (S (S (NE-Type-1-drug (NP (NN (Rifampin)))) (VP (VBG (Following)) (NP (NP (JJ (concomitant)) (NN (administration))) (PP (IN (of)) (NP (NP (DT (a)) (JJ (single)) (NN (dose))) (PP (IN (of)) (drug_ENTITY (NP (NN (ARAVA)))))))) (PP (TO (to)) (NP (NP (NNS (subjects))) (VP (VBG (receiving)) (NP (NP (JJ (multiple)) (NNS (doses))) (PP (IN (of)) (drug_ENTITY (NP (NN (rifampin))))))))))) (, (,)) (S (NP (NN (M1)) (NN (peak)) (NNS (levels))) (VP (VBD (were)) (VP (VBN (increased)) (PRN (-LRB- (<LB>)) (NP (CD (~40)) (NN (%))) (-RRB- (<RB>))) (PP (IN (over)) (NP (NP (DT (those))) (VP (VBN (seen)) (SBAR (WHADVP (WRB (when))) (S (NE-Type-2-drug (NP (NN (ARAVA))))))))))))) |ET|
1  |BT|  (VP (NP (PP (NP (PP (NE-Type-1-drug (NP (NN (ARAVA)))))))) (PP (TO (to)) (NP (NP (NNS (subjects))) (VP (VBG (receiving)) (NP (NP (JJ (multiple)) (NNS (doses))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (rifampin)))))))))) |ET|
-1  |BT|  (S (S (VP (NP (PP (NP (PP (NE-Type-1-drug (NP (NN (ARAVA)))))))) (PP (TO (to)) (NP (NP (NNS (subjects))) (VP (VBG (receiving)) (NP (NP (JJ (multiple)) (NNS (doses))) (PP (IN (of)) (drug_ENTITY (NP (NN (rifampin))))))))))) (, (,)) (S (NP (NN (M1)) (NN (peak)) (NNS (levels))) (VP (VBD (were)) (VP (VBN (increased)) (PRN (-LRB- (<LB>)) (NP (CD (~40)) (NN (%))) (-RRB- (<RB>))) (PP (IN (over)) (NP (NP (DT (those))) (VP (VBN (seen)) (SBAR (WHADVP (WRB (when))) (S (NE-Type-2-drug (NP (NN (ARAVA))))))))))))) |ET|
-1  |BT|  (S (S (VP (PP (NP (VP (NP (PP (NE-Type-1-drug (NP (NN (rifampin))))))))))) (, (,)) (S (NP (NN (M1)) (NN (peak)) (NNS (levels))) (VP (VBD (were)) (VP (VBN (increased)) (PRN (-LRB- (<LB>)) (NP (CD (~40)) (NN (%))) (-RRB- (<RB>))) (PP (IN (over)) (NP (NP (DT (those))) (VP (VBN (seen)) (SBAR (WHADVP (WRB (when))) (S (NE-Type-2-drug (NP (NN (ARAVA))))))))))))) |ET|
-1  |BT|  (S (PP (PP (NP (PP (NE-Type-1-drug (NP (NN (ARAVA)) (NNS (levels))))) (S (VP (TO (to)) (VP (VBP (continue)) (S (VP (TO (to)) (VP (VB (increase)) (PP (IN (with)) (NP (JJ (multiple)) (NN (dosing))))))))))))) (, (,)) (NP (NN (caution))) (VP (MD (should)) (VP (VB (be)) (VP (VBN (used)) (SBAR (IN (if)) (S (NP (NNS (patients))) (VP (VBP (are)) (S (VP (TO (to)) (VP (VB (be)) (VP (VBG (receiving)) (NP (CC (both)) (NE-Type-2-drug (NP (NN (ARAVA)))))))))))))))) |ET|
-1  |BT|  (S (PP (PP (NP (PP (NE-Type-1-drug (NP (NN (ARAVA)) (NNS (levels))))) (S (VP (TO (to)) (VP (VBP (continue)) (S (VP (TO (to)) (VP (VB (increase)) (PP (IN (with)) (NP (JJ (multiple)) (NN (dosing))))))))))))) (, (,)) (NP (NN (caution))) (VP (MD (should)) (VP (VB (be)) (VP (VBN (used)) (SBAR (IN (if)) (S (NP (NNS (patients))) (VP (VBP (are)) (S (VP (TO (to)) (VP (VB (be)) (VP (VBG (receiving)) (NP (CC (both)) (drug_ENTITY (NP (NN (ARAVA)))) (CC (and)) (NE-Type-2-drug (NP (NN (rifampin)))))))))))))))) |ET|
1  |BT|  (NP (NE-Type-1-drug (NP (NN (ARAVA)))) (CC (and)) (NE-Type-2-drug (NP (NN (rifampin))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (JJ (Warfarin)) (VBN (Increased)) (NN (INR)))) (PRN (-LRB- (<LB>)) (NP (NP (NNP (International))) (VBN (Normalized)) (NN (Ratio))) (-RRB- (<RB>)))) (SBAR (WHADVP (WRB (when))) (S (NP (NE-Type-2-drug (NP (NN (ARAVA)))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (JJ (Warfarin)) (VBN (Increased)) (NN (INR)))) (PRN (-LRB- (<LB>)) (NP (NP (NNP (International))) (VBN (Normalized)) (NN (Ratio))) (-RRB- (<RB>)))) (SBAR (WHADVP (WRB (when))) (S (NP (drug_ENTITY (NP (NN (ARAVA)))) (CC (and)) (NE-Type-2-drug (NP (NN (warfarin)))))))) |ET|
1  |BT|  (NP (NE-Type-1-drug (NP (NN (ARAVA)))) (CC (and)) (NE-Type-2-drug (NP (NN (warfarin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (cimetidine)))) (CC (and)) (NE-Type-2-drug (NP (NN (warfarin))))) |ET|
-1  |BT|  (S (NP (PP (NP (NE-Type-1-drug (NP (NN (cimetidine)))) (CC (and)) (drug_ENTITY (NP (NN (warfarin))))))) (VP (VBD (indicated)) (SBAR (IN (that)) (S (NP (NP (DT (the)) (NN (coadministration))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (Femara)))))))))) |ET|
-1  |BT|  (S (NP (PP (NP (NE-Type-1-drug (NP (NN (cimetidine)))) (CC (and)) (drug_ENTITY (NP (NN (warfarin))))))) (VP (VBD (indicated)) (SBAR (IN (that)) (S (NP (NP (DT (the)) (NN (coadministration))) (PP (IN (of)) (drug_ENTITY (NP (NN (Femara))))) (PP (IN (with)) (NE-Type-2-drug (NP (DT (these)) (NNS (drugs)))))))))) |ET|
-1  |BT|  (S (NP (PP (NP (NE-Type-1-drug (NP (NN (warfarin))))))) (VP (VBD (indicated)) (SBAR (IN (that)) (S (NP (NP (DT (the)) (NN (coadministration))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (Femara)))))))))) |ET|
-1  |BT|  (S (NP (PP (NP (NE-Type-1-drug (NP (NN (warfarin))))))) (VP (VBD (indicated)) (SBAR (IN (that)) (S (NP (NP (DT (the)) (NN (coadministration))) (PP (IN (of)) (drug_ENTITY (NP (NN (Femara))))) (PP (IN (with)) (NE-Type-2-drug (NP (DT (these)) (NNS (drugs)))))))))) |ET|
-1  |BT|  (NP (PP (NE-Type-1-drug (NP (NN (Femara))))) (PP (IN (with)) (NE-Type-2-drug (NP (DT (these)) (NNS (drugs)))))) |ET|
1  |BT|  (NP (NP (PP (NE-Type-1-drug (NP (NN (Femara)))))) (CC (and)) (NP (NE-Type-2-drug (NP (NN (tamoxifen)) (CD (20)) (NN (mg)))))) |ET|
-1  |BT|  (S (NP (NP (PP (NE-Type-1-drug (NP (NN (Femara)))))) (CC (and)) (NP (drug_ENTITY (NP (NN (tamoxifen)) (CD (20)) (NN (mg)))) (ADVP (RB (daily))))) (VP (VBD (resulted)) (PP (IN (in)) (NP (NP (DT (a)) (NN (reduction))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (letrozole))))))))) |ET|
-1  |BT|  (S (NP (NP (NE-Type-1-drug (NP (NN (tamoxifen)) (CD (20)) (NN (mg)))) (ADVP (RB (daily))))) (VP (VBD (resulted)) (PP (IN (in)) (NP (NP (DT (a)) (NN (reduction))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (letrozole))))))))) |ET|
-1  |BT|  (S (NP (NE-Type-1-drug (NP (JJ (Folic)) (NN (acid)))) (PP (IN (in)) (NP (JJ (large)) (NNS (amounts))))) (VP (MD (may)) (VP (VP (VB (counteract)) (NP (NE-Type-2-drug (NP (DT (the)) (JJ (antiepileptic))))))))) |ET|
1  |BT|  (S (NP (NE-Type-1-drug (NP (JJ (Folic)) (NN (acid)))) (PP (IN (in)) (NP (JJ (large)) (NNS (amounts))))) (VP (MD (may)) (VP (VP (VB (counteract)) (NP (drug_ENTITY (NP (DT (the)) (JJ (antiepileptic)) (NN (effect)))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (NN (phenobarbital))))))))))) |ET|
-1  |BT|  (S (NP (NE-Type-1-drug (NP (JJ (Folic)) (NN (acid)))) (PP (IN (in)) (NP (JJ (large)) (NNS (amounts))))) (VP (MD (may)) (VP (VP (VB (counteract)) (NP (drug_ENTITY (NP (DT (the)) (JJ (antiepileptic)) (NN (effect)))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (phenobarbital)))) (, (,)) (NE-Type-2-drug (NP (NN (phenytoin))))))))))) |ET|
1  |BT|  (S (NP (NE-Type-1-drug (NP (JJ (Folic)) (NN (acid)))) (PP (IN (in)) (NP (JJ (large)) (NNS (amounts))))) (VP (MD (may)) (VP (VP (VB (counteract)) (NP (drug_ENTITY (NP (DT (the)) (JJ (antiepileptic)) (NN (effect)))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (phenobarbital)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (CC (and)) (NE-Type-2-drug (NP (NN (primidone))))))))))) |ET|
-1  |BT|  (S (NP (NE-Type-1-drug (NP (JJ (Folic)) (NN (acid)))) (PP (IN (in)) (NP (JJ (large)) (NNS (amounts))))) (VP (MD (may)) (VP (VP (VB (counteract)) (NP (drug_ENTITY (NP (DT (the)) (JJ (antiepileptic)) (NN (effect)))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (phenobarbital)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (CC (and)) (drug_ENTITY (NP (NN (primidone)))))))) (, (,)) (CC (and)) (VP (VB (increase)) (NP (NP (DT (the)) (NN (frequency))) (PP (IN (of)) (NP (NNS (seizures)))) (PP (IN (in)) (NE-Type-2-drug (NP (JJ (susceptible)) (JJ (pediatric)))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (JJ (antiepileptic)) (NN (effect)))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (NN (phenobarbital))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (JJ (antiepileptic)) (NN (effect)))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (phenobarbital)))) (, (,)) (NE-Type-2-drug (NP (NN (phenytoin))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (JJ (antiepileptic)) (NN (effect)))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (phenobarbital)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (CC (and)) (NE-Type-2-drug (NP (NN (primidone))))))) |ET|
-1  |BT|  (VP (VP (NP (NE-Type-1-drug (NP (JJ (antiepileptic)) (NN (effect)))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (phenobarbital)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (CC (and)) (drug_ENTITY (NP (NN (primidone)))))))) (, (,)) (CC (and)) (VP (VB (increase)) (NP (NP (DT (the)) (NN (frequency))) (PP (IN (of)) (NP (NNS (seizures)))) (PP (IN (in)) (NE-Type-2-drug (NP (JJ (susceptible)) (JJ (pediatric)))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (phenobarbital)))) (, (,)) (NE-Type-2-drug (NP (NN (phenytoin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (phenobarbital)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (CC (and)) (NE-Type-2-drug (NP (NN (primidone))))) |ET|
-1  |BT|  (VP (VP (NP (PP (NP (NE-Type-1-drug (NP (NN (phenobarbital)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (CC (and)) (drug_ENTITY (NP (NN (primidone)))))))) (, (,)) (CC (and)) (VP (VB (increase)) (NP (NP (DT (the)) (NN (frequency))) (PP (IN (of)) (NP (NNS (seizures)))) (PP (IN (in)) (NE-Type-2-drug (NP (JJ (susceptible)) (JJ (pediatric)))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (phenytoin)))) (CC (and)) (NE-Type-2-drug (NP (NN (primidone))))) |ET|
-1  |BT|  (VP (VP (NP (PP (NP (NE-Type-1-drug (NP (NN (phenytoin)))) (CC (and)) (drug_ENTITY (NP (NN (primidone)))))))) (, (,)) (CC (and)) (VP (VB (increase)) (NP (NP (DT (the)) (NN (frequency))) (PP (IN (of)) (NP (NNS (seizures)))) (PP (IN (in)) (NE-Type-2-drug (NP (JJ (susceptible)) (JJ (pediatric)))))))) |ET|
-1  |BT|  (VP (VP (NP (PP (NP (NE-Type-1-drug (NP (NN (primidone)))))))) (, (,)) (CC (and)) (VP (VB (increase)) (NP (NP (DT (the)) (NN (frequency))) (PP (IN (of)) (NP (NNS (seizures)))) (PP (IN (in)) (NE-Type-2-drug (NP (JJ (susceptible)) (JJ (pediatric)))))))) |ET|
-1  |BT|  (S (NP (PP (NE-Type-1-drug (NP (NN (leucovorin)))))) (VP (VP (VBP (enter)) (NP (DT (the)) (NN (CSF))) (PP (ADVP (RB (primarily))) (IN (as)) (NP (NN (5-methyltetrahydro-folate))))) (CC (and)) (, (,)) (PP (IN (in)) (NP (NNS (humans)))) (, (,)) (VP (VBP (remain)) (NP (NP (QP (CD (1)) (TO (to)) (CD (3))) (NNS (orders))) (PP (IN (of)) (NP (NN (magnitude)))) (ADJP (JJR (lower)) (PP (IN (than)) (NP (NE-Type-2-drug (NP (DT (the)) (JJ (usual)) (NN (methotrexate))))))))))) |ET|
1  |BT|  (S (NP (PP (NE-Type-1-drug (NP (NN (leucovorin)))))) (VP (MD (may)) (VP (VB (reduce)) (NP (NP (DT (the)) (NN (efficacy))) (PP (IN (of)) (NE-Type-2-drug (NP (ADJP (RB (intrathecally)) (VBN (administered))) (NN (methotrexate))))))))) |ET|
1  |BT|  (S (NE-Type-1-drug (NP (NN (Leucovorin)))) (VP (MD (may)) (VP (VB (enhance)) (NP (NP (DT (the)) (NN (toxicity))) (PP (IN (of)) (NE-Type-2-drug (NP (CD (5-)) (NN (fluorouracil))))))))) |ET|
-1  |BT|  (S (SBAR (S (NP (NE-Type-1-drug (NP (NN (BETAGAN)))) (VP (VBN (used)) (ADVP (RB (alone))))) (VP (VBZ (has)) (NP (NP (ADJP (JJ (little)))) (CC (or)) (NP (NP (DT (no)) (NN (effect))) (PP (IN (on)) (NP (NN (pupil)) (NN (size))))))))) (, (,)) (NP (NP (NNS (mydriasis))) (VP (VBG (resulting)) (PP (IN (from)) (NP (NP (JJ (concomitant)) (NN (therapy))) (PP (IN (with)) (NP (NE-Type-2-drug (NP (NN (BETAGAN))))))))))) |ET|
-1  |BT|  (S (SBAR (S (NP (NE-Type-1-drug (NP (NN (BETAGAN)))) (VP (VBN (used)) (ADVP (RB (alone))))) (VP (VBZ (has)) (NP (NP (ADJP (JJ (little)))) (CC (or)) (NP (NP (DT (no)) (NN (effect))) (PP (IN (on)) (NP (NN (pupil)) (NN (size))))))))) (, (,)) (NP (NP (NNS (mydriasis))) (VP (VBG (resulting)) (PP (IN (from)) (NP (NP (JJ (concomitant)) (NN (therapy))) (PP (IN (with)) (NP (drug_ENTITY (NP (NN (BETAGAN)))) (CC (and)) (NE-Type-2-drug (NP (NN (epinephrine))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (BETAGAN)))) (CC (and)) (NE-Type-2-drug (NP (NN (epinephrine))))) |ET|
1  |BT|  (S (NE-Type-1-drug (NP (NN (beta-blocker)))) (VP (VBZ (is)) (VP (VBN (administered)) (PP (TO (to)) (NP (NP (NNS (patients))) (VP (VBG (receiving)) (NP (NE-Type-2-drug (NP (JJ (catecholamine-depleting)) (NNS (drugs))))))))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NN (beta-blocker)))) (VP (VBZ (is)) (VP (VBN (administered)) (PP (TO (to)) (NP (NP (NNS (patients))) (VP (VBG (receiving)) (NP (drug_ENTITY (NP (JJ (catecholamine-depleting)) (NNS (drugs)))) (PP (JJ (such)) (IN (as)) (NE-Type-2-drug (NP (NN (reserpine)))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (drugs)))) (PP (JJ (such)) (IN (as)) (NE-Type-2-drug (NP (NN (reserpine)))))) |ET|
1  |BT|  (VP (NE-Type-1-drug (NP (JJ (beta-adrenergic)) (NN (blocking)) (NNS (agents)))) (PP (IN (along)) (PP (IN (with)) (NE-Type-2-drug (NP (ADJP (CC (either)) (ADJP (JJ (oral))) (CC (or)) (ADJP (JJ (intravenous)))) (NN (calcium)) (NN (antagonist))))))) |ET|
1  |BT|  (NP (NE-Type-1-drug (NP (JJ (beta-adrenergic)) (NN (blocking)) (NNS (agents)))) (PP (IN (with)) (NP (NE-Type-2-drug (NP (NN (digitalis))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (JJ (beta-adrenergic)) (NN (blocking)) (NNS (agents)))) (PP (IN (with)) (NP (drug_ENTITY (NP (NN (digitalis)))) (CC (and)) (NE-Type-2-drug (NP (NN (calcium)) (NN (antagonist))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (digitalis)))) (CC (and)) (NE-Type-2-drug (NP (NN (calcium)) (NN (antagonist))))) |ET|
1  |BT|  (NP (NE-Type-1-drug (NP (JJ (Phenothiazine)) (JJ (-related)) (NNS (compounds)))) (CC (and)) (NE-Type-2-drug (NP (JJ (beta-adrenergic)) (NN (blocking)) (NNS (agents))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (hydrochlorothiazide)))) (, (,)) (NE-Type-2-drug (NP (NN (digoxin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (hydrochlorothiazide)))) (, (,)) (drug_ENTITY (NP (NN (digoxin)))) (, (,)) (NE-Type-2-drug (NP (NN (warfarin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (hydrochlorothiazide)))) (, (,)) (drug_ENTITY (NP (NN (digoxin)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (NE-Type-2-drug (NP (NN (cimetidine))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (hydrochlorothiazide)))) (, (,)) (drug_ENTITY (NP (NN (digoxin)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (drug_ENTITY (NP (NN (cimetidine)))) (CC (and)) (NE-Type-2-drug (NP (NN (phenobarbital))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (digoxin)))) (, (,)) (NE-Type-2-drug (NP (NN (warfarin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (digoxin)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (NE-Type-2-drug (NP (NN (cimetidine))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (digoxin)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (drug_ENTITY (NP (NN (cimetidine)))) (CC (and)) (NE-Type-2-drug (NP (NN (phenobarbital))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (warfarin)))) (, (,)) (NE-Type-2-drug (NP (NN (cimetidine))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (warfarin)))) (, (,)) (drug_ENTITY (NP (NN (cimetidine)))) (CC (and)) (NE-Type-2-drug (NP (NN (phenobarbital))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (cimetidine)))) (CC (and)) (NE-Type-2-drug (NP (NN (phenobarbital))))) |ET|
1  |BT|  (S (NP (NE-Type-1-drug (NP (NN (Rifampin)))) (, (,)) (NP (NP (DT (an)) (NN (inducer))) (PP (IN (of)) (NP (NN (drug)) (NN (metabolism))))) (, (,))) (VP (VBD (decreased)) (NP (NP (DT (the)) (NNS (concentrations))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (NN (losartan))))))))) |ET|
-1  |BT|  (S (NP (NE-Type-1-drug (NP (NN (Rifampin)))) (, (,)) (NP (NP (DT (an)) (NN (inducer))) (PP (IN (of)) (NP (NN (drug)) (NN (metabolism))))) (, (,))) (VP (VBD (decreased)) (NP (NP (DT (the)) (NNS (concentrations))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (losartan)))) (CC (and)) (NE-Type-2-drug (NP (PRP$ (its)) (JJ (active)) (NN (metabolite))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (losartan)))) (CC (and)) (NE-Type-2-drug (NP (PRP$ (its)) (JJ (active)) (NN (metabolite))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NN (Ketoconazole)))) (VP (VBD (did)) (RB (not)) (VP (VB (affect)) (NP (NP (DT (the)) (NN (conversion))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (losartan))))))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NN (Ketoconazole)))) (VP (VBD (did)) (RB (not)) (VP (VB (affect)) (NP (NP (DT (the)) (NN (conversion))) (PP (IN (of)) (drug_ENTITY (NP (NN (losartan))))) (PP (TO (to)) (NP (NE-Type-2-drug (NP (DT (the)) (JJ (active)) (NN (metabolite)))))))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NN (Ketoconazole)))) (VP (VBD (did)) (RB (not)) (VP (VB (affect)) (NP (NP (DT (the)) (NN (conversion))) (PP (IN (of)) (drug_ENTITY (NP (NN (losartan))))) (PP (TO (to)) (NP (drug_ENTITY (NP (DT (the)) (JJ (active)) (NN (metabolite)))) (PP (IN (after)) (NP (NP (JJ (intravenous)) (NN (administration))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (losartan))))))))))))) |ET|
-1  |BT|  (S (S (NE-Type-1-drug (NP (NN (Ketoconazole)))) (VP (VBD (did)) (RB (not)) (VP (VB (affect)) (NP (NP (DT (the)) (NN (conversion))) (PP (IN (of)) (drug_ENTITY (NP (NN (losartan))))) (PP (TO (to)) (NP (drug_ENTITY (NP (DT (the)) (JJ (active)) (NN (metabolite)))) (PP (IN (after)) (NP (NP (JJ (intravenous)) (NN (administration))) (PP (IN (of)) (drug_ENTITY (NP (NN (losartan))))))))))))) (, (,)) (CC (and)) (S (NE-Type-2-drug (NP (NN (erythromycin)))))) |ET|
-1  |BT|  (NP (PP (NE-Type-1-drug (NP (NN (losartan))))) (PP (TO (to)) (NP (NE-Type-2-drug (NP (DT (the)) (JJ (active)) (NN (metabolite))))))) |ET|
-1  |BT|  (NP (PP (NE-Type-1-drug (NP (NN (losartan))))) (PP (TO (to)) (NP (drug_ENTITY (NP (DT (the)) (JJ (active)) (NN (metabolite)))) (PP (IN (after)) (NP (NP (JJ (intravenous)) (NN (administration))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (losartan)))))))))) |ET|
-1  |BT|  (S (S (VP (VP (NP (PP (NE-Type-1-drug (NP (NN (losartan))))) (PP (TO (to)) (NP (drug_ENTITY (NP (DT (the)) (JJ (active)) (NN (metabolite)))) (PP (IN (after)) (NP (NP (JJ (intravenous)) (NN (administration))) (PP (IN (of)) (drug_ENTITY (NP (NN (losartan))))))))))))) (, (,)) (CC (and)) (S (NE-Type-2-drug (NP (NN (erythromycin)))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (JJ (active)) (NN (metabolite)))) (PP (IN (after)) (NP (NP (JJ (intravenous)) (NN (administration))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (losartan)))))))) |ET|
-1  |BT|  (S (S (VP (VP (NP (PP (NP (NE-Type-1-drug (NP (JJ (active)) (NN (metabolite)))) (PP (IN (after)) (NP (NP (JJ (intravenous)) (NN (administration))) (PP (IN (of)) (drug_ENTITY (NP (NN (losartan))))))))))))) (, (,)) (CC (and)) (S (NE-Type-2-drug (NP (NN (erythromycin)))))) |ET|
-1  |BT|  (S (S (VP (VP (NP (PP (NP (PP (NP (PP (NE-Type-1-drug (NP (NN (losartan))))))))))))) (, (,)) (CC (and)) (S (NE-Type-2-drug (NP (NN (erythromycin)))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Fluconazole)))) (, (,)) (NP (NP (DT (an)) (NN (inhibitor))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (P450))))))) |ET|
1  |BT|  (S (NP (NE-Type-1-drug (NP (NN (Fluconazole)))) (, (,)) (NP (NP (DT (an)) (NN (inhibitor))) (PP (IN (of)) (drug_ENTITY (NP (NN (P450)) (NNS (2C9)))))) (, (,))) (VP (VP (VBD (decreased)) (NE-Type-2-drug (NP (JJ (active)) (NN (metabolite))))))) |ET|
-1  |BT|  (S (NP (NE-Type-1-drug (NP (NN (Fluconazole)))) (, (,)) (NP (NP (DT (an)) (NN (inhibitor))) (PP (IN (of)) (drug_ENTITY (NP (NN (P450)) (NNS (2C9)))))) (, (,))) (VP (VP (VBD (decreased)) (drug_ENTITY (NP (JJ (active)) (NN (metabolite)) (NN (concentration))))) (CC (and)) (VP (VBD (increased)) (NE-Type-2-drug (NP (NN (losartan))))))) |ET|
-1  |BT|  (S (NP (NP (PP (NE-Type-1-drug (NP (NN (P450)) (NNS (2C9)))))) (, (,))) (VP (VP (VBD (decreased)) (NE-Type-2-drug (NP (JJ (active)) (NN (metabolite))))))) |ET|
-1  |BT|  (S (NP (NP (PP (NE-Type-1-drug (NP (NN (P450)) (NNS (2C9)))))) (, (,))) (VP (VP (VBD (decreased)) (drug_ENTITY (NP (JJ (active)) (NN (metabolite)) (NN (concentration))))) (CC (and)) (VP (VBD (increased)) (NE-Type-2-drug (NP (NN (losartan))))))) |ET|
-1  |BT|  (VP (VP (NE-Type-1-drug (NP (JJ (active)) (NN (metabolite)) (NN (concentration))))) (CC (and)) (VP (VBD (increased)) (NE-Type-2-drug (NP (NN (losartan)))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (losartan)))) (CC (and)) (NP (NP (NNS (inhibitors))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (P450))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (losartan)))) (PP (TO (to)) (NE-Type-2-drug (NP (JJ (active)) (NN (metabolite)))))) |ET|
-1  |BT|  (S (NP (SBAR (S (VP (VP (NP (NE-Type-1-drug (NP (NN (losartan)))) (PP (TO (to)) (drug_ENTITY (NP (JJ (active)) (NN (metabolite))))))))))) (VP (VBP (have)) (VP (VBN (been)) (VP (VBN (shown)) (S (VP (TO (to)) (VP (VB (have)) (NP (DT (a)) (ADJP (ADJP (JJ (specific))) (, (,)) (ADJP (JJ (rare)))) (NN (defect))) (PP (IN (in)) (NE-Type-2-drug (NP (NN (cytochrome)) (NN (P450)) (NN (2C9)))))))))))) |ET|
-1  |BT|  (S (NP (SBAR (S (VP (VP (NP (PP (NE-Type-1-drug (NP (JJ (active)) (NN (metabolite))))))))))) (VP (VBP (have)) (VP (VBN (been)) (VP (VBN (shown)) (S (VP (TO (to)) (VP (VB (have)) (NP (DT (a)) (ADJP (ADJP (JJ (specific))) (, (,)) (ADJP (JJ (rare)))) (NN (defect))) (PP (IN (in)) (NE-Type-2-drug (NP (NN (cytochrome)) (NN (P450)) (NN (2C9)))))))))))) |ET|
-1  |BT|  (NP (PP (NE-Type-1-drug (NP (NN (losartan))))) (PP (TO (to)) (NE-Type-2-drug (NP (PRP$ (its)) (JJ (active)) (NN (metabolite)))))) |ET|
1  |BT|  (S (NP (PP (NE-Type-1-drug (NP (NN (losartan))))) (PP (TO (to)) (drug_ENTITY (NP (PRP$ (its)) (JJ (active)) (NN (metabolite)))))) (VP (VP (VBZ (is)) (VP (VBN (mediated)) (ADVP (RB (primarily))) (PP (IN (by)) (NE-Type-2-drug (NP (NN (P450))))))))) |ET|
-1  |BT|  (S (NP (PP (NE-Type-1-drug (NP (NN (losartan))))) (PP (TO (to)) (drug_ENTITY (NP (PRP$ (its)) (JJ (active)) (NN (metabolite)))))) (VP (VP (VBZ (is)) (VP (VBN (mediated)) (ADVP (RB (primarily))) (PP (IN (by)) (drug_ENTITY (NP (NN (P450)) (NN (2C9))))))) (CC (and)) (VP (ADVP (RB (not))) (NE-Type-2-drug (NP (NN (P450)) (NN (3A4))))))) |ET|
-1  |BT|  (S (NP (PP (NE-Type-1-drug (NP (JJ (active)) (NN (metabolite)))))) (VP (VP (VBZ (is)) (VP (VBN (mediated)) (ADVP (RB (primarily))) (PP (IN (by)) (NE-Type-2-drug (NP (NN (P450))))))))) |ET|
-1  |BT|  (S (NP (PP (NE-Type-1-drug (NP (JJ (active)) (NN (metabolite)))))) (VP (VP (VBZ (is)) (VP (VBN (mediated)) (ADVP (RB (primarily))) (PP (IN (by)) (drug_ENTITY (NP (NN (P450)) (NN (2C9))))))) (CC (and)) (VP (ADVP (RB (not))) (NE-Type-2-drug (NP (NN (P450)) (NN (3A4))))))) |ET|
-1  |BT|  (VP (VP (VP (PP (NE-Type-1-drug (NP (NN (P450)) (NN (2C9))))))) (CC (and)) (VP (ADVP (RB (not))) (NE-Type-2-drug (NP (NN (P450)) (NN (3A4)))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (drugs)))) (SBAR (WHNP (WDT (that))) (S (VP (VBP (block)) (NP (NE-Type-2-drug (NP (NN (angiotensin)) (CD (II))))))))) |ET|
-1  |BT|  (S (PP (PP (NP (NE-Type-1-drug (NP (NNS (drugs)))) (SBAR (WHNP (WDT (that))) (S (VP (VBP (block)) (NP (drug_ENTITY (NP (NN (angiotensin)) (CD (II)))) (CC (or)) (NP (PRP$ (its)) (NNS (effects)))))))))) (, (,)) (NP (NP (JJ (concomitant)) (NN (use))) (PP (IN (of)) (NP (NP (NE-Type-2-drug (NP (JJ (potassium-sparing)) (NNS (diuretics))))))))) |ET|
-1  |BT|  (S (PP (PP (NP (NE-Type-1-drug (NP (NNS (drugs)))) (SBAR (WHNP (WDT (that))) (S (VP (VBP (block)) (NP (drug_ENTITY (NP (NN (angiotensin)) (CD (II)))) (CC (or)) (NP (PRP$ (its)) (NNS (effects)))))))))) (, (,)) (NP (NP (JJ (concomitant)) (NN (use))) (PP (IN (of)) (NP (NP (drug_ENTITY (NP (JJ (potassium-sparing)) (NNS (diuretics)))) (PRN (-LRB- (<LB>)) (PP (FW (e.g.)) (, (,)) (NP (NE-Type-2-drug (NP (NN (spironolactone)))))))))))) |ET|
-1  |BT|  (S (PP (PP (NP (NE-Type-1-drug (NP (NNS (drugs)))) (SBAR (WHNP (WDT (that))) (S (VP (VBP (block)) (NP (drug_ENTITY (NP (NN (angiotensin)) (CD (II)))) (CC (or)) (NP (PRP$ (its)) (NNS (effects)))))))))) (, (,)) (NP (NP (JJ (concomitant)) (NN (use))) (PP (IN (of)) (NP (NP (drug_ENTITY (NP (JJ (potassium-sparing)) (NNS (diuretics)))) (PRN (-LRB- (<LB>)) (PP (FW (e.g.)) (, (,)) (NP (drug_ENTITY (NP (NN (spironolactone)))) (, (,)) (NE-Type-2-drug (NP (NN (triamterene)))))))))))) |ET|
-1  |BT|  (S (PP (PP (NP (NE-Type-1-drug (NP (NNS (drugs)))) (SBAR (WHNP (WDT (that))) (S (VP (VBP (block)) (NP (drug_ENTITY (NP (NN (angiotensin)) (CD (II)))) (CC (or)) (NP (PRP$ (its)) (NNS (effects)))))))))) (, (,)) (NP (NP (JJ (concomitant)) (NN (use))) (PP (IN (of)) (NP (NP (drug_ENTITY (NP (JJ (potassium-sparing)) (NNS (diuretics)))) (PRN (-LRB- (<LB>)) (PP (FW (e.g.)) (, (,)) (NP (drug_ENTITY (NP (NN (spironolactone)))) (, (,)) (drug_ENTITY (NP (NN (triamterene)))) (, (,)) (NE-Type-2-drug (NP (NN (amiloride)))))))))))) |ET|
-1  |BT|  (S (PP (PP (NP (NE-Type-1-drug (NP (NNS (drugs)))) (SBAR (WHNP (WDT (that))) (S (VP (VBP (block)) (NP (drug_ENTITY (NP (NN (angiotensin)) (CD (II)))) (CC (or)) (NP (PRP$ (its)) (NNS (effects)))))))))) (, (,)) (NP (NP (JJ (concomitant)) (NN (use))) (PP (IN (of)) (NP (NP (drug_ENTITY (NP (JJ (potassium-sparing)) (NNS (diuretics)))) (PRN (-LRB- (<LB>)) (PP (FW (e.g.)) (, (,)) (NP (drug_ENTITY (NP (NN (spironolactone)))) (, (,)) (drug_ENTITY (NP (NN (triamterene)))) (, (,)) (drug_ENTITY (NP (NN (amiloride)))))) (-RRB- (<RB>)))) (, (,)) (NE-Type-2-drug (NP (NN (potassium)) (NN (supplement)))))))) |ET|
-1  |BT|  (S (PP (PP (NP (NE-Type-1-drug (NP (NNS (drugs)))) (SBAR (WHNP (WDT (that))) (S (VP (VBP (block)) (NP (drug_ENTITY (NP (NN (angiotensin)) (CD (II)))) (CC (or)) (NP (PRP$ (its)) (NNS (effects)))))))))) (, (,)) (NP (NP (JJ (concomitant)) (NN (use))) (PP (IN (of)) (NP (NP (drug_ENTITY (NP (JJ (potassium-sparing)) (NNS (diuretics)))) (PRN (-LRB- (<LB>)) (PP (FW (e.g.)) (, (,)) (NP (drug_ENTITY (NP (NN (spironolactone)))) (, (,)) (drug_ENTITY (NP (NN (triamterene)))) (, (,)) (drug_ENTITY (NP (NN (amiloride)))))) (-RRB- (<RB>)))) (, (,)) (drug_ENTITY (NP (NN (potassium)) (NN (supplement)) (NNS (s)))) (, (,)) (CC (or)) (NP (NE-Type-2-drug (NP (NN (salt))))))))) |ET|
-1  |BT|  (S (PP (PP (NP (NE-Type-1-drug (NP (NNS (drugs)))) (SBAR (WHNP (WDT (that))) (S (VP (VBP (block)) (NP (drug_ENTITY (NP (NN (angiotensin)) (CD (II)))) (CC (or)) (NP (PRP$ (its)) (NNS (effects)))))))))) (, (,)) (NP (NP (JJ (concomitant)) (NN (use))) (PP (IN (of)) (NP (NP (drug_ENTITY (NP (JJ (potassium-sparing)) (NNS (diuretics)))) (PRN (-LRB- (<LB>)) (PP (FW (e.g.)) (, (,)) (NP (drug_ENTITY (NP (NN (spironolactone)))) (, (,)) (drug_ENTITY (NP (NN (triamterene)))) (, (,)) (drug_ENTITY (NP (NN (amiloride)))))) (-RRB- (<RB>)))) (, (,)) (drug_ENTITY (NP (NN (potassium)) (NN (supplement)) (NNS (s)))) (, (,)) (CC (or)) (NP (drug_ENTITY (NP (NN (salt)) (VBZ (substitutes)))) (VP (VBG (containing)) (NE-Type-2-drug (NP (NN (potassium)))))))))) |ET|
-1  |BT|  (S (PP (PP (NP (SBAR (S (VP (NP (NE-Type-1-drug (NP (NN (angiotensin)) (CD (II)))) (CC (or)) (NP (PRP$ (its)) (NNS (effects)))))))))) (, (,)) (NP (NP (JJ (concomitant)) (NN (use))) (PP (IN (of)) (NP (NP (NE-Type-2-drug (NP (JJ (potassium-sparing)) (NNS (diuretics))))))))) |ET|
-1  |BT|  (S (PP (PP (NP (SBAR (S (VP (NP (NE-Type-1-drug (NP (NN (angiotensin)) (CD (II)))) (CC (or)) (NP (PRP$ (its)) (NNS (effects)))))))))) (, (,)) (NP (NP (JJ (concomitant)) (NN (use))) (PP (IN (of)) (NP (NP (drug_ENTITY (NP (JJ (potassium-sparing)) (NNS (diuretics)))) (PRN (-LRB- (<LB>)) (PP (FW (e.g.)) (, (,)) (NP (NE-Type-2-drug (NP (NN (spironolactone)))))))))))) |ET|
-1  |BT|  (S (PP (PP (NP (SBAR (S (VP (NP (NE-Type-1-drug (NP (NN (angiotensin)) (CD (II)))) (CC (or)) (NP (PRP$ (its)) (NNS (effects)))))))))) (, (,)) (NP (NP (JJ (concomitant)) (NN (use))) (PP (IN (of)) (NP (NP (drug_ENTITY (NP (JJ (potassium-sparing)) (NNS (diuretics)))) (PRN (-LRB- (<LB>)) (PP (FW (e.g.)) (, (,)) (NP (drug_ENTITY (NP (NN (spironolactone)))) (, (,)) (NE-Type-2-drug (NP (NN (triamterene)))))))))))) |ET|
-1  |BT|  (S (PP (PP (NP (SBAR (S (VP (NP (NE-Type-1-drug (NP (NN (angiotensin)) (CD (II)))) (CC (or)) (NP (PRP$ (its)) (NNS (effects)))))))))) (, (,)) (NP (NP (JJ (concomitant)) (NN (use))) (PP (IN (of)) (NP (NP (drug_ENTITY (NP (JJ (potassium-sparing)) (NNS (diuretics)))) (PRN (-LRB- (<LB>)) (PP (FW (e.g.)) (, (,)) (NP (drug_ENTITY (NP (NN (spironolactone)))) (, (,)) (drug_ENTITY (NP (NN (triamterene)))) (, (,)) (NE-Type-2-drug (NP (NN (amiloride)))))))))))) |ET|
-1  |BT|  (S (PP (PP (NP (SBAR (S (VP (NP (NE-Type-1-drug (NP (NN (angiotensin)) (CD (II)))) (CC (or)) (NP (PRP$ (its)) (NNS (effects)))))))))) (, (,)) (NP (NP (JJ (concomitant)) (NN (use))) (PP (IN (of)) (NP (NP (drug_ENTITY (NP (JJ (potassium-sparing)) (NNS (diuretics)))) (PRN (-LRB- (<LB>)) (PP (FW (e.g.)) (, (,)) (NP (drug_ENTITY (NP (NN (spironolactone)))) (, (,)) (drug_ENTITY (NP (NN (triamterene)))) (, (,)) (drug_ENTITY (NP (NN (amiloride)))))) (-RRB- (<RB>)))) (, (,)) (NE-Type-2-drug (NP (NN (potassium)) (NN (supplement)))))))) |ET|
-1  |BT|  (S (PP (PP (NP (SBAR (S (VP (NP (NE-Type-1-drug (NP (NN (angiotensin)) (CD (II)))) (CC (or)) (NP (PRP$ (its)) (NNS (effects)))))))))) (, (,)) (NP (NP (JJ (concomitant)) (NN (use))) (PP (IN (of)) (NP (NP (drug_ENTITY (NP (JJ (potassium-sparing)) (NNS (diuretics)))) (PRN (-LRB- (<LB>)) (PP (FW (e.g.)) (, (,)) (NP (drug_ENTITY (NP (NN (spironolactone)))) (, (,)) (drug_ENTITY (NP (NN (triamterene)))) (, (,)) (drug_ENTITY (NP (NN (amiloride)))))) (-RRB- (<RB>)))) (, (,)) (drug_ENTITY (NP (NN (potassium)) (NN (supplement)) (NNS (s)))) (, (,)) (CC (or)) (NP (NE-Type-2-drug (NP (NN (salt))))))))) |ET|
-1  |BT|  (S (PP (PP (NP (SBAR (S (VP (NP (NE-Type-1-drug (NP (NN (angiotensin)) (CD (II)))) (CC (or)) (NP (PRP$ (its)) (NNS (effects)))))))))) (, (,)) (NP (NP (JJ (concomitant)) (NN (use))) (PP (IN (of)) (NP (NP (drug_ENTITY (NP (JJ (potassium-sparing)) (NNS (diuretics)))) (PRN (-LRB- (<LB>)) (PP (FW (e.g.)) (, (,)) (NP (drug_ENTITY (NP (NN (spironolactone)))) (, (,)) (drug_ENTITY (NP (NN (triamterene)))) (, (,)) (drug_ENTITY (NP (NN (amiloride)))))) (-RRB- (<RB>)))) (, (,)) (drug_ENTITY (NP (NN (potassium)) (NN (supplement)) (NNS (s)))) (, (,)) (CC (or)) (NP (drug_ENTITY (NP (NN (salt)) (VBZ (substitutes)))) (VP (VBG (containing)) (NE-Type-2-drug (NP (NN (potassium)))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (JJ (potassium-sparing)) (NNS (diuretics)))) (PRN (-LRB- (<LB>)) (PP (FW (e.g.)) (, (,)) (NP (NE-Type-2-drug (NP (NN (spironolactone)))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (JJ (potassium-sparing)) (NNS (diuretics)))) (PRN (-LRB- (<LB>)) (PP (FW (e.g.)) (, (,)) (NP (drug_ENTITY (NP (NN (spironolactone)))) (, (,)) (NE-Type-2-drug (NP (NN (triamterene)))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (JJ (potassium-sparing)) (NNS (diuretics)))) (PRN (-LRB- (<LB>)) (PP (FW (e.g.)) (, (,)) (NP (drug_ENTITY (NP (NN (spironolactone)))) (, (,)) (drug_ENTITY (NP (NN (triamterene)))) (, (,)) (NE-Type-2-drug (NP (NN (amiloride)))))))) |ET|
1  |BT|  (NP (NP (NE-Type-1-drug (NP (JJ (potassium-sparing)) (NNS (diuretics)))) (PRN (-LRB- (<LB>)) (PP (FW (e.g.)) (, (,)) (NP (drug_ENTITY (NP (NN (spironolactone)))) (, (,)) (drug_ENTITY (NP (NN (triamterene)))) (, (,)) (drug_ENTITY (NP (NN (amiloride)))))) (-RRB- (<RB>)))) (, (,)) (NE-Type-2-drug (NP (NN (potassium)) (NN (supplement))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (JJ (potassium-sparing)) (NNS (diuretics)))) (PRN (-LRB- (<LB>)) (PP (FW (e.g.)) (, (,)) (NP (drug_ENTITY (NP (NN (spironolactone)))) (, (,)) (drug_ENTITY (NP (NN (triamterene)))) (, (,)) (drug_ENTITY (NP (NN (amiloride)))))) (-RRB- (<RB>)))) (, (,)) (drug_ENTITY (NP (NN (potassium)) (NN (supplement)) (NNS (s)))) (, (,)) (CC (or)) (NP (NE-Type-2-drug (NP (NN (salt)))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (JJ (potassium-sparing)) (NNS (diuretics)))) (PRN (-LRB- (<LB>)) (PP (FW (e.g.)) (, (,)) (NP (drug_ENTITY (NP (NN (spironolactone)))) (, (,)) (drug_ENTITY (NP (NN (triamterene)))) (, (,)) (drug_ENTITY (NP (NN (amiloride)))))) (-RRB- (<RB>)))) (, (,)) (drug_ENTITY (NP (NN (potassium)) (NN (supplement)) (NNS (s)))) (, (,)) (CC (or)) (NP (drug_ENTITY (NP (NN (salt)) (VBZ (substitutes)))) (VP (VBG (containing)) (NE-Type-2-drug (NP (NN (potassium))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (spironolactone)))) (, (,)) (NE-Type-2-drug (NP (NN (triamterene))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (spironolactone)))) (, (,)) (drug_ENTITY (NP (NN (triamterene)))) (, (,)) (NE-Type-2-drug (NP (NN (amiloride))))) |ET|
-1  |BT|  (NP (NP (PRN (PP (NP (NE-Type-1-drug (NP (NN (spironolactone)))) (, (,)) (drug_ENTITY (NP (NN (triamterene)))) (, (,)) (drug_ENTITY (NP (NN (amiloride)))))) (-RRB- (<RB>)))) (, (,)) (NE-Type-2-drug (NP (NN (potassium)) (NN (supplement))))) |ET|
1  |BT|  (NP (NP (PRN (PP (NP (NE-Type-1-drug (NP (NN (spironolactone)))) (, (,)) (drug_ENTITY (NP (NN (triamterene)))) (, (,)) (drug_ENTITY (NP (NN (amiloride)))))) (-RRB- (<RB>)))) (, (,)) (drug_ENTITY (NP (NN (potassium)) (NN (supplement)) (NNS (s)))) (, (,)) (CC (or)) (NP (NE-Type-2-drug (NP (NN (salt)))))) |ET|
-1  |BT|  (NP (NP (PRN (PP (NP (NE-Type-1-drug (NP (NN (spironolactone)))) (, (,)) (drug_ENTITY (NP (NN (triamterene)))) (, (,)) (drug_ENTITY (NP (NN (amiloride)))))) (-RRB- (<RB>)))) (, (,)) (drug_ENTITY (NP (NN (potassium)) (NN (supplement)) (NNS (s)))) (, (,)) (CC (or)) (NP (drug_ENTITY (NP (NN (salt)) (VBZ (substitutes)))) (VP (VBG (containing)) (NE-Type-2-drug (NP (NN (potassium))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (triamterene)))) (, (,)) (NE-Type-2-drug (NP (NN (amiloride))))) |ET|
1  |BT|  (NP (NP (PRN (PP (NP (NE-Type-1-drug (NP (NN (triamterene)))) (, (,)) (drug_ENTITY (NP (NN (amiloride)))))) (-RRB- (<RB>)))) (, (,)) (NE-Type-2-drug (NP (NN (potassium)) (NN (supplement))))) |ET|
-1  |BT|  (NP (NP (PRN (PP (NP (NE-Type-1-drug (NP (NN (triamterene)))) (, (,)) (drug_ENTITY (NP (NN (amiloride)))))) (-RRB- (<RB>)))) (, (,)) (drug_ENTITY (NP (NN (potassium)) (NN (supplement)) (NNS (s)))) (, (,)) (CC (or)) (NP (NE-Type-2-drug (NP (NN (salt)))))) |ET|
-1  |BT|  (NP (NP (PRN (PP (NP (NE-Type-1-drug (NP (NN (triamterene)))) (, (,)) (drug_ENTITY (NP (NN (amiloride)))))) (-RRB- (<RB>)))) (, (,)) (drug_ENTITY (NP (NN (potassium)) (NN (supplement)) (NNS (s)))) (, (,)) (CC (or)) (NP (drug_ENTITY (NP (NN (salt)) (VBZ (substitutes)))) (VP (VBG (containing)) (NE-Type-2-drug (NP (NN (potassium))))))) |ET|
-1  |BT|  (NP (NP (PRN (PP (NP (NE-Type-1-drug (NP (NN (amiloride)))))) (-RRB- (<RB>)))) (, (,)) (NE-Type-2-drug (NP (NN (potassium)) (NN (supplement))))) |ET|
1  |BT|  (NP (NP (PRN (PP (NP (NE-Type-1-drug (NP (NN (amiloride)))))) (-RRB- (<RB>)))) (, (,)) (drug_ENTITY (NP (NN (potassium)) (NN (supplement)) (NNS (s)))) (, (,)) (CC (or)) (NP (NE-Type-2-drug (NP (NN (salt)))))) |ET|
-1  |BT|  (NP (NP (PRN (PP (NP (NE-Type-1-drug (NP (NN (amiloride)))))) (-RRB- (<RB>)))) (, (,)) (drug_ENTITY (NP (NN (potassium)) (NN (supplement)) (NNS (s)))) (, (,)) (CC (or)) (NP (drug_ENTITY (NP (NN (salt)) (VBZ (substitutes)))) (VP (VBG (containing)) (NE-Type-2-drug (NP (NN (potassium))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (potassium)) (NN (supplement)) (NNS (s)))) (, (,)) (CC (or)) (NP (NE-Type-2-drug (NP (NN (salt)))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (potassium)) (NN (supplement)) (NNS (s)))) (, (,)) (CC (or)) (NP (drug_ENTITY (NP (NN (salt)) (VBZ (substitutes)))) (VP (VBG (containing)) (NE-Type-2-drug (NP (NN (potassium))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (salt)) (VBZ (substitutes)))) (VP (VBG (containing)) (NE-Type-2-drug (NP (NN (potassium)))))) |ET|
-1  |BT|  (S (PP (PP (NE-Type-1-drug (NP (JJ (antihypertensive)) (NNS (agents)))))) (, (,)) (NP (NE-Type-2-drug (NP (DT (the)) (JJ (antihypertensive)))))) |ET|
-1  |BT|  (S (PP (PP (NE-Type-1-drug (NP (JJ (antihypertensive)) (NNS (agents)))))) (, (,)) (NP (drug_ENTITY (NP (DT (the)) (JJ (antihypertensive)) (NN (effect)))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (losartan))))))) |ET|
-1  |BT|  (S (PP (PP (NE-Type-1-drug (NP (JJ (antihypertensive)) (NNS (agents)))))) (, (,)) (NP (drug_ENTITY (NP (DT (the)) (JJ (antihypertensive)) (NN (effect)))) (PP (IN (of)) (drug_ENTITY (NP (NN (losartan)))))) (VP (MD (may)) (VP (VB (be)) (VP (VBN (blunted)) (PP (IN (by)) (NP (NE-Type-2-drug (NP (DT (the)) (JJ (non-steroidal)) (JJ (anti-inflammatory)) (NN (drug)))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (JJ (antihypertensive)) (NN (effect)))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (losartan)))))) |ET|
-1  |BT|  (S (NP (NE-Type-1-drug (NP (JJ (antihypertensive)) (NN (effect)))) (PP (IN (of)) (drug_ENTITY (NP (NN (losartan)))))) (VP (MD (may)) (VP (VB (be)) (VP (VBN (blunted)) (PP (IN (by)) (NP (NE-Type-2-drug (NP (DT (the)) (JJ (non-steroidal)) (JJ (anti-inflammatory)) (NN (drug)))))))))) |ET|
1  |BT|  (S (NP (PP (NE-Type-1-drug (NP (NN (losartan)))))) (VP (MD (may)) (VP (VB (be)) (VP (VBN (blunted)) (PP (IN (by)) (NP (NE-Type-2-drug (NP (DT (the)) (JJ (non-steroidal)) (JJ (anti-inflammatory)) (NN (drug)))))))))) |ET|
1  |BT|  (S (NE-Type-1-drug (NP (NNS (drugs)))) (VP (MD (may)) (VP (VB (interact)) (PP (IN (with)) (NP (NE-Type-2-drug (NP (JJ (beta-adrenergic)) (NN (receptor)) (NN (blocking)) (NNS (agents))))))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NNS (drugs)))) (VP (MD (may)) (VP (VB (interact)) (PP (IN (with)) (NP (drug_ENTITY (NP (JJ (beta-adrenergic)) (NN (receptor)) (NN (blocking)) (NNS (agents)))) (: (:)) (NP (NE-Type-2-drug (NP (NN (Anesthetics)))))))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NNS (drugs)))) (VP (MD (may)) (VP (VB (interact)) (PP (IN (with)) (NP (drug_ENTITY (NP (JJ (beta-adrenergic)) (NN (receptor)) (NN (blocking)) (NNS (agents)))) (: (:)) (NP (drug_ENTITY (NP (NN (Anesthetics)))) (, (,)) (NP (ADJP (JJ (general)))) (: (:)) (NP (NP (NN (exaggeration))) (PP (IN (of)) (NP (NP (DT (the)) (NN (hypotension))) (VP (VBN (induced)) (PP (IN (by)) (NE-Type-2-drug (NP (JJ (general)) (NNS (anesthetics))))))))))))))) |ET|
1  |BT|  (NP (NE-Type-1-drug (NP (JJ (beta-adrenergic)) (NN (receptor)) (NN (blocking)) (NNS (agents)))) (: (:)) (NP (NE-Type-2-drug (NP (NN (Anesthetics)))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (JJ (beta-adrenergic)) (NN (receptor)) (NN (blocking)) (NNS (agents)))) (: (:)) (NP (drug_ENTITY (NP (NN (Anesthetics)))) (, (,)) (NP (ADJP (JJ (general)))) (: (:)) (NP (NP (NN (exaggeration))) (PP (IN (of)) (NP (NP (DT (the)) (NN (hypotension))) (VP (VBN (induced)) (PP (IN (by)) (NE-Type-2-drug (NP (JJ (general)) (NNS (anesthetics))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Anesthetics)))) (, (,)) (NP (ADJP (JJ (general)))) (: (:)) (NP (NP (NN (exaggeration))) (PP (IN (of)) (NP (NP (DT (the)) (NN (hypotension))) (VP (VBN (induced)) (PP (IN (by)) (NE-Type-2-drug (NP (JJ (general)) (NNS (anesthetics)))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (JJ (Antidiabetic)) (NNS (drugs)))) (PRN (-LRB- (<LB>)) (NP (NP (JJ (oral)) (NNS (agents))) (CC (and)) (NE-Type-2-drug (NP (NN (insulin))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (drugs)))) (PRN (-LRB- (<LB>)) (PP (FW (e.g.)) (, (,)) (NE-Type-2-drug (NP (NN (reserpine))))))) |ET|
1  |BT|  (S (NP (PP (NE-Type-1-drug (NP (NN (theophylline)))))) (VP (VBP (have)) (VP (VBN (been)) (VP (VBN (reported)) (PP (IN (with)) (NE-Type-2-drug (NP (JJ (concomitant)) (NN (quinolone))))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (ADJP (NN (theophylline)) (JJ (-related)))) (JJ (side)) (NNS (effects))) (PP (IN (in)) (NP (NP (NNS (patients))) (PP (IN (on)) (NP (NP (JJ (concomitant)) (NN (therapy))) (PP (IN (with)) (NP (NE-Type-2-drug (NP (NNS (quinolones))))))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (ADJP (NN (theophylline)) (JJ (-related)))) (JJ (side)) (NNS (effects))) (PP (IN (in)) (NP (NP (NNS (patients))) (PP (IN (on)) (NP (NP (JJ (concomitant)) (NN (therapy))) (PP (IN (with)) (NP (drug_ENTITY (NP (NNS (quinolones)))) (CC (and)) (NE-Type-2-drug (NP (NN (theophylline))))))))))) |ET|
1  |BT|  (NP (NE-Type-1-drug (NP (NNS (quinolones)))) (CC (and)) (NE-Type-2-drug (NP (NN (theophylline))))) |ET|
1  |BT|  (S (NE-Type-1-drug (NP (NNS (Quinolones)))) (VP (VBP (have)) (VP (VBN (been)) (VP (VBN (shown)) (S (VP (TO (to)) (VP (VB (interfere)) (PP (IN (with)) (NP (NP (DT (the)) (NN (metabolism))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (caffeine)))))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (Quinolones)))) (, (,)) (PP (VBG (including)) (NE-Type-2-drug (NP (JJ (nalidixic)) (NN (acid)))))) |ET|
1  |BT|  (S (NP (NE-Type-1-drug (NP (NNS (Quinolones)))) (, (,)) (PP (VBG (including)) (drug_ENTITY (NP (JJ (nalidixic)) (NN (acid))))) (, (,))) (VP (MD (may)) (VP (VB (enhance)) (NP (NP (DT (the)) (NNS (effects))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (DT (the)) (JJ (oral)) (NN (anticoagulant)) (NN (warfarin)))))))))) |ET|
-1  |BT|  (S (NP (NE-Type-1-drug (NP (NNS (Quinolones)))) (, (,)) (PP (VBG (including)) (drug_ENTITY (NP (JJ (nalidixic)) (NN (acid))))) (, (,))) (VP (MD (may)) (VP (VB (enhance)) (NP (NP (DT (the)) (NNS (effects))) (PP (IN (of)) (NP (drug_ENTITY (NP (DT (the)) (JJ (oral)) (NN (anticoagulant)) (NN (warfarin)))) (CC (or)) (NE-Type-2-drug (NP (PRP$ (its)) (NNS (derivatives)))))))))) |ET|
-1  |BT|  (S (NP (PP (NE-Type-1-drug (NP (JJ (nalidixic)) (NN (acid))))) (, (,))) (VP (MD (may)) (VP (VB (enhance)) (NP (NP (DT (the)) (NNS (effects))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (DT (the)) (JJ (oral)) (NN (anticoagulant)) (NN (warfarin)))))))))) |ET|
1  |BT|  (S (NP (PP (NE-Type-1-drug (NP (JJ (nalidixic)) (NN (acid))))) (, (,))) (VP (MD (may)) (VP (VB (enhance)) (NP (NP (DT (the)) (NNS (effects))) (PP (IN (of)) (NP (drug_ENTITY (NP (DT (the)) (JJ (oral)) (NN (anticoagulant)) (NN (warfarin)))) (CC (or)) (NE-Type-2-drug (NP (PRP$ (its)) (NNS (derivatives)))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (JJ (oral)) (NN (anticoagulant)) (NN (warfarin)))) (CC (or)) (NE-Type-2-drug (NP (PRP$ (its)) (NNS (derivatives))))) |ET|
1  |BT|  (S (NE-Type-1-drug (NP (NN (Nitrofurantoin)))) (VP (VBZ (interferes)) (PP (IN (with)) (NP (NP (DT (the)) (JJ (therapeutic)) (NN (action))) (PP (IN (of)) (NE-Type-2-drug (NP (JJ (nalidixic)) (NN (acid))))))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NNS (Antacids)))) (VP (VBG (containing)) (NP (NE-Type-2-drug (NP (NN (magnesium))))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NNS (Antacids)))) (VP (VBG (containing)) (NP (drug_ENTITY (NP (NN (magnesium)))) (, (,)) (NP (NN (aluminum))) (, (,)) (CC (or)) (NE-Type-2-drug (NP (NN (calcium))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (magnesium)))) (, (,)) (NP (NN (aluminum))) (, (,)) (CC (or)) (NE-Type-2-drug (NP (NN (calcium))))) |ET|
-1  |BT|  (NE-Type-1-drug (VP (VBP (sucralfate)) (NP (NE-Type-2-drug (NP (ADJP (CC (or)) (ADJP (JJ (divalent))) (CC (or)) (ADJP (JJ (trivalent)))) (NNS (cations))))))) |ET|
-1  |BT|  (NE-Type-1-drug (VP (VBP (sucralfate)) (NP (NP (ADJP (CC (or)) (ADJP (JJ (divalent))) (CC (or)) (ADJP (JJ (trivalent)))) (NNS (cations))) (PP (JJ (such)) (IN (as)) (NE-Type-2-drug (NP (NN (iron)))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (cations)))) (PP (JJ (such)) (IN (as)) (NE-Type-2-drug (NP (NN (iron)))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NNS (multivitamins)))) (VP (VBG (containing)) (NE-Type-2-drug (NP (NN (zinc)))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Didanosine)) (-RRB- (<RB>)))) (, (,)) (NE-Type-2-drug (NP (NN (chewable/)) (NN (buffer))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (Didanosine)) (-RRB- (<RB>)))) (, (,)) (drug_ENTITY (NP (NN (chewable/)) (NN (buffer)) (NN (ed)) (NNS (tablets))))) (CC (or)) (NP (NE-Type-2-drug (NP (DT (the)) (JJ (pediatric)))))) |ET|
1  |BT|  (S (NP (NP (NE-Type-1-drug (NP (NN (Didanosine)) (-RRB- (<RB>)))) (, (,)) (drug_ENTITY (NP (NN (chewable/)) (NN (buffer)) (NN (ed)) (NNS (tablets))))) (CC (or)) (NP (drug_ENTITY (NP (DT (the)) (JJ (pediatric)) (NN (powder)))) (PP (IN (for)) (NP (JJ (oral)) (NN (solution)))))) (VP (MD (may)) (ADVP (RB (substantially))) (VP (VB (interfere)) (PP (IN (with)) (NP (NP (DT (the)) (NN (absorption))) (PP (IN (of)) (NE-Type-2-drug (NP (NNS (quinolones)))))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (buffer)) (NN (ed)) (NNS (tablets))))) (CC (or)) (NP (NE-Type-2-drug (NP (DT (the)) (JJ (pediatric)))))) |ET|
1  |BT|  (S (NP (NP (NE-Type-1-drug (NP (NN (buffer)) (NN (ed)) (NNS (tablets))))) (CC (or)) (NP (drug_ENTITY (NP (DT (the)) (JJ (pediatric)) (NN (powder)))) (PP (IN (for)) (NP (JJ (oral)) (NN (solution)))))) (VP (MD (may)) (ADVP (RB (substantially))) (VP (VB (interfere)) (PP (IN (with)) (NP (NP (DT (the)) (NN (absorption))) (PP (IN (of)) (NE-Type-2-drug (NP (NNS (quinolones)))))))))) |ET|
1  |BT|  (S (NP (NP (NE-Type-1-drug (NP (JJ (pediatric)) (NN (powder)))) (PP (IN (for)) (NP (JJ (oral)) (NN (solution)))))) (VP (MD (may)) (ADVP (RB (substantially))) (VP (VB (interfere)) (PP (IN (with)) (NP (NP (DT (the)) (NN (absorption))) (PP (IN (of)) (NE-Type-2-drug (NP (NNS (quinolones)))))))))) |ET|
-1  |BT|  (S (NP (PP (NE-Type-1-drug (NP (NN (cyclosporine)))))) (VP (VBP (have)) (VP (VBN (been)) (VP (VBN (reported)) (PP (IN (with)) (NP (NP (DT (the)) (JJ (concomitant)) (NN (use))) (PP (IN (of)) (NP (DT (some)) (NP (NE-Type-2-drug (NP (NN (quinolones))))))))))))) |ET|
-1  |BT|  (S (NP (PP (NE-Type-1-drug (NP (NN (cyclosporine)))))) (VP (VBP (have)) (VP (VBN (been)) (VP (VBN (reported)) (PP (IN (with)) (NP (NP (DT (the)) (JJ (concomitant)) (NN (use))) (PP (IN (of)) (NP (DT (some)) (NP (drug_ENTITY (NP (NN (quinolones)))) (CC (and)) (NE-Type-2-drug (NP (NN (cyclosporine))))))))))))) |ET|
1  |BT|  (NP (NE-Type-1-drug (NP (NN (quinolones)))) (CC (and)) (NE-Type-2-drug (NP (NN (cyclosporine))))) |ET|
-1  |BT|  (S (S (NE-Type-1-drug (NP (NN (cyclosporine)) (NN (serum)) (NNS (levels)))) (VP (MD (should)) (VP (VB (be)) (VP (VBN (monitored)))))) (CC (and)) (S (NE-Type-2-drug (NP (JJ (appropriate)) (NN (cyclosporine)))))) |ET|
-1  |BT|  (S (S (NE-Type-1-drug (NP (NN (cyclosporine)) (NN (serum)) (NNS (levels)))) (VP (MD (should)) (VP (VB (be)) (VP (VBN (monitored)))))) (CC (and)) (S (drug_ENTITY (NP (JJ (appropriate)) (NN (cyclosporine)) (NN (dosage)) (NNS (adjustments)))) (VP (VBD (made)) (SBAR (WHADVP (WRB (when))) (S (NE-Type-2-drug (NP (DT (these)) (NNS (drugs))))))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NN (cyclosporine)) (NN (dosage)) (NNS (adjustments)))) (VP (VBD (made)) (SBAR (WHADVP (WRB (when))) (S (NE-Type-2-drug (NP (DT (these)) (NNS (drugs)))))))) |ET|
1  |BT|  (S (NE-Type-1-drug (NP (NN (Starlix)))) (VP (VBZ (is)) (ADVP (RB (predominantly))) (VP (VBN (metabolized)) (PP (PP (IN (by)) (NP (NE-Type-2-drug (NP (DT (the)) (NN (cytochrome)) (NN (P450)))))))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NN (Starlix)))) (VP (VBZ (is)) (ADVP (RB (predominantly))) (VP (VBN (metabolized)) (PP (PP (IN (by)) (NP (drug_ENTITY (NP (DT (the)) (NN (cytochrome)) (NN (P450)) (NN (isozyme)) (NN (CYP2C9)))) (PRN (-LRB- (<LB>)) (NP (CD (70)) (NN (%))) (-RRB- (<RB>))))) (CC (and)) (PP (TO (to)) (NP (DT (a)) (JJR (lesser)) (NN (extent)))) (NE-Type-2-drug (NP (NN (CYP3A4)))))))) |ET|
-1  |BT|  (PP (PP (NP (NE-Type-1-drug (NP (NN (cytochrome)) (NN (P450)) (NN (isozyme)) (NN (CYP2C9)))) (PRN (-LRB- (<LB>)) (NP (CD (70)) (NN (%))) (-RRB- (<RB>))))) (CC (and)) (PP (TO (to)) (NP (DT (a)) (JJR (lesser)) (NN (extent)))) (NE-Type-2-drug (NP (NN (CYP3A4))))) |ET|
1  |BT|  (S (NE-Type-1-drug (NP (NN (Starlix)))) (VP (VBZ (is)) (NP (NP (DT (a)) (JJ (potential)) (NN (inhibitor))) (PP (IN (of)) (NE-Type-2-drug (NP (DT (the)) (NN (CYP2C9)) (NN (isoenzyme)))))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NN (Starlix)))) (VP (VBZ (is)) (NP (NP (DT (a)) (JJ (potential)) (NN (inhibitor))) (PP (IN (of)) (drug_ENTITY (NP (DT (the)) (NN (CYP2C9)) (NN (isoenzyme)))))) (ADVP (FW (in)) (FW (vivo))) (SBAR (IN (as)) (S (VP (VBN (indicated)) (PP (IN (by)) (NP (PRP$ (its)) (NN (ability)) (S (VP (TO (to)) (VP (VB (inhibit)) (NP (NP (DT (the)) (ADJP (FW (in)) (FW (vitro))) (NN (metabolism))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (tolbutamide)))))))))))))))) |ET|
-1  |BT|  (VP (NP (PP (NE-Type-1-drug (NP (NN (CYP2C9)) (NN (isoenzyme)))))) (ADVP (FW (in)) (FW (vivo))) (SBAR (IN (as)) (S (VP (VBN (indicated)) (PP (IN (by)) (NP (PRP$ (its)) (NN (ability)) (S (VP (TO (to)) (VP (VB (inhibit)) (NP (NP (DT (the)) (ADJP (FW (in)) (FW (vitro))) (NN (metabolism))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (tolbutamide))))))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Glyburide)))) (: (:)) (S (PP (IN (In)) (NP (DT (a)) (ADJP (ADJP (JJ (randomized))) (, (,)) (ADJP (JJ (multiple-dose)))) (NN (crossover)) (NN (study)))) (, (,)) (NP (NP (NNS (patients))) (PP (IN (with)) (NP (NN (Type)) (CD (2)) (NNS (diabetes))))) (VP (VBD (were)) (VP (VBN (administered)) (NP (NE-Type-2-drug (NP (CD (120)) (NN (mg)) (NN (Starlix))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Glyburide)))) (: (:)) (S (PP (IN (In)) (NP (DT (a)) (ADJP (ADJP (JJ (randomized))) (, (,)) (ADJP (JJ (multiple-dose)))) (NN (crossover)) (NN (study)))) (, (,)) (NP (NP (NNS (patients))) (PP (IN (with)) (NP (NN (Type)) (CD (2)) (NNS (diabetes))))) (VP (VBD (were)) (VP (VBN (administered)) (NP (drug_ENTITY (NP (CD (120)) (NN (mg)) (NN (Starlix)) (CD (three)) (NNS (times)))) (NP (NP (DT (a)) (NN (day))) (PP (IN (before)) (NP (NN (meals)))) (PP (IN (for)) (NP (CD (1)) (NN (day)))))) (PP (IN (in)) (NP (NP (NN (combination))) (PP (IN (with)) (NP (NE-Type-2-drug (NP (NN (glyburide)))))))))))) |ET|
-1  |BT|  (VP (NP (NE-Type-1-drug (NP (NN (Starlix)) (CD (three)) (NNS (times)))) (NP (NP (DT (a)) (NN (day))) (PP (IN (before)) (NP (NN (meals)))) (PP (IN (for)) (NP (CD (1)) (NN (day)))))) (PP (IN (in)) (NP (NP (NN (combination))) (PP (IN (with)) (NP (NE-Type-2-drug (NP (NN (glyburide))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Metformin)))) (: (:)) (S (SBAR (WHADVP (WRB (When))) (S (NP (NE-Type-2-drug (NP (NN (Starlix))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Metformin)))) (: (:)) (S (SBAR (WHADVP (WRB (When))) (S (NP (drug_ENTITY (NP (NN (Starlix)) (CD (120)) (NN (mg)))) (ADVP (NP (CD (three)) (NNS (times))) (RB (daily)) (PP (IN (before)) (NP (NN (meals)))))) (VP (VBD (was)) (VP (VBN (administered)) (PP (IN (in)) (NP (NP (NN (combination))) (PP (IN (with)) (NP (NE-Type-2-drug (NP (NN (metformin)) (CD (500)) (NN (mg)))))))))))))) |ET|
-1  |BT|  (S (NP (NE-Type-1-drug (NP (NN (Starlix)) (CD (120)) (NN (mg)))) (ADVP (NP (CD (three)) (NNS (times))) (RB (daily)) (PP (IN (before)) (NP (NN (meals)))))) (VP (VBD (was)) (VP (VBN (administered)) (PP (IN (in)) (NP (NP (NN (combination))) (PP (IN (with)) (NP (NE-Type-2-drug (NP (NN (metformin)) (CD (500)) (NN (mg))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Digoxin)))) (: (:)) (S (SBAR (WHADVP (WRB (When))) (S (NP (NE-Type-2-drug (NP (NN (Starlix))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Digoxin)))) (: (:)) (S (SBAR (WHADVP (WRB (When))) (S (NP (drug_ENTITY (NP (NN (Starlix)) (CD (120)) (NN (mg)))) (PP (IN (before)) (NP (NN (meals))))) (VP (VBD (was)) (VP (VBN (administered)) (PP (IN (in)) (NP (NP (NN (combination))) (PP (IN (with)) (NP (NP (DT (a)) (JJ (single)) (JJ (1-mg)) (NN (dose))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (digoxin))))))))))))))) |ET|
-1  |BT|  (S (NP (NE-Type-1-drug (NP (NN (Starlix)) (CD (120)) (NN (mg)))) (PP (IN (before)) (NP (NN (meals))))) (VP (VBD (was)) (VP (VBN (administered)) (PP (IN (in)) (NP (NP (NN (combination))) (PP (IN (with)) (NP (NP (DT (a)) (JJ (single)) (JJ (1-mg)) (NN (dose))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (digoxin)))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Warfarin)))) (: (:)) (S (SBAR (WHADVP (WRB (When))) (S (NP (JJ (healthy)) (NNS (subjects))) (VP (VBD (were)) (VP (VBN (administered)) (ADVP (NE-Type-2-drug (NP (NN (Starlix))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Warfarin)))) (: (:)) (S (SBAR (WHADVP (WRB (When))) (S (NP (JJ (healthy)) (NNS (subjects))) (VP (VBD (were)) (VP (VBN (administered)) (ADVP (drug_ENTITY (NP (NN (Starlix)) (CD (120)) (NN (mg)) (CD (three)) (NNS (times)))) (RB (daily))) (PP (IN (before)) (NP (NN (meals)))) (PP (IN (for)) (NP (NP (CD (four)) (NNS (days))) (PP (IN (in)) (NP (NP (NN (combination))) (PP (IN (with)) (NP (NP (DT (a)) (JJ (single)) (NN (dose))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (NN (warfarin)))))))))))))))))) |ET|
-1  |BT|  (VP (ADVP (NE-Type-1-drug (NP (NN (Starlix)) (CD (120)) (NN (mg)) (CD (three)) (NNS (times)))) (RB (daily))) (PP (IN (before)) (NP (NN (meals)))) (PP (IN (for)) (NP (NP (CD (four)) (NNS (days))) (PP (IN (in)) (NP (NP (NN (combination))) (PP (IN (with)) (NP (NP (DT (a)) (JJ (single)) (NN (dose))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (NN (warfarin))))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Diclofenac)))) (: (:)) (S (NP (NP (NN (Administration))) (PP (IN (of)) (NP (NP (NP (NP (NN (morning))) (CC (and)) (NP (NN (lunch)))) (NNS (doses))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (NN (Starlix))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Diclofenac)))) (: (:)) (S (NP (NP (NN (Administration))) (PP (IN (of)) (NP (NP (NP (NP (NN (morning))) (CC (and)) (NP (NN (lunch)))) (NNS (doses))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (Starlix)) (CD (120)) (NN (mg)))) (PP (IN (in)) (NP (NP (NN (combination))) (PP (IN (with)) (NP (NP (DT (a)) (JJ (single)) (NN (75-mg)) (NN (dose))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (diclofenac)))))))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Starlix)) (CD (120)) (NN (mg)))) (PP (IN (in)) (NP (NP (NN (combination))) (PP (IN (with)) (NP (NP (DT (a)) (JJ (single)) (NN (75-mg)) (NN (dose))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (diclofenac)))))))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NN (Nateglinide)))) (VP (VBZ (is)) (ADVP (RB (highly))) (VP (VBN (bound)) (PP (TO (to)) (NP (NP (NE-Type-2-drug (NP (NN (plasma)) (NNS (proteins)))))))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NN (Nateglinide)))) (VP (VBZ (is)) (ADVP (RB (highly))) (VP (VBN (bound)) (PP (TO (to)) (NP (NP (drug_ENTITY (NP (NN (plasma)) (NNS (proteins)))) (PRN (-LRB- (<LB>)) (NP (CD (98)) (NN (%))) (-RRB- (<RB>)))) (, (,)) (NP (ADVP (RB (mainly))) (NE-Type-2-drug (NP (NN (albumin)))))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (plasma)) (NNS (proteins)))) (PRN (-LRB- (<LB>)) (NP (CD (98)) (NN (%))) (-RRB- (<RB>)))) (, (,)) (NP (ADVP (RB (mainly))) (NE-Type-2-drug (NP (NN (albumin)))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (ADJP (NN (protein)) (JJ (-bound)))) (NNS (drugs))) (PP (JJ (such)) (IN (as)) (NP (NE-Type-2-drug (NP (NN (furosemide))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (ADJP (NN (protein)) (JJ (-bound)))) (NNS (drugs))) (PP (JJ (such)) (IN (as)) (NP (drug_ENTITY (NP (NN (furosemide)))) (, (,)) (NE-Type-2-drug (NP (NN (propranolol))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (ADJP (NN (protein)) (JJ (-bound)))) (NNS (drugs))) (PP (JJ (such)) (IN (as)) (NP (drug_ENTITY (NP (NN (furosemide)))) (, (,)) (drug_ENTITY (NP (NN (propranolol)))) (, (,)) (NE-Type-2-drug (NP (NN (captopril))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (ADJP (NN (protein)) (JJ (-bound)))) (NNS (drugs))) (PP (JJ (such)) (IN (as)) (NP (drug_ENTITY (NP (NN (furosemide)))) (, (,)) (drug_ENTITY (NP (NN (propranolol)))) (, (,)) (drug_ENTITY (NP (NN (captopril)))) (, (,)) (NE-Type-2-drug (NP (NN (nicardipine))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (ADJP (NN (protein)) (JJ (-bound)))) (NNS (drugs))) (PP (JJ (such)) (IN (as)) (NP (drug_ENTITY (NP (NN (furosemide)))) (, (,)) (drug_ENTITY (NP (NN (propranolol)))) (, (,)) (drug_ENTITY (NP (NN (captopril)))) (, (,)) (drug_ENTITY (NP (NN (nicardipine)))) (, (,)) (NE-Type-2-drug (NP (NN (pravastatin))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (ADJP (NN (protein)) (JJ (-bound)))) (NNS (drugs))) (PP (JJ (such)) (IN (as)) (NP (drug_ENTITY (NP (NN (furosemide)))) (, (,)) (drug_ENTITY (NP (NN (propranolol)))) (, (,)) (drug_ENTITY (NP (NN (captopril)))) (, (,)) (drug_ENTITY (NP (NN (nicardipine)))) (, (,)) (drug_ENTITY (NP (NN (pravastatin)))) (, (,)) (NE-Type-2-drug (NP (NN (glyburide))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (ADJP (NN (protein)) (JJ (-bound)))) (NNS (drugs))) (PP (JJ (such)) (IN (as)) (NP (drug_ENTITY (NP (NN (furosemide)))) (, (,)) (drug_ENTITY (NP (NN (propranolol)))) (, (,)) (drug_ENTITY (NP (NN (captopril)))) (, (,)) (drug_ENTITY (NP (NN (nicardipine)))) (, (,)) (drug_ENTITY (NP (NN (pravastatin)))) (, (,)) (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (NE-Type-2-drug (NP (NN (warfarin))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (ADJP (NN (protein)) (JJ (-bound)))) (NNS (drugs))) (PP (JJ (such)) (IN (as)) (NP (drug_ENTITY (NP (NN (furosemide)))) (, (,)) (drug_ENTITY (NP (NN (propranolol)))) (, (,)) (drug_ENTITY (NP (NN (captopril)))) (, (,)) (drug_ENTITY (NP (NN (nicardipine)))) (, (,)) (drug_ENTITY (NP (NN (pravastatin)))) (, (,)) (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (NE-Type-2-drug (NP (NN (phenytoin))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (ADJP (NN (protein)) (JJ (-bound)))) (NNS (drugs))) (PP (JJ (such)) (IN (as)) (NP (drug_ENTITY (NP (NN (furosemide)))) (, (,)) (drug_ENTITY (NP (NN (propranolol)))) (, (,)) (drug_ENTITY (NP (NN (captopril)))) (, (,)) (drug_ENTITY (NP (NN (nicardipine)))) (, (,)) (drug_ENTITY (NP (NN (pravastatin)))) (, (,)) (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (NE-Type-2-drug (NP (JJ (acetylsalicylic)) (NN (acid))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (ADJP (NN (protein)) (JJ (-bound)))) (NNS (drugs))) (PP (JJ (such)) (IN (as)) (NP (drug_ENTITY (NP (NN (furosemide)))) (, (,)) (drug_ENTITY (NP (NN (propranolol)))) (, (,)) (drug_ENTITY (NP (NN (captopril)))) (, (,)) (drug_ENTITY (NP (NN (nicardipine)))) (, (,)) (drug_ENTITY (NP (NN (pravastatin)))) (, (,)) (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (drug_ENTITY (NP (JJ (acetylsalicylic)) (NN (acid)))) (, (,)) (NE-Type-2-drug (NP (NN (tolbutamide))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (ADJP (NN (protein)) (JJ (-bound)))) (NNS (drugs))) (PP (JJ (such)) (IN (as)) (NP (drug_ENTITY (NP (NN (furosemide)))) (, (,)) (drug_ENTITY (NP (NN (propranolol)))) (, (,)) (drug_ENTITY (NP (NN (captopril)))) (, (,)) (drug_ENTITY (NP (NN (nicardipine)))) (, (,)) (drug_ENTITY (NP (NN (pravastatin)))) (, (,)) (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (drug_ENTITY (NP (JJ (acetylsalicylic)) (NN (acid)))) (, (,)) (drug_ENTITY (NP (NN (tolbutamide)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NN (metformin))))))) |ET|
-1  |BT|  (S (NP (PP (NP (NP (NE-Type-1-drug (ADJP (NN (protein)) (JJ (-bound)))) (NNS (drugs))) (PP (JJ (such)) (IN (as)) (NP (drug_ENTITY (NP (NN (furosemide)))) (, (,)) (drug_ENTITY (NP (NN (propranolol)))) (, (,)) (drug_ENTITY (NP (NN (captopril)))) (, (,)) (drug_ENTITY (NP (NN (nicardipine)))) (, (,)) (drug_ENTITY (NP (NN (pravastatin)))) (, (,)) (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (drug_ENTITY (NP (JJ (acetylsalicylic)) (NN (acid)))) (, (,)) (drug_ENTITY (NP (NN (tolbutamide)))) (, (,)) (CC (and)) (drug_ENTITY (NP (NN (metformin))))))))) (VP (VBD (showed)) (NP (NP (DT (no)) (NN (influence))) (PP (IN (on)) (NP (NP (DT (the)) (NN (extent))) (PP (IN (of)) (NE-Type-2-drug (NP (JJ (nateglinide)))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (furosemide)))) (, (,)) (NE-Type-2-drug (NP (NN (propranolol))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (furosemide)))) (, (,)) (drug_ENTITY (NP (NN (propranolol)))) (, (,)) (NE-Type-2-drug (NP (NN (captopril))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (furosemide)))) (, (,)) (drug_ENTITY (NP (NN (propranolol)))) (, (,)) (drug_ENTITY (NP (NN (captopril)))) (, (,)) (NE-Type-2-drug (NP (NN (nicardipine))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (furosemide)))) (, (,)) (drug_ENTITY (NP (NN (propranolol)))) (, (,)) (drug_ENTITY (NP (NN (captopril)))) (, (,)) (drug_ENTITY (NP (NN (nicardipine)))) (, (,)) (NE-Type-2-drug (NP (NN (pravastatin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (furosemide)))) (, (,)) (drug_ENTITY (NP (NN (propranolol)))) (, (,)) (drug_ENTITY (NP (NN (captopril)))) (, (,)) (drug_ENTITY (NP (NN (nicardipine)))) (, (,)) (drug_ENTITY (NP (NN (pravastatin)))) (, (,)) (NE-Type-2-drug (NP (NN (glyburide))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (furosemide)))) (, (,)) (drug_ENTITY (NP (NN (propranolol)))) (, (,)) (drug_ENTITY (NP (NN (captopril)))) (, (,)) (drug_ENTITY (NP (NN (nicardipine)))) (, (,)) (drug_ENTITY (NP (NN (pravastatin)))) (, (,)) (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (NE-Type-2-drug (NP (NN (warfarin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (furosemide)))) (, (,)) (drug_ENTITY (NP (NN (propranolol)))) (, (,)) (drug_ENTITY (NP (NN (captopril)))) (, (,)) (drug_ENTITY (NP (NN (nicardipine)))) (, (,)) (drug_ENTITY (NP (NN (pravastatin)))) (, (,)) (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (NE-Type-2-drug (NP (NN (phenytoin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (furosemide)))) (, (,)) (drug_ENTITY (NP (NN (propranolol)))) (, (,)) (drug_ENTITY (NP (NN (captopril)))) (, (,)) (drug_ENTITY (NP (NN (nicardipine)))) (, (,)) (drug_ENTITY (NP (NN (pravastatin)))) (, (,)) (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (NE-Type-2-drug (NP (JJ (acetylsalicylic)) (NN (acid))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (furosemide)))) (, (,)) (drug_ENTITY (NP (NN (propranolol)))) (, (,)) (drug_ENTITY (NP (NN (captopril)))) (, (,)) (drug_ENTITY (NP (NN (nicardipine)))) (, (,)) (drug_ENTITY (NP (NN (pravastatin)))) (, (,)) (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (drug_ENTITY (NP (JJ (acetylsalicylic)) (NN (acid)))) (, (,)) (NE-Type-2-drug (NP (NN (tolbutamide))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (furosemide)))) (, (,)) (drug_ENTITY (NP (NN (propranolol)))) (, (,)) (drug_ENTITY (NP (NN (captopril)))) (, (,)) (drug_ENTITY (NP (NN (nicardipine)))) (, (,)) (drug_ENTITY (NP (NN (pravastatin)))) (, (,)) (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (drug_ENTITY (NP (JJ (acetylsalicylic)) (NN (acid)))) (, (,)) (drug_ENTITY (NP (NN (tolbutamide)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NN (metformin))))) |ET|
-1  |BT|  (S (NP (PP (NP (PP (NP (NE-Type-1-drug (NP (NN (furosemide)))) (, (,)) (drug_ENTITY (NP (NN (propranolol)))) (, (,)) (drug_ENTITY (NP (NN (captopril)))) (, (,)) (drug_ENTITY (NP (NN (nicardipine)))) (, (,)) (drug_ENTITY (NP (NN (pravastatin)))) (, (,)) (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (drug_ENTITY (NP (JJ (acetylsalicylic)) (NN (acid)))) (, (,)) (drug_ENTITY (NP (NN (tolbutamide)))) (, (,)) (CC (and)) (drug_ENTITY (NP (NN (metformin))))))))) (VP (VBD (showed)) (NP (NP (DT (no)) (NN (influence))) (PP (IN (on)) (NP (NP (DT (the)) (NN (extent))) (PP (IN (of)) (NE-Type-2-drug (NP (JJ (nateglinide)))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (propranolol)))) (, (,)) (NE-Type-2-drug (NP (NN (captopril))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (propranolol)))) (, (,)) (drug_ENTITY (NP (NN (captopril)))) (, (,)) (NE-Type-2-drug (NP (NN (nicardipine))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (propranolol)))) (, (,)) (drug_ENTITY (NP (NN (captopril)))) (, (,)) (drug_ENTITY (NP (NN (nicardipine)))) (, (,)) (NE-Type-2-drug (NP (NN (pravastatin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (propranolol)))) (, (,)) (drug_ENTITY (NP (NN (captopril)))) (, (,)) (drug_ENTITY (NP (NN (nicardipine)))) (, (,)) (drug_ENTITY (NP (NN (pravastatin)))) (, (,)) (NE-Type-2-drug (NP (NN (glyburide))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (propranolol)))) (, (,)) (drug_ENTITY (NP (NN (captopril)))) (, (,)) (drug_ENTITY (NP (NN (nicardipine)))) (, (,)) (drug_ENTITY (NP (NN (pravastatin)))) (, (,)) (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (NE-Type-2-drug (NP (NN (warfarin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (propranolol)))) (, (,)) (drug_ENTITY (NP (NN (captopril)))) (, (,)) (drug_ENTITY (NP (NN (nicardipine)))) (, (,)) (drug_ENTITY (NP (NN (pravastatin)))) (, (,)) (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (NE-Type-2-drug (NP (NN (phenytoin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (propranolol)))) (, (,)) (drug_ENTITY (NP (NN (captopril)))) (, (,)) (drug_ENTITY (NP (NN (nicardipine)))) (, (,)) (drug_ENTITY (NP (NN (pravastatin)))) (, (,)) (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (NE-Type-2-drug (NP (JJ (acetylsalicylic)) (NN (acid))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (propranolol)))) (, (,)) (drug_ENTITY (NP (NN (captopril)))) (, (,)) (drug_ENTITY (NP (NN (nicardipine)))) (, (,)) (drug_ENTITY (NP (NN (pravastatin)))) (, (,)) (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (drug_ENTITY (NP (JJ (acetylsalicylic)) (NN (acid)))) (, (,)) (NE-Type-2-drug (NP (NN (tolbutamide))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (propranolol)))) (, (,)) (drug_ENTITY (NP (NN (captopril)))) (, (,)) (drug_ENTITY (NP (NN (nicardipine)))) (, (,)) (drug_ENTITY (NP (NN (pravastatin)))) (, (,)) (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (drug_ENTITY (NP (JJ (acetylsalicylic)) (NN (acid)))) (, (,)) (drug_ENTITY (NP (NN (tolbutamide)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NN (metformin))))) |ET|
-1  |BT|  (S (NP (PP (NP (PP (NP (NE-Type-1-drug (NP (NN (propranolol)))) (, (,)) (drug_ENTITY (NP (NN (captopril)))) (, (,)) (drug_ENTITY (NP (NN (nicardipine)))) (, (,)) (drug_ENTITY (NP (NN (pravastatin)))) (, (,)) (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (drug_ENTITY (NP (JJ (acetylsalicylic)) (NN (acid)))) (, (,)) (drug_ENTITY (NP (NN (tolbutamide)))) (, (,)) (CC (and)) (drug_ENTITY (NP (NN (metformin))))))))) (VP (VBD (showed)) (NP (NP (DT (no)) (NN (influence))) (PP (IN (on)) (NP (NP (DT (the)) (NN (extent))) (PP (IN (of)) (NE-Type-2-drug (NP (JJ (nateglinide)))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (captopril)))) (, (,)) (NE-Type-2-drug (NP (NN (nicardipine))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (captopril)))) (, (,)) (drug_ENTITY (NP (NN (nicardipine)))) (, (,)) (NE-Type-2-drug (NP (NN (pravastatin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (captopril)))) (, (,)) (drug_ENTITY (NP (NN (nicardipine)))) (, (,)) (drug_ENTITY (NP (NN (pravastatin)))) (, (,)) (NE-Type-2-drug (NP (NN (glyburide))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (captopril)))) (, (,)) (drug_ENTITY (NP (NN (nicardipine)))) (, (,)) (drug_ENTITY (NP (NN (pravastatin)))) (, (,)) (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (NE-Type-2-drug (NP (NN (warfarin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (captopril)))) (, (,)) (drug_ENTITY (NP (NN (nicardipine)))) (, (,)) (drug_ENTITY (NP (NN (pravastatin)))) (, (,)) (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (NE-Type-2-drug (NP (NN (phenytoin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (captopril)))) (, (,)) (drug_ENTITY (NP (NN (nicardipine)))) (, (,)) (drug_ENTITY (NP (NN (pravastatin)))) (, (,)) (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (NE-Type-2-drug (NP (JJ (acetylsalicylic)) (NN (acid))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (captopril)))) (, (,)) (drug_ENTITY (NP (NN (nicardipine)))) (, (,)) (drug_ENTITY (NP (NN (pravastatin)))) (, (,)) (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (drug_ENTITY (NP (JJ (acetylsalicylic)) (NN (acid)))) (, (,)) (NE-Type-2-drug (NP (NN (tolbutamide))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (captopril)))) (, (,)) (drug_ENTITY (NP (NN (nicardipine)))) (, (,)) (drug_ENTITY (NP (NN (pravastatin)))) (, (,)) (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (drug_ENTITY (NP (JJ (acetylsalicylic)) (NN (acid)))) (, (,)) (drug_ENTITY (NP (NN (tolbutamide)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NN (metformin))))) |ET|
-1  |BT|  (S (NP (PP (NP (PP (NP (NE-Type-1-drug (NP (NN (captopril)))) (, (,)) (drug_ENTITY (NP (NN (nicardipine)))) (, (,)) (drug_ENTITY (NP (NN (pravastatin)))) (, (,)) (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (drug_ENTITY (NP (JJ (acetylsalicylic)) (NN (acid)))) (, (,)) (drug_ENTITY (NP (NN (tolbutamide)))) (, (,)) (CC (and)) (drug_ENTITY (NP (NN (metformin))))))))) (VP (VBD (showed)) (NP (NP (DT (no)) (NN (influence))) (PP (IN (on)) (NP (NP (DT (the)) (NN (extent))) (PP (IN (of)) (NE-Type-2-drug (NP (JJ (nateglinide)))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (nicardipine)))) (, (,)) (NE-Type-2-drug (NP (NN (pravastatin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (nicardipine)))) (, (,)) (drug_ENTITY (NP (NN (pravastatin)))) (, (,)) (NE-Type-2-drug (NP (NN (glyburide))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (nicardipine)))) (, (,)) (drug_ENTITY (NP (NN (pravastatin)))) (, (,)) (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (NE-Type-2-drug (NP (NN (warfarin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (nicardipine)))) (, (,)) (drug_ENTITY (NP (NN (pravastatin)))) (, (,)) (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (NE-Type-2-drug (NP (NN (phenytoin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (nicardipine)))) (, (,)) (drug_ENTITY (NP (NN (pravastatin)))) (, (,)) (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (NE-Type-2-drug (NP (JJ (acetylsalicylic)) (NN (acid))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (nicardipine)))) (, (,)) (drug_ENTITY (NP (NN (pravastatin)))) (, (,)) (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (drug_ENTITY (NP (JJ (acetylsalicylic)) (NN (acid)))) (, (,)) (NE-Type-2-drug (NP (NN (tolbutamide))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (nicardipine)))) (, (,)) (drug_ENTITY (NP (NN (pravastatin)))) (, (,)) (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (drug_ENTITY (NP (JJ (acetylsalicylic)) (NN (acid)))) (, (,)) (drug_ENTITY (NP (NN (tolbutamide)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NN (metformin))))) |ET|
-1  |BT|  (S (NP (PP (NP (PP (NP (NE-Type-1-drug (NP (NN (nicardipine)))) (, (,)) (drug_ENTITY (NP (NN (pravastatin)))) (, (,)) (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (drug_ENTITY (NP (JJ (acetylsalicylic)) (NN (acid)))) (, (,)) (drug_ENTITY (NP (NN (tolbutamide)))) (, (,)) (CC (and)) (drug_ENTITY (NP (NN (metformin))))))))) (VP (VBD (showed)) (NP (NP (DT (no)) (NN (influence))) (PP (IN (on)) (NP (NP (DT (the)) (NN (extent))) (PP (IN (of)) (NE-Type-2-drug (NP (JJ (nateglinide)))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (pravastatin)))) (, (,)) (NE-Type-2-drug (NP (NN (glyburide))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (pravastatin)))) (, (,)) (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (NE-Type-2-drug (NP (NN (warfarin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (pravastatin)))) (, (,)) (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (NE-Type-2-drug (NP (NN (phenytoin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (pravastatin)))) (, (,)) (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (NE-Type-2-drug (NP (JJ (acetylsalicylic)) (NN (acid))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (pravastatin)))) (, (,)) (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (drug_ENTITY (NP (JJ (acetylsalicylic)) (NN (acid)))) (, (,)) (NE-Type-2-drug (NP (NN (tolbutamide))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (pravastatin)))) (, (,)) (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (drug_ENTITY (NP (JJ (acetylsalicylic)) (NN (acid)))) (, (,)) (drug_ENTITY (NP (NN (tolbutamide)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NN (metformin))))) |ET|
-1  |BT|  (S (NP (PP (NP (PP (NP (NE-Type-1-drug (NP (NN (pravastatin)))) (, (,)) (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (drug_ENTITY (NP (JJ (acetylsalicylic)) (NN (acid)))) (, (,)) (drug_ENTITY (NP (NN (tolbutamide)))) (, (,)) (CC (and)) (drug_ENTITY (NP (NN (metformin))))))))) (VP (VBD (showed)) (NP (NP (DT (no)) (NN (influence))) (PP (IN (on)) (NP (NP (DT (the)) (NN (extent))) (PP (IN (of)) (NE-Type-2-drug (NP (JJ (nateglinide)))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (glyburide)))) (, (,)) (NE-Type-2-drug (NP (NN (warfarin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (NE-Type-2-drug (NP (NN (phenytoin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (NE-Type-2-drug (NP (JJ (acetylsalicylic)) (NN (acid))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (drug_ENTITY (NP (JJ (acetylsalicylic)) (NN (acid)))) (, (,)) (NE-Type-2-drug (NP (NN (tolbutamide))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (drug_ENTITY (NP (JJ (acetylsalicylic)) (NN (acid)))) (, (,)) (drug_ENTITY (NP (NN (tolbutamide)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NN (metformin))))) |ET|
-1  |BT|  (S (NP (PP (NP (PP (NP (NE-Type-1-drug (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (drug_ENTITY (NP (JJ (acetylsalicylic)) (NN (acid)))) (, (,)) (drug_ENTITY (NP (NN (tolbutamide)))) (, (,)) (CC (and)) (drug_ENTITY (NP (NN (metformin))))))))) (VP (VBD (showed)) (NP (NP (DT (no)) (NN (influence))) (PP (IN (on)) (NP (NP (DT (the)) (NN (extent))) (PP (IN (of)) (NE-Type-2-drug (NP (JJ (nateglinide)))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (warfarin)))) (, (,)) (NE-Type-2-drug (NP (NN (phenytoin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (warfarin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (NE-Type-2-drug (NP (JJ (acetylsalicylic)) (NN (acid))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (warfarin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (drug_ENTITY (NP (JJ (acetylsalicylic)) (NN (acid)))) (, (,)) (NE-Type-2-drug (NP (NN (tolbutamide))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (warfarin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (drug_ENTITY (NP (JJ (acetylsalicylic)) (NN (acid)))) (, (,)) (drug_ENTITY (NP (NN (tolbutamide)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NN (metformin))))) |ET|
-1  |BT|  (S (NP (PP (NP (PP (NP (NE-Type-1-drug (NP (NN (warfarin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (drug_ENTITY (NP (JJ (acetylsalicylic)) (NN (acid)))) (, (,)) (drug_ENTITY (NP (NN (tolbutamide)))) (, (,)) (CC (and)) (drug_ENTITY (NP (NN (metformin))))))))) (VP (VBD (showed)) (NP (NP (DT (no)) (NN (influence))) (PP (IN (on)) (NP (NP (DT (the)) (NN (extent))) (PP (IN (of)) (NE-Type-2-drug (NP (JJ (nateglinide)))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (phenytoin)))) (, (,)) (NE-Type-2-drug (NP (JJ (acetylsalicylic)) (NN (acid))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (phenytoin)))) (, (,)) (drug_ENTITY (NP (JJ (acetylsalicylic)) (NN (acid)))) (, (,)) (NE-Type-2-drug (NP (NN (tolbutamide))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (phenytoin)))) (, (,)) (drug_ENTITY (NP (JJ (acetylsalicylic)) (NN (acid)))) (, (,)) (drug_ENTITY (NP (NN (tolbutamide)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NN (metformin))))) |ET|
-1  |BT|  (S (NP (PP (NP (PP (NP (NE-Type-1-drug (NP (NN (phenytoin)))) (, (,)) (drug_ENTITY (NP (JJ (acetylsalicylic)) (NN (acid)))) (, (,)) (drug_ENTITY (NP (NN (tolbutamide)))) (, (,)) (CC (and)) (drug_ENTITY (NP (NN (metformin))))))))) (VP (VBD (showed)) (NP (NP (DT (no)) (NN (influence))) (PP (IN (on)) (NP (NP (DT (the)) (NN (extent))) (PP (IN (of)) (NE-Type-2-drug (NP (JJ (nateglinide)))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (JJ (acetylsalicylic)) (NN (acid)))) (, (,)) (NE-Type-2-drug (NP (NN (tolbutamide))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (JJ (acetylsalicylic)) (NN (acid)))) (, (,)) (drug_ENTITY (NP (NN (tolbutamide)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NN (metformin))))) |ET|
-1  |BT|  (S (NP (PP (NP (PP (NP (NE-Type-1-drug (NP (JJ (acetylsalicylic)) (NN (acid)))) (, (,)) (drug_ENTITY (NP (NN (tolbutamide)))) (, (,)) (CC (and)) (drug_ENTITY (NP (NN (metformin))))))))) (VP (VBD (showed)) (NP (NP (DT (no)) (NN (influence))) (PP (IN (on)) (NP (NP (DT (the)) (NN (extent))) (PP (IN (of)) (NE-Type-2-drug (NP (JJ (nateglinide)))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (tolbutamide)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NN (metformin))))) |ET|
-1  |BT|  (S (NP (PP (NP (PP (NP (NE-Type-1-drug (NP (NN (tolbutamide)))) (, (,)) (CC (and)) (drug_ENTITY (NP (NN (metformin))))))))) (VP (VBD (showed)) (NP (NP (DT (no)) (NN (influence))) (PP (IN (on)) (NP (NP (DT (the)) (NN (extent))) (PP (IN (of)) (NE-Type-2-drug (NP (JJ (nateglinide)))))))))) |ET|
-1  |BT|  (S (NP (PP (NP (PP (NP (NE-Type-1-drug (NP (NN (metformin))))))))) (VP (VBD (showed)) (NP (NP (DT (no)) (NN (influence))) (PP (IN (on)) (NP (NP (DT (the)) (NN (extent))) (PP (IN (of)) (NE-Type-2-drug (NP (JJ (nateglinide)))))))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NN (nateglinide)))) (VP (VBD (had)) (NP (DT (no)) (NN (influence))) (PP (IN (on)) (NP (NE-Type-2-drug (NP (DT (the)) (NN (serum)) (NN (protein)) (NN (binding)))))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NN (nateglinide)))) (VP (VBD (had)) (NP (DT (no)) (NN (influence))) (PP (IN (on)) (NP (drug_ENTITY (NP (DT (the)) (NN (serum)) (NN (protein)) (NN (binding)))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (NN (propranolol)))))))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NN (nateglinide)))) (VP (VBD (had)) (NP (DT (no)) (NN (influence))) (PP (IN (on)) (NP (drug_ENTITY (NP (DT (the)) (NN (serum)) (NN (protein)) (NN (binding)))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (propranolol)))) (, (,)) (NE-Type-2-drug (NP (NN (glyburide)))))))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NN (nateglinide)))) (VP (VBD (had)) (NP (DT (no)) (NN (influence))) (PP (IN (on)) (NP (drug_ENTITY (NP (DT (the)) (NN (serum)) (NN (protein)) (NN (binding)))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (propranolol)))) (, (,)) (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (NE-Type-2-drug (NP (NN (nicardipine)))))))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NN (nateglinide)))) (VP (VBD (had)) (NP (DT (no)) (NN (influence))) (PP (IN (on)) (NP (drug_ENTITY (NP (DT (the)) (NN (serum)) (NN (protein)) (NN (binding)))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (propranolol)))) (, (,)) (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (nicardipine)))) (, (,)) (NE-Type-2-drug (NP (NN (warfarin)))))))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NN (nateglinide)))) (VP (VBD (had)) (NP (DT (no)) (NN (influence))) (PP (IN (on)) (NP (drug_ENTITY (NP (DT (the)) (NN (serum)) (NN (protein)) (NN (binding)))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (propranolol)))) (, (,)) (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (nicardipine)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (NE-Type-2-drug (NP (NN (phenytoin)))))))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NN (nateglinide)))) (VP (VBD (had)) (NP (DT (no)) (NN (influence))) (PP (IN (on)) (NP (drug_ENTITY (NP (DT (the)) (NN (serum)) (NN (protein)) (NN (binding)))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (propranolol)))) (, (,)) (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (nicardipine)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (NE-Type-2-drug (NP (JJ (acetylsalicylic)) (NN (acid)))))))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NN (nateglinide)))) (VP (VBD (had)) (NP (DT (no)) (NN (influence))) (PP (IN (on)) (NP (drug_ENTITY (NP (DT (the)) (NN (serum)) (NN (protein)) (NN (binding)))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (propranolol)))) (, (,)) (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (nicardipine)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (drug_ENTITY (NP (JJ (acetylsalicylic)) (NN (acid)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NN (tolbutamide)))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (protein)) (NN (binding)))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (NN (propranolol))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (protein)) (NN (binding)))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (propranolol)))) (, (,)) (NE-Type-2-drug (NP (NN (glyburide))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (protein)) (NN (binding)))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (propranolol)))) (, (,)) (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (NE-Type-2-drug (NP (NN (nicardipine))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (protein)) (NN (binding)))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (propranolol)))) (, (,)) (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (nicardipine)))) (, (,)) (NE-Type-2-drug (NP (NN (warfarin))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (protein)) (NN (binding)))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (propranolol)))) (, (,)) (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (nicardipine)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (NE-Type-2-drug (NP (NN (phenytoin))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (protein)) (NN (binding)))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (propranolol)))) (, (,)) (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (nicardipine)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (NE-Type-2-drug (NP (JJ (acetylsalicylic)) (NN (acid))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (protein)) (NN (binding)))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (propranolol)))) (, (,)) (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (nicardipine)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (drug_ENTITY (NP (JJ (acetylsalicylic)) (NN (acid)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NN (tolbutamide))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (propranolol)))) (, (,)) (NE-Type-2-drug (NP (NN (glyburide))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (propranolol)))) (, (,)) (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (NE-Type-2-drug (NP (NN (nicardipine))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (propranolol)))) (, (,)) (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (nicardipine)))) (, (,)) (NE-Type-2-drug (NP (NN (warfarin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (propranolol)))) (, (,)) (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (nicardipine)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (NE-Type-2-drug (NP (NN (phenytoin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (propranolol)))) (, (,)) (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (nicardipine)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (NE-Type-2-drug (NP (JJ (acetylsalicylic)) (NN (acid))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (propranolol)))) (, (,)) (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (nicardipine)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (drug_ENTITY (NP (JJ (acetylsalicylic)) (NN (acid)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NN (tolbutamide))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (glyburide)))) (, (,)) (NE-Type-2-drug (NP (NN (nicardipine))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (nicardipine)))) (, (,)) (NE-Type-2-drug (NP (NN (warfarin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (nicardipine)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (NE-Type-2-drug (NP (NN (phenytoin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (nicardipine)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (NE-Type-2-drug (NP (JJ (acetylsalicylic)) (NN (acid))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (nicardipine)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (drug_ENTITY (NP (JJ (acetylsalicylic)) (NN (acid)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NN (tolbutamide))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (nicardipine)))) (, (,)) (NE-Type-2-drug (NP (NN (warfarin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (nicardipine)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (NE-Type-2-drug (NP (NN (phenytoin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (nicardipine)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (NE-Type-2-drug (NP (JJ (acetylsalicylic)) (NN (acid))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (nicardipine)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (drug_ENTITY (NP (JJ (acetylsalicylic)) (NN (acid)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NN (tolbutamide))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (warfarin)))) (, (,)) (NE-Type-2-drug (NP (NN (phenytoin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (warfarin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (NE-Type-2-drug (NP (JJ (acetylsalicylic)) (NN (acid))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (warfarin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (drug_ENTITY (NP (JJ (acetylsalicylic)) (NN (acid)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NN (tolbutamide))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (phenytoin)))) (, (,)) (NE-Type-2-drug (NP (JJ (acetylsalicylic)) (NN (acid))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (phenytoin)))) (, (,)) (drug_ENTITY (NP (JJ (acetylsalicylic)) (NN (acid)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NN (tolbutamide))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (JJ (acetylsalicylic)) (NN (acid)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NN (tolbutamide))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (drugs)))) (, (,)) (PP (VBG (including)) (NP (NP (NE-Type-2-drug (NP (JJ (nonsteroidal)) (JJ (anti-inflammatory)) (NNS (agents)))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (drugs)))) (, (,)) (PP (VBG (including)) (NP (NP (drug_ENTITY (NP (JJ (nonsteroidal)) (JJ (anti-inflammatory)) (NNS (agents)))) (PRN (-LRB- (<LB>)) (NE-Type-2-drug (NP (NNS (NSAIDs))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (drugs)))) (, (,)) (PP (VBG (including)) (NP (NP (drug_ENTITY (NP (JJ (nonsteroidal)) (JJ (anti-inflammatory)) (NNS (agents)))) (PRN (-LRB- (<LB>)) (drug_ENTITY (NP (NNS (NSAIDs)))) (-RRB- (<RB>)))) (, (,)) (NE-Type-2-drug (NP (NNS (salicylates))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (drugs)))) (, (,)) (PP (VBG (including)) (NP (NP (drug_ENTITY (NP (JJ (nonsteroidal)) (JJ (anti-inflammatory)) (NNS (agents)))) (PRN (-LRB- (<LB>)) (drug_ENTITY (NP (NNS (NSAIDs)))) (-RRB- (<RB>)))) (, (,)) (drug_ENTITY (NP (NNS (salicylates)))) (, (,)) (NE-Type-2-drug (NP (NP (NN (monoamine)) (NN (oxidase))) (NNS (inhibitors))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (drugs)))) (, (,)) (PP (VBG (including)) (NP (NP (drug_ENTITY (NP (JJ (nonsteroidal)) (JJ (anti-inflammatory)) (NNS (agents)))) (PRN (-LRB- (<LB>)) (drug_ENTITY (NP (NNS (NSAIDs)))) (-RRB- (<RB>)))) (, (,)) (drug_ENTITY (NP (NNS (salicylates)))) (, (,)) (drug_ENTITY (NP (NP (NN (monoamine)) (NN (oxidase))) (NNS (inhibitors)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (JJ (non-selective)) (JJ (beta-adrenergic-blocking)) (NNS (agents))))))) |ET|
-1  |BT|  (S (NP (NE-Type-1-drug (NP (NNS (drugs)))) (, (,)) (PP (VBG (including)) (NP (NP (drug_ENTITY (NP (JJ (nonsteroidal)) (JJ (anti-inflammatory)) (NNS (agents)))) (PRN (-LRB- (<LB>)) (drug_ENTITY (NP (NNS (NSAIDs)))) (-RRB- (<RB>)))) (, (,)) (drug_ENTITY (NP (NNS (salicylates)))) (, (,)) (drug_ENTITY (NP (NP (NN (monoamine)) (NN (oxidase))) (NNS (inhibitors)))) (, (,)) (CC (and)) (drug_ENTITY (NP (JJ (non-selective)) (JJ (beta-adrenergic-blocking)) (NNS (agents))))))) (VP (MD (may)) (VP (VB (potentiate)) (NP (NE-Type-2-drug (NP (DT (the)) (JJ (hypoglycemic)) (NN (action)))))))) |ET|
-1  |BT|  (S (NP (NE-Type-1-drug (NP (NNS (drugs)))) (, (,)) (PP (VBG (including)) (NP (NP (drug_ENTITY (NP (JJ (nonsteroidal)) (JJ (anti-inflammatory)) (NNS (agents)))) (PRN (-LRB- (<LB>)) (drug_ENTITY (NP (NNS (NSAIDs)))) (-RRB- (<RB>)))) (, (,)) (drug_ENTITY (NP (NNS (salicylates)))) (, (,)) (drug_ENTITY (NP (NP (NN (monoamine)) (NN (oxidase))) (NNS (inhibitors)))) (, (,)) (CC (and)) (drug_ENTITY (NP (JJ (non-selective)) (JJ (beta-adrenergic-blocking)) (NNS (agents))))))) (VP (MD (may)) (VP (VB (potentiate)) (NP (drug_ENTITY (NP (DT (the)) (JJ (hypoglycemic)) (NN (action)))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (NN (Starlix)))))))))) |ET|
-1  |BT|  (S (NP (NE-Type-1-drug (NP (NNS (drugs)))) (, (,)) (PP (VBG (including)) (NP (NP (drug_ENTITY (NP (JJ (nonsteroidal)) (JJ (anti-inflammatory)) (NNS (agents)))) (PRN (-LRB- (<LB>)) (drug_ENTITY (NP (NNS (NSAIDs)))) (-RRB- (<RB>)))) (, (,)) (drug_ENTITY (NP (NNS (salicylates)))) (, (,)) (drug_ENTITY (NP (NP (NN (monoamine)) (NN (oxidase))) (NNS (inhibitors)))) (, (,)) (CC (and)) (drug_ENTITY (NP (JJ (non-selective)) (JJ (beta-adrenergic-blocking)) (NNS (agents))))))) (VP (MD (may)) (VP (VB (potentiate)) (NP (drug_ENTITY (NP (DT (the)) (JJ (hypoglycemic)) (NN (action)))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (Starlix)))) (CC (and)) (NE-Type-2-drug (NP (JJ (other)) (JJ (oral)) (JJ (antidiabetic)) (NNS (drugs)))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (JJ (nonsteroidal)) (JJ (anti-inflammatory)) (NNS (agents)))) (PRN (-LRB- (<LB>)) (NE-Type-2-drug (NP (NNS (NSAIDs)))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (JJ (nonsteroidal)) (JJ (anti-inflammatory)) (NNS (agents)))) (PRN (-LRB- (<LB>)) (drug_ENTITY (NP (NNS (NSAIDs)))) (-RRB- (<RB>)))) (, (,)) (NE-Type-2-drug (NP (NNS (salicylates))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (JJ (nonsteroidal)) (JJ (anti-inflammatory)) (NNS (agents)))) (PRN (-LRB- (<LB>)) (drug_ENTITY (NP (NNS (NSAIDs)))) (-RRB- (<RB>)))) (, (,)) (drug_ENTITY (NP (NNS (salicylates)))) (, (,)) (NE-Type-2-drug (NP (NP (NN (monoamine)) (NN (oxidase))) (NNS (inhibitors))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (JJ (nonsteroidal)) (JJ (anti-inflammatory)) (NNS (agents)))) (PRN (-LRB- (<LB>)) (drug_ENTITY (NP (NNS (NSAIDs)))) (-RRB- (<RB>)))) (, (,)) (drug_ENTITY (NP (NNS (salicylates)))) (, (,)) (drug_ENTITY (NP (NP (NN (monoamine)) (NN (oxidase))) (NNS (inhibitors)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (JJ (non-selective)) (JJ (beta-adrenergic-blocking)) (NNS (agents))))) |ET|
-1  |BT|  (S (NP (PP (NP (NP (NE-Type-1-drug (NP (JJ (nonsteroidal)) (JJ (anti-inflammatory)) (NNS (agents)))) (PRN (-LRB- (<LB>)) (drug_ENTITY (NP (NNS (NSAIDs)))) (-RRB- (<RB>)))) (, (,)) (drug_ENTITY (NP (NNS (salicylates)))) (, (,)) (drug_ENTITY (NP (NP (NN (monoamine)) (NN (oxidase))) (NNS (inhibitors)))) (, (,)) (CC (and)) (drug_ENTITY (NP (JJ (non-selective)) (JJ (beta-adrenergic-blocking)) (NNS (agents))))))) (VP (MD (may)) (VP (VB (potentiate)) (NP (NE-Type-2-drug (NP (DT (the)) (JJ (hypoglycemic)) (NN (action)))))))) |ET|
-1  |BT|  (S (NP (PP (NP (NP (NE-Type-1-drug (NP (JJ (nonsteroidal)) (JJ (anti-inflammatory)) (NNS (agents)))) (PRN (-LRB- (<LB>)) (drug_ENTITY (NP (NNS (NSAIDs)))) (-RRB- (<RB>)))) (, (,)) (drug_ENTITY (NP (NNS (salicylates)))) (, (,)) (drug_ENTITY (NP (NP (NN (monoamine)) (NN (oxidase))) (NNS (inhibitors)))) (, (,)) (CC (and)) (drug_ENTITY (NP (JJ (non-selective)) (JJ (beta-adrenergic-blocking)) (NNS (agents))))))) (VP (MD (may)) (VP (VB (potentiate)) (NP (drug_ENTITY (NP (DT (the)) (JJ (hypoglycemic)) (NN (action)))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (NN (Starlix)))))))))) |ET|
-1  |BT|  (S (NP (PP (NP (NP (NE-Type-1-drug (NP (JJ (nonsteroidal)) (JJ (anti-inflammatory)) (NNS (agents)))) (PRN (-LRB- (<LB>)) (drug_ENTITY (NP (NNS (NSAIDs)))) (-RRB- (<RB>)))) (, (,)) (drug_ENTITY (NP (NNS (salicylates)))) (, (,)) (drug_ENTITY (NP (NP (NN (monoamine)) (NN (oxidase))) (NNS (inhibitors)))) (, (,)) (CC (and)) (drug_ENTITY (NP (JJ (non-selective)) (JJ (beta-adrenergic-blocking)) (NNS (agents))))))) (VP (MD (may)) (VP (VB (potentiate)) (NP (drug_ENTITY (NP (DT (the)) (JJ (hypoglycemic)) (NN (action)))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (Starlix)))) (CC (and)) (NE-Type-2-drug (NP (JJ (other)) (JJ (oral)) (JJ (antidiabetic)) (NNS (drugs)))))))))) |ET|
-1  |BT|  (NP (NP (PRN (NE-Type-1-drug (NP (NNS (NSAIDs)))) (-RRB- (<RB>)))) (, (,)) (NE-Type-2-drug (NP (NNS (salicylates))))) |ET|
-1  |BT|  (NP (NP (PRN (NE-Type-1-drug (NP (NNS (NSAIDs)))) (-RRB- (<RB>)))) (, (,)) (drug_ENTITY (NP (NNS (salicylates)))) (, (,)) (NE-Type-2-drug (NP (NP (NN (monoamine)) (NN (oxidase))) (NNS (inhibitors))))) |ET|
-1  |BT|  (NP (NP (PRN (NE-Type-1-drug (NP (NNS (NSAIDs)))) (-RRB- (<RB>)))) (, (,)) (drug_ENTITY (NP (NNS (salicylates)))) (, (,)) (drug_ENTITY (NP (NP (NN (monoamine)) (NN (oxidase))) (NNS (inhibitors)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (JJ (non-selective)) (JJ (beta-adrenergic-blocking)) (NNS (agents))))) |ET|
-1  |BT|  (S (NP (PP (NP (NP (PRN (NE-Type-1-drug (NP (NNS (NSAIDs)))) (-RRB- (<RB>)))) (, (,)) (drug_ENTITY (NP (NNS (salicylates)))) (, (,)) (drug_ENTITY (NP (NP (NN (monoamine)) (NN (oxidase))) (NNS (inhibitors)))) (, (,)) (CC (and)) (drug_ENTITY (NP (JJ (non-selective)) (JJ (beta-adrenergic-blocking)) (NNS (agents))))))) (VP (MD (may)) (VP (VB (potentiate)) (NP (NE-Type-2-drug (NP (DT (the)) (JJ (hypoglycemic)) (NN (action)))))))) |ET|
-1  |BT|  (S (NP (PP (NP (NP (PRN (NE-Type-1-drug (NP (NNS (NSAIDs)))) (-RRB- (<RB>)))) (, (,)) (drug_ENTITY (NP (NNS (salicylates)))) (, (,)) (drug_ENTITY (NP (NP (NN (monoamine)) (NN (oxidase))) (NNS (inhibitors)))) (, (,)) (CC (and)) (drug_ENTITY (NP (JJ (non-selective)) (JJ (beta-adrenergic-blocking)) (NNS (agents))))))) (VP (MD (may)) (VP (VB (potentiate)) (NP (drug_ENTITY (NP (DT (the)) (JJ (hypoglycemic)) (NN (action)))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (NN (Starlix)))))))))) |ET|
-1  |BT|  (S (NP (PP (NP (NP (PRN (NE-Type-1-drug (NP (NNS (NSAIDs)))) (-RRB- (<RB>)))) (, (,)) (drug_ENTITY (NP (NNS (salicylates)))) (, (,)) (drug_ENTITY (NP (NP (NN (monoamine)) (NN (oxidase))) (NNS (inhibitors)))) (, (,)) (CC (and)) (drug_ENTITY (NP (JJ (non-selective)) (JJ (beta-adrenergic-blocking)) (NNS (agents))))))) (VP (MD (may)) (VP (VB (potentiate)) (NP (drug_ENTITY (NP (DT (the)) (JJ (hypoglycemic)) (NN (action)))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (Starlix)))) (CC (and)) (NE-Type-2-drug (NP (JJ (other)) (JJ (oral)) (JJ (antidiabetic)) (NNS (drugs)))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (salicylates)))) (, (,)) (NE-Type-2-drug (NP (NP (NN (monoamine)) (NN (oxidase))) (NNS (inhibitors))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (salicylates)))) (, (,)) (drug_ENTITY (NP (NP (NN (monoamine)) (NN (oxidase))) (NNS (inhibitors)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (JJ (non-selective)) (JJ (beta-adrenergic-blocking)) (NNS (agents))))) |ET|
-1  |BT|  (S (NP (PP (NP (NE-Type-1-drug (NP (NNS (salicylates)))) (, (,)) (drug_ENTITY (NP (NP (NN (monoamine)) (NN (oxidase))) (NNS (inhibitors)))) (, (,)) (CC (and)) (drug_ENTITY (NP (JJ (non-selective)) (JJ (beta-adrenergic-blocking)) (NNS (agents))))))) (VP (MD (may)) (VP (VB (potentiate)) (NP (NE-Type-2-drug (NP (DT (the)) (JJ (hypoglycemic)) (NN (action)))))))) |ET|
-1  |BT|  (S (NP (PP (NP (NE-Type-1-drug (NP (NNS (salicylates)))) (, (,)) (drug_ENTITY (NP (NP (NN (monoamine)) (NN (oxidase))) (NNS (inhibitors)))) (, (,)) (CC (and)) (drug_ENTITY (NP (JJ (non-selective)) (JJ (beta-adrenergic-blocking)) (NNS (agents))))))) (VP (MD (may)) (VP (VB (potentiate)) (NP (drug_ENTITY (NP (DT (the)) (JJ (hypoglycemic)) (NN (action)))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (NN (Starlix)))))))))) |ET|
-1  |BT|  (S (NP (PP (NP (NE-Type-1-drug (NP (NNS (salicylates)))) (, (,)) (drug_ENTITY (NP (NP (NN (monoamine)) (NN (oxidase))) (NNS (inhibitors)))) (, (,)) (CC (and)) (drug_ENTITY (NP (JJ (non-selective)) (JJ (beta-adrenergic-blocking)) (NNS (agents))))))) (VP (MD (may)) (VP (VB (potentiate)) (NP (drug_ENTITY (NP (DT (the)) (JJ (hypoglycemic)) (NN (action)))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (Starlix)))) (CC (and)) (NE-Type-2-drug (NP (JJ (other)) (JJ (oral)) (JJ (antidiabetic)) (NNS (drugs)))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NP (NN (monoamine)) (NN (oxidase))) (NNS (inhibitors)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (JJ (non-selective)) (JJ (beta-adrenergic-blocking)) (NNS (agents))))) |ET|
-1  |BT|  (S (NP (PP (NP (NE-Type-1-drug (NP (NP (NN (monoamine)) (NN (oxidase))) (NNS (inhibitors)))) (, (,)) (CC (and)) (drug_ENTITY (NP (JJ (non-selective)) (JJ (beta-adrenergic-blocking)) (NNS (agents))))))) (VP (MD (may)) (VP (VB (potentiate)) (NP (NE-Type-2-drug (NP (DT (the)) (JJ (hypoglycemic)) (NN (action)))))))) |ET|
-1  |BT|  (S (NP (PP (NP (NE-Type-1-drug (NP (NP (NN (monoamine)) (NN (oxidase))) (NNS (inhibitors)))) (, (,)) (CC (and)) (drug_ENTITY (NP (JJ (non-selective)) (JJ (beta-adrenergic-blocking)) (NNS (agents))))))) (VP (MD (may)) (VP (VB (potentiate)) (NP (drug_ENTITY (NP (DT (the)) (JJ (hypoglycemic)) (NN (action)))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (NN (Starlix)))))))))) |ET|
-1  |BT|  (S (NP (PP (NP (NE-Type-1-drug (NP (NP (NN (monoamine)) (NN (oxidase))) (NNS (inhibitors)))) (, (,)) (CC (and)) (drug_ENTITY (NP (JJ (non-selective)) (JJ (beta-adrenergic-blocking)) (NNS (agents))))))) (VP (MD (may)) (VP (VB (potentiate)) (NP (drug_ENTITY (NP (DT (the)) (JJ (hypoglycemic)) (NN (action)))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (Starlix)))) (CC (and)) (NE-Type-2-drug (NP (JJ (other)) (JJ (oral)) (JJ (antidiabetic)) (NNS (drugs)))))))))) |ET|
-1  |BT|  (S (NP (PP (NP (NE-Type-1-drug (NP (JJ (non-selective)) (JJ (beta-adrenergic-blocking)) (NNS (agents))))))) (VP (MD (may)) (VP (VB (potentiate)) (NP (NE-Type-2-drug (NP (DT (the)) (JJ (hypoglycemic)) (NN (action)))))))) |ET|
-1  |BT|  (S (NP (PP (NP (NE-Type-1-drug (NP (JJ (non-selective)) (JJ (beta-adrenergic-blocking)) (NNS (agents))))))) (VP (MD (may)) (VP (VB (potentiate)) (NP (drug_ENTITY (NP (DT (the)) (JJ (hypoglycemic)) (NN (action)))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (NN (Starlix)))))))))) |ET|
-1  |BT|  (S (NP (PP (NP (NE-Type-1-drug (NP (JJ (non-selective)) (JJ (beta-adrenergic-blocking)) (NNS (agents))))))) (VP (MD (may)) (VP (VB (potentiate)) (NP (drug_ENTITY (NP (DT (the)) (JJ (hypoglycemic)) (NN (action)))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (Starlix)))) (CC (and)) (NE-Type-2-drug (NP (JJ (other)) (JJ (oral)) (JJ (antidiabetic)) (NNS (drugs)))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (JJ (hypoglycemic)) (NN (action)))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (NN (Starlix))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (JJ (hypoglycemic)) (NN (action)))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (Starlix)))) (CC (and)) (NE-Type-2-drug (NP (JJ (other)) (JJ (oral)) (JJ (antidiabetic)) (NNS (drugs))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Starlix)))) (CC (and)) (NE-Type-2-drug (NP (JJ (other)) (JJ (oral)) (JJ (antidiabetic)) (NNS (drugs))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (drugs)))) (PP (VBG (including)) (NP (NE-Type-2-drug (NP (NNS (thiazides))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (drugs)))) (PP (VBG (including)) (NP (drug_ENTITY (NP (NNS (thiazides)))) (, (,)) (NE-Type-2-drug (NP (NNS (corticosteroids))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (drugs)))) (PP (VBG (including)) (NP (drug_ENTITY (NP (NNS (thiazides)))) (, (,)) (drug_ENTITY (NP (NNS (corticosteroids)))) (, (,)) (NE-Type-2-drug (NP (NN (thyroid))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (drugs)))) (PP (VBG (including)) (NP (drug_ENTITY (NP (NNS (thiazides)))) (, (,)) (drug_ENTITY (NP (NNS (corticosteroids)))) (, (,)) (drug_ENTITY (NP (NN (thyroid)) (NNS (products)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NNS (sympathomimetics))))))) |ET|
-1  |BT|  (S (NP (NE-Type-1-drug (NP (NNS (drugs)))) (PP (VBG (including)) (NP (drug_ENTITY (NP (NNS (thiazides)))) (, (,)) (drug_ENTITY (NP (NNS (corticosteroids)))) (, (,)) (drug_ENTITY (NP (NN (thyroid)) (NNS (products)))) (, (,)) (CC (and)) (drug_ENTITY (NP (NNS (sympathomimetics))))))) (VP (MD (may)) (VP (VB (reduce)) (NP (NE-Type-2-drug (NP (DT (the)) (JJ (hypoglycemic)) (NN (action)))))))) |ET|
-1  |BT|  (S (NP (NE-Type-1-drug (NP (NNS (drugs)))) (PP (VBG (including)) (NP (drug_ENTITY (NP (NNS (thiazides)))) (, (,)) (drug_ENTITY (NP (NNS (corticosteroids)))) (, (,)) (drug_ENTITY (NP (NN (thyroid)) (NNS (products)))) (, (,)) (CC (and)) (drug_ENTITY (NP (NNS (sympathomimetics))))))) (VP (MD (may)) (VP (VB (reduce)) (NP (drug_ENTITY (NP (DT (the)) (JJ (hypoglycemic)) (NN (action)))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (NN (Starlix)))))))))) |ET|
-1  |BT|  (S (NP (NE-Type-1-drug (NP (NNS (drugs)))) (PP (VBG (including)) (NP (drug_ENTITY (NP (NNS (thiazides)))) (, (,)) (drug_ENTITY (NP (NNS (corticosteroids)))) (, (,)) (drug_ENTITY (NP (NN (thyroid)) (NNS (products)))) (, (,)) (CC (and)) (drug_ENTITY (NP (NNS (sympathomimetics))))))) (VP (MD (may)) (VP (VB (reduce)) (NP (drug_ENTITY (NP (DT (the)) (JJ (hypoglycemic)) (NN (action)))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (Starlix)))) (CC (and)) (NE-Type-2-drug (NP (JJ (other)) (JJ (oral)) (JJ (antidiabetic)) (NNS (drugs)))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (thiazides)))) (, (,)) (NE-Type-2-drug (NP (NNS (corticosteroids))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (thiazides)))) (, (,)) (drug_ENTITY (NP (NNS (corticosteroids)))) (, (,)) (NE-Type-2-drug (NP (NN (thyroid))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (thiazides)))) (, (,)) (drug_ENTITY (NP (NNS (corticosteroids)))) (, (,)) (drug_ENTITY (NP (NN (thyroid)) (NNS (products)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NNS (sympathomimetics))))) |ET|
-1  |BT|  (S (NP (PP (NP (NE-Type-1-drug (NP (NNS (thiazides)))) (, (,)) (drug_ENTITY (NP (NNS (corticosteroids)))) (, (,)) (drug_ENTITY (NP (NN (thyroid)) (NNS (products)))) (, (,)) (CC (and)) (drug_ENTITY (NP (NNS (sympathomimetics))))))) (VP (MD (may)) (VP (VB (reduce)) (NP (NE-Type-2-drug (NP (DT (the)) (JJ (hypoglycemic)) (NN (action)))))))) |ET|
-1  |BT|  (S (NP (PP (NP (NE-Type-1-drug (NP (NNS (thiazides)))) (, (,)) (drug_ENTITY (NP (NNS (corticosteroids)))) (, (,)) (drug_ENTITY (NP (NN (thyroid)) (NNS (products)))) (, (,)) (CC (and)) (drug_ENTITY (NP (NNS (sympathomimetics))))))) (VP (MD (may)) (VP (VB (reduce)) (NP (drug_ENTITY (NP (DT (the)) (JJ (hypoglycemic)) (NN (action)))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (NN (Starlix)))))))))) |ET|
-1  |BT|  (S (NP (PP (NP (NE-Type-1-drug (NP (NNS (thiazides)))) (, (,)) (drug_ENTITY (NP (NNS (corticosteroids)))) (, (,)) (drug_ENTITY (NP (NN (thyroid)) (NNS (products)))) (, (,)) (CC (and)) (drug_ENTITY (NP (NNS (sympathomimetics))))))) (VP (MD (may)) (VP (VB (reduce)) (NP (drug_ENTITY (NP (DT (the)) (JJ (hypoglycemic)) (NN (action)))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (Starlix)))) (CC (and)) (NE-Type-2-drug (NP (JJ (other)) (JJ (oral)) (JJ (antidiabetic)) (NNS (drugs)))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (corticosteroids)))) (, (,)) (NE-Type-2-drug (NP (NN (thyroid))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (corticosteroids)))) (, (,)) (drug_ENTITY (NP (NN (thyroid)) (NNS (products)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NNS (sympathomimetics))))) |ET|
-1  |BT|  (S (NP (PP (NP (NE-Type-1-drug (NP (NNS (corticosteroids)))) (, (,)) (drug_ENTITY (NP (NN (thyroid)) (NNS (products)))) (, (,)) (CC (and)) (drug_ENTITY (NP (NNS (sympathomimetics))))))) (VP (MD (may)) (VP (VB (reduce)) (NP (NE-Type-2-drug (NP (DT (the)) (JJ (hypoglycemic)) (NN (action)))))))) |ET|
-1  |BT|  (S (NP (PP (NP (NE-Type-1-drug (NP (NNS (corticosteroids)))) (, (,)) (drug_ENTITY (NP (NN (thyroid)) (NNS (products)))) (, (,)) (CC (and)) (drug_ENTITY (NP (NNS (sympathomimetics))))))) (VP (MD (may)) (VP (VB (reduce)) (NP (drug_ENTITY (NP (DT (the)) (JJ (hypoglycemic)) (NN (action)))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (NN (Starlix)))))))))) |ET|
-1  |BT|  (S (NP (PP (NP (NE-Type-1-drug (NP (NNS (corticosteroids)))) (, (,)) (drug_ENTITY (NP (NN (thyroid)) (NNS (products)))) (, (,)) (CC (and)) (drug_ENTITY (NP (NNS (sympathomimetics))))))) (VP (MD (may)) (VP (VB (reduce)) (NP (drug_ENTITY (NP (DT (the)) (JJ (hypoglycemic)) (NN (action)))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (Starlix)))) (CC (and)) (NE-Type-2-drug (NP (JJ (other)) (JJ (oral)) (JJ (antidiabetic)) (NNS (drugs)))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (thyroid)) (NNS (products)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NNS (sympathomimetics))))) |ET|
-1  |BT|  (S (NP (PP (NP (NE-Type-1-drug (NP (NN (thyroid)) (NNS (products)))) (, (,)) (CC (and)) (drug_ENTITY (NP (NNS (sympathomimetics))))))) (VP (MD (may)) (VP (VB (reduce)) (NP (NE-Type-2-drug (NP (DT (the)) (JJ (hypoglycemic)) (NN (action)))))))) |ET|
-1  |BT|  (S (NP (PP (NP (NE-Type-1-drug (NP (NN (thyroid)) (NNS (products)))) (, (,)) (CC (and)) (drug_ENTITY (NP (NNS (sympathomimetics))))))) (VP (MD (may)) (VP (VB (reduce)) (NP (drug_ENTITY (NP (DT (the)) (JJ (hypoglycemic)) (NN (action)))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (NN (Starlix)))))))))) |ET|
-1  |BT|  (S (NP (PP (NP (NE-Type-1-drug (NP (NN (thyroid)) (NNS (products)))) (, (,)) (CC (and)) (drug_ENTITY (NP (NNS (sympathomimetics))))))) (VP (MD (may)) (VP (VB (reduce)) (NP (drug_ENTITY (NP (DT (the)) (JJ (hypoglycemic)) (NN (action)))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (Starlix)))) (CC (and)) (NE-Type-2-drug (NP (JJ (other)) (JJ (oral)) (JJ (antidiabetic)) (NNS (drugs)))))))))) |ET|
-1  |BT|  (S (NP (PP (NP (NE-Type-1-drug (NP (NNS (sympathomimetics))))))) (VP (MD (may)) (VP (VB (reduce)) (NP (NE-Type-2-drug (NP (DT (the)) (JJ (hypoglycemic)) (NN (action)))))))) |ET|
-1  |BT|  (S (NP (PP (NP (NE-Type-1-drug (NP (NNS (sympathomimetics))))))) (VP (MD (may)) (VP (VB (reduce)) (NP (drug_ENTITY (NP (DT (the)) (JJ (hypoglycemic)) (NN (action)))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (NN (Starlix)))))))))) |ET|
-1  |BT|  (S (NP (PP (NP (NE-Type-1-drug (NP (NNS (sympathomimetics))))))) (VP (MD (may)) (VP (VB (reduce)) (NP (drug_ENTITY (NP (DT (the)) (JJ (hypoglycemic)) (NN (action)))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (Starlix)))) (CC (and)) (NE-Type-2-drug (NP (JJ (other)) (JJ (oral)) (JJ (antidiabetic)) (NNS (drugs)))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (JJ (hypoglycemic)) (NN (action)))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (NN (Starlix))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (JJ (hypoglycemic)) (NN (action)))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (Starlix)))) (CC (and)) (NE-Type-2-drug (NP (JJ (other)) (JJ (oral)) (JJ (antidiabetic)) (NNS (drugs))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Starlix)))) (CC (and)) (NE-Type-2-drug (NP (JJ (other)) (JJ (oral)) (JJ (antidiabetic)) (NNS (drugs))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NNS (drugs)))) (VP (VBP (are)) (VP (VP (VBN (administered)) (PP (TO (to)))) (CC (or)) (VP (VBN (withdrawn)) (PP (IN (from)) (NP (NP (NNS (patients))) (VP (VBG (receiving)) (NE-Type-2-drug (NP (NN (Starlix))))))))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NN (Tilade)))) (VP (VBZ (has)) (VP (VBN (been)) (VP (VBN (co-administered)) (PP (IN (with)) (NP (NP (NE-Type-2-drug (NP (JJ (other)) (NN (anti-asthma)) (NNS (medications))))))))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NN (Tilade)))) (VP (VBZ (has)) (VP (VBN (been)) (VP (VBN (co-administered)) (PP (IN (with)) (NP (NP (drug_ENTITY (NP (JJ (other)) (NN (anti-asthma)) (NNS (medications)))) (, (,)) (PP (VBG (including)) (NE-Type-2-drug (NP (JJ (inhaled)) (CC (and)) (JJ (oral)) (NNS (bronchodilators)))))))))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NN (Tilade)))) (VP (VBZ (has)) (VP (VBN (been)) (VP (VBN (co-administered)) (PP (IN (with)) (NP (NP (drug_ENTITY (NP (JJ (other)) (NN (anti-asthma)) (NNS (medications)))) (, (,)) (PP (VBG (including)) (drug_ENTITY (NP (JJ (inhaled)) (CC (and)) (JJ (oral)) (NNS (bronchodilators))))) (, (,))) (CC (and)) (NE-Type-2-drug (NP (JJ (inhaled)) (NNS (corticosteroids)))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (anti-asthma)) (NNS (medications)))) (, (,)) (PP (VBG (including)) (NE-Type-2-drug (NP (JJ (inhaled)) (CC (and)) (JJ (oral)) (NNS (bronchodilators)))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (anti-asthma)) (NNS (medications)))) (, (,)) (PP (VBG (including)) (drug_ENTITY (NP (JJ (inhaled)) (CC (and)) (JJ (oral)) (NNS (bronchodilators))))) (, (,))) (CC (and)) (NE-Type-2-drug (NP (JJ (inhaled)) (NNS (corticosteroids))))) |ET|
-1  |BT|  (NP (NP (PP (NE-Type-1-drug (NP (NNS (bronchodilators))))) (, (,))) (CC (and)) (NE-Type-2-drug (NP (JJ (inhaled)) (NNS (corticosteroids))))) |ET|
1  |BT|  (NP (NE-Type-1-drug (NP (NNS (drugs)))) (PP (IN (because)) (PP (IN (of)) (NP (NP (JJ (possible)) (NN (enhancement))) (PP (IN (of)) (NP (NP (DT (the)) (DISO_ENTITY (NP (NN (nephrotoxicity)))) (CC (and/or)) (NP (NN (ototoxicity)))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (neomycin))))))))))) |ET|
1  |BT|  (NP (NE-Type-1-drug (NP (NNS (aminoglycosides)))) (CC (and)) (NE-Type-2-drug (NP (NNS (polymyxins))))) |ET|
-1  |BT|  (VP (PP (NP (PP (NP (NE-Type-1-drug (NP (NNS (aminoglycosides)))) (CC (and)) (drug_ENTITY (NP (NNS (polymyxins)))))))) (SBAR (IN (because)) (S (NP (PRP (they))) (VP (MD (may)) (VP (VP (VB (enhance)) (NP (DISO_ENTITY (NP (NN (neomycin)) (NN (@)) (NN (s)) (NN (nephrotoxicity)))) (CC (and/or)) (NP (NN (ototoxicity))))) (CC (and)) (VP (VB (potentiate)) (NP (NE-Type-2-drug (ADJP (NN (neomycin))))))))))) |ET|
-1  |BT|  (VP (PP (NP (PP (NP (NE-Type-1-drug (NP (NNS (polymyxins)))))))) (SBAR (IN (because)) (S (NP (PRP (they))) (VP (MD (may)) (VP (VP (VB (enhance)) (NP (DISO_ENTITY (NP (NN (neomycin)) (NN (@)) (NN (s)) (NN (nephrotoxicity)))) (CC (and/or)) (NP (NN (ototoxicity))))) (CC (and)) (VP (VB (potentiate)) (NP (NE-Type-2-drug (ADJP (NN (neomycin))))))))))) |ET|
1  |BT|  (S (NE-Type-1-drug (NP (JJ (Oral)) (NN (neomycin)))) (VP (VBZ (inhibits)) (NP (NP (NP (DT (the)) (JJ (gastrointestinal)) (NN (absorption))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (penicillin)) (NN (V))))))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (JJ (Oral)) (NN (neomycin)))) (VP (VBZ (inhibits)) (NP (NP (NP (DT (the)) (JJ (gastrointestinal)) (NN (absorption))) (PP (IN (of)) (drug_ENTITY (NP (NN (penicillin)) (NN (V)))))) (, (,)) (NE-Type-2-drug (NP (JJ (oral)) (NN (vitamin)) (NN (B-12))))))) |ET|
1  |BT|  (S (NE-Type-1-drug (NP (JJ (Oral)) (NN (neomycin)))) (VP (VBZ (inhibits)) (NP (NP (NP (DT (the)) (JJ (gastrointestinal)) (NN (absorption))) (PP (IN (of)) (drug_ENTITY (NP (NN (penicillin)) (NN (V)))))) (, (,)) (drug_ENTITY (NP (JJ (oral)) (NN (vitamin)) (NN (B-12)))) (, (,)) (NP (NE-Type-2-drug (NP (NN (methotrexate)))))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (JJ (Oral)) (NN (neomycin)))) (VP (VBZ (inhibits)) (NP (NP (NP (DT (the)) (JJ (gastrointestinal)) (NN (absorption))) (PP (IN (of)) (drug_ENTITY (NP (NN (penicillin)) (NN (V)))))) (, (,)) (drug_ENTITY (NP (JJ (oral)) (NN (vitamin)) (NN (B-12)))) (, (,)) (NP (drug_ENTITY (NP (NN (methotrexate)))) (CC (and)) (NE-Type-2-drug (NP (NN (5-fluorouracil)))))))) |ET|
-1  |BT|  (NP (NP (PP (NE-Type-1-drug (NP (NN (penicillin)) (NN (V)))))) (, (,)) (NE-Type-2-drug (NP (JJ (oral)) (NN (vitamin)) (NN (B-12))))) |ET|
-1  |BT|  (NP (NP (PP (NE-Type-1-drug (NP (NN (penicillin)) (NN (V)))))) (, (,)) (drug_ENTITY (NP (JJ (oral)) (NN (vitamin)) (NN (B-12)))) (, (,)) (NP (NE-Type-2-drug (NP (NN (methotrexate)))))) |ET|
-1  |BT|  (NP (NP (PP (NE-Type-1-drug (NP (NN (penicillin)) (NN (V)))))) (, (,)) (drug_ENTITY (NP (JJ (oral)) (NN (vitamin)) (NN (B-12)))) (, (,)) (NP (drug_ENTITY (NP (NN (methotrexate)))) (CC (and)) (NE-Type-2-drug (NP (NN (5-fluorouracil)))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (JJ (oral)) (NN (vitamin)) (NN (B-12)))) (, (,)) (NP (NE-Type-2-drug (NP (NN (methotrexate)))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (JJ (oral)) (NN (vitamin)) (NN (B-12)))) (, (,)) (NP (drug_ENTITY (NP (NN (methotrexate)))) (CC (and)) (NE-Type-2-drug (NP (NN (5-fluorouracil)))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (methotrexate)))) (CC (and)) (NE-Type-2-drug (NP (NN (5-fluorouracil))))) |ET|
1  |BT|  (S (NE-Type-1-drug (NP (JJ (Oral)) (NN (neomycin)) (NN (sulfate)))) (VP (MD (may)) (VP (VB (enhance)) (NP (NP (DT (the)) (NN (effect))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (coumarin))))))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (JJ (Oral)) (NN (neomycin)) (NN (sulfate)))) (VP (MD (may)) (VP (VB (enhance)) (NP (NP (DT (the)) (NN (effect))) (PP (IN (of)) (drug_ENTITY (NP (NN (coumarin))))) (PP (IN (in)) (NE-Type-2-drug (NP (NNS (anticoagulants))))))))) |ET|
-1  |BT|  (NP (PP (NE-Type-1-drug (NP (NN (coumarin))))) (PP (IN (in)) (NE-Type-2-drug (NP (NNS (anticoagulants)))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (JJ (Beta-adrenergic)) (NN (Blocking)) (NNS (Agents)))) (: (:)) (S (VP (VBP (Experience)) (PP (IN (in)) (NP (QP (IN (over)) (CD (1400))) (NNS (patients)))) (SBAR (IN (in)) (S (NP (DT (a)) (JJ (non-comparative)) (JJ (clinical)) (NN (trial))) (VP (VBZ (has)) (VP (VBN (shown)) (SBAR (IN (that)) (S (S (NP (NP (JJ (concomitant)) (NN (administration))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (NN (nifedipine))))))))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (JJ (Beta-adrenergic)) (NN (Blocking)) (NNS (Agents)))) (: (:)) (S (VP (VBP (Experience)) (PP (IN (in)) (NP (QP (IN (over)) (CD (1400))) (NNS (patients)))) (SBAR (IN (in)) (S (NP (DT (a)) (JJ (non-comparative)) (JJ (clinical)) (NN (trial))) (VP (VBZ (has)) (VP (VBN (shown)) (SBAR (IN (that)) (S (S (NP (NP (JJ (concomitant)) (NN (administration))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (nifedipine)))) (CC (and)) (NE-Type-2-drug (NP (JJ (beta-blocking)) (NN (agent))))))))))))))))) |ET|
1  |BT|  (NP (NE-Type-1-drug (NP (NN (nifedipine)))) (CC (and)) (NE-Type-2-drug (NP (JJ (beta-blocking)) (NN (agent))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (Nitrates)))) (: (:)) (S (S (NE-Type-2-drug (NP (NN (Nifedipine))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (Nitrates)))) (: (:)) (S (S (drug_ENTITY (NP (NN (Nifedipine)))) (VP (MD (may)) (VP (VB (be)) (ADVP (RB (safely))) (VP (VBN (co-administered)) (PP (IN (with)) (NE-Type-2-drug (NP (NNS (nitrates))))))))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NN (Nifedipine)))) (VP (MD (may)) (VP (VB (be)) (ADVP (RB (safely))) (VP (VBN (co-administered)) (PP (IN (with)) (NE-Type-2-drug (NP (NNS (nitrates))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Digitalis)) (: (:)) (NP (JJ (Immediate)) (NN (Release)) (NNS (Capsules))))) (: (:)) (S (SBAR (IN (Since)) (S (S (NP (EX (there))) (VP (VBP (have)) (VP (VBN (been)) (NP (NP (VBN (isolated)) (NNS (reports))) (PP (IN (of)) (NP (NP (NNS (patients))) (PP (IN (with)) (NP (JJ (elevated)) (NN (digoxin)) (NNS (levels)))))))))) (, (,)) (CC (and)) (S (NP (EX (there))) (VP (VBZ (is)) (NP (NP (DT (a)) (JJ (possible)) (NN (interaction))) (PP (IN (between)) (NP (NE-Type-2-drug (NP (NN (digoxin))))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Digitalis)) (: (:)) (NP (JJ (Immediate)) (NN (Release)) (NNS (Capsules))))) (: (:)) (S (SBAR (IN (Since)) (S (S (NP (EX (there))) (VP (VBP (have)) (VP (VBN (been)) (NP (NP (VBN (isolated)) (NNS (reports))) (PP (IN (of)) (NP (NP (NNS (patients))) (PP (IN (with)) (NP (JJ (elevated)) (NN (digoxin)) (NNS (levels)))))))))) (, (,)) (CC (and)) (S (NP (EX (there))) (VP (VBZ (is)) (NP (NP (DT (a)) (JJ (possible)) (NN (interaction))) (PP (IN (between)) (NP (drug_ENTITY (NP (NN (digoxin)))) (CC (and)) (NE-Type-2-drug (NP (NN (nifedipine))))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Digitalis)) (: (:)) (NP (JJ (Immediate)) (NN (Release)) (NNS (Capsules))))) (: (:)) (S (SBAR (IN (Since)) (S (S (NP (EX (there))) (VP (VBP (have)) (VP (VBN (been)) (NP (NP (VBN (isolated)) (NNS (reports))) (PP (IN (of)) (NP (NP (NNS (patients))) (PP (IN (with)) (NP (JJ (elevated)) (NN (digoxin)) (NNS (levels)))))))))) (, (,)) (CC (and)) (S (NP (EX (there))) (VP (VBZ (is)) (NP (NP (DT (a)) (JJ (possible)) (NN (interaction))) (PP (IN (between)) (NP (drug_ENTITY (NP (NN (digoxin)))) (CC (and)) (drug_ENTITY (NP (NN (nifedipine))))))))))) (, (,)) (NP (PRP (it))) (VP (VBZ (is)) (VP (VBN (recommended)) (SBAR (IN (that)) (S (NP (NN (digoxin)) (NNS (levels))) (VP (VB (be)) (VP (VBN (monitored)) (SBAR (WHADVP (WRB (when))) (S (VP (VP (VBG (initiating))) (, (,)) (VP (VBG (adjusting))) (, (,)) (CC (and)) (VP (VBG (discontinuing)) (NE-Type-2-drug (NP (NN (nifedipine)))))))))))))))) |ET|
1  |BT|  (NP (NE-Type-1-drug (NP (NN (digoxin)))) (CC (and)) (NE-Type-2-drug (NP (NN (nifedipine))))) |ET|
-1  |BT|  (S (SBAR (S (S (VP (NP (PP (NP (NE-Type-1-drug (NP (NN (digoxin)))) (CC (and)) (drug_ENTITY (NP (NN (nifedipine))))))))))) (, (,)) (NP (PRP (it))) (VP (VBZ (is)) (VP (VBN (recommended)) (SBAR (IN (that)) (S (NP (NN (digoxin)) (NNS (levels))) (VP (VB (be)) (VP (VBN (monitored)) (SBAR (WHADVP (WRB (when))) (S (VP (VP (VBG (initiating))) (, (,)) (VP (VBG (adjusting))) (, (,)) (CC (and)) (VP (VBG (discontinuing)) (NE-Type-2-drug (NP (NN (nifedipine))))))))))))))) |ET|
-1  |BT|  (S (SBAR (S (S (VP (NP (PP (NP (NE-Type-1-drug (NP (NN (nifedipine))))))))))) (, (,)) (NP (PRP (it))) (VP (VBZ (is)) (VP (VBN (recommended)) (SBAR (IN (that)) (S (NP (NN (digoxin)) (NNS (levels))) (VP (VB (be)) (VP (VBN (monitored)) (SBAR (WHADVP (WRB (when))) (S (VP (VP (VBG (initiating))) (, (,)) (VP (VBG (adjusting))) (, (,)) (CC (and)) (VP (VBG (discontinuing)) (NE-Type-2-drug (NP (NN (nifedipine))))))))))))))) |ET|
1  |BT|  (NP (PP (NE-Type-1-drug (NP (NN (nifedipine))))) (PP (IN (with)) (NE-Type-2-drug (NP (NN (digoxin)))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Quinidine)) (: (:)) (NP (JJ (Immediate)) (NN (Release)) (NNS (Capsules))))) (: (:)) (S (NP (EX (There))) (VP (VBP (have)) (VP (VBN (been)) (NP (NP (JJ (rare)) (NNS (reports))) (PP (IN (of)) (NP (NP (DT (an)) (NN (interaction))) (PP (IN (between)) (NP (NE-Type-2-drug (NP (NN (quinidine))))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Quinidine)) (: (:)) (NP (JJ (Immediate)) (NN (Release)) (NNS (Capsules))))) (: (:)) (S (NP (EX (There))) (VP (VBP (have)) (VP (VBN (been)) (NP (NP (JJ (rare)) (NNS (reports))) (PP (IN (of)) (NP (NP (DT (an)) (NN (interaction))) (PP (IN (between)) (NP (drug_ENTITY (NP (NN (quinidine)))) (CC (and)) (NE-Type-2-drug (NP (NN (nifedipine))))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Quinidine)) (: (:)) (NP (JJ (Immediate)) (NN (Release)) (NNS (Capsules))))) (: (:)) (S (NP (EX (There))) (VP (VBP (have)) (VP (VBN (been)) (NP (NP (JJ (rare)) (NNS (reports))) (PP (IN (of)) (NP (NP (DT (an)) (NN (interaction))) (PP (IN (between)) (NP (drug_ENTITY (NP (NN (quinidine)))) (CC (and)) (drug_ENTITY (NP (NN (nifedipine)))))) (-LRB- (<LB>)) (PP (IN (with)) (NP (NP (DT (a)) (VBN (decreased)) (NN (plasma)) (NN (level))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (quinidine)))))))))))))) |ET|
1  |BT|  (NP (NE-Type-1-drug (NP (NN (quinidine)))) (CC (and)) (NE-Type-2-drug (NP (NN (nifedipine))))) |ET|
-1  |BT|  (NP (PP (NP (NE-Type-1-drug (NP (NN (quinidine)))) (CC (and)) (drug_ENTITY (NP (NN (nifedipine)))))) (-LRB- (<LB>)) (PP (IN (with)) (NP (NP (DT (a)) (VBN (decreased)) (NN (plasma)) (NN (level))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (quinidine)))))))) |ET|
-1  |BT|  (NP (PP (NP (NE-Type-1-drug (NP (NN (nifedipine)))))) (-LRB- (<LB>)) (PP (IN (with)) (NP (NP (DT (a)) (VBN (decreased)) (NN (plasma)) (NN (level))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (quinidine)))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Coumarin)) (NN (Anticoagulant)) (NNS (s)))) (: (:)) (S (NP (EX (There))) (VP (VBP (have)) (VP (VBN (been)) (NP (NP (JJ (rare)) (NNS (reports))) (PP (IN (of)) (NP (VBN (increased)) (NN (prothrombin)) (NN (time)))) (PP (IN (in)) (NP (NP (NNS (patients))) (VP (VBG (taking)) (NP (NE-Type-2-drug (NP (NN (coumarin)) (NN (anticoagulant))))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Coumarin)) (NN (Anticoagulant)) (NNS (s)))) (: (:)) (S (NP (EX (There))) (VP (VBP (have)) (VP (VBN (been)) (NP (NP (JJ (rare)) (NNS (reports))) (PP (IN (of)) (NP (VBN (increased)) (NN (prothrombin)) (NN (time)))) (PP (IN (in)) (NP (NP (NNS (patients))) (VP (VBG (taking)) (NP (drug_ENTITY (NP (NN (coumarin)) (NN (anticoagulant)) (NNS (s)))) (SBAR (WHPP (TO (to)) (WHNP (WP (whom)))) (S (NE-Type-2-drug (NP (NN (nifedipine))))))))))))))) |ET|
1  |BT|  (NP (NE-Type-1-drug (NP (NN (coumarin)) (NN (anticoagulant)) (NNS (s)))) (SBAR (WHPP (TO (to)) (WHNP (WP (whom)))) (S (NE-Type-2-drug (NP (NN (nifedipine))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Cimetidine)))) (: (:)) (S (NP (NP (DT (A)) (NN (study))) (PP (IN (in)) (NP (CD (6)) (JJ (healthy)) (NNS (volunteers))))) (VP (VBZ (has)) (VP (VBN (shown)) (NP (NP (DT (a)) (JJ (significant)) (NN (increase))) (PP (IN (in)) (NP (NP (NE-Type-2-drug (NP (NN (peak)) (NN (nifedipine)))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Cimetidine)))) (: (:)) (S (NP (NP (DT (A)) (NN (study))) (PP (IN (in)) (NP (CD (6)) (JJ (healthy)) (NNS (volunteers))))) (VP (VBZ (has)) (VP (VBN (shown)) (NP (NP (DT (a)) (JJ (significant)) (NN (increase))) (PP (IN (in)) (NP (NP (drug_ENTITY (NP (NN (peak)) (NN (nifedipine)) (NN (plasma)) (NNS (levels)))) (PRN (-LRB- (<LB>)) (NP (CD (80)) (NN (%))) (-RRB- (<RB>)))) (CC (and)) (NP (NP (JJ (area-under-the-curve))) (PRN (-LRB- (<LB>)) (NP (CD (74)) (NN (%))) (-RRB- (<RB>))))))) (PP (IN (after)) (NP (NP (DT (a)) (CD (1)) (NN (week)) (NN (course))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (NN (cimetidine)))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Cimetidine)))) (: (:)) (S (NP (NP (DT (A)) (NN (study))) (PP (IN (in)) (NP (CD (6)) (JJ (healthy)) (NNS (volunteers))))) (VP (VBZ (has)) (VP (VBN (shown)) (NP (NP (DT (a)) (JJ (significant)) (NN (increase))) (PP (IN (in)) (NP (NP (drug_ENTITY (NP (NN (peak)) (NN (nifedipine)) (NN (plasma)) (NNS (levels)))) (PRN (-LRB- (<LB>)) (NP (CD (80)) (NN (%))) (-RRB- (<RB>)))) (CC (and)) (NP (NP (JJ (area-under-the-curve))) (PRN (-LRB- (<LB>)) (NP (CD (74)) (NN (%))) (-RRB- (<RB>))))))) (PP (IN (after)) (NP (NP (DT (a)) (CD (1)) (NN (week)) (NN (course))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (cimetidine)))) (PP (IN (at)) (NP (NP (CD (1000)) (NN (mg))) (PP (IN (per)) (NP (NP (NN (day))) (CC (and)) (NE-Type-2-drug (NP (NN (nifedipine)))))))))))))))) |ET|
-1  |BT|  (VP (NP (PP (NP (NP (NE-Type-1-drug (NP (NN (nifedipine)) (NN (plasma)) (NNS (levels)))) (PRN (-LRB- (<LB>)) (NP (CD (80)) (NN (%))) (-RRB- (<RB>)))) (CC (and)) (NP (NP (JJ (area-under-the-curve))) (PRN (-LRB- (<LB>)) (NP (CD (74)) (NN (%))) (-RRB- (<RB>))))))) (PP (IN (after)) (NP (NP (DT (a)) (CD (1)) (NN (week)) (NN (course))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (NN (cimetidine))))))))) |ET|
-1  |BT|  (VP (NP (PP (NP (NP (NE-Type-1-drug (NP (NN (nifedipine)) (NN (plasma)) (NNS (levels)))) (PRN (-LRB- (<LB>)) (NP (CD (80)) (NN (%))) (-RRB- (<RB>)))) (CC (and)) (NP (NP (JJ (area-under-the-curve))) (PRN (-LRB- (<LB>)) (NP (CD (74)) (NN (%))) (-RRB- (<RB>))))))) (PP (IN (after)) (NP (NP (DT (a)) (CD (1)) (NN (week)) (NN (course))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (cimetidine)))) (PP (IN (at)) (NP (NP (CD (1000)) (NN (mg))) (PP (IN (per)) (NP (NP (NN (day))) (CC (and)) (NE-Type-2-drug (NP (NN (nifedipine))))))))))))) |ET|
1  |BT|  (NP (NE-Type-1-drug (NP (NN (cimetidine)))) (PP (IN (at)) (NP (NP (CD (1000)) (NN (mg))) (PP (IN (per)) (NP (NP (NN (day))) (CC (and)) (NE-Type-2-drug (NP (NN (nifedipine))))))))) |ET|
-1  |BT|  (NP (PP (NE-Type-1-drug (NP (NN (cimetidine))))) (PP (IN (on)) (NP (NE-Type-2-drug (NP (JJ (hepatic)) (NN (cytochrome)) (NN (P-450))))))) |ET|
1  |BT|  (NP (PP (NE-Type-1-drug (NP (NN (cimetidine))))) (PP (IN (on)) (NP (drug_ENTITY (NP (JJ (hepatic)) (NN (cytochrome)) (NN (P-450)))) (, (,)) (NP (NP (DT (the)) (NN (enzyme)) (NN (system))) (ADJP (ADVP (RB (probably))) (JJ (responsible)) (PP (IN (for)) (NP (NP (DT (the)) (NN (first-pass)) (NN (metabolism))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (nifedipine)))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (cytochrome)) (NN (P-450)))) (, (,)) (NP (NP (DT (the)) (NN (enzyme)) (NN (system))) (ADJP (ADVP (RB (probably))) (JJ (responsible)) (PP (IN (for)) (NP (NP (DT (the)) (NN (first-pass)) (NN (metabolism))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (nifedipine)))))))))) |ET|
1  |BT|  (S (NE-Type-1-drug (NP (NN (nifedipine)) (NN (therapy)))) (VP (VBZ (is)) (VP (VBN (initiated)) (PP (IN (in)) (NP (NP (DT (a)) (NN (patient))) (VP (ADVP (RB (currently))) (VBG (receiving)) (NE-Type-2-drug (NP (NN (cimetidine)))))))))) |ET|
1  |BT|  (S (NP (PP (NP (PP (NE-Type-1-drug (NP (NN (nisoldipine)))))))) (VP (VBD (was)) (VP (VBN (observed)) (PP (IN (with)) (NP (NP (JJ (concomitant)) (NN (administration))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (NN (cimetidine)) (CD (400)) (NN (mg))))))))))) |ET|
-1  |BT|  (S (NP (NE-Type-1-drug (NP (NN (Ranitidine)) (CD (150)) (NN (mg)))) (ADVP (RB (twice)) (RB (daily)))) (VP (VBD (did)) (RB (not)) (VP (VB (interact)) (ADVP (RB (significantly))) (PP (IN (with)) (NE-Type-2-drug (NP (NN (nisoldipine)))))))) |ET|
1  |BT|  (NP (PP (NE-Type-1-drug (NP (NN (phenytoin))))) (PP (IN (with)) (NP (NE-Type-2-drug (NP (CD (40)) (NN (mg)) (NN (SULAR))))))) |ET|
-1  |BT|  (S (NP (PP (NE-Type-1-drug (NP (NN (phenytoin))))) (PP (IN (with)) (NP (drug_ENTITY (NP (CD (40)) (NN (mg)) (NN (SULAR)) (NNS (tablets)))) (PP (IN (in)) (NP (JJ (epileptic)) (NNS (patients))))))) (VP (VBD (lowered)) (NE-Type-2-drug (NP (DT (the)) (NN (nisoldipine)))))) |ET|
-1  |BT|  (S (NP (PP (NP (NE-Type-1-drug (NP (NN (SULAR)) (NNS (tablets)))) (PP (IN (in)) (NP (JJ (epileptic)) (NNS (patients))))))) (VP (VBD (lowered)) (NE-Type-2-drug (NP (DT (the)) (NN (nisoldipine)))))) |ET|
1  |BT|  (NP (PP (NE-Type-1-drug (NP (NN (SULAR))))) (PP (IN (with)) (NP (NE-Type-2-drug (NP (NN (phenytoin))))))) |ET|
-1  |BT|  (NP (PP (NE-Type-1-drug (NP (NN (SULAR))))) (PP (IN (with)) (NP (drug_ENTITY (NP (NN (phenytoin)))) (CC (or)) (NE-Type-2-drug (NP (DT (any)) (JJ (known)) (NN (CYP3A4))))))) |ET|
-1  |BT|  (S (S (NP (PP (NE-Type-1-drug (NP (NN (SULAR))))) (PP (IN (with)) (NP (drug_ENTITY (NP (NN (phenytoin)))) (CC (or)) (drug_ENTITY (NP (DT (any)) (JJ (known)) (NN (CYP3A4)) (NN (inducer))))))) (VP (MD (should)) (VP (VB (be)) (VP (VBN (avoided)))))) (CC (and)) (S (NE-Type-2-drug (NP (JJ (alternative)) (JJ (antihypertensive)))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (phenytoin)))) (CC (or)) (NE-Type-2-drug (NP (DT (any)) (JJ (known)) (NN (CYP3A4))))) |ET|
-1  |BT|  (S (S (NP (PP (NP (NE-Type-1-drug (NP (NN (phenytoin)))) (CC (or)) (drug_ENTITY (NP (DT (any)) (JJ (known)) (NN (CYP3A4)) (NN (inducer))))))) (VP (MD (should)) (VP (VB (be)) (VP (VBN (avoided)))))) (CC (and)) (S (NE-Type-2-drug (NP (JJ (alternative)) (JJ (antihypertensive)))))) |ET|
-1  |BT|  (S (S (NP (PP (NP (NE-Type-1-drug (NP (NN (CYP3A4)) (NN (inducer))))))) (VP (MD (should)) (VP (VB (be)) (VP (VBN (avoided)))))) (CC (and)) (S (NE-Type-2-drug (NP (JJ (alternative)) (JJ (antihypertensive)))))) |ET|
1  |BT|  (NP (NE-Type-1-drug (NP (NN (nisoldipine)))) (CC (and)) (NP (NE-Type-2-drug (NP (NNS (beta-blockers)))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (nisoldipine)))) (CC (and)) (NP (drug_ENTITY (NP (NNS (beta-blockers)))) (PRN (-LRB- (<LB>)) (NP (NE-Type-2-drug (NP (NN (atenolol)))))))) |ET|
1  |BT|  (NP (NE-Type-1-drug (NP (NN (nisoldipine)))) (CC (and)) (NP (drug_ENTITY (NP (NNS (beta-blockers)))) (PRN (-LRB- (<LB>)) (NP (drug_ENTITY (NP (NN (atenolol)))) (, (,)) (NE-Type-2-drug (NP (NN (propranolol)))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (beta-blockers)))) (PRN (-LRB- (<LB>)) (NP (NE-Type-2-drug (NP (NN (atenolol))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (beta-blockers)))) (PRN (-LRB- (<LB>)) (NP (drug_ENTITY (NP (NN (atenolol)))) (, (,)) (NE-Type-2-drug (NP (NN (propranolol))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (atenolol)))) (, (,)) (NE-Type-2-drug (NP (NN (propranolol))))) |ET|
1  |BT|  (S (NE-Type-1-drug (NP (NN (Propranolol)))) (VP (VBD (attenuated)) (NP (DT (the)) (NN (heart)) (NN (rate)) (NN (increase))) (PP (VBG (following)) (NP (NP (NN (administration))) (PP (IN (of)) (NE-Type-2-drug (NP (JJ (immediate)) (NN (release)) (NN (nisoldipine))))))))) |ET|
1  |BT|  (S (NP (PP (NE-Type-1-drug (NP (NN (SULAR)))))) (VP (VBD (tended)) (S (VP (TO (to)) (VP (VB (be)) (ADJP (ADJP (JJR (greater))) (PP (IN (in)) (NP (NP (NNS (patients))) (PP (IN (on)) (NE-Type-2-drug (NP (NN (atenolol))))))))))))) |ET|
-1  |BT|  (S (NP (PP (NE-Type-1-drug (NP (NN (SULAR)))))) (VP (VBD (tended)) (S (VP (TO (to)) (VP (VB (be)) (ADJP (ADJP (JJR (greater))) (PP (IN (in)) (NP (NP (NNS (patients))) (PP (IN (on)) (drug_ENTITY (NP (NN (atenolol))))))) (PP (IN (than)) (PP (IN (in)) (NP (NP (NNS (patients))) (PP (IN (on)) (NE-Type-2-drug (NP (DT (no)) (JJ (other)) (JJ (antihypertensive)))))))))))))) |ET|
-1  |BT|  (ADJP (PP (NP (PP (NE-Type-1-drug (NP (NN (atenolol))))))) (PP (IN (than)) (PP (IN (in)) (NP (NP (NNS (patients))) (PP (IN (on)) (NE-Type-2-drug (NP (DT (no)) (JJ (other)) (JJ (antihypertensive))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Quinidine)))) (PP (IN (at)) (NE-Type-2-drug (NP (ADJP (CD (648)) (NN (mg))) (NN (bid)))))) |ET|
1  |BT|  (S (NP (NE-Type-1-drug (NP (NN (Quinidine)))) (PP (IN (at)) (drug_ENTITY (NP (ADJP (CD (648)) (NN (mg))) (NN (bid)))))) (VP (VBD (decreased)) (NP (NP (NP (DT (the)) (NN (bioavailability))) (PRN (-LRB- (<LB>)) (NP (NN (AUC))) (-RRB- (<RB>)))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (nisoldipine)))))))) |ET|
-1  |BT|  (S (NP (PP (NE-Type-1-drug (NP (NN (bid)))))) (VP (VBD (decreased)) (NP (NP (NP (DT (the)) (NN (bioavailability))) (PRN (-LRB- (<LB>)) (NP (NN (AUC))) (-RRB- (<RB>)))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (nisoldipine)))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (nisoldipine)))) (CC (and)) (NE-Type-2-drug (NP (NN (warfarin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (nisoldipine)))) (CC (and)) (drug_ENTITY (NP (NN (warfarin)))) (CC (or)) (NE-Type-2-drug (NP (NN (digoxin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (warfarin)))) (CC (or)) (NE-Type-2-drug (NP (NN (digoxin))))) |ET|
1  |BT|  (S (NE-Type-1-drug (NP (NN (Tizoxanide)))) (VP (VBZ (is)) (ADVP (RB (highly))) (VP (VBN (bound)) (PP (TO (to)) (NE-Type-2-drug (NP (NN (plasma)) (NN (protein)))))))) |ET|
1  |BT|  (VP (VP (SBAR (S (VP (NP (NE-Type-1-drug (NP (NN (nitazoxanide)))) (PP (ADVP (RB (concurrently))) (IN (with)) (NP (JJ (other)) (ADJP (RB (highly)) (NN (plasma)) (JJ (protein-bound))) (NNS (drugs))))) (PP (IN (with)) (NP (JJ (narrow)) (JJ (therapeutic)) (NNS (indices))))))) (, (,)) (SBAR (IN (as)) (S (NP (NP (NN (competition))) (PP (IN (for)) (NP (NN (binding)) (NNS (sites))))) (VP (MD (may)) (VP (VB (occur))))))) (PRN (-LRB- (<LB>)) (PP (FW (e.g.)) (, (,)) (NE-Type-2-drug (NP (NN (warfarin))))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NN (tizoxanide)))) (VP (VBZ (has)) (NP (DT (no)) (JJ (significant)) (JJ (inhibitory)) (NN (effect))) (PP (IN (on)) (NE-Type-2-drug (NP (NN (cytochrome)) (NN (P450))))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NN (nitazoxanide)))) (VP (VBZ (is)) (VP (VBN (co-administered)) (PP (IN (with)) (NP (NE-Type-2-drug (NP (NNS (drugs))))))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NN (nitazoxanide)))) (VP (VBZ (is)) (VP (VBN (co-administered)) (PP (IN (with)) (NP (drug_ENTITY (NP (NNS (drugs)))) (SBAR (WHNP (WDT (that))) (S (ADVP (RB (either))) (VP (VP (VBP (are)) (VP (VBN (metabolized)) (PP (IN (by))))) (CC (or)) (VP (VB (inhibit)) (NE-Type-2-drug (NP (NN (cytochrome)) (NN (P450))))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (drugs)))) (SBAR (WHNP (WDT (that))) (S (ADVP (RB (either))) (VP (VP (VBP (are)) (VP (VBN (metabolized)) (PP (IN (by))))) (CC (or)) (VP (VB (inhibit)) (NE-Type-2-drug (NP (NN (cytochrome)) (NN (P450))))))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NN (Oxcarbazepine)))) (VP (MD (can)) (VP (VP (VB (inhibit)) (NE-Type-2-drug (NP (NN (CYP2C19)))))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NN (Oxcarbazepine)))) (VP (MD (can)) (VP (VP (VB (inhibit)) (drug_ENTITY (NP (NN (CYP2C19))))) (CC (and)) (VP (VB (induce)) (NP (NE-Type-2-drug (NP (NN (CYP3A4))))))))) |ET|
1  |BT|  (S (NE-Type-1-drug (NP (NN (Oxcarbazepine)))) (VP (MD (can)) (VP (VP (VB (inhibit)) (drug_ENTITY (NP (NN (CYP2C19))))) (CC (and)) (VP (VB (induce)) (NP (drug_ENTITY (NP (NN (CYP3A4)) (NN (/5)))) (PP (IN (with)) (NP (NP (ADJP (RB (potentially)) (JJ (important))) (NNS (effects))) (PP (IN (on)) (NP (NP (NN (plasma)) (NNS (concentrations))) (PP (IN (of)) (NE-Type-2-drug (NP (JJ (other)) (NNS (drugs)))))))))))))) |ET|
-1  |BT|  (VP (VP (NE-Type-1-drug (NP (NN (CYP2C19))))) (CC (and)) (VP (VB (induce)) (NP (NE-Type-2-drug (NP (NN (CYP3A4))))))) |ET|
-1  |BT|  (VP (VP (NE-Type-1-drug (NP (NN (CYP2C19))))) (CC (and)) (VP (VB (induce)) (NP (drug_ENTITY (NP (NN (CYP3A4)) (NN (/5)))) (PP (IN (with)) (NP (NP (ADJP (RB (potentially)) (JJ (important))) (NNS (effects))) (PP (IN (on)) (NP (NP (NN (plasma)) (NNS (concentrations))) (PP (IN (of)) (NE-Type-2-drug (NP (JJ (other)) (NNS (drugs)))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (CYP3A4)) (NN (/5)))) (PP (IN (with)) (NP (NP (ADJP (RB (potentially)) (JJ (important))) (NNS (effects))) (PP (IN (on)) (NP (NP (NN (plasma)) (NNS (concentrations))) (PP (IN (of)) (NE-Type-2-drug (NP (JJ (other)) (NNS (drugs)))))))))) |ET|
-1  |BT|  (S (NP (SBAR (S (VP (NE-Type-1-drug (NP (NN (cytochrome)) (NN (P450)) (NNS (inducers)))))))) (VP (MD (can)) (VP (VB (decrease)) (NP (NP (NN (plasma)) (NNS (concentrations))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (NN (oxcarbazepine)))))))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NN (Oxcarbazepine)))) (VP (VBD (was)) (VP (VBN (evaluated)) (PP (IN (in)) (NP (JJ (human)) (NN (liver)) (NNS (microsomes)))) (S (VP (TO (to)) (VP (VB (determine)) (NP (PRP$ (its)) (NN (capacity)) (S (VP (TO (to)) (VP (VB (inhibit)) (NP (NE-Type-2-drug (NP (DT (the)) (JJ (major)) (NN (cytochrome)) (NN (P450))))))))))))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NN (Oxcarbazepine)))) (VP (VBD (was)) (VP (VBN (evaluated)) (PP (IN (in)) (NP (JJ (human)) (NN (liver)) (NNS (microsomes)))) (S (VP (TO (to)) (VP (VB (determine)) (NP (PRP$ (its)) (NN (capacity)) (S (VP (TO (to)) (VP (VB (inhibit)) (NP (drug_ENTITY (NP (DT (the)) (JJ (major)) (NN (cytochrome)) (NN (P450)) (NNS (enzymes)))) (ADJP (JJ (responsible)) (PP (IN (for)) (NP (NP (DT (the)) (NN (metabolism))) (PP (IN (of)) (NE-Type-2-drug (NP (JJ (other)) (NNS (drugs))))))))))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (cytochrome)) (NN (P450)) (NNS (enzymes)))) (ADJP (JJ (responsible)) (PP (IN (for)) (NP (NP (DT (the)) (NN (metabolism))) (PP (IN (of)) (NE-Type-2-drug (NP (JJ (other)) (NNS (drugs))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (oxcarbazepine)))) (CC (and)) (NP (NE-Type-2-drug (NP (PRP$ (its)) (ADJP (RB (pharmacologically)) (JJ (active))) (NN (10-monohydroxy)) (NN (metabolite)))))) |ET|
-1  |BT|  (S (NP (NE-Type-1-drug (NP (NN (oxcarbazepine)))) (CC (and)) (NP (drug_ENTITY (NP (PRP$ (its)) (ADJP (RB (pharmacologically)) (JJ (active))) (NN (10-monohydroxy)) (NN (metabolite)))) (PRN (-LRB- (<LB>)) (NP (NN (MHD))) (-RRB- (<RB>))))) (VP (VBP (have)) (NP (NP (ADJP (JJ (little)))) (CC (or)) (NP (DT (no)) (NN (capacity)) (S (VP (TO (to)) (VP (VB (function)) (PP (IN (as)) (NP (NP (NNS (inhibitors))) (PP (IN (for)) (NP (NP (JJS (most))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (DT (the)) (JJ (human)) (NN (cytochrome)) (NN (P450))))))))))))))))) |ET|
-1  |BT|  (S (NP (NE-Type-1-drug (NP (NN (oxcarbazepine)))) (CC (and)) (NP (drug_ENTITY (NP (PRP$ (its)) (ADJP (RB (pharmacologically)) (JJ (active))) (NN (10-monohydroxy)) (NN (metabolite)))) (PRN (-LRB- (<LB>)) (NP (NN (MHD))) (-RRB- (<RB>))))) (VP (VBP (have)) (NP (NP (ADJP (JJ (little)))) (CC (or)) (NP (DT (no)) (NN (capacity)) (S (VP (TO (to)) (VP (VB (function)) (PP (IN (as)) (NP (NP (NNS (inhibitors))) (PP (IN (for)) (NP (NP (JJS (most))) (PP (IN (of)) (NP (drug_ENTITY (NP (DT (the)) (JJ (human)) (NN (cytochrome)) (NN (P450)) (NNS (enzymes)))) (VP (VBN (evaluated)) (PRN (-LRB- (<LB>)) (NP (NE-Type-2-drug (NP (NN (CYP1A2)))))))))))))))))))) |ET|
-1  |BT|  (S (NP (NE-Type-1-drug (NP (NN (oxcarbazepine)))) (CC (and)) (NP (drug_ENTITY (NP (PRP$ (its)) (ADJP (RB (pharmacologically)) (JJ (active))) (NN (10-monohydroxy)) (NN (metabolite)))) (PRN (-LRB- (<LB>)) (NP (NN (MHD))) (-RRB- (<RB>))))) (VP (VBP (have)) (NP (NP (ADJP (JJ (little)))) (CC (or)) (NP (DT (no)) (NN (capacity)) (S (VP (TO (to)) (VP (VB (function)) (PP (IN (as)) (NP (NP (NNS (inhibitors))) (PP (IN (for)) (NP (NP (JJS (most))) (PP (IN (of)) (NP (drug_ENTITY (NP (DT (the)) (JJ (human)) (NN (cytochrome)) (NN (P450)) (NNS (enzymes)))) (VP (VBN (evaluated)) (PRN (-LRB- (<LB>)) (NP (drug_ENTITY (NP (NN (CYP1A2)))) (, (,)) (NE-Type-2-drug (NP (NN (CYP2A6)))))))))))))))))))) |ET|
-1  |BT|  (S (NP (NE-Type-1-drug (NP (NN (oxcarbazepine)))) (CC (and)) (NP (drug_ENTITY (NP (PRP$ (its)) (ADJP (RB (pharmacologically)) (JJ (active))) (NN (10-monohydroxy)) (NN (metabolite)))) (PRN (-LRB- (<LB>)) (NP (NN (MHD))) (-RRB- (<RB>))))) (VP (VBP (have)) (NP (NP (ADJP (JJ (little)))) (CC (or)) (NP (DT (no)) (NN (capacity)) (S (VP (TO (to)) (VP (VB (function)) (PP (IN (as)) (NP (NP (NNS (inhibitors))) (PP (IN (for)) (NP (NP (JJS (most))) (PP (IN (of)) (NP (drug_ENTITY (NP (DT (the)) (JJ (human)) (NN (cytochrome)) (NN (P450)) (NNS (enzymes)))) (VP (VBN (evaluated)) (PRN (-LRB- (<LB>)) (NP (drug_ENTITY (NP (NN (CYP1A2)))) (, (,)) (drug_ENTITY (NP (NN (CYP2A6)))) (, (,)) (NE-Type-2-drug (NP (NN (CYP2C9)))))))))))))))))))) |ET|
-1  |BT|  (S (NP (NE-Type-1-drug (NP (NN (oxcarbazepine)))) (CC (and)) (NP (drug_ENTITY (NP (PRP$ (its)) (ADJP (RB (pharmacologically)) (JJ (active))) (NN (10-monohydroxy)) (NN (metabolite)))) (PRN (-LRB- (<LB>)) (NP (NN (MHD))) (-RRB- (<RB>))))) (VP (VBP (have)) (NP (NP (ADJP (JJ (little)))) (CC (or)) (NP (DT (no)) (NN (capacity)) (S (VP (TO (to)) (VP (VB (function)) (PP (IN (as)) (NP (NP (NNS (inhibitors))) (PP (IN (for)) (NP (NP (JJS (most))) (PP (IN (of)) (NP (drug_ENTITY (NP (DT (the)) (JJ (human)) (NN (cytochrome)) (NN (P450)) (NNS (enzymes)))) (VP (VBN (evaluated)) (PRN (-LRB- (<LB>)) (NP (drug_ENTITY (NP (NN (CYP1A2)))) (, (,)) (drug_ENTITY (NP (NN (CYP2A6)))) (, (,)) (drug_ENTITY (NP (NN (CYP2C9)))) (, (,)) (NE-Type-2-drug (NP (NN (CYP2D6)))))))))))))))))))) |ET|
-1  |BT|  (S (NP (NE-Type-1-drug (NP (NN (oxcarbazepine)))) (CC (and)) (NP (drug_ENTITY (NP (PRP$ (its)) (ADJP (RB (pharmacologically)) (JJ (active))) (NN (10-monohydroxy)) (NN (metabolite)))) (PRN (-LRB- (<LB>)) (NP (NN (MHD))) (-RRB- (<RB>))))) (VP (VBP (have)) (NP (NP (ADJP (JJ (little)))) (CC (or)) (NP (DT (no)) (NN (capacity)) (S (VP (TO (to)) (VP (VB (function)) (PP (IN (as)) (NP (NP (NNS (inhibitors))) (PP (IN (for)) (NP (NP (JJS (most))) (PP (IN (of)) (NP (drug_ENTITY (NP (DT (the)) (JJ (human)) (NN (cytochrome)) (NN (P450)) (NNS (enzymes)))) (VP (VBN (evaluated)) (PRN (-LRB- (<LB>)) (NP (drug_ENTITY (NP (NN (CYP1A2)))) (, (,)) (drug_ENTITY (NP (NN (CYP2A6)))) (, (,)) (drug_ENTITY (NP (NN (CYP2C9)))) (, (,)) (drug_ENTITY (NP (NN (CYP2D6)))) (, (,)) (NE-Type-2-drug (NP (NN (CYP2E1)))))))))))))))))))) |ET|
-1  |BT|  (S (NP (NE-Type-1-drug (NP (NN (oxcarbazepine)))) (CC (and)) (NP (drug_ENTITY (NP (PRP$ (its)) (ADJP (RB (pharmacologically)) (JJ (active))) (NN (10-monohydroxy)) (NN (metabolite)))) (PRN (-LRB- (<LB>)) (NP (NN (MHD))) (-RRB- (<RB>))))) (VP (VBP (have)) (NP (NP (ADJP (JJ (little)))) (CC (or)) (NP (DT (no)) (NN (capacity)) (S (VP (TO (to)) (VP (VB (function)) (PP (IN (as)) (NP (NP (NNS (inhibitors))) (PP (IN (for)) (NP (NP (JJS (most))) (PP (IN (of)) (NP (drug_ENTITY (NP (DT (the)) (JJ (human)) (NN (cytochrome)) (NN (P450)) (NNS (enzymes)))) (VP (VBN (evaluated)) (PRN (-LRB- (<LB>)) (NP (drug_ENTITY (NP (NN (CYP1A2)))) (, (,)) (drug_ENTITY (NP (NN (CYP2A6)))) (, (,)) (drug_ENTITY (NP (NN (CYP2C9)))) (, (,)) (drug_ENTITY (NP (NN (CYP2D6)))) (, (,)) (drug_ENTITY (NP (NN (CYP2E1)))) (, (,)) (NP (NN (CYP4A9))) (CC (and)) (NE-Type-2-drug (NP (NN (CYP4A11)))))))))))))))))))) |ET|
-1  |BT|  (S (NP (NE-Type-1-drug (NP (NN (oxcarbazepine)))) (CC (and)) (NP (drug_ENTITY (NP (PRP$ (its)) (ADJP (RB (pharmacologically)) (JJ (active))) (NN (10-monohydroxy)) (NN (metabolite)))) (PRN (-LRB- (<LB>)) (NP (NN (MHD))) (-RRB- (<RB>))))) (VP (VBP (have)) (NP (NP (ADJP (JJ (little)))) (CC (or)) (NP (DT (no)) (NN (capacity)) (S (VP (TO (to)) (VP (VB (function)) (PP (IN (as)) (NP (NP (NNS (inhibitors))) (PP (IN (for)) (NP (NP (JJS (most))) (PP (IN (of)) (NP (drug_ENTITY (NP (DT (the)) (JJ (human)) (NN (cytochrome)) (NN (P450)) (NNS (enzymes)))) (VP (VBN (evaluated)) (PRN (-LRB- (<LB>)) (NP (drug_ENTITY (NP (NN (CYP1A2)))) (, (,)) (drug_ENTITY (NP (NN (CYP2A6)))) (, (,)) (drug_ENTITY (NP (NN (CYP2C9)))) (, (,)) (drug_ENTITY (NP (NN (CYP2D6)))) (, (,)) (drug_ENTITY (NP (NN (CYP2E1)))) (, (,)) (NP (NN (CYP4A9))) (CC (and)) (drug_ENTITY (NP (NN (CYP4A11))))) (-RRB- (<RB>))) (PP (IN (with)) (NP (NP (DT (the)) (NN (exception))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (NN (CYP2C19)))))))))))))))))))))) |ET|
-1  |BT|  (S (NP (NE-Type-1-drug (NP (NN (oxcarbazepine)))) (CC (and)) (NP (drug_ENTITY (NP (PRP$ (its)) (ADJP (RB (pharmacologically)) (JJ (active))) (NN (10-monohydroxy)) (NN (metabolite)))) (PRN (-LRB- (<LB>)) (NP (NN (MHD))) (-RRB- (<RB>))))) (VP (VBP (have)) (NP (NP (ADJP (JJ (little)))) (CC (or)) (NP (DT (no)) (NN (capacity)) (S (VP (TO (to)) (VP (VB (function)) (PP (IN (as)) (NP (NP (NNS (inhibitors))) (PP (IN (for)) (NP (NP (JJS (most))) (PP (IN (of)) (NP (drug_ENTITY (NP (DT (the)) (JJ (human)) (NN (cytochrome)) (NN (P450)) (NNS (enzymes)))) (VP (VBN (evaluated)) (PRN (-LRB- (<LB>)) (NP (drug_ENTITY (NP (NN (CYP1A2)))) (, (,)) (drug_ENTITY (NP (NN (CYP2A6)))) (, (,)) (drug_ENTITY (NP (NN (CYP2C9)))) (, (,)) (drug_ENTITY (NP (NN (CYP2D6)))) (, (,)) (drug_ENTITY (NP (NN (CYP2E1)))) (, (,)) (NP (NN (CYP4A9))) (CC (and)) (drug_ENTITY (NP (NN (CYP4A11))))) (-RRB- (<RB>))) (PP (IN (with)) (NP (NP (DT (the)) (NN (exception))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (CYP2C19)))) (CC (and)) (NE-Type-2-drug (NP (NN (CYP3A4)))))))))))))))))))))) |ET|
-1  |BT|  (S (NP (NP (NE-Type-1-drug (NP (ADJP (JJ (active))) (NN (10-monohydroxy)) (NN (metabolite)))) (PRN (-LRB- (<LB>)) (NP (NN (MHD))) (-RRB- (<RB>))))) (VP (VBP (have)) (NP (NP (ADJP (JJ (little)))) (CC (or)) (NP (DT (no)) (NN (capacity)) (S (VP (TO (to)) (VP (VB (function)) (PP (IN (as)) (NP (NP (NNS (inhibitors))) (PP (IN (for)) (NP (NP (JJS (most))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (DT (the)) (JJ (human)) (NN (cytochrome)) (NN (P450))))))))))))))))) |ET|
-1  |BT|  (S (NP (NP (NE-Type-1-drug (NP (ADJP (JJ (active))) (NN (10-monohydroxy)) (NN (metabolite)))) (PRN (-LRB- (<LB>)) (NP (NN (MHD))) (-RRB- (<RB>))))) (VP (VBP (have)) (NP (NP (ADJP (JJ (little)))) (CC (or)) (NP (DT (no)) (NN (capacity)) (S (VP (TO (to)) (VP (VB (function)) (PP (IN (as)) (NP (NP (NNS (inhibitors))) (PP (IN (for)) (NP (NP (JJS (most))) (PP (IN (of)) (NP (drug_ENTITY (NP (DT (the)) (JJ (human)) (NN (cytochrome)) (NN (P450)) (NNS (enzymes)))) (VP (VBN (evaluated)) (PRN (-LRB- (<LB>)) (NP (NE-Type-2-drug (NP (NN (CYP1A2)))))))))))))))))))) |ET|
-1  |BT|  (S (NP (NP (NE-Type-1-drug (NP (ADJP (JJ (active))) (NN (10-monohydroxy)) (NN (metabolite)))) (PRN (-LRB- (<LB>)) (NP (NN (MHD))) (-RRB- (<RB>))))) (VP (VBP (have)) (NP (NP (ADJP (JJ (little)))) (CC (or)) (NP (DT (no)) (NN (capacity)) (S (VP (TO (to)) (VP (VB (function)) (PP (IN (as)) (NP (NP (NNS (inhibitors))) (PP (IN (for)) (NP (NP (JJS (most))) (PP (IN (of)) (NP (drug_ENTITY (NP (DT (the)) (JJ (human)) (NN (cytochrome)) (NN (P450)) (NNS (enzymes)))) (VP (VBN (evaluated)) (PRN (-LRB- (<LB>)) (NP (drug_ENTITY (NP (NN (CYP1A2)))) (, (,)) (NE-Type-2-drug (NP (NN (CYP2A6)))))))))))))))))))) |ET|
-1  |BT|  (S (NP (NP (NE-Type-1-drug (NP (ADJP (JJ (active))) (NN (10-monohydroxy)) (NN (metabolite)))) (PRN (-LRB- (<LB>)) (NP (NN (MHD))) (-RRB- (<RB>))))) (VP (VBP (have)) (NP (NP (ADJP (JJ (little)))) (CC (or)) (NP (DT (no)) (NN (capacity)) (S (VP (TO (to)) (VP (VB (function)) (PP (IN (as)) (NP (NP (NNS (inhibitors))) (PP (IN (for)) (NP (NP (JJS (most))) (PP (IN (of)) (NP (drug_ENTITY (NP (DT (the)) (JJ (human)) (NN (cytochrome)) (NN (P450)) (NNS (enzymes)))) (VP (VBN (evaluated)) (PRN (-LRB- (<LB>)) (NP (drug_ENTITY (NP (NN (CYP1A2)))) (, (,)) (drug_ENTITY (NP (NN (CYP2A6)))) (, (,)) (NE-Type-2-drug (NP (NN (CYP2C9)))))))))))))))))))) |ET|
-1  |BT|  (S (NP (NP (NE-Type-1-drug (NP (ADJP (JJ (active))) (NN (10-monohydroxy)) (NN (metabolite)))) (PRN (-LRB- (<LB>)) (NP (NN (MHD))) (-RRB- (<RB>))))) (VP (VBP (have)) (NP (NP (ADJP (JJ (little)))) (CC (or)) (NP (DT (no)) (NN (capacity)) (S (VP (TO (to)) (VP (VB (function)) (PP (IN (as)) (NP (NP (NNS (inhibitors))) (PP (IN (for)) (NP (NP (JJS (most))) (PP (IN (of)) (NP (drug_ENTITY (NP (DT (the)) (JJ (human)) (NN (cytochrome)) (NN (P450)) (NNS (enzymes)))) (VP (VBN (evaluated)) (PRN (-LRB- (<LB>)) (NP (drug_ENTITY (NP (NN (CYP1A2)))) (, (,)) (drug_ENTITY (NP (NN (CYP2A6)))) (, (,)) (drug_ENTITY (NP (NN (CYP2C9)))) (, (,)) (NE-Type-2-drug (NP (NN (CYP2D6)))))))))))))))))))) |ET|
-1  |BT|  (S (NP (NP (NE-Type-1-drug (NP (ADJP (JJ (active))) (NN (10-monohydroxy)) (NN (metabolite)))) (PRN (-LRB- (<LB>)) (NP (NN (MHD))) (-RRB- (<RB>))))) (VP (VBP (have)) (NP (NP (ADJP (JJ (little)))) (CC (or)) (NP (DT (no)) (NN (capacity)) (S (VP (TO (to)) (VP (VB (function)) (PP (IN (as)) (NP (NP (NNS (inhibitors))) (PP (IN (for)) (NP (NP (JJS (most))) (PP (IN (of)) (NP (drug_ENTITY (NP (DT (the)) (JJ (human)) (NN (cytochrome)) (NN (P450)) (NNS (enzymes)))) (VP (VBN (evaluated)) (PRN (-LRB- (<LB>)) (NP (drug_ENTITY (NP (NN (CYP1A2)))) (, (,)) (drug_ENTITY (NP (NN (CYP2A6)))) (, (,)) (drug_ENTITY (NP (NN (CYP2C9)))) (, (,)) (drug_ENTITY (NP (NN (CYP2D6)))) (, (,)) (NE-Type-2-drug (NP (NN (CYP2E1)))))))))))))))))))) |ET|
-1  |BT|  (S (NP (NP (NE-Type-1-drug (NP (ADJP (JJ (active))) (NN (10-monohydroxy)) (NN (metabolite)))) (PRN (-LRB- (<LB>)) (NP (NN (MHD))) (-RRB- (<RB>))))) (VP (VBP (have)) (NP (NP (ADJP (JJ (little)))) (CC (or)) (NP (DT (no)) (NN (capacity)) (S (VP (TO (to)) (VP (VB (function)) (PP (IN (as)) (NP (NP (NNS (inhibitors))) (PP (IN (for)) (NP (NP (JJS (most))) (PP (IN (of)) (NP (drug_ENTITY (NP (DT (the)) (JJ (human)) (NN (cytochrome)) (NN (P450)) (NNS (enzymes)))) (VP (VBN (evaluated)) (PRN (-LRB- (<LB>)) (NP (drug_ENTITY (NP (NN (CYP1A2)))) (, (,)) (drug_ENTITY (NP (NN (CYP2A6)))) (, (,)) (drug_ENTITY (NP (NN (CYP2C9)))) (, (,)) (drug_ENTITY (NP (NN (CYP2D6)))) (, (,)) (drug_ENTITY (NP (NN (CYP2E1)))) (, (,)) (NP (NN (CYP4A9))) (CC (and)) (NE-Type-2-drug (NP (NN (CYP4A11)))))))))))))))))))) |ET|
-1  |BT|  (S (NP (NP (NE-Type-1-drug (NP (ADJP (JJ (active))) (NN (10-monohydroxy)) (NN (metabolite)))) (PRN (-LRB- (<LB>)) (NP (NN (MHD))) (-RRB- (<RB>))))) (VP (VBP (have)) (NP (NP (ADJP (JJ (little)))) (CC (or)) (NP (DT (no)) (NN (capacity)) (S (VP (TO (to)) (VP (VB (function)) (PP (IN (as)) (NP (NP (NNS (inhibitors))) (PP (IN (for)) (NP (NP (JJS (most))) (PP (IN (of)) (NP (drug_ENTITY (NP (DT (the)) (JJ (human)) (NN (cytochrome)) (NN (P450)) (NNS (enzymes)))) (VP (VBN (evaluated)) (PRN (-LRB- (<LB>)) (NP (drug_ENTITY (NP (NN (CYP1A2)))) (, (,)) (drug_ENTITY (NP (NN (CYP2A6)))) (, (,)) (drug_ENTITY (NP (NN (CYP2C9)))) (, (,)) (drug_ENTITY (NP (NN (CYP2D6)))) (, (,)) (drug_ENTITY (NP (NN (CYP2E1)))) (, (,)) (NP (NN (CYP4A9))) (CC (and)) (drug_ENTITY (NP (NN (CYP4A11))))) (-RRB- (<RB>))) (PP (IN (with)) (NP (NP (DT (the)) (NN (exception))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (NN (CYP2C19)))))))))))))))))))))) |ET|
-1  |BT|  (S (NP (NP (NE-Type-1-drug (NP (ADJP (JJ (active))) (NN (10-monohydroxy)) (NN (metabolite)))) (PRN (-LRB- (<LB>)) (NP (NN (MHD))) (-RRB- (<RB>))))) (VP (VBP (have)) (NP (NP (ADJP (JJ (little)))) (CC (or)) (NP (DT (no)) (NN (capacity)) (S (VP (TO (to)) (VP (VB (function)) (PP (IN (as)) (NP (NP (NNS (inhibitors))) (PP (IN (for)) (NP (NP (JJS (most))) (PP (IN (of)) (NP (drug_ENTITY (NP (DT (the)) (JJ (human)) (NN (cytochrome)) (NN (P450)) (NNS (enzymes)))) (VP (VBN (evaluated)) (PRN (-LRB- (<LB>)) (NP (drug_ENTITY (NP (NN (CYP1A2)))) (, (,)) (drug_ENTITY (NP (NN (CYP2A6)))) (, (,)) (drug_ENTITY (NP (NN (CYP2C9)))) (, (,)) (drug_ENTITY (NP (NN (CYP2D6)))) (, (,)) (drug_ENTITY (NP (NN (CYP2E1)))) (, (,)) (NP (NN (CYP4A9))) (CC (and)) (drug_ENTITY (NP (NN (CYP4A11))))) (-RRB- (<RB>))) (PP (IN (with)) (NP (NP (DT (the)) (NN (exception))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (CYP2C19)))) (CC (and)) (NE-Type-2-drug (NP (NN (CYP3A4)))))))))))))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (cytochrome)) (NN (P450)) (NNS (enzymes)))) (VP (VBN (evaluated)) (PRN (-LRB- (<LB>)) (NP (NE-Type-2-drug (NP (NN (CYP1A2)))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (cytochrome)) (NN (P450)) (NNS (enzymes)))) (VP (VBN (evaluated)) (PRN (-LRB- (<LB>)) (NP (drug_ENTITY (NP (NN (CYP1A2)))) (, (,)) (NE-Type-2-drug (NP (NN (CYP2A6)))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (cytochrome)) (NN (P450)) (NNS (enzymes)))) (VP (VBN (evaluated)) (PRN (-LRB- (<LB>)) (NP (drug_ENTITY (NP (NN (CYP1A2)))) (, (,)) (drug_ENTITY (NP (NN (CYP2A6)))) (, (,)) (NE-Type-2-drug (NP (NN (CYP2C9)))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (cytochrome)) (NN (P450)) (NNS (enzymes)))) (VP (VBN (evaluated)) (PRN (-LRB- (<LB>)) (NP (drug_ENTITY (NP (NN (CYP1A2)))) (, (,)) (drug_ENTITY (NP (NN (CYP2A6)))) (, (,)) (drug_ENTITY (NP (NN (CYP2C9)))) (, (,)) (NE-Type-2-drug (NP (NN (CYP2D6)))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (cytochrome)) (NN (P450)) (NNS (enzymes)))) (VP (VBN (evaluated)) (PRN (-LRB- (<LB>)) (NP (drug_ENTITY (NP (NN (CYP1A2)))) (, (,)) (drug_ENTITY (NP (NN (CYP2A6)))) (, (,)) (drug_ENTITY (NP (NN (CYP2C9)))) (, (,)) (drug_ENTITY (NP (NN (CYP2D6)))) (, (,)) (NE-Type-2-drug (NP (NN (CYP2E1)))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (cytochrome)) (NN (P450)) (NNS (enzymes)))) (VP (VBN (evaluated)) (PRN (-LRB- (<LB>)) (NP (drug_ENTITY (NP (NN (CYP1A2)))) (, (,)) (drug_ENTITY (NP (NN (CYP2A6)))) (, (,)) (drug_ENTITY (NP (NN (CYP2C9)))) (, (,)) (drug_ENTITY (NP (NN (CYP2D6)))) (, (,)) (drug_ENTITY (NP (NN (CYP2E1)))) (, (,)) (NP (NN (CYP4A9))) (CC (and)) (NE-Type-2-drug (NP (NN (CYP4A11)))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (cytochrome)) (NN (P450)) (NNS (enzymes)))) (VP (VBN (evaluated)) (PRN (-LRB- (<LB>)) (NP (drug_ENTITY (NP (NN (CYP1A2)))) (, (,)) (drug_ENTITY (NP (NN (CYP2A6)))) (, (,)) (drug_ENTITY (NP (NN (CYP2C9)))) (, (,)) (drug_ENTITY (NP (NN (CYP2D6)))) (, (,)) (drug_ENTITY (NP (NN (CYP2E1)))) (, (,)) (NP (NN (CYP4A9))) (CC (and)) (drug_ENTITY (NP (NN (CYP4A11))))) (-RRB- (<RB>))) (PP (IN (with)) (NP (NP (DT (the)) (NN (exception))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (NN (CYP2C19)))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (cytochrome)) (NN (P450)) (NNS (enzymes)))) (VP (VBN (evaluated)) (PRN (-LRB- (<LB>)) (NP (drug_ENTITY (NP (NN (CYP1A2)))) (, (,)) (drug_ENTITY (NP (NN (CYP2A6)))) (, (,)) (drug_ENTITY (NP (NN (CYP2C9)))) (, (,)) (drug_ENTITY (NP (NN (CYP2D6)))) (, (,)) (drug_ENTITY (NP (NN (CYP2E1)))) (, (,)) (NP (NN (CYP4A9))) (CC (and)) (drug_ENTITY (NP (NN (CYP4A11))))) (-RRB- (<RB>))) (PP (IN (with)) (NP (NP (DT (the)) (NN (exception))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (CYP2C19)))) (CC (and)) (NE-Type-2-drug (NP (NN (CYP3A4)))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (CYP1A2)))) (, (,)) (NE-Type-2-drug (NP (NN (CYP2A6))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (CYP1A2)))) (, (,)) (drug_ENTITY (NP (NN (CYP2A6)))) (, (,)) (NE-Type-2-drug (NP (NN (CYP2C9))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (CYP1A2)))) (, (,)) (drug_ENTITY (NP (NN (CYP2A6)))) (, (,)) (drug_ENTITY (NP (NN (CYP2C9)))) (, (,)) (NE-Type-2-drug (NP (NN (CYP2D6))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (CYP1A2)))) (, (,)) (drug_ENTITY (NP (NN (CYP2A6)))) (, (,)) (drug_ENTITY (NP (NN (CYP2C9)))) (, (,)) (drug_ENTITY (NP (NN (CYP2D6)))) (, (,)) (NE-Type-2-drug (NP (NN (CYP2E1))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (CYP1A2)))) (, (,)) (drug_ENTITY (NP (NN (CYP2A6)))) (, (,)) (drug_ENTITY (NP (NN (CYP2C9)))) (, (,)) (drug_ENTITY (NP (NN (CYP2D6)))) (, (,)) (drug_ENTITY (NP (NN (CYP2E1)))) (, (,)) (NP (NN (CYP4A9))) (CC (and)) (NE-Type-2-drug (NP (NN (CYP4A11))))) |ET|
-1  |BT|  (VP (PRN (NP (NE-Type-1-drug (NP (NN (CYP1A2)))) (, (,)) (drug_ENTITY (NP (NN (CYP2A6)))) (, (,)) (drug_ENTITY (NP (NN (CYP2C9)))) (, (,)) (drug_ENTITY (NP (NN (CYP2D6)))) (, (,)) (drug_ENTITY (NP (NN (CYP2E1)))) (, (,)) (NP (NN (CYP4A9))) (CC (and)) (drug_ENTITY (NP (NN (CYP4A11))))) (-RRB- (<RB>))) (PP (IN (with)) (NP (NP (DT (the)) (NN (exception))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (NN (CYP2C19))))))))) |ET|
-1  |BT|  (VP (PRN (NP (NE-Type-1-drug (NP (NN (CYP1A2)))) (, (,)) (drug_ENTITY (NP (NN (CYP2A6)))) (, (,)) (drug_ENTITY (NP (NN (CYP2C9)))) (, (,)) (drug_ENTITY (NP (NN (CYP2D6)))) (, (,)) (drug_ENTITY (NP (NN (CYP2E1)))) (, (,)) (NP (NN (CYP4A9))) (CC (and)) (drug_ENTITY (NP (NN (CYP4A11))))) (-RRB- (<RB>))) (PP (IN (with)) (NP (NP (DT (the)) (NN (exception))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (CYP2C19)))) (CC (and)) (NE-Type-2-drug (NP (NN (CYP3A4))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (CYP2A6)))) (, (,)) (NE-Type-2-drug (NP (NN (CYP2C9))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (CYP2A6)))) (, (,)) (drug_ENTITY (NP (NN (CYP2C9)))) (, (,)) (NE-Type-2-drug (NP (NN (CYP2D6))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (CYP2A6)))) (, (,)) (drug_ENTITY (NP (NN (CYP2C9)))) (, (,)) (drug_ENTITY (NP (NN (CYP2D6)))) (, (,)) (NE-Type-2-drug (NP (NN (CYP2E1))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (CYP2A6)))) (, (,)) (drug_ENTITY (NP (NN (CYP2C9)))) (, (,)) (drug_ENTITY (NP (NN (CYP2D6)))) (, (,)) (drug_ENTITY (NP (NN (CYP2E1)))) (, (,)) (NP (NN (CYP4A9))) (CC (and)) (NE-Type-2-drug (NP (NN (CYP4A11))))) |ET|
-1  |BT|  (VP (PRN (NP (NE-Type-1-drug (NP (NN (CYP2A6)))) (, (,)) (drug_ENTITY (NP (NN (CYP2C9)))) (, (,)) (drug_ENTITY (NP (NN (CYP2D6)))) (, (,)) (drug_ENTITY (NP (NN (CYP2E1)))) (, (,)) (NP (NN (CYP4A9))) (CC (and)) (drug_ENTITY (NP (NN (CYP4A11))))) (-RRB- (<RB>))) (PP (IN (with)) (NP (NP (DT (the)) (NN (exception))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (NN (CYP2C19))))))))) |ET|
-1  |BT|  (VP (PRN (NP (NE-Type-1-drug (NP (NN (CYP2A6)))) (, (,)) (drug_ENTITY (NP (NN (CYP2C9)))) (, (,)) (drug_ENTITY (NP (NN (CYP2D6)))) (, (,)) (drug_ENTITY (NP (NN (CYP2E1)))) (, (,)) (NP (NN (CYP4A9))) (CC (and)) (drug_ENTITY (NP (NN (CYP4A11))))) (-RRB- (<RB>))) (PP (IN (with)) (NP (NP (DT (the)) (NN (exception))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (CYP2C19)))) (CC (and)) (NE-Type-2-drug (NP (NN (CYP3A4))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (CYP2C9)))) (, (,)) (NE-Type-2-drug (NP (NN (CYP2D6))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (CYP2C9)))) (, (,)) (drug_ENTITY (NP (NN (CYP2D6)))) (, (,)) (NE-Type-2-drug (NP (NN (CYP2E1))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (CYP2C9)))) (, (,)) (drug_ENTITY (NP (NN (CYP2D6)))) (, (,)) (drug_ENTITY (NP (NN (CYP2E1)))) (, (,)) (NP (NN (CYP4A9))) (CC (and)) (NE-Type-2-drug (NP (NN (CYP4A11))))) |ET|
-1  |BT|  (VP (PRN (NP (NE-Type-1-drug (NP (NN (CYP2C9)))) (, (,)) (drug_ENTITY (NP (NN (CYP2D6)))) (, (,)) (drug_ENTITY (NP (NN (CYP2E1)))) (, (,)) (NP (NN (CYP4A9))) (CC (and)) (drug_ENTITY (NP (NN (CYP4A11))))) (-RRB- (<RB>))) (PP (IN (with)) (NP (NP (DT (the)) (NN (exception))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (NN (CYP2C19))))))))) |ET|
-1  |BT|  (VP (PRN (NP (NE-Type-1-drug (NP (NN (CYP2C9)))) (, (,)) (drug_ENTITY (NP (NN (CYP2D6)))) (, (,)) (drug_ENTITY (NP (NN (CYP2E1)))) (, (,)) (NP (NN (CYP4A9))) (CC (and)) (drug_ENTITY (NP (NN (CYP4A11))))) (-RRB- (<RB>))) (PP (IN (with)) (NP (NP (DT (the)) (NN (exception))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (CYP2C19)))) (CC (and)) (NE-Type-2-drug (NP (NN (CYP3A4))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (CYP2D6)))) (, (,)) (NE-Type-2-drug (NP (NN (CYP2E1))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (CYP2D6)))) (, (,)) (drug_ENTITY (NP (NN (CYP2E1)))) (, (,)) (NP (NN (CYP4A9))) (CC (and)) (NE-Type-2-drug (NP (NN (CYP4A11))))) |ET|
-1  |BT|  (VP (PRN (NP (NE-Type-1-drug (NP (NN (CYP2D6)))) (, (,)) (drug_ENTITY (NP (NN (CYP2E1)))) (, (,)) (NP (NN (CYP4A9))) (CC (and)) (drug_ENTITY (NP (NN (CYP4A11))))) (-RRB- (<RB>))) (PP (IN (with)) (NP (NP (DT (the)) (NN (exception))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (NN (CYP2C19))))))))) |ET|
-1  |BT|  (VP (PRN (NP (NE-Type-1-drug (NP (NN (CYP2D6)))) (, (,)) (drug_ENTITY (NP (NN (CYP2E1)))) (, (,)) (NP (NN (CYP4A9))) (CC (and)) (drug_ENTITY (NP (NN (CYP4A11))))) (-RRB- (<RB>))) (PP (IN (with)) (NP (NP (DT (the)) (NN (exception))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (CYP2C19)))) (CC (and)) (NE-Type-2-drug (NP (NN (CYP3A4))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (CYP2E1)))) (, (,)) (NP (NN (CYP4A9))) (CC (and)) (NE-Type-2-drug (NP (NN (CYP4A11))))) |ET|
-1  |BT|  (VP (PRN (NP (NE-Type-1-drug (NP (NN (CYP2E1)))) (, (,)) (NP (NN (CYP4A9))) (CC (and)) (drug_ENTITY (NP (NN (CYP4A11))))) (-RRB- (<RB>))) (PP (IN (with)) (NP (NP (DT (the)) (NN (exception))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (NN (CYP2C19))))))))) |ET|
-1  |BT|  (VP (PRN (NP (NE-Type-1-drug (NP (NN (CYP2E1)))) (, (,)) (NP (NN (CYP4A9))) (CC (and)) (drug_ENTITY (NP (NN (CYP4A11))))) (-RRB- (<RB>))) (PP (IN (with)) (NP (NP (DT (the)) (NN (exception))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (CYP2C19)))) (CC (and)) (NE-Type-2-drug (NP (NN (CYP3A4))))))))) |ET|
-1  |BT|  (VP (PRN (NP (NE-Type-1-drug (NP (NN (CYP4A11))))) (-RRB- (<RB>))) (PP (IN (with)) (NP (NP (DT (the)) (NN (exception))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (NN (CYP2C19))))))))) |ET|
-1  |BT|  (VP (PRN (NP (NE-Type-1-drug (NP (NN (CYP4A11))))) (-RRB- (<RB>))) (PP (IN (with)) (NP (NP (DT (the)) (NN (exception))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (CYP2C19)))) (CC (and)) (NE-Type-2-drug (NP (NN (CYP3A4))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (CYP2C19)))) (CC (and)) (NE-Type-2-drug (NP (NN (CYP3A4))))) |ET|
-1  |BT|  (S (SBAR (S (VP (NP (PP (NE-Type-1-drug (NP (NN (UDP-glucuronyl)) (NN (transferase))))))))) (, (,)) (NP (PRP (it))) (VP (VBZ (is)) (ADJP (JJ (unlikely)) (S (VP (TO (to)) (VP (VB (have)) (NP (DT (an)) (NN (effect))) (PP (IN (on)) (NP (NE-Type-2-drug (NP (NNS (drugs)))))))))))) |ET|
-1  |BT|  (S (SBAR (S (VP (NP (PP (NE-Type-1-drug (NP (NN (UDP-glucuronyl)) (NN (transferase))))))))) (, (,)) (NP (PRP (it))) (VP (VBZ (is)) (ADJP (JJ (unlikely)) (S (VP (TO (to)) (VP (VB (have)) (NP (DT (an)) (NN (effect))) (PP (IN (on)) (NP (drug_ENTITY (NP (NNS (drugs)))) (SBAR (WHNP (WDT (that))) (S (VP (VBP (are)) (ADVP (RB (mainly))) (VP (VBN (eliminated)) (PP (IN (by)) (NP (NN (conjugation)))) (PP (IN (through)) (NP (NE-Type-2-drug (NP (JJ (UDP-glucuronyl)) (NN (transferase)))))))))))))))))) |ET|
-1  |BT|  (S (SBAR (S (VP (NP (PP (NE-Type-1-drug (NP (NN (UDP-glucuronyl)) (NN (transferase))))))))) (, (,)) (NP (PRP (it))) (VP (VBZ (is)) (ADJP (JJ (unlikely)) (S (VP (TO (to)) (VP (VB (have)) (NP (DT (an)) (NN (effect))) (PP (IN (on)) (NP (drug_ENTITY (NP (NNS (drugs)))) (SBAR (WHNP (WDT (that))) (S (VP (VBP (are)) (ADVP (RB (mainly))) (VP (VBN (eliminated)) (PP (IN (by)) (NP (NN (conjugation)))) (PP (IN (through)) (NP (drug_ENTITY (NP (JJ (UDP-glucuronyl)) (NN (transferase)))) (PRN (-LRB- (<LB>)) (PP (FW (e.g.)) (, (,)) (NE-Type-2-drug (NP (JJ (valproic)) (NN (acid)))))))))))))))))))) |ET|
-1  |BT|  (S (SBAR (S (VP (NP (PP (NE-Type-1-drug (NP (NN (UDP-glucuronyl)) (NN (transferase))))))))) (, (,)) (NP (PRP (it))) (VP (VBZ (is)) (ADJP (JJ (unlikely)) (S (VP (TO (to)) (VP (VB (have)) (NP (DT (an)) (NN (effect))) (PP (IN (on)) (NP (drug_ENTITY (NP (NNS (drugs)))) (SBAR (WHNP (WDT (that))) (S (VP (VBP (are)) (ADVP (RB (mainly))) (VP (VBN (eliminated)) (PP (IN (by)) (NP (NN (conjugation)))) (PP (IN (through)) (NP (drug_ENTITY (NP (JJ (UDP-glucuronyl)) (NN (transferase)))) (PRN (-LRB- (<LB>)) (PP (FW (e.g.)) (, (,)) (drug_ENTITY (NP (JJ (valproic)) (NN (acid))))) (, (,)) (NE-Type-2-drug (NP (NN (lamotrigine))))))))))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (drugs)))) (SBAR (WHNP (WDT (that))) (S (VP (VBP (are)) (ADVP (RB (mainly))) (VP (VBN (eliminated)) (PP (IN (by)) (NP (NN (conjugation)))) (PP (IN (through)) (NP (NE-Type-2-drug (NP (JJ (UDP-glucuronyl)) (NN (transferase))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (drugs)))) (SBAR (WHNP (WDT (that))) (S (VP (VBP (are)) (ADVP (RB (mainly))) (VP (VBN (eliminated)) (PP (IN (by)) (NP (NN (conjugation)))) (PP (IN (through)) (NP (drug_ENTITY (NP (JJ (UDP-glucuronyl)) (NN (transferase)))) (PRN (-LRB- (<LB>)) (PP (FW (e.g.)) (, (,)) (NE-Type-2-drug (NP (JJ (valproic)) (NN (acid))))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (drugs)))) (SBAR (WHNP (WDT (that))) (S (VP (VBP (are)) (ADVP (RB (mainly))) (VP (VBN (eliminated)) (PP (IN (by)) (NP (NN (conjugation)))) (PP (IN (through)) (NP (drug_ENTITY (NP (JJ (UDP-glucuronyl)) (NN (transferase)))) (PRN (-LRB- (<LB>)) (PP (FW (e.g.)) (, (,)) (drug_ENTITY (NP (JJ (valproic)) (NN (acid))))) (, (,)) (NE-Type-2-drug (NP (NN (lamotrigine)))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (JJ (UDP-glucuronyl)) (NN (transferase)))) (PRN (-LRB- (<LB>)) (PP (FW (e.g.)) (, (,)) (NE-Type-2-drug (NP (JJ (valproic)) (NN (acid))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (JJ (UDP-glucuronyl)) (NN (transferase)))) (PRN (-LRB- (<LB>)) (PP (FW (e.g.)) (, (,)) (drug_ENTITY (NP (JJ (valproic)) (NN (acid))))) (, (,)) (NE-Type-2-drug (NP (NN (lamotrigine)))))) |ET|
-1  |BT|  (PRN (PP (NE-Type-1-drug (NP (JJ (valproic)) (NN (acid))))) (, (,)) (NE-Type-2-drug (NP (NN (lamotrigine))))) |ET|
-1  |BT|  (S (NP (NE-Type-1-drug (NP (NN (oxcarbazepine)))) (CC (and)) (NP (NN (MHD)))) (VP (VBP (induce)) (NP (NP (DT (a)) (NN (subgroup))) (PP (IN (of)) (NP (NP (NE-Type-2-drug (NP (DT (the)) (NN (cytochrome)) (NN (P450)) (NN (3A)))))))))) |ET|
-1  |BT|  (S (NP (NE-Type-1-drug (NP (NN (oxcarbazepine)))) (CC (and)) (NP (NN (MHD)))) (VP (VBP (induce)) (NP (NP (DT (a)) (NN (subgroup))) (PP (IN (of)) (NP (NP (drug_ENTITY (NP (DT (the)) (NN (cytochrome)) (NN (P450)) (NN (3A)) (NN (family)))) (PRN (-LRB- (<LB>)) (NP (NE-Type-2-drug (NP (NN (CYP3A4)))))))))))) |ET|
-1  |BT|  (S (NP (NE-Type-1-drug (NP (NN (oxcarbazepine)))) (CC (and)) (NP (NN (MHD)))) (VP (VBP (induce)) (NP (NP (DT (a)) (NN (subgroup))) (PP (IN (of)) (NP (NP (drug_ENTITY (NP (DT (the)) (NN (cytochrome)) (NN (P450)) (NN (3A)) (NN (family)))) (PRN (-LRB- (<LB>)) (NP (drug_ENTITY (NP (NN (CYP3A4)))) (CC (and)) (NE-Type-2-drug (NP (NN (CYP3A5)))))))))))) |ET|
1  |BT|  (S (NP (NE-Type-1-drug (NP (NN (oxcarbazepine)))) (CC (and)) (NP (NN (MHD)))) (VP (VBP (induce)) (NP (NP (DT (a)) (NN (subgroup))) (PP (IN (of)) (NP (NP (drug_ENTITY (NP (DT (the)) (NN (cytochrome)) (NN (P450)) (NN (3A)) (NN (family)))) (PRN (-LRB- (<LB>)) (NP (drug_ENTITY (NP (NN (CYP3A4)))) (CC (and)) (drug_ENTITY (NP (NN (CYP3A5))))) (-RRB- (<RB>)))) (ADJP (JJ (responsible)) (PP (IN (for)) (NP (NP (DT (the)) (NN (metabolism))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (NN (dihydropyridine)) (NN (calcium)) (NN (antagonist)))))))))))))) |ET|
1  |BT|  (S (NP (NE-Type-1-drug (NP (NN (oxcarbazepine)))) (CC (and)) (NP (NN (MHD)))) (VP (VBP (induce)) (NP (NP (DT (a)) (NN (subgroup))) (PP (IN (of)) (NP (NP (drug_ENTITY (NP (DT (the)) (NN (cytochrome)) (NN (P450)) (NN (3A)) (NN (family)))) (PRN (-LRB- (<LB>)) (NP (drug_ENTITY (NP (NN (CYP3A4)))) (CC (and)) (drug_ENTITY (NP (NN (CYP3A5))))) (-RRB- (<RB>)))) (ADJP (JJ (responsible)) (PP (IN (for)) (NP (NP (DT (the)) (NN (metabolism))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (dihydropyridine)) (NN (calcium)) (NN (antagonist)) (NN (s)))) (CC (and)) (NE-Type-2-drug (NP (JJ (oral)) (NNS (contraceptives)))))))))))))) |ET|
-1  |BT|  (S (NP (NE-Type-1-drug (NP (NN (oxcarbazepine)))) (CC (and)) (NP (NN (MHD)))) (VP (VBP (induce)) (NP (NP (DT (a)) (NN (subgroup))) (PP (IN (of)) (NP (NP (drug_ENTITY (NP (DT (the)) (NN (cytochrome)) (NN (P450)) (NN (3A)) (NN (family)))) (PRN (-LRB- (<LB>)) (NP (drug_ENTITY (NP (NN (CYP3A4)))) (CC (and)) (drug_ENTITY (NP (NN (CYP3A5))))) (-RRB- (<RB>)))) (ADJP (JJ (responsible)) (PP (IN (for)) (NP (NP (DT (the)) (NN (metabolism))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (dihydropyridine)) (NN (calcium)) (NN (antagonist)) (NN (s)))) (CC (and)) (drug_ENTITY (NP (JJ (oral)) (NNS (contraceptives)))))))))))) (, (,)) (S (VP (VBG (resulting)) (PP (IN (in)) (NP (NP (DT (a)) (JJR (lower)) (NN (plasma)) (NN (concentration))) (PP (IN (of)) (NE-Type-2-drug (NP (DT (these)) (NNS (drugs))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (cytochrome)) (NN (P450)) (NN (3A)) (NN (family)))) (PRN (-LRB- (<LB>)) (NP (NE-Type-2-drug (NP (NN (CYP3A4))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (cytochrome)) (NN (P450)) (NN (3A)) (NN (family)))) (PRN (-LRB- (<LB>)) (NP (drug_ENTITY (NP (NN (CYP3A4)))) (CC (and)) (NE-Type-2-drug (NP (NN (CYP3A5))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (cytochrome)) (NN (P450)) (NN (3A)) (NN (family)))) (PRN (-LRB- (<LB>)) (NP (drug_ENTITY (NP (NN (CYP3A4)))) (CC (and)) (drug_ENTITY (NP (NN (CYP3A5))))) (-RRB- (<RB>)))) (ADJP (JJ (responsible)) (PP (IN (for)) (NP (NP (DT (the)) (NN (metabolism))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (NN (dihydropyridine)) (NN (calcium)) (NN (antagonist)))))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (cytochrome)) (NN (P450)) (NN (3A)) (NN (family)))) (PRN (-LRB- (<LB>)) (NP (drug_ENTITY (NP (NN (CYP3A4)))) (CC (and)) (drug_ENTITY (NP (NN (CYP3A5))))) (-RRB- (<RB>)))) (ADJP (JJ (responsible)) (PP (IN (for)) (NP (NP (DT (the)) (NN (metabolism))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (dihydropyridine)) (NN (calcium)) (NN (antagonist)) (NN (s)))) (CC (and)) (NE-Type-2-drug (NP (JJ (oral)) (NNS (contraceptives)))))))))) |ET|
-1  |BT|  (VP (NP (PP (NP (NP (NE-Type-1-drug (NP (NN (cytochrome)) (NN (P450)) (NN (3A)) (NN (family)))) (PRN (-LRB- (<LB>)) (NP (drug_ENTITY (NP (NN (CYP3A4)))) (CC (and)) (drug_ENTITY (NP (NN (CYP3A5))))) (-RRB- (<RB>)))) (ADJP (JJ (responsible)) (PP (IN (for)) (NP (NP (DT (the)) (NN (metabolism))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (dihydropyridine)) (NN (calcium)) (NN (antagonist)) (NN (s)))) (CC (and)) (drug_ENTITY (NP (JJ (oral)) (NNS (contraceptives)))))))))))) (, (,)) (S (VP (VBG (resulting)) (PP (IN (in)) (NP (NP (DT (a)) (JJR (lower)) (NN (plasma)) (NN (concentration))) (PP (IN (of)) (NE-Type-2-drug (NP (DT (these)) (NNS (drugs)))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (CYP3A4)))) (CC (and)) (NE-Type-2-drug (NP (NN (CYP3A5))))) |ET|
-1  |BT|  (NP (NP (PRN (NP (NE-Type-1-drug (NP (NN (CYP3A4)))) (CC (and)) (drug_ENTITY (NP (NN (CYP3A5))))) (-RRB- (<RB>)))) (ADJP (JJ (responsible)) (PP (IN (for)) (NP (NP (DT (the)) (NN (metabolism))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (NN (dihydropyridine)) (NN (calcium)) (NN (antagonist)))))))))) |ET|
-1  |BT|  (NP (NP (PRN (NP (NE-Type-1-drug (NP (NN (CYP3A4)))) (CC (and)) (drug_ENTITY (NP (NN (CYP3A5))))) (-RRB- (<RB>)))) (ADJP (JJ (responsible)) (PP (IN (for)) (NP (NP (DT (the)) (NN (metabolism))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (dihydropyridine)) (NN (calcium)) (NN (antagonist)) (NN (s)))) (CC (and)) (NE-Type-2-drug (NP (JJ (oral)) (NNS (contraceptives)))))))))) |ET|
-1  |BT|  (VP (NP (PP (NP (NP (PRN (NP (NE-Type-1-drug (NP (NN (CYP3A4)))) (CC (and)) (drug_ENTITY (NP (NN (CYP3A5))))) (-RRB- (<RB>)))) (ADJP (JJ (responsible)) (PP (IN (for)) (NP (NP (DT (the)) (NN (metabolism))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (dihydropyridine)) (NN (calcium)) (NN (antagonist)) (NN (s)))) (CC (and)) (drug_ENTITY (NP (JJ (oral)) (NNS (contraceptives)))))))))))) (, (,)) (S (VP (VBG (resulting)) (PP (IN (in)) (NP (NP (DT (a)) (JJR (lower)) (NN (plasma)) (NN (concentration))) (PP (IN (of)) (NE-Type-2-drug (NP (DT (these)) (NNS (drugs)))))))))) |ET|
-1  |BT|  (NP (NP (PRN (NP (NE-Type-1-drug (NP (NN (CYP3A5))))) (-RRB- (<RB>)))) (ADJP (JJ (responsible)) (PP (IN (for)) (NP (NP (DT (the)) (NN (metabolism))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (NN (dihydropyridine)) (NN (calcium)) (NN (antagonist)))))))))) |ET|
-1  |BT|  (NP (NP (PRN (NP (NE-Type-1-drug (NP (NN (CYP3A5))))) (-RRB- (<RB>)))) (ADJP (JJ (responsible)) (PP (IN (for)) (NP (NP (DT (the)) (NN (metabolism))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (dihydropyridine)) (NN (calcium)) (NN (antagonist)) (NN (s)))) (CC (and)) (NE-Type-2-drug (NP (JJ (oral)) (NNS (contraceptives)))))))))) |ET|
-1  |BT|  (VP (NP (PP (NP (NP (PRN (NP (NE-Type-1-drug (NP (NN (CYP3A5))))) (-RRB- (<RB>)))) (ADJP (JJ (responsible)) (PP (IN (for)) (NP (NP (DT (the)) (NN (metabolism))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (dihydropyridine)) (NN (calcium)) (NN (antagonist)) (NN (s)))) (CC (and)) (drug_ENTITY (NP (JJ (oral)) (NNS (contraceptives)))))))))))) (, (,)) (S (VP (VBG (resulting)) (PP (IN (in)) (NP (NP (DT (a)) (JJR (lower)) (NN (plasma)) (NN (concentration))) (PP (IN (of)) (NE-Type-2-drug (NP (DT (these)) (NNS (drugs)))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (calcium)) (NN (antagonist)) (NN (s)))) (CC (and)) (NE-Type-2-drug (NP (JJ (oral)) (NNS (contraceptives))))) |ET|
-1  |BT|  (VP (NP (PP (NP (ADJP (PP (NP (PP (NP (NE-Type-1-drug (NP (NN (calcium)) (NN (antagonist)) (NN (s)))) (CC (and)) (drug_ENTITY (NP (JJ (oral)) (NNS (contraceptives)))))))))))) (, (,)) (S (VP (VBG (resulting)) (PP (IN (in)) (NP (NP (DT (a)) (JJR (lower)) (NN (plasma)) (NN (concentration))) (PP (IN (of)) (NE-Type-2-drug (NP (DT (these)) (NNS (drugs)))))))))) |ET|
-1  |BT|  (VP (NP (PP (NP (ADJP (PP (NP (PP (NP (NE-Type-1-drug (NP (JJ (oral)) (NNS (contraceptives)))))))))))) (, (,)) (S (VP (VBG (resulting)) (PP (IN (in)) (NP (NP (DT (a)) (JJR (lower)) (NN (plasma)) (NN (concentration))) (PP (IN (of)) (NE-Type-2-drug (NP (DT (these)) (NNS (drugs)))))))))) |ET|
-1  |BT|  (S (SBAR (S (NP (PP (NE-Type-1-drug (NP (NN (plasma)) (NNS (proteins)))))) (VP (VBZ (is)) (ADJP (ADJP (JJ (low))) (PRN (-LRB- (<LB>)) (NP (CD (40)) (NN (%))) (-RRB- (<RB>))))))) (, (,)) (NP (NP (ADJP (RB (clinically)) (JJ (significant))) (NNS (interactions))) (PP (IN (with)) (NE-Type-2-drug (NP (JJ (other)) (NNS (drugs))))))) |ET|
-1  |BT|  (S (SBAR (S (NP (PP (NE-Type-1-drug (NP (NN (plasma)) (NNS (proteins)))))) (VP (VBZ (is)) (ADJP (ADJP (JJ (low))) (PRN (-LRB- (<LB>)) (NP (CD (40)) (NN (%))) (-RRB- (<RB>))))))) (, (,)) (NP (NP (ADJP (RB (clinically)) (JJ (significant))) (NNS (interactions))) (PP (IN (with)) (drug_ENTITY (NP (JJ (other)) (NNS (drugs))))) (PP (IN (through)) (NP (NP (NN (competition))) (PP (IN (for)) (NE-Type-2-drug (NP (NN (protein))))))))) |ET|
-1  |BT|  (NP (PP (NE-Type-1-drug (NP (NNS (drugs))))) (PP (IN (through)) (NP (NP (NN (competition))) (PP (IN (for)) (NE-Type-2-drug (NP (NN (protein)))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (JJ (Antiepileptic)) (NNS (drugs)))) (NP (NP (JJ (Potential)) (NNS (interactions))) (PP (IN (between)) (NP (NE-Type-2-drug (NP (NNP (Trileptal)))))))) |ET|
-1  |BT|  (S (S (VP (NP (PP (NP (PP (NE-Type-1-drug (NP (NN (Trileptal)) (NNS (doses)))))))) (ADVP (FW (In)) (FW (vivo))))) (, (,)) (S (NP (NP (DT (the)) (NN (plasma)) (NNS (levels))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (phenytoin)))))))) |ET|
-1  |BT|  (S (S (VP (NP (PP (NP (PP (NE-Type-1-drug (NP (NN (Trileptal)) (NNS (doses)))))))) (ADVP (FW (In)) (FW (vivo))))) (, (,)) (S (NP (NP (DT (the)) (NN (plasma)) (NNS (levels))) (PP (IN (of)) (drug_ENTITY (NP (NN (phenytoin)))))) (VP (VBD (increased)) (PP (IN (by)) (NP (QP (RB (up)) (TO (to)) (CD (40))) (NN (%)))) (, (,)) (SBAR (WHADVP (WRB (when))) (S (NE-Type-2-drug (NP (NN (Trileptal))))))))) |ET|
1  |BT|  (S (NP (PP (NE-Type-1-drug (NP (NN (phenytoin)))))) (VP (VBD (increased)) (PP (IN (by)) (NP (QP (RB (up)) (TO (to)) (CD (40))) (NN (%)))) (, (,)) (SBAR (WHADVP (WRB (when))) (S (NE-Type-2-drug (NP (NN (Trileptal)))))))) |ET|
1  |BT|  (S (SBAR (S (VP (NP (PP (NE-Type-1-drug (NP (NN (Trileptal))))) (ADJP (QP (JJR (greater)) (IN (than)) (CD (1200))) (NN (mg/day)))) (PP (IN (during)) (NP (JJ (adjunctive)) (NN (therapy))))))) (, (,)) (NP (NP (DT (a)) (NN (decrease))) (PP (IN (in)) (NP (NP (DT (the)) (NN (dose))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (phenytoin))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (cytochrome)) (NN (P450)) (NNS (enzymes)))) (PRN (-LRB- (<LB>)) (PP (FW (i.e.))) (NP (NE-Type-2-drug (NP (NN (carbamazepine))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (cytochrome)) (NN (P450)) (NNS (enzymes)))) (PRN (-LRB- (<LB>)) (PP (FW (i.e.))) (NP (drug_ENTITY (NP (NN (carbamazepine)))) (, (,)) (NE-Type-2-drug (NP (NN (phenytoin))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (cytochrome)) (NN (P450)) (NNS (enzymes)))) (PRN (-LRB- (<LB>)) (PP (FW (i.e.))) (NP (drug_ENTITY (NP (NN (carbamazepine)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (CC (and)) (NE-Type-2-drug (NP (NN (phenobarbital))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (carbamazepine)))) (, (,)) (NE-Type-2-drug (NP (NN (phenytoin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (carbamazepine)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (CC (and)) (NE-Type-2-drug (NP (NN (phenobarbital))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (phenytoin)))) (CC (and)) (NE-Type-2-drug (NP (NN (phenobarbital))))) |ET|
1  |BT|  (NP (PP (NE-Type-1-drug (NP (NN (Trileptal))))) (PP (IN (with)) (NE-Type-2-drug (NP (DT (an)) (JJ (oral)) (NN (contraceptive)))))) |ET|
-1  |BT|  (S (NP (PP (NE-Type-1-drug (NP (NN (Trileptal))))) (PP (IN (with)) (drug_ENTITY (NP (DT (an)) (JJ (oral)) (NN (contraceptive)))))) (VP (VBZ (has)) (VP (VBN (been)) (VP (VBN (shown)) (S (VP (TO (to)) (VP (VB (influence)) (NP (NP (DT (the)) (NN (plasma)) (NNS (concentrations))) (PP (IN (of)) (NP (NP (DT (the)) (CD (two)) (JJ (hormonal)) (NNS (components))) (, (,)) (NP (NP (NE-Type-2-drug (NP (NN (ethinylestradiol)))))))))))))))) |ET|
-1  |BT|  (S (NP (PP (NE-Type-1-drug (NP (NN (Trileptal))))) (PP (IN (with)) (drug_ENTITY (NP (DT (an)) (JJ (oral)) (NN (contraceptive)))))) (VP (VBZ (has)) (VP (VBN (been)) (VP (VBN (shown)) (S (VP (TO (to)) (VP (VB (influence)) (NP (NP (DT (the)) (NN (plasma)) (NNS (concentrations))) (PP (IN (of)) (NP (NP (DT (the)) (CD (two)) (JJ (hormonal)) (NNS (components))) (, (,)) (NP (NP (drug_ENTITY (NP (NN (ethinylestradiol)))) (PRN (-LRB- (<LB>)) (NP (NN (EE))) (-RRB- (<RB>)))) (CC (and)) (NP (NE-Type-2-drug (NP (NN (levonorgestrel)))))))))))))))) |ET|
-1  |BT|  (S (NP (PP (NE-Type-1-drug (NP (JJ (oral)) (NN (contraceptive)))))) (VP (VBZ (has)) (VP (VBN (been)) (VP (VBN (shown)) (S (VP (TO (to)) (VP (VB (influence)) (NP (NP (DT (the)) (NN (plasma)) (NNS (concentrations))) (PP (IN (of)) (NP (NP (DT (the)) (CD (two)) (JJ (hormonal)) (NNS (components))) (, (,)) (NP (NP (NE-Type-2-drug (NP (NN (ethinylestradiol)))))))))))))))) |ET|
-1  |BT|  (S (NP (PP (NE-Type-1-drug (NP (JJ (oral)) (NN (contraceptive)))))) (VP (VBZ (has)) (VP (VBN (been)) (VP (VBN (shown)) (S (VP (TO (to)) (VP (VB (influence)) (NP (NP (DT (the)) (NN (plasma)) (NNS (concentrations))) (PP (IN (of)) (NP (NP (DT (the)) (CD (two)) (JJ (hormonal)) (NNS (components))) (, (,)) (NP (NP (drug_ENTITY (NP (NN (ethinylestradiol)))) (PRN (-LRB- (<LB>)) (NP (NN (EE))) (-RRB- (<RB>)))) (CC (and)) (NP (NE-Type-2-drug (NP (NN (levonorgestrel)))))))))))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (ethinylestradiol)))) (PRN (-LRB- (<LB>)) (NP (NN (EE))) (-RRB- (<RB>)))) (CC (and)) (NP (NE-Type-2-drug (NP (NN (levonorgestrel)))))) |ET|
1  |BT|  (NP (PP (NE-Type-1-drug (NP (NN (Trileptal))))) (PP (IN (with)) (NE-Type-2-drug (NP (JJ (hormonal)) (NNS (contraceptives)))))) |ET|
-1  |BT|  (S (NP (PP (NE-Type-1-drug (NP (NN (Trileptal))))) (PP (IN (with)) (drug_ENTITY (NP (JJ (hormonal)) (NNS (contraceptives)))))) (VP (MD (may)) (VP (VB (render)) (S (NE-Type-2-drug (NP (DT (these)) (NNS (contraceptives)))))))) |ET|
-1  |BT|  (S (NP (PP (NE-Type-1-drug (NP (NNS (contraceptives)))))) (VP (MD (may)) (VP (VB (render)) (S (NE-Type-2-drug (NP (DT (these)) (NNS (contraceptives)))))))) |ET|
-1  |BT|  (PP (NE-Type-1-drug (NP (NN (Calcium)) (NN (Antagonist)) (NN (s)))) (IN (After)) (NP (NP (JJ (repeated)) (NN (co-administration))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (Trileptal))))))) |ET|
-1  |BT|  (S (PP (NE-Type-1-drug (NP (NN (Calcium)) (NN (Antagonist)) (NN (s)))) (IN (After)) (NP (NP (JJ (repeated)) (NN (co-administration))) (PP (IN (of)) (drug_ENTITY (NP (NN (Trileptal))))))) (, (,)) (NP (NP (DT (the)) (NN (AUC))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (felodipine))))))) |ET|
1  |BT|  (S (PP (NP (PP (NE-Type-1-drug (NP (NN (Trileptal))))))) (, (,)) (NP (NP (DT (the)) (NN (AUC))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (felodipine))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Cimetidine)))) (, (,)) (NE-Type-2-drug (NP (NN (erythromycin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Cimetidine)))) (, (,)) (drug_ENTITY (NP (NN (erythromycin)))) (CC (and)) (NE-Type-2-drug (NP (NN (dextropropoxyphene))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (erythromycin)))) (CC (and)) (NE-Type-2-drug (NP (NN (dextropropoxyphene))))) |ET|
-1  |BT|  (S (NP (PP (NE-Type-1-drug (NP (NN (warfarin)))))) (VP (VBP (wshow)) (NP (NP (DT (no)) (NN (evidence))) (PP (IN (of)) (NP (NP (NN (interaction))) (PP (IN (with)) (NP (NP (ADJP (CC (either)) (ADJP (JJ (single))) (CC (or)) (ADJP (JJ (repeated)))) (NNS (doses))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (Trileptal)))))))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (TAXOL)))) (PRN (-LRB- (<LB>)) (NP (CD (110-200)) (NN (mg/m2))) (-RRB- (<RB>)))) (CC (and)) (NP (NE-Type-2-drug (NP (NN (cisplatin)))))) |ET|
-1  |BT|  (S (PP (NP (VP (NP (NP (PP (NP (NP (NE-Type-1-drug (NP (NN (TAXOL)))) (PRN (-LRB- (<LB>)) (NP (CD (110-200)) (NN (mg/m2))) (-RRB- (<RB>)))) (CC (and)) (NP (drug_ENTITY (NP (NN (cisplatin)))) (PRN (-LRB- (<LB>)) (NP (QP (CD (50)) (CC (or)) (CD (75))) (NN (mg/m2))) (-RRB- (<RB>))))))) (VP (VBN (given)) (PP (IN (as)) (NP (JJ (sequential)) (NNS (infusions))))))))) (, (,)) (NP (NN (myelosuppression))) (VP (VBD (was)) (ADJP (RBR (more)) (JJ (profound))) (SBAR (WHADVP (WRB (when))) (S (NE-Type-2-drug (NP (NN (TAXOL)))))))) |ET|
-1  |BT|  (S (PP (NP (VP (NP (NP (PP (NP (NP (NE-Type-1-drug (NP (NN (TAXOL)))) (PRN (-LRB- (<LB>)) (NP (CD (110-200)) (NN (mg/m2))) (-RRB- (<RB>)))) (CC (and)) (NP (drug_ENTITY (NP (NN (cisplatin)))) (PRN (-LRB- (<LB>)) (NP (QP (CD (50)) (CC (or)) (CD (75))) (NN (mg/m2))) (-RRB- (<RB>))))))) (VP (VBN (given)) (PP (IN (as)) (NP (JJ (sequential)) (NNS (infusions))))))))) (, (,)) (NP (NN (myelosuppression))) (VP (VBD (was)) (ADJP (RBR (more)) (JJ (profound))) (SBAR (WHADVP (WRB (when))) (S (drug_ENTITY (NP (NN (TAXOL)))) (VP (VBD (was)) (VP (VBN (given)) (PP (IN (after)) (NE-Type-2-drug (NP (NN (cisplatin))))))))))) |ET|
-1  |BT|  (S (PP (NP (VP (NP (NP (PP (NP (NP (NE-Type-1-drug (NP (NN (TAXOL)))) (PRN (-LRB- (<LB>)) (NP (CD (110-200)) (NN (mg/m2))) (-RRB- (<RB>)))) (CC (and)) (NP (drug_ENTITY (NP (NN (cisplatin)))) (PRN (-LRB- (<LB>)) (NP (QP (CD (50)) (CC (or)) (CD (75))) (NN (mg/m2))) (-RRB- (<RB>))))))) (VP (VBN (given)) (PP (IN (as)) (NP (JJ (sequential)) (NNS (infusions))))))))) (, (,)) (NP (NN (myelosuppression))) (VP (VBD (was)) (ADJP (RBR (more)) (JJ (profound))) (SBAR (WHADVP (WRB (when))) (S (drug_ENTITY (NP (NN (TAXOL)))) (VP (VBD (was)) (VP (VBN (given)) (PP (IN (after)) (drug_ENTITY (NP (NN (cisplatin))))) (PP (IN (than)) (PP (IN (with)) (NP (NP (DT (the)) (JJ (alternate)) (NN (sequence))) (PRN (-LRB- (<LB>)) (PP (FW (ie))) (, (,)) (NP (NE-Type-2-drug (NP (NN (TAXOL))))))))))))))) |ET|
-1  |BT|  (S (PP (NP (VP (NP (NP (PP (NP (NP (NE-Type-1-drug (NP (NN (TAXOL)))) (PRN (-LRB- (<LB>)) (NP (CD (110-200)) (NN (mg/m2))) (-RRB- (<RB>)))) (CC (and)) (NP (drug_ENTITY (NP (NN (cisplatin)))) (PRN (-LRB- (<LB>)) (NP (QP (CD (50)) (CC (or)) (CD (75))) (NN (mg/m2))) (-RRB- (<RB>))))))) (VP (VBN (given)) (PP (IN (as)) (NP (JJ (sequential)) (NNS (infusions))))))))) (, (,)) (NP (NN (myelosuppression))) (VP (VBD (was)) (ADJP (RBR (more)) (JJ (profound))) (SBAR (WHADVP (WRB (when))) (S (drug_ENTITY (NP (NN (TAXOL)))) (VP (VBD (was)) (VP (VBN (given)) (PP (IN (after)) (drug_ENTITY (NP (NN (cisplatin))))) (PP (IN (than)) (PP (IN (with)) (NP (NP (DT (the)) (JJ (alternate)) (NN (sequence))) (PRN (-LRB- (<LB>)) (PP (FW (ie))) (, (,)) (NP (drug_ENTITY (NP (NN (TAXOL)))) (PP (IN (before)) (NE-Type-2-drug (NP (NN (cisplatin)))))))))))))))) |ET|
-1  |BT|  (S (PP (NP (VP (NP (NP (PP (NP (NP (NE-Type-1-drug (NP (NN (cisplatin)))) (PRN (-LRB- (<LB>)) (NP (QP (CD (50)) (CC (or)) (CD (75))) (NN (mg/m2))) (-RRB- (<RB>))))))) (VP (VBN (given)) (PP (IN (as)) (NP (JJ (sequential)) (NNS (infusions))))))))) (, (,)) (NP (NN (myelosuppression))) (VP (VBD (was)) (ADJP (RBR (more)) (JJ (profound))) (SBAR (WHADVP (WRB (when))) (S (NE-Type-2-drug (NP (NN (TAXOL)))))))) |ET|
-1  |BT|  (S (PP (NP (VP (NP (NP (PP (NP (NP (NE-Type-1-drug (NP (NN (cisplatin)))) (PRN (-LRB- (<LB>)) (NP (QP (CD (50)) (CC (or)) (CD (75))) (NN (mg/m2))) (-RRB- (<RB>))))))) (VP (VBN (given)) (PP (IN (as)) (NP (JJ (sequential)) (NNS (infusions))))))))) (, (,)) (NP (NN (myelosuppression))) (VP (VBD (was)) (ADJP (RBR (more)) (JJ (profound))) (SBAR (WHADVP (WRB (when))) (S (drug_ENTITY (NP (NN (TAXOL)))) (VP (VBD (was)) (VP (VBN (given)) (PP (IN (after)) (NE-Type-2-drug (NP (NN (cisplatin))))))))))) |ET|
-1  |BT|  (S (PP (NP (VP (NP (NP (PP (NP (NP (NE-Type-1-drug (NP (NN (cisplatin)))) (PRN (-LRB- (<LB>)) (NP (QP (CD (50)) (CC (or)) (CD (75))) (NN (mg/m2))) (-RRB- (<RB>))))))) (VP (VBN (given)) (PP (IN (as)) (NP (JJ (sequential)) (NNS (infusions))))))))) (, (,)) (NP (NN (myelosuppression))) (VP (VBD (was)) (ADJP (RBR (more)) (JJ (profound))) (SBAR (WHADVP (WRB (when))) (S (drug_ENTITY (NP (NN (TAXOL)))) (VP (VBD (was)) (VP (VBN (given)) (PP (IN (after)) (drug_ENTITY (NP (NN (cisplatin))))) (PP (IN (than)) (PP (IN (with)) (NP (NP (DT (the)) (JJ (alternate)) (NN (sequence))) (PRN (-LRB- (<LB>)) (PP (FW (ie))) (, (,)) (NP (NE-Type-2-drug (NP (NN (TAXOL))))))))))))))) |ET|
-1  |BT|  (S (PP (NP (VP (NP (NP (PP (NP (NP (NE-Type-1-drug (NP (NN (cisplatin)))) (PRN (-LRB- (<LB>)) (NP (QP (CD (50)) (CC (or)) (CD (75))) (NN (mg/m2))) (-RRB- (<RB>))))))) (VP (VBN (given)) (PP (IN (as)) (NP (JJ (sequential)) (NNS (infusions))))))))) (, (,)) (NP (NN (myelosuppression))) (VP (VBD (was)) (ADJP (RBR (more)) (JJ (profound))) (SBAR (WHADVP (WRB (when))) (S (drug_ENTITY (NP (NN (TAXOL)))) (VP (VBD (was)) (VP (VBN (given)) (PP (IN (after)) (drug_ENTITY (NP (NN (cisplatin))))) (PP (IN (than)) (PP (IN (with)) (NP (NP (DT (the)) (JJ (alternate)) (NN (sequence))) (PRN (-LRB- (<LB>)) (PP (FW (ie))) (, (,)) (NP (drug_ENTITY (NP (NN (TAXOL)))) (PP (IN (before)) (NE-Type-2-drug (NP (NN (cisplatin)))))))))))))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NN (TAXOL)))) (VP (VBD (was)) (VP (VBN (given)) (PP (IN (after)) (NE-Type-2-drug (NP (NN (cisplatin)))))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NN (TAXOL)))) (VP (VBD (was)) (VP (VBN (given)) (PP (IN (after)) (drug_ENTITY (NP (NN (cisplatin))))) (PP (IN (than)) (PP (IN (with)) (NP (NP (DT (the)) (JJ (alternate)) (NN (sequence))) (PRN (-LRB- (<LB>)) (PP (FW (ie))) (, (,)) (NP (NE-Type-2-drug (NP (NN (TAXOL)))))))))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NN (TAXOL)))) (VP (VBD (was)) (VP (VBN (given)) (PP (IN (after)) (drug_ENTITY (NP (NN (cisplatin))))) (PP (IN (than)) (PP (IN (with)) (NP (NP (DT (the)) (JJ (alternate)) (NN (sequence))) (PRN (-LRB- (<LB>)) (PP (FW (ie))) (, (,)) (NP (drug_ENTITY (NP (NN (TAXOL)))) (PP (IN (before)) (NE-Type-2-drug (NP (NN (cisplatin))))))))))))) |ET|
-1  |BT|  (VP (PP (NE-Type-1-drug (NP (NN (cisplatin))))) (PP (IN (than)) (PP (IN (with)) (NP (NP (DT (the)) (JJ (alternate)) (NN (sequence))) (PRN (-LRB- (<LB>)) (PP (FW (ie))) (, (,)) (NP (NE-Type-2-drug (NP (NN (TAXOL)))))))))) |ET|
-1  |BT|  (VP (PP (NE-Type-1-drug (NP (NN (cisplatin))))) (PP (IN (than)) (PP (IN (with)) (NP (NP (DT (the)) (JJ (alternate)) (NN (sequence))) (PRN (-LRB- (<LB>)) (PP (FW (ie))) (, (,)) (NP (drug_ENTITY (NP (NN (TAXOL)))) (PP (IN (before)) (NE-Type-2-drug (NP (NN (cisplatin))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (TAXOL)))) (PP (IN (before)) (NE-Type-2-drug (NP (NN (cisplatin)))))) |ET|
-1  |BT|  (VP (NP (PP (NP (NE-Type-1-drug (NP (NN (paclitaxel)) (NN (clearance)))) (PP (IN (of)) (NP (QP (RB (approximately)) (CD (33))) (NN (%))))))) (SBAR (WHADVP (WRB (when))) (S (NE-Type-2-drug (NP (NN (TAXOL))))))) |ET|
-1  |BT|  (VP (NP (PP (NP (NE-Type-1-drug (NP (NN (paclitaxel)) (NN (clearance)))) (PP (IN (of)) (NP (QP (RB (approximately)) (CD (33))) (NN (%))))))) (SBAR (WHADVP (WRB (when))) (S (drug_ENTITY (NP (NN (TAXOL)))) (VP (VBD (was)) (VP (VBN (administered)) (PP (VBG (following)) (NE-Type-2-drug (NP (NN (cisplatin)))))))))) |ET|
1  |BT|  (S (NE-Type-1-drug (NP (NN (TAXOL)))) (VP (VBD (was)) (VP (VBN (administered)) (PP (VBG (following)) (NE-Type-2-drug (NP (NN (cisplatin)))))))) |ET|
1  |BT|  (S (NP (PP (NE-Type-1-drug (NP (NN (TAXOL)))))) (VP (VBZ (is)) (VP (VBN (catalyzed)) (PP (IN (by)) (NE-Type-2-drug (NP (NN (cytochrome)) (NN (P450)))))))) |ET|
1  |BT|  (S (NP (PP (NE-Type-1-drug (NP (NN (TAXOL)))))) (VP (VBZ (is)) (VP (VBN (catalyzed)) (PP (IN (by)) (drug_ENTITY (NP (NN (cytochrome)) (NN (P450)) (NNS (isoen-zymes)) (NP (NP (NN (CYP2C8))) (CC (and)) (NE-Type-2-drug (NP (NN (CYP3A4))))))))))) |ET|
-1  |BT|  (NE-Type-1-drug (NP (NN (cytochrome)) (NN (P450)) (NNS (isoen-zymes)) (NP (NP (NN (CYP2C8))) (CC (and)) (NE-Type-2-drug (NP (NN (CYP3A4))))))) |ET|
1  |BT|  (VP (NP (NE-Type-1-drug (NP (NN (TAXOL)))) (ADVP (RB (concomitantly)))) (PP (IN (with)) (NP (NP (JJ (known)) (NNS (substrates))) (CC (or)) (NP (NP (NNS (inhibitors))) (PP (IN (of)) (NE-Type-2-drug (NP (DT (the)) (NN (cytochrome)) (NN (P450))))))))) |ET|
1  |BT|  (VP (NP (NE-Type-1-drug (NP (NN (TAXOL)))) (ADVP (RB (concomitantly)))) (PP (IN (with)) (NP (NP (JJ (known)) (NNS (substrates))) (CC (or)) (NP (NP (NNS (inhibitors))) (PP (IN (of)) (drug_ENTITY (NP (DT (the)) (NN (cytochrome)) (NN (P450)) (NNS (isoenzymes)) (NP (NP (NN (CYP2C8))) (CC (and)) (NE-Type-2-drug (NP (NN (CYP3A4)))))))))))) |ET|
-1  |BT|  (NE-Type-1-drug (NP (NN (cytochrome)) (NN (P450)) (NNS (isoenzymes)) (NP (NP (NN (CYP2C8))) (CC (and)) (NE-Type-2-drug (NP (NN (CYP3A4))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (TAXOL)))) (, (,)) (NP (NP (DT (a)) (NN (substrate))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (CYP3A4))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (TAXOL)))) (, (,)) (NP (NP (DT (a)) (NN (substrate))) (PP (IN (of)) (drug_ENTITY (NP (NN (CYP3A4)))))) (, (,))) (CC (and)) (NP (NE-Type-2-drug (NP (NN (protease)) (NNS (inhibitors)))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (TAXOL)))) (, (,)) (NP (NP (DT (a)) (NN (substrate))) (PP (IN (of)) (drug_ENTITY (NP (NN (CYP3A4)))))) (, (,))) (CC (and)) (NP (drug_ENTITY (NP (NN (protease)) (NNS (inhibitors)))) (PRN (-LRB- (<LB>)) (NP (NE-Type-2-drug (NP (NN (ritonavir)))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (TAXOL)))) (, (,)) (NP (NP (DT (a)) (NN (substrate))) (PP (IN (of)) (drug_ENTITY (NP (NN (CYP3A4)))))) (, (,))) (CC (and)) (NP (drug_ENTITY (NP (NN (protease)) (NNS (inhibitors)))) (PRN (-LRB- (<LB>)) (NP (drug_ENTITY (NP (NN (ritonavir)))) (, (,)) (NE-Type-2-drug (NP (NN (saquinavir)))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (TAXOL)))) (, (,)) (NP (NP (DT (a)) (NN (substrate))) (PP (IN (of)) (drug_ENTITY (NP (NN (CYP3A4)))))) (, (,))) (CC (and)) (NP (drug_ENTITY (NP (NN (protease)) (NNS (inhibitors)))) (PRN (-LRB- (<LB>)) (NP (drug_ENTITY (NP (NN (ritonavir)))) (, (,)) (drug_ENTITY (NP (NN (saquinavir)))) (, (,)) (NE-Type-2-drug (NP (NN (indinavir)))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (TAXOL)))) (, (,)) (NP (NP (DT (a)) (NN (substrate))) (PP (IN (of)) (drug_ENTITY (NP (NN (CYP3A4)))))) (, (,))) (CC (and)) (NP (drug_ENTITY (NP (NN (protease)) (NNS (inhibitors)))) (PRN (-LRB- (<LB>)) (NP (drug_ENTITY (NP (NN (ritonavir)))) (, (,)) (drug_ENTITY (NP (NN (saquinavir)))) (, (,)) (drug_ENTITY (NP (NN (indinavir)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NN (nelfinavir)))))))) |ET|
-1  |BT|  (NP (PP (NP (NP (NE-Type-1-drug (NP (NN (TAXOL)))) (, (,)) (NP (NP (DT (a)) (NN (substrate))) (PP (IN (of)) (drug_ENTITY (NP (NN (CYP3A4)))))) (, (,))) (CC (and)) (NP (drug_ENTITY (NP (NN (protease)) (NNS (inhibitors)))) (PRN (-LRB- (<LB>)) (NP (drug_ENTITY (NP (NN (ritonavir)))) (, (,)) (drug_ENTITY (NP (NN (saquinavir)))) (, (,)) (drug_ENTITY (NP (NN (indinavir)))) (, (,)) (CC (and)) (drug_ENTITY (NP (NN (nelfinavir))))) (-RRB- (<RB>)))))) (, (,)) (SBAR (WHNP (WDT (which))) (S (VP (VBP (are)) (NP (NP (NP (NNS (substrates))) (CC (and/or)) (NP (NNS (inhibitors)))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (CYP3A4)))))))))) |ET|
-1  |BT|  (NP (NP (NP (PP (NE-Type-1-drug (NP (NN (CYP3A4)))))) (, (,))) (CC (and)) (NP (NE-Type-2-drug (NP (NN (protease)) (NNS (inhibitors)))))) |ET|
-1  |BT|  (NP (NP (NP (PP (NE-Type-1-drug (NP (NN (CYP3A4)))))) (, (,))) (CC (and)) (NP (drug_ENTITY (NP (NN (protease)) (NNS (inhibitors)))) (PRN (-LRB- (<LB>)) (NP (NE-Type-2-drug (NP (NN (ritonavir)))))))) |ET|
-1  |BT|  (NP (NP (NP (PP (NE-Type-1-drug (NP (NN (CYP3A4)))))) (, (,))) (CC (and)) (NP (drug_ENTITY (NP (NN (protease)) (NNS (inhibitors)))) (PRN (-LRB- (<LB>)) (NP (drug_ENTITY (NP (NN (ritonavir)))) (, (,)) (NE-Type-2-drug (NP (NN (saquinavir)))))))) |ET|
-1  |BT|  (NP (NP (NP (PP (NE-Type-1-drug (NP (NN (CYP3A4)))))) (, (,))) (CC (and)) (NP (drug_ENTITY (NP (NN (protease)) (NNS (inhibitors)))) (PRN (-LRB- (<LB>)) (NP (drug_ENTITY (NP (NN (ritonavir)))) (, (,)) (drug_ENTITY (NP (NN (saquinavir)))) (, (,)) (NE-Type-2-drug (NP (NN (indinavir)))))))) |ET|
-1  |BT|  (NP (NP (NP (PP (NE-Type-1-drug (NP (NN (CYP3A4)))))) (, (,))) (CC (and)) (NP (drug_ENTITY (NP (NN (protease)) (NNS (inhibitors)))) (PRN (-LRB- (<LB>)) (NP (drug_ENTITY (NP (NN (ritonavir)))) (, (,)) (drug_ENTITY (NP (NN (saquinavir)))) (, (,)) (drug_ENTITY (NP (NN (indinavir)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NN (nelfinavir)))))))) |ET|
-1  |BT|  (NP (PP (NP (NP (NP (PP (NE-Type-1-drug (NP (NN (CYP3A4)))))) (, (,))) (CC (and)) (NP (drug_ENTITY (NP (NN (protease)) (NNS (inhibitors)))) (PRN (-LRB- (<LB>)) (NP (drug_ENTITY (NP (NN (ritonavir)))) (, (,)) (drug_ENTITY (NP (NN (saquinavir)))) (, (,)) (drug_ENTITY (NP (NN (indinavir)))) (, (,)) (CC (and)) (drug_ENTITY (NP (NN (nelfinavir))))) (-RRB- (<RB>)))))) (, (,)) (SBAR (WHNP (WDT (which))) (S (VP (VBP (are)) (NP (NP (NP (NNS (substrates))) (CC (and/or)) (NP (NNS (inhibitors)))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (CYP3A4)))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (protease)) (NNS (inhibitors)))) (PRN (-LRB- (<LB>)) (NP (NE-Type-2-drug (NP (NN (ritonavir))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (protease)) (NNS (inhibitors)))) (PRN (-LRB- (<LB>)) (NP (drug_ENTITY (NP (NN (ritonavir)))) (, (,)) (NE-Type-2-drug (NP (NN (saquinavir))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (protease)) (NNS (inhibitors)))) (PRN (-LRB- (<LB>)) (NP (drug_ENTITY (NP (NN (ritonavir)))) (, (,)) (drug_ENTITY (NP (NN (saquinavir)))) (, (,)) (NE-Type-2-drug (NP (NN (indinavir))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (protease)) (NNS (inhibitors)))) (PRN (-LRB- (<LB>)) (NP (drug_ENTITY (NP (NN (ritonavir)))) (, (,)) (drug_ENTITY (NP (NN (saquinavir)))) (, (,)) (drug_ENTITY (NP (NN (indinavir)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NN (nelfinavir))))))) |ET|
-1  |BT|  (NP (PP (NP (NP (NE-Type-1-drug (NP (NN (protease)) (NNS (inhibitors)))) (PRN (-LRB- (<LB>)) (NP (drug_ENTITY (NP (NN (ritonavir)))) (, (,)) (drug_ENTITY (NP (NN (saquinavir)))) (, (,)) (drug_ENTITY (NP (NN (indinavir)))) (, (,)) (CC (and)) (drug_ENTITY (NP (NN (nelfinavir))))) (-RRB- (<RB>)))))) (, (,)) (SBAR (WHNP (WDT (which))) (S (VP (VBP (are)) (NP (NP (NP (NNS (substrates))) (CC (and/or)) (NP (NNS (inhibitors)))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (CYP3A4)))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (ritonavir)))) (, (,)) (NE-Type-2-drug (NP (NN (saquinavir))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (ritonavir)))) (, (,)) (drug_ENTITY (NP (NN (saquinavir)))) (, (,)) (NE-Type-2-drug (NP (NN (indinavir))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (ritonavir)))) (, (,)) (drug_ENTITY (NP (NN (saquinavir)))) (, (,)) (drug_ENTITY (NP (NN (indinavir)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NN (nelfinavir))))) |ET|
-1  |BT|  (NP (PP (NP (NP (PRN (NP (NE-Type-1-drug (NP (NN (ritonavir)))) (, (,)) (drug_ENTITY (NP (NN (saquinavir)))) (, (,)) (drug_ENTITY (NP (NN (indinavir)))) (, (,)) (CC (and)) (drug_ENTITY (NP (NN (nelfinavir))))) (-RRB- (<RB>)))))) (, (,)) (SBAR (WHNP (WDT (which))) (S (VP (VBP (are)) (NP (NP (NP (NNS (substrates))) (CC (and/or)) (NP (NNS (inhibitors)))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (CYP3A4)))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (saquinavir)))) (, (,)) (NE-Type-2-drug (NP (NN (indinavir))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (saquinavir)))) (, (,)) (drug_ENTITY (NP (NN (indinavir)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NN (nelfinavir))))) |ET|
-1  |BT|  (NP (PP (NP (NP (PRN (NP (NE-Type-1-drug (NP (NN (saquinavir)))) (, (,)) (drug_ENTITY (NP (NN (indinavir)))) (, (,)) (CC (and)) (drug_ENTITY (NP (NN (nelfinavir))))) (-RRB- (<RB>)))))) (, (,)) (SBAR (WHNP (WDT (which))) (S (VP (VBP (are)) (NP (NP (NP (NNS (substrates))) (CC (and/or)) (NP (NNS (inhibitors)))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (CYP3A4)))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (indinavir)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NN (nelfinavir))))) |ET|
-1  |BT|  (NP (PP (NP (NP (PRN (NP (NE-Type-1-drug (NP (NN (indinavir)))) (, (,)) (CC (and)) (drug_ENTITY (NP (NN (nelfinavir))))) (-RRB- (<RB>)))))) (, (,)) (SBAR (WHNP (WDT (which))) (S (VP (VBP (are)) (NP (NP (NP (NNS (substrates))) (CC (and/or)) (NP (NNS (inhibitors)))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (CYP3A4)))))))))) |ET|
-1  |BT|  (NP (PP (NP (NP (PRN (NP (NE-Type-1-drug (NP (NN (nelfinavir))))) (-RRB- (<RB>)))))) (, (,)) (SBAR (WHNP (WDT (which))) (S (VP (VBP (are)) (NP (NP (NP (NNS (substrates))) (CC (and/or)) (NP (NNS (inhibitors)))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (CYP3A4)))))))))) |ET|
-1  |BT|  (NP (NP (PP (NE-Type-1-drug (NP (NN (doxorubicin)))))) (-LRB- (<LB>)) (CC (and)) (NE-Type-2-drug (NP (PRP$ (its)) (JJ (active)) (NN (metabolite))))) |ET|
-1  |BT|  (S (NP (NP (PP (NE-Type-1-drug (NP (NN (doxorubicin)))))) (-LRB- (<LB>)) (CC (and)) (drug_ENTITY (NP (PRP$ (its)) (JJ (active)) (NN (metabolite)) (NN (doxorubicinol)))) (-RRB- (<RB>))) (VP (MD (may)) (VP (VB (be)) (VP (VBN (increased)) (SBAR (WHADVP (WRB (when))) (S (NP (NE-Type-2-drug (NP (NN (paclitaxel))))))))))) |ET|
-1  |BT|  (S (NP (NP (PP (NE-Type-1-drug (NP (NN (doxorubicin)))))) (-LRB- (<LB>)) (CC (and)) (drug_ENTITY (NP (PRP$ (its)) (JJ (active)) (NN (metabolite)) (NN (doxorubicinol)))) (-RRB- (<RB>))) (VP (MD (may)) (VP (VB (be)) (VP (VBN (increased)) (SBAR (WHADVP (WRB (when))) (S (NP (drug_ENTITY (NP (NN (paclitaxel)))) (CC (and)) (NE-Type-2-drug (NP (NN (doxorubicin))))))))))) |ET|
-1  |BT|  (S (NP (NE-Type-1-drug (NP (JJ (active)) (NN (metabolite)) (NN (doxorubicinol)))) (-RRB- (<RB>))) (VP (MD (may)) (VP (VB (be)) (VP (VBN (increased)) (SBAR (WHADVP (WRB (when))) (S (NP (NE-Type-2-drug (NP (NN (paclitaxel))))))))))) |ET|
-1  |BT|  (S (NP (NE-Type-1-drug (NP (JJ (active)) (NN (metabolite)) (NN (doxorubicinol)))) (-RRB- (<RB>))) (VP (MD (may)) (VP (VB (be)) (VP (VBN (increased)) (SBAR (WHADVP (WRB (when))) (S (NP (drug_ENTITY (NP (NN (paclitaxel)))) (CC (and)) (NE-Type-2-drug (NP (NN (doxorubicin))))))))))) |ET|
1  |BT|  (NP (NE-Type-1-drug (NP (NN (paclitaxel)))) (CC (and)) (NE-Type-2-drug (NP (NN (doxorubicin))))) |ET|
-1  |BT|  (S (PP (NP (PP (NP (NE-Type-1-drug (NP (NN (HIV)) (NN (disease)))) (CC (and)) (DISO_ENTITY (NP (JJ (poor-risk)) (JJ (AIDS-related)) (NN (Kaposi)) (NN (@)) (NN (s)) (NN (sarcoma)))))))) (, (,)) (NP (NE-Type-2-drug (NP (NN (TAXOL)))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (cyclosporin)))) (PP (IN (for)) (NP (NP (NN (injection))) (NP (NN (concentrate))) (CC (and)) (NE-Type-2-drug (NP (NN (teniposide))))))) |ET|
1  |BT|  (S (NP (PP (NP (PP (NP (PP (NP (VP (NP (PRN (NP (NP (NE-Type-1-drug (NP (NN (cyclosporin)))) (PP (IN (for)) (NP (NP (NN (injection))) (NP (NN (concentrate))) (CC (and)) (drug_ENTITY (NP (NN (teniposide)))))) (PP (IN (for)) (NP (NN (injection)) (NN (concentrate)))))) (-RRB- (<RB>)))))))))))) (VP (MD (should)) (RB (not)) (VP (VB (be)) (VP (VBN (treated)) (PP (IN (with)) (NE-Type-2-drug (NP (NN (TAXOL))))))))) |ET|
1  |BT|  (S (NP (PP (NP (PP (NP (PP (NP (VP (NP (PRN (NP (NP (PP (NP (NE-Type-1-drug (NP (NN (teniposide)))))) (PP (IN (for)) (NP (NN (injection)) (NN (concentrate)))))) (-RRB- (<RB>)))))))))))) (VP (MD (should)) (RB (not)) (VP (VB (be)) (VP (VBN (treated)) (PP (IN (with)) (NE-Type-2-drug (NP (NN (TAXOL))))))))) |ET|
-1  |BT|  (S (NP (VP (PP (NE-Type-1-drug (NP (NN (TAXOL))))))) (VP (MD (should)) (VP (VB (be)) (VP (VBN (premedicated)) (PP (IN (with)) (NP (NP (NE-Type-2-drug (NP (NNS (corticosteroids))))))))))) |ET|
-1  |BT|  (S (NP (VP (PP (NE-Type-1-drug (NP (NN (TAXOL))))))) (VP (MD (should)) (VP (VB (be)) (VP (VBN (premedicated)) (PP (IN (with)) (NP (NP (drug_ENTITY (NP (NNS (corticosteroids)))) (PRN (-LRB- (<LB>)) (ADJP (JJ (such)) (PP (IN (as)) (NE-Type-2-drug (NP (NN (dexamethasone)))))))))))))) |ET|
-1  |BT|  (S (NP (VP (PP (NE-Type-1-drug (NP (NN (TAXOL))))))) (VP (MD (should)) (VP (VB (be)) (VP (VBN (premedicated)) (PP (IN (with)) (NP (NP (drug_ENTITY (NP (NNS (corticosteroids)))) (PRN (-LRB- (<LB>)) (ADJP (JJ (such)) (PP (IN (as)) (drug_ENTITY (NP (NN (dexamethasone)))))) (-RRB- (<RB>)))) (, (,)) (NE-Type-2-drug (NP (NN (diphen)))))))))) |ET|
-1  |BT|  (S (NP (VP (PP (NE-Type-1-drug (NP (NN (TAXOL))))))) (VP (MD (should)) (VP (VB (be)) (VP (VBN (premedicated)) (PP (IN (with)) (NP (NP (drug_ENTITY (NP (NNS (corticosteroids)))) (PRN (-LRB- (<LB>)) (ADJP (JJ (such)) (PP (IN (as)) (drug_ENTITY (NP (NN (dexamethasone)))))) (-RRB- (<RB>)))) (, (,)) (drug_ENTITY (NP (NN (diphen)) (NN (-hydramine)))) (CC (and)) (NP (NP (NN (H2)) (NNS (antagonists))) (PRN (-LRB- (<LB>)) (ADJP (JJ (such)) (PP (IN (as)) (NP (NE-Type-2-drug (NP (NN (cimetidine))))))))))))))) |ET|
-1  |BT|  (S (NP (VP (PP (NE-Type-1-drug (NP (NN (TAXOL))))))) (VP (MD (should)) (VP (VB (be)) (VP (VBN (premedicated)) (PP (IN (with)) (NP (NP (drug_ENTITY (NP (NNS (corticosteroids)))) (PRN (-LRB- (<LB>)) (ADJP (JJ (such)) (PP (IN (as)) (drug_ENTITY (NP (NN (dexamethasone)))))) (-RRB- (<RB>)))) (, (,)) (drug_ENTITY (NP (NN (diphen)) (NN (-hydramine)))) (CC (and)) (NP (NP (NN (H2)) (NNS (antagonists))) (PRN (-LRB- (<LB>)) (ADJP (JJ (such)) (PP (IN (as)) (NP (drug_ENTITY (NP (NN (cimetidine)))) (CC (or)) (NE-Type-2-drug (NP (NN (ranitidine))))))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (corticosteroids)))) (PRN (-LRB- (<LB>)) (ADJP (JJ (such)) (PP (IN (as)) (NE-Type-2-drug (NP (NN (dexamethasone)))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NNS (corticosteroids)))) (PRN (-LRB- (<LB>)) (ADJP (JJ (such)) (PP (IN (as)) (drug_ENTITY (NP (NN (dexamethasone)))))) (-RRB- (<RB>)))) (, (,)) (NE-Type-2-drug (NP (NN (diphen))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NNS (corticosteroids)))) (PRN (-LRB- (<LB>)) (ADJP (JJ (such)) (PP (IN (as)) (drug_ENTITY (NP (NN (dexamethasone)))))) (-RRB- (<RB>)))) (, (,)) (drug_ENTITY (NP (NN (diphen)) (NN (-hydramine)))) (CC (and)) (NP (NP (NN (H2)) (NNS (antagonists))) (PRN (-LRB- (<LB>)) (ADJP (JJ (such)) (PP (IN (as)) (NP (NE-Type-2-drug (NP (NN (cimetidine)))))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NNS (corticosteroids)))) (PRN (-LRB- (<LB>)) (ADJP (JJ (such)) (PP (IN (as)) (drug_ENTITY (NP (NN (dexamethasone)))))) (-RRB- (<RB>)))) (, (,)) (drug_ENTITY (NP (NN (diphen)) (NN (-hydramine)))) (CC (and)) (NP (NP (NN (H2)) (NNS (antagonists))) (PRN (-LRB- (<LB>)) (ADJP (JJ (such)) (PP (IN (as)) (NP (drug_ENTITY (NP (NN (cimetidine)))) (CC (or)) (NE-Type-2-drug (NP (NN (ranitidine)))))))))) |ET|
-1  |BT|  (NP (NP (PRN (ADJP (PP (NE-Type-1-drug (NP (NN (dexamethasone)))))) (-RRB- (<RB>)))) (, (,)) (NE-Type-2-drug (NP (NN (diphen))))) |ET|
-1  |BT|  (NP (NP (PRN (ADJP (PP (NE-Type-1-drug (NP (NN (dexamethasone)))))) (-RRB- (<RB>)))) (, (,)) (drug_ENTITY (NP (NN (diphen)) (NN (-hydramine)))) (CC (and)) (NP (NP (NN (H2)) (NNS (antagonists))) (PRN (-LRB- (<LB>)) (ADJP (JJ (such)) (PP (IN (as)) (NP (NE-Type-2-drug (NP (NN (cimetidine)))))))))) |ET|
-1  |BT|  (NP (NP (PRN (ADJP (PP (NE-Type-1-drug (NP (NN (dexamethasone)))))) (-RRB- (<RB>)))) (, (,)) (drug_ENTITY (NP (NN (diphen)) (NN (-hydramine)))) (CC (and)) (NP (NP (NN (H2)) (NNS (antagonists))) (PRN (-LRB- (<LB>)) (ADJP (JJ (such)) (PP (IN (as)) (NP (drug_ENTITY (NP (NN (cimetidine)))) (CC (or)) (NE-Type-2-drug (NP (NN (ranitidine)))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (diphen)) (NN (-hydramine)))) (CC (and)) (NP (NP (NN (H2)) (NNS (antagonists))) (PRN (-LRB- (<LB>)) (ADJP (JJ (such)) (PP (IN (as)) (NP (NE-Type-2-drug (NP (NN (cimetidine)))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (diphen)) (NN (-hydramine)))) (CC (and)) (NP (NP (NN (H2)) (NNS (antagonists))) (PRN (-LRB- (<LB>)) (ADJP (JJ (such)) (PP (IN (as)) (NP (drug_ENTITY (NP (NN (cimetidine)))) (CC (or)) (NE-Type-2-drug (NP (NN (ranitidine)))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (cimetidine)))) (CC (or)) (NE-Type-2-drug (NP (NN (ranitidine))))) |ET|
-1  |BT|  (S (NP (PP (NP (VP (NP (NP (VP (NE-Type-1-drug (NP (NNS (bronchodilators)))))) (, (,)) (NP (NN (angioedema))) (, (,)) (CC (or)) (NP (JJ (generalized)) (NN (urticaria)))))))) (VP (VBP (require)) (NP (NP (JJ (immediate)) (NN (discontinuation))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (NN (TAXOL))))))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NN (TAXOL)))) (VP (VBZ (contains)) (NP (NE-Type-2-drug (NP (JJ (dehydrated)) (NN (alcohol)) (NN (USP))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (Aminoglycosides)))) (: (:)) (S (NP (NP (DT (The)) (NN (mixing))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (piperacillin)))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (Aminoglycosides)))) (: (:)) (S (NP (NP (DT (The)) (NN (mixing))) (PP (IN (of)) (drug_ENTITY (NP (NN (piperacillin))))) (PP (IN (with)) (NP (NE-Type-2-drug (NP (DT (an)) (NN (aminoglycoside))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (Aminoglycosides)))) (: (:)) (S (NP (NP (DT (The)) (NN (mixing))) (PP (IN (of)) (drug_ENTITY (NP (NN (piperacillin))))) (PP (IN (with)) (NP (drug_ENTITY (NP (DT (an)) (NN (aminoglycoside)))) (PP (IN (in)) (NP (FW (vitro))))))) (VP (MD (can)) (VP (VB (result)) (PP (IN (in)) (NP (NP (JJ (substantial)) (NN (inactivation))) (PP (IN (of)) (NE-Type-2-drug (NP (DT (the)) (NN (aminoglycoside))))))))))) |ET|
1  |BT|  (NP (PP (NE-Type-1-drug (NP (NN (piperacillin))))) (PP (IN (with)) (NP (NE-Type-2-drug (NP (DT (an)) (NN (aminoglycoside))))))) |ET|
-1  |BT|  (S (NP (PP (NE-Type-1-drug (NP (NN (piperacillin))))) (PP (IN (with)) (NP (drug_ENTITY (NP (DT (an)) (NN (aminoglycoside)))) (PP (IN (in)) (NP (FW (vitro))))))) (VP (MD (can)) (VP (VB (result)) (PP (IN (in)) (NP (NP (JJ (substantial)) (NN (inactivation))) (PP (IN (of)) (NE-Type-2-drug (NP (DT (the)) (NN (aminoglycoside)))))))))) |ET|
-1  |BT|  (S (NP (PP (NP (NE-Type-1-drug (NP (NN (aminoglycoside)))) (PP (IN (in)) (NP (FW (vitro))))))) (VP (MD (can)) (VP (VB (result)) (PP (IN (in)) (NP (NP (JJ (substantial)) (NN (inactivation))) (PP (IN (of)) (NE-Type-2-drug (NP (DT (the)) (NN (aminoglycoside)))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Vecuronium)))) (: (:)) (S (SBAR (WHADVP (WRB (When))) (S (VP (VBN (used)) (PP (IN (in)) (NP (DT (the)) (JJ (perioperative)) (NN (period))))))) (, (,)) (NE-Type-2-drug (NP (NN (piperacillin)))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Vecuronium)))) (: (:)) (S (SBAR (WHADVP (WRB (When))) (S (VP (VBN (used)) (PP (IN (in)) (NP (DT (the)) (JJ (perioperative)) (NN (period))))))) (, (,)) (drug_ENTITY (NP (NN (piperacillin)))) (VP (VBZ (has)) (VP (VBN (been)) (VP (VBN (implicated)) (PP (IN (in)) (NP (NP (DT (the)) (NN (prolongation))) (PP (IN (of)) (NP (NP (DT (the)) (JJ (neuromuscular)) (NN (blockade))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (vecuronium)))))))))))))) |ET|
1  |BT|  (S (NE-Type-1-drug (NP (NN (piperacillin)))) (VP (VBZ (has)) (VP (VBN (been)) (VP (VBN (implicated)) (PP (IN (in)) (NP (NP (DT (the)) (NN (prolongation))) (PP (IN (of)) (NP (NP (DT (the)) (JJ (neuromuscular)) (NN (blockade))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (vecuronium))))))))))))) |ET|
1  |BT|  (S (NP (PP (NE-Type-1-drug (NP (NN (piperacillin))))) (, (,))) (VP (VBD (were)) (VP (VBN (reported)) (S (VP (TO (to)) (VP (VB (prolong)) (NP (NP (DT (the)) (NN (action))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (vecuronium)))))))))))) |ET|
1  |BT|  (S (NP (VP (PP (NP (PP (NE-Type-1-drug (NP (JJ (non-depolarizing)) (NN (muscle)) (NNS (relaxants))))))))) (VP (MD (could)) (VP (VB (be)) (VP (VBD (prolonged)) (PP (IN (in)) (NP (NP (DT (the)) (NN (presence))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (piperacillin))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Probenecid)))) (: (:)) (S (NP (NP (DT (The)) (JJ (oral)) (NN (combination))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (probenecid)))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Probenecid)))) (: (:)) (S (NP (NP (DT (The)) (JJ (oral)) (NN (combination))) (PP (IN (of)) (drug_ENTITY (NP (NN (probenecid))))) (PP (IN (before)) (NP (NP (JJ (intramuscular)) (NN (injection))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (PIPRACIL)))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Probenecid)))) (: (:)) (S (NP (NP (DT (The)) (JJ (oral)) (NN (combination))) (PP (IN (of)) (drug_ENTITY (NP (NN (probenecid))))) (PP (IN (before)) (NP (NP (JJ (intramuscular)) (NN (injection))) (PP (IN (of)) (drug_ENTITY (NP (NN (PIPRACIL)))))))) (VP (VBZ (produces)) (NP (NP (DT (an)) (NN (increase))) (PP (IN (in)) (NP (NE-Type-2-drug (NP (JJ (piperacillin)))))))))) |ET|
1  |BT|  (NP (PP (NE-Type-1-drug (NP (NN (probenecid))))) (PP (IN (before)) (NP (NP (JJ (intramuscular)) (NN (injection))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (PIPRACIL)))))))) |ET|
-1  |BT|  (S (NP (PP (NE-Type-1-drug (NP (NN (probenecid))))) (PP (IN (before)) (NP (NP (JJ (intramuscular)) (NN (injection))) (PP (IN (of)) (drug_ENTITY (NP (NN (PIPRACIL)))))))) (VP (VBZ (produces)) (NP (NP (DT (an)) (NN (increase))) (PP (IN (in)) (NP (NE-Type-2-drug (NP (JJ (piperacillin))))))))) |ET|
-1  |BT|  (S (NP (PP (NP (PP (NE-Type-1-drug (NP (NN (PIPRACIL)))))))) (VP (VBZ (produces)) (NP (NP (DT (an)) (NN (increase))) (PP (IN (in)) (NP (NE-Type-2-drug (NP (JJ (piperacillin))))))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NNS (Anticoagulants)) (NN (Coagulation)) (NNS (parameters)))) (VP (MD (should)) (VP (VB (be)) (VP (VP (VBN (tested)) (ADVP (RBR (more)) (RB (frequently)))) (CC (and)) (VP (VBN (monitored)) (ADVP (RB (regularly))) (PP (IN (during)) (NP (NP (NP (JJ (simultaneous)) (NN (administration))) (PP (IN (of)) (NP (NP (JJ (high)) (NNS (doses))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (heparin))))))))))))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NNS (Anticoagulants)) (NN (Coagulation)) (NNS (parameters)))) (VP (MD (should)) (VP (VB (be)) (VP (VP (VBN (tested)) (ADVP (RBR (more)) (RB (frequently)))) (CC (and)) (VP (VBN (monitored)) (ADVP (RB (regularly))) (PP (IN (during)) (NP (NP (NP (JJ (simultaneous)) (NN (administration))) (PP (IN (of)) (NP (NP (JJ (high)) (NNS (doses))) (PP (IN (of)) (drug_ENTITY (NP (NN (heparin)))))))) (, (,)) (NE-Type-2-drug (NP (JJ (oral)) (NNS (anticoagulants))))))))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NNS (Anticoagulants)) (NN (Coagulation)) (NNS (parameters)))) (VP (MD (should)) (VP (VB (be)) (VP (VP (VBN (tested)) (ADVP (RBR (more)) (RB (frequently)))) (CC (and)) (VP (VBN (monitored)) (ADVP (RB (regularly))) (PP (IN (during)) (NP (NP (NP (JJ (simultaneous)) (NN (administration))) (PP (IN (of)) (NP (NP (JJ (high)) (NNS (doses))) (PP (IN (of)) (drug_ENTITY (NP (NN (heparin)))))))) (, (,)) (drug_ENTITY (NP (JJ (oral)) (NNS (anticoagulants)))) (, (,)) (CC (or)) (NP (NE-Type-2-drug (NP (JJ (other)) (NNS (drugs)))))))))))) |ET|
-1  |BT|  (NP (NP (PP (NP (PP (NE-Type-1-drug (NP (NN (heparin)))))))) (, (,)) (NE-Type-2-drug (NP (JJ (oral)) (NNS (anticoagulants))))) |ET|
-1  |BT|  (NP (NP (PP (NP (PP (NE-Type-1-drug (NP (NN (heparin)))))))) (, (,)) (drug_ENTITY (NP (JJ (oral)) (NNS (anticoagulants)))) (, (,)) (CC (or)) (NP (NE-Type-2-drug (NP (JJ (other)) (NNS (drugs)))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (JJ (oral)) (NNS (anticoagulants)))) (, (,)) (CC (or)) (NP (NE-Type-2-drug (NP (JJ (other)) (NNS (drugs)))))) |ET|
1  |BT|  (S (NE-Type-1-drug (NP (NN (Methotrexate)) (NN (Piperacillin)) (NN (sodium)))) (VP (MD (may)) (VP (VB (reduce)) (NP (NP (DT (the)) (NN (excretion))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (methotrexate))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Drug)) (NN (/Laboratory)) (NN (Test)) (NNS (Interactions)))) (: (:)) (S (PP (IN (As)) (PP (IN (with)) (NE-Type-2-drug (NP (JJ (other)) (NNS (penicillins)))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Drug)) (NN (/Laboratory)) (NN (Test)) (NNS (Interactions)))) (: (:)) (S (PP (IN (As)) (PP (IN (with)) (drug_ENTITY (NP (JJ (other)) (NNS (penicillins)))))) (, (,)) (NP (NP (DT (the)) (NN (administration))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (PIPRACIL)))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Drug)) (NN (/Laboratory)) (NN (Test)) (NNS (Interactions)))) (: (:)) (S (PP (IN (As)) (PP (IN (with)) (drug_ENTITY (NP (JJ (other)) (NNS (penicillins)))))) (, (,)) (NP (NP (DT (the)) (NN (administration))) (PP (IN (of)) (drug_ENTITY (NP (NN (PIPRACIL)))))) (VP (MD (may)) (VP (VB (result)) (PP (IN (in)) (NP (NP (DT (a)) (JJ (false-positive)) (NN (reaction))) (PP (IN (for)) (NE-Type-2-drug (NP (NN (glucose))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Drug)) (NN (/Laboratory)) (NN (Test)) (NNS (Interactions)))) (: (:)) (S (PP (IN (As)) (PP (IN (with)) (drug_ENTITY (NP (JJ (other)) (NNS (penicillins)))))) (, (,)) (NP (NP (DT (the)) (NN (administration))) (PP (IN (of)) (drug_ENTITY (NP (NN (PIPRACIL)))))) (VP (MD (may)) (VP (VB (result)) (PP (IN (in)) (NP (NP (DT (a)) (JJ (false-positive)) (NN (reaction))) (PP (IN (for)) (drug_ENTITY (NP (NN (glucose))))) (PP (IN (in)) (NP (NP (DT (the)) (NN (urine))) (VP (VBG (using)) (NE-Type-2-drug (NP (DT (a)) (NN (copper))))))))))))) |ET|
-1  |BT|  (S (PP (PP (NE-Type-1-drug (NP (JJ (other)) (NNS (penicillins)))))) (, (,)) (NP (NP (DT (the)) (NN (administration))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (PIPRACIL))))))) |ET|
-1  |BT|  (S (PP (PP (NE-Type-1-drug (NP (JJ (other)) (NNS (penicillins)))))) (, (,)) (NP (NP (DT (the)) (NN (administration))) (PP (IN (of)) (drug_ENTITY (NP (NN (PIPRACIL)))))) (VP (MD (may)) (VP (VB (result)) (PP (IN (in)) (NP (NP (DT (a)) (JJ (false-positive)) (NN (reaction))) (PP (IN (for)) (NE-Type-2-drug (NP (NN (glucose)))))))))) |ET|
-1  |BT|  (S (PP (PP (NE-Type-1-drug (NP (JJ (other)) (NNS (penicillins)))))) (, (,)) (NP (NP (DT (the)) (NN (administration))) (PP (IN (of)) (drug_ENTITY (NP (NN (PIPRACIL)))))) (VP (MD (may)) (VP (VB (result)) (PP (IN (in)) (NP (NP (DT (a)) (JJ (false-positive)) (NN (reaction))) (PP (IN (for)) (drug_ENTITY (NP (NN (glucose))))) (PP (IN (in)) (NP (NP (DT (the)) (NN (urine))) (VP (VBG (using)) (NE-Type-2-drug (NP (DT (a)) (NN (copper)))))))))))) |ET|
-1  |BT|  (S (NP (PP (NE-Type-1-drug (NP (NN (PIPRACIL)))))) (VP (MD (may)) (VP (VB (result)) (PP (IN (in)) (NP (NP (DT (a)) (JJ (false-positive)) (NN (reaction))) (PP (IN (for)) (NE-Type-2-drug (NP (NN (glucose)))))))))) |ET|
-1  |BT|  (S (NP (PP (NE-Type-1-drug (NP (NN (PIPRACIL)))))) (VP (MD (may)) (VP (VB (result)) (PP (IN (in)) (NP (NP (DT (a)) (JJ (false-positive)) (NN (reaction))) (PP (IN (for)) (drug_ENTITY (NP (NN (glucose))))) (PP (IN (in)) (NP (NP (DT (the)) (NN (urine))) (VP (VBG (using)) (NE-Type-2-drug (NP (DT (a)) (NN (copper)))))))))))) |ET|
-1  |BT|  (NP (PP (NE-Type-1-drug (NP (NN (glucose))))) (PP (IN (in)) (NP (NP (DT (the)) (NN (urine))) (VP (VBG (using)) (NE-Type-2-drug (NP (DT (a)) (NN (copper)))))))) |ET|
-1  |BT|  (NE-Type-2-drug (NP (NN (piperacillin)) (: (/)) (NN (tazobactam)))) |ET|
-1  |BT|  (NP (PP (NE-Type-1-drug (NP (NNS (drugs))))) (PP (IN (on)) (NE-Type-2-drug (NP (NN (Vardenafil)))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NN (vardenafil)))) (VP (VBZ (is)) (VP (VP (VBN (metabolized)) (ADVP (RB (primarily))) (PP (IN (by)) (drug_ENTITY (NP (NP (NE-Type-2-drug (NP (NN (cytochrome)) (NN (P450)))))))))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NN (vardenafil)))) (VP (VBZ (is)) (VP (VP (VBN (metabolized)) (ADVP (RB (primarily))) (PP (IN (by)) (drug_ENTITY (NP (NP (drug_ENTITY (NP (NN (cytochrome)) (NN (P450)))) (PRN (-LRB- (<LB>)) (NE-Type-2-drug (NP (NN (CYP))))))))))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NN (vardenafil)))) (VP (VBZ (is)) (VP (VP (VBN (metabolized)) (ADVP (RB (primarily))) (PP (IN (by)) (NE-Type-2-drug (NP (NP (drug_ENTITY (NP (NN (cytochrome)) (NN (P450)))) (PRN (-LRB- (<LB>)) (drug_ENTITY (NP (NN (CYP)))) (-RRB- (<RB>)))) (NNS (isoforms))))))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NN (vardenafil)))) (VP (VBZ (is)) (VP (VP (VBN (metabolized)) (ADVP (RB (primarily))) (PP (IN (by)) (drug_ENTITY (NP (NP (drug_ENTITY (NP (NN (cytochrome)) (NN (P450)))) (PRN (-LRB- (<LB>)) (drug_ENTITY (NP (NN (CYP)))) (-RRB- (<RB>)))) (NNS (isoforms)) (NN (3A4/5)))))) (, (,)) (CC (and)) (PP (TO (to)) (NP (DT (a)) (JJR (lesser)) (NN (degree)))) (PP (IN (by)) (NE-Type-2-drug (NP (NN (CYP2C9)))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (cytochrome)) (NN (P450)))) (PRN (-LRB- (<LB>)) (NE-Type-2-drug (NP (NN (CYP)))))) |ET|
-1  |BT|  (NE-Type-2-drug (NP (NP (NE-Type-1-drug (NP (NN (cytochrome)) (NN (P450)))) (PRN (-LRB- (<LB>)) (drug_ENTITY (NP (NN (CYP)))) (-RRB- (<RB>)))) (NNS (isoforms)))) |ET|
-1  |BT|  (VP (VP (PP (drug_ENTITY (NP (NP (NE-Type-1-drug (NP (NN (cytochrome)) (NN (P450)))) (PRN (-LRB- (<LB>)) (drug_ENTITY (NP (NN (CYP)))) (-RRB- (<RB>)))) (NNS (isoforms)) (NN (3A4/5)))))) (, (,)) (CC (and)) (PP (TO (to)) (NP (DT (a)) (JJR (lesser)) (NN (degree)))) (PP (IN (by)) (NE-Type-2-drug (NP (NN (CYP2C9)))))) |ET|
-1  |BT|  (NE-Type-2-drug (NP (NP (PRN (NE-Type-1-drug (NP (NN (CYP)))) (-RRB- (<RB>)))) (NNS (isoforms)))) |ET|
-1  |BT|  (VP (VP (PP (drug_ENTITY (NP (NP (PRN (NE-Type-1-drug (NP (NN (CYP)))) (-RRB- (<RB>)))) (NNS (isoforms)) (NN (3A4/5)))))) (, (,)) (CC (and)) (PP (TO (to)) (NP (DT (a)) (JJR (lesser)) (NN (degree)))) (PP (IN (by)) (NE-Type-2-drug (NP (NN (CYP2C9)))))) |ET|
-1  |BT|  (VP (VP (PP (NE-Type-1-drug (NP (NNS (isoforms)) (NN (3A4/5)))))) (, (,)) (CC (and)) (PP (TO (to)) (NP (DT (a)) (JJR (lesser)) (NN (degree)))) (PP (IN (by)) (NE-Type-2-drug (NP (NN (CYP2C9)))))) |ET|
-1  |BT|  (S (NP (NE-Type-1-drug (NP (NN (Cimetidine)))) (PRN (-LRB- (<LB>)) (NP (ADJP (CD (400)) (NN (mg))) (NN (b.i.d.))) (-RRB- (<RB>)))) (VP (VBD (had)) (NP (NP (DT (no)) (NN (effect))) (PP (IN (on)) (NP (NP (NE-Type-2-drug (NP (NN (vardenafil)))))))))) |ET|
-1  |BT|  (S (NP (NE-Type-1-drug (NP (NN (Cimetidine)))) (PRN (-LRB- (<LB>)) (NP (ADJP (CD (400)) (NN (mg))) (NN (b.i.d.))) (-RRB- (<RB>)))) (VP (VBD (had)) (NP (NP (DT (no)) (NN (effect))) (PP (IN (on)) (NP (NP (drug_ENTITY (NP (NN (vardenafil)) (NN (bioavailability)))) (PRN (-LRB- (<LB>)) (NP (NN (AUC))) (-RRB- (<RB>)))) (CC (and)) (NP (NP (NN (maximum)) (NN (concentration))) (PRN (-LRB- (<LB>)) (NP (NN (Cmax))) (-RRB- (<RB>)))))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (vardenafil)))))))) |ET|
-1  |BT|  (S (NP (NE-Type-1-drug (NP (NN (Cimetidine)))) (PRN (-LRB- (<LB>)) (NP (ADJP (CD (400)) (NN (mg))) (NN (b.i.d.))) (-RRB- (<RB>)))) (VP (VBD (had)) (NP (NP (DT (no)) (NN (effect))) (PP (IN (on)) (NP (NP (drug_ENTITY (NP (NN (vardenafil)) (NN (bioavailability)))) (PRN (-LRB- (<LB>)) (NP (NN (AUC))) (-RRB- (<RB>)))) (CC (and)) (NP (NP (NN (maximum)) (NN (concentration))) (PRN (-LRB- (<LB>)) (NP (NN (Cmax))) (-RRB- (<RB>)))))) (PP (IN (of)) (drug_ENTITY (NP (NN (vardenafil)))))) (SBAR (WHADVP (WRB (when))) (S (VP (VBN (co-administered)) (PP (IN (with)) (NE-Type-2-drug (NP (CD (20)) (NN (mg)) (NN (Vardenafil)))))))))) |ET|
-1  |BT|  (NP (PP (NP (NP (NE-Type-1-drug (NP (NN (vardenafil)) (NN (bioavailability)))) (PRN (-LRB- (<LB>)) (NP (NN (AUC))) (-RRB- (<RB>)))) (CC (and)) (NP (NP (NN (maximum)) (NN (concentration))) (PRN (-LRB- (<LB>)) (NP (NN (Cmax))) (-RRB- (<RB>)))))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (vardenafil)))))) |ET|
-1  |BT|  (VP (NP (PP (NP (NP (NE-Type-1-drug (NP (NN (vardenafil)) (NN (bioavailability)))) (PRN (-LRB- (<LB>)) (NP (NN (AUC))) (-RRB- (<RB>)))) (CC (and)) (NP (NP (NN (maximum)) (NN (concentration))) (PRN (-LRB- (<LB>)) (NP (NN (Cmax))) (-RRB- (<RB>)))))) (PP (IN (of)) (drug_ENTITY (NP (NN (vardenafil)))))) (SBAR (WHADVP (WRB (when))) (S (VP (VBN (co-administered)) (PP (IN (with)) (NE-Type-2-drug (NP (CD (20)) (NN (mg)) (NN (Vardenafil))))))))) |ET|
-1  |BT|  (VP (NP (PP (NE-Type-1-drug (NP (NN (vardenafil)))))) (SBAR (WHADVP (WRB (when))) (S (VP (VBN (co-administered)) (PP (IN (with)) (NE-Type-2-drug (NP (CD (20)) (NN (mg)) (NN (Vardenafil))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Erythromycin)))) (PRN (-LRB- (<LB>)) (NE-Type-2-drug (NP (CD (500)))))) |ET|
1  |BT|  (S (NP (NE-Type-1-drug (NP (NN (Erythromycin)))) (PRN (-LRB- (<LB>)) (drug_ENTITY (NP (CD (500)) (NN (mg)) (CD (t.i.d)))) (-RRB- (<RB>)))) (VP (VBD (produced)) (NP (NP (NP (DT (a)) (JJ (4-fold)) (NN (increase))) (PP (IN (in)) (NE-Type-2-drug (NP (NN (vardenafil))))))))) |ET|
-1  |BT|  (S (NP (NE-Type-1-drug (NP (NN (Erythromycin)))) (PRN (-LRB- (<LB>)) (drug_ENTITY (NP (CD (500)) (NN (mg)) (CD (t.i.d)))) (-RRB- (<RB>)))) (VP (VBD (produced)) (NP (NP (NP (DT (a)) (JJ (4-fold)) (NN (increase))) (PP (IN (in)) (drug_ENTITY (NP (NN (vardenafil)) (NN (AUC)))))) (CC (and)) (NP (NP (DT (a)) (JJ (3-fold)) (NN (increase))) (PP (IN (in)) (NP (NN (Cmax)))))) (SBAR (WHADVP (WRB (when))) (S (VP (VBN (co-administered)) (PP (IN (with)) (NP (NE-Type-2-drug (NP (NN (Vardenafil)) (CD (5)) (NN (mg))))))))))) |ET|
-1  |BT|  (S (NP (PRN (NE-Type-1-drug (NP (CD (500)) (NN (mg)) (CD (t.i.d)))) (-RRB- (<RB>)))) (VP (VBD (produced)) (NP (NP (NP (DT (a)) (JJ (4-fold)) (NN (increase))) (PP (IN (in)) (NE-Type-2-drug (NP (NN (vardenafil))))))))) |ET|
-1  |BT|  (S (NP (PRN (NE-Type-1-drug (NP (CD (500)) (NN (mg)) (CD (t.i.d)))) (-RRB- (<RB>)))) (VP (VBD (produced)) (NP (NP (NP (DT (a)) (JJ (4-fold)) (NN (increase))) (PP (IN (in)) (drug_ENTITY (NP (NN (vardenafil)) (NN (AUC)))))) (CC (and)) (NP (NP (DT (a)) (JJ (3-fold)) (NN (increase))) (PP (IN (in)) (NP (NN (Cmax)))))) (SBAR (WHADVP (WRB (when))) (S (VP (VBN (co-administered)) (PP (IN (with)) (NP (NE-Type-2-drug (NP (NN (Vardenafil)) (CD (5)) (NN (mg))))))))))) |ET|
-1  |BT|  (VP (NP (NP (PP (NE-Type-1-drug (NP (NN (vardenafil)) (NN (AUC)))))) (CC (and)) (NP (NP (DT (a)) (JJ (3-fold)) (NN (increase))) (PP (IN (in)) (NP (NN (Cmax)))))) (SBAR (WHADVP (WRB (when))) (S (VP (VBN (co-administered)) (PP (IN (with)) (NP (NE-Type-2-drug (NP (NN (Vardenafil)) (CD (5)) (NN (mg)))))))))) |ET|
1  |BT|  (VP (NP (PP (NE-Type-1-drug (NP (NN (Vardenafil)))))) (PP (IN (in)) (NP (NP (DT (a)) (JJ (24-hour)) (NN (period))) (SBAR (WHADVP (WRB (when))) (S (VP (VBN (used)) (PP (IN (in)) (NP (NP (NN (combination))) (PP (IN (with)) (NE-Type-2-drug (NP (NN (erythromycin))))))))))))) |ET|
1  |BT|  (S (NP (NE-Type-1-drug (NP (NN (Ketoconazole)))) (PRN (-LRB- (<LB>)) (NP (NP (CD (200)) (NN (mg))) (ADJP (RB (once)) (JJ (daily)))) (-RRB- (<RB>)))) (VP (VBD (produced)) (NP (NP (NP (DT (a)) (JJ (10-fold)) (NN (increase))) (PP (IN (in)) (NE-Type-2-drug (NP (NN (vardenafil))))))))) |ET|
-1  |BT|  (S (NP (NE-Type-1-drug (NP (NN (Ketoconazole)))) (PRN (-LRB- (<LB>)) (NP (NP (CD (200)) (NN (mg))) (ADJP (RB (once)) (JJ (daily)))) (-RRB- (<RB>)))) (VP (VBD (produced)) (NP (NP (NP (DT (a)) (JJ (10-fold)) (NN (increase))) (PP (IN (in)) (drug_ENTITY (NP (NN (vardenafil)) (NN (AUC)))))) (CC (and)) (NP (NP (DT (a)) (JJ (4-fold)) (NN (increase))) (PP (IN (in)) (NP (NN (Cmax)))))) (SBAR (WHADVP (WRB (when))) (S (VP (VBN (co-administered)) (PP (IN (with)) (NP (NP (NE-Type-2-drug (NP (NN (Vardenafil)))))))))))) |ET|
-1  |BT|  (VP (NP (NP (PP (NE-Type-1-drug (NP (NN (vardenafil)) (NN (AUC)))))) (CC (and)) (NP (NP (DT (a)) (JJ (4-fold)) (NN (increase))) (PP (IN (in)) (NP (NN (Cmax)))))) (SBAR (WHADVP (WRB (when))) (S (VP (VBN (co-administered)) (PP (IN (with)) (NP (NP (NE-Type-2-drug (NP (NN (Vardenafil))))))))))) |ET|
1  |BT|  (S (NE-Type-1-drug (NP (NN (Vardenafil)) (NN (dose)))) (VP (MD (should)) (RB (not)) (VP (VB (be)) (VP (VBD (exceeded)) (SBAR (WHADVP (WRB (when))) (S (VP (VBN (used)) (PP (IN (in)) (NP (NP (NN (combination))) (PP (IN (with)) (NP (NP (CD (200)) (NN (mg))) (PP (IN (once)) (NE-Type-2-drug (NP (JJ (daily)) (NN (ketoconazole)))))))))))))))) |ET|
1  |BT|  (S (SBAR (S (NP (NP (PP (NE-Type-1-drug (NP (NN (ketoconazole)))))) (PRN (-LRB- (<LB>)) (NP (NP (CD (400)) (NN (mg))) (ADVP (RB (daily)))) (-RRB- (<RB>)))) (VP (MD (may)) (VP (VB (result)) (PP (IN (in)) (NP (NP (JJR (higher)) (NNS (increases))) (PP (IN (in)) (NP (NP (NN (Cmax))) (CC (and)) (NP (NN (AUC))))))))))) (, (,)) (NP (NP (DT (a)) (JJ (single)) (ADJP (CD (2.5)) (NN (mg))) (NN (dose))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (Vardenafil))))))) |ET|
-1  |BT|  (S (SBAR (S (NP (NP (PP (NE-Type-1-drug (NP (NN (ketoconazole)))))) (PRN (-LRB- (<LB>)) (NP (NP (CD (400)) (NN (mg))) (ADVP (RB (daily)))) (-RRB- (<RB>)))) (VP (MD (may)) (VP (VB (result)) (PP (IN (in)) (NP (NP (JJR (higher)) (NNS (increases))) (PP (IN (in)) (NP (NP (NN (Cmax))) (CC (and)) (NP (NN (AUC))))))))))) (, (,)) (NP (NP (DT (a)) (JJ (single)) (ADJP (CD (2.5)) (NN (mg))) (NN (dose))) (PP (IN (of)) (drug_ENTITY (NP (NN (Vardenafil)))))) (VP (MD (should)) (RB (not)) (VP (VB (be)) (VP (VBD (exceeded)) (PP (IN (in)) (NP (DT (a)) (JJ (24-hour)) (NN (period)))) (SBAR (WHADVP (WRB (when))) (S (VP (VBN (used)) (PP (IN (in)) (NP (NP (NN (combination))) (PP (IN (with)) (NP (NE-Type-2-drug (NP (NN (ketoconazole)) (CD (400)) (NN (mg))))))))))))))) |ET|
-1  |BT|  (S (NP (PP (NE-Type-1-drug (NP (NN (Vardenafil)))))) (VP (MD (should)) (RB (not)) (VP (VB (be)) (VP (VBD (exceeded)) (PP (IN (in)) (NP (DT (a)) (JJ (24-hour)) (NN (period)))) (SBAR (WHADVP (WRB (when))) (S (VP (VBN (used)) (PP (IN (in)) (NP (NP (NN (combination))) (PP (IN (with)) (NP (NE-Type-2-drug (NP (NN (ketoconazole)) (CD (400)) (NN (mg))))))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (HIV)) (NN (Protease)) (NNS (Inhibitors)))) (: (:)) (NP (NE-Type-2-drug (NP (NN (Indinavir)))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (HIV)) (NN (Protease)) (NNS (Inhibitors)))) (: (:)) (NP (drug_ENTITY (NP (NN (Indinavir)))) (PRN (-LRB- (<LB>)) (NP (NE-Type-2-drug (ADJP (CD (800)))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (HIV)) (NN (Protease)) (NNS (Inhibitors)))) (: (:)) (NP (drug_ENTITY (NP (NN (Indinavir)))) (PRN (-LRB- (<LB>)) (NP (drug_ENTITY (ADJP (CD (800)) (NN (mg)))) (NN (t.i.d.))) (-RRB- (<RB>))))) (VP (VBN (co-administered)) (PP (IN (with)) (NE-Type-2-drug (NP (NP (NN (Vardenafil))) (ADJP (CD (10)) (NN (mg)))))))) |ET|
-1  |BT|  (S (NP (NP (NE-Type-1-drug (NP (NN (HIV)) (NN (Protease)) (NNS (Inhibitors)))) (: (:)) (NP (drug_ENTITY (NP (NN (Indinavir)))) (PRN (-LRB- (<LB>)) (NP (drug_ENTITY (ADJP (CD (800)) (NN (mg)))) (NN (t.i.d.))) (-RRB- (<RB>))))) (VP (VBN (co-administered)) (PP (IN (with)) (drug_ENTITY (NP (NP (NN (Vardenafil))) (ADJP (CD (10)) (NN (mg)))))))) (VP (VBD (resulted)) (PP (IN (in)) (NP (NP (NP (DT (a)) (JJ (16-fold)) (NN (increase))) (PP (IN (in)) (NE-Type-2-drug (NP (NN (vardenafil)))))))))) |ET|
-1  |BT|  (S (NP (NP (NE-Type-1-drug (NP (NN (HIV)) (NN (Protease)) (NNS (Inhibitors)))) (: (:)) (NP (drug_ENTITY (NP (NN (Indinavir)))) (PRN (-LRB- (<LB>)) (NP (drug_ENTITY (ADJP (CD (800)) (NN (mg)))) (NN (t.i.d.))) (-RRB- (<RB>))))) (VP (VBN (co-administered)) (PP (IN (with)) (drug_ENTITY (NP (NP (NN (Vardenafil))) (ADJP (CD (10)) (NN (mg)))))))) (VP (VBD (resulted)) (PP (IN (in)) (NP (NP (NP (DT (a)) (JJ (16-fold)) (NN (increase))) (PP (IN (in)) (drug_ENTITY (NP (NN (vardenafil)) (NN (AUC)))))) (, (,)) (NP (NP (DT (a)) (JJ (7-fold)) (NN (increase))) (PP (IN (in)) (NE-Type-2-drug (NP (NN (vardenafil)))))))))) |ET|
-1  |BT|  (S (NP (NP (NE-Type-1-drug (NP (NN (HIV)) (NN (Protease)) (NNS (Inhibitors)))) (: (:)) (NP (drug_ENTITY (NP (NN (Indinavir)))) (PRN (-LRB- (<LB>)) (NP (drug_ENTITY (ADJP (CD (800)) (NN (mg)))) (NN (t.i.d.))) (-RRB- (<RB>))))) (VP (VBN (co-administered)) (PP (IN (with)) (drug_ENTITY (NP (NP (NN (Vardenafil))) (ADJP (CD (10)) (NN (mg)))))))) (VP (VBD (resulted)) (PP (IN (in)) (NP (NP (NP (DT (a)) (JJ (16-fold)) (NN (increase))) (PP (IN (in)) (drug_ENTITY (NP (NN (vardenafil)) (NN (AUC)))))) (, (,)) (NP (NP (DT (a)) (JJ (7-fold)) (NN (increase))) (PP (IN (in)) (drug_ENTITY (NP (NN (vardenafil)) (NN (Cmax)))))) (CC (and)) (NP (NP (DT (a)) (JJ (2-fold)) (NN (increase))) (PP (IN (in)) (NE-Type-2-drug (NP (NN (vardenafil)))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Indinavir)))) (PRN (-LRB- (<LB>)) (NP (NE-Type-2-drug (ADJP (CD (800))))))) |ET|
1  |BT|  (NP (NP (NP (NE-Type-1-drug (NP (NN (Indinavir)))) (PRN (-LRB- (<LB>)) (NP (drug_ENTITY (ADJP (CD (800)) (NN (mg)))) (NN (t.i.d.))) (-RRB- (<RB>))))) (VP (VBN (co-administered)) (PP (IN (with)) (NE-Type-2-drug (NP (NP (NN (Vardenafil))) (ADJP (CD (10)) (NN (mg)))))))) |ET|
-1  |BT|  (S (NP (NP (NP (NE-Type-1-drug (NP (NN (Indinavir)))) (PRN (-LRB- (<LB>)) (NP (drug_ENTITY (ADJP (CD (800)) (NN (mg)))) (NN (t.i.d.))) (-RRB- (<RB>))))) (VP (VBN (co-administered)) (PP (IN (with)) (drug_ENTITY (NP (NP (NN (Vardenafil))) (ADJP (CD (10)) (NN (mg)))))))) (VP (VBD (resulted)) (PP (IN (in)) (NP (NP (NP (DT (a)) (JJ (16-fold)) (NN (increase))) (PP (IN (in)) (NE-Type-2-drug (NP (NN (vardenafil)))))))))) |ET|
-1  |BT|  (S (NP (NP (NP (NE-Type-1-drug (NP (NN (Indinavir)))) (PRN (-LRB- (<LB>)) (NP (drug_ENTITY (ADJP (CD (800)) (NN (mg)))) (NN (t.i.d.))) (-RRB- (<RB>))))) (VP (VBN (co-administered)) (PP (IN (with)) (drug_ENTITY (NP (NP (NN (Vardenafil))) (ADJP (CD (10)) (NN (mg)))))))) (VP (VBD (resulted)) (PP (IN (in)) (NP (NP (NP (DT (a)) (JJ (16-fold)) (NN (increase))) (PP (IN (in)) (drug_ENTITY (NP (NN (vardenafil)) (NN (AUC)))))) (, (,)) (NP (NP (DT (a)) (JJ (7-fold)) (NN (increase))) (PP (IN (in)) (NE-Type-2-drug (NP (NN (vardenafil)))))))))) |ET|
-1  |BT|  (S (NP (NP (NP (NE-Type-1-drug (NP (NN (Indinavir)))) (PRN (-LRB- (<LB>)) (NP (drug_ENTITY (ADJP (CD (800)) (NN (mg)))) (NN (t.i.d.))) (-RRB- (<RB>))))) (VP (VBN (co-administered)) (PP (IN (with)) (drug_ENTITY (NP (NP (NN (Vardenafil))) (ADJP (CD (10)) (NN (mg)))))))) (VP (VBD (resulted)) (PP (IN (in)) (NP (NP (NP (DT (a)) (JJ (16-fold)) (NN (increase))) (PP (IN (in)) (drug_ENTITY (NP (NN (vardenafil)) (NN (AUC)))))) (, (,)) (NP (NP (DT (a)) (JJ (7-fold)) (NN (increase))) (PP (IN (in)) (drug_ENTITY (NP (NN (vardenafil)) (NN (Cmax)))))) (CC (and)) (NP (NP (DT (a)) (JJ (2-fold)) (NN (increase))) (PP (IN (in)) (NE-Type-2-drug (NP (NN (vardenafil)))))))))) |ET|
-1  |BT|  (NP (NP (NP (PRN (NP (NE-Type-1-drug (ADJP (CD (800)) (NN (mg)))) (NN (t.i.d.))) (-RRB- (<RB>))))) (VP (VBN (co-administered)) (PP (IN (with)) (NE-Type-2-drug (NP (NP (NN (Vardenafil))) (ADJP (CD (10)) (NN (mg)))))))) |ET|
-1  |BT|  (S (NP (NP (NP (PRN (NP (NE-Type-1-drug (ADJP (CD (800)) (NN (mg)))) (NN (t.i.d.))) (-RRB- (<RB>))))) (VP (VBN (co-administered)) (PP (IN (with)) (drug_ENTITY (NP (NP (NN (Vardenafil))) (ADJP (CD (10)) (NN (mg)))))))) (VP (VBD (resulted)) (PP (IN (in)) (NP (NP (NP (DT (a)) (JJ (16-fold)) (NN (increase))) (PP (IN (in)) (NE-Type-2-drug (NP (NN (vardenafil)))))))))) |ET|
-1  |BT|  (S (NP (NP (NP (PRN (NP (NE-Type-1-drug (ADJP (CD (800)) (NN (mg)))) (NN (t.i.d.))) (-RRB- (<RB>))))) (VP (VBN (co-administered)) (PP (IN (with)) (drug_ENTITY (NP (NP (NN (Vardenafil))) (ADJP (CD (10)) (NN (mg)))))))) (VP (VBD (resulted)) (PP (IN (in)) (NP (NP (NP (DT (a)) (JJ (16-fold)) (NN (increase))) (PP (IN (in)) (drug_ENTITY (NP (NN (vardenafil)) (NN (AUC)))))) (, (,)) (NP (NP (DT (a)) (JJ (7-fold)) (NN (increase))) (PP (IN (in)) (NE-Type-2-drug (NP (NN (vardenafil)))))))))) |ET|
-1  |BT|  (S (NP (NP (NP (PRN (NP (NE-Type-1-drug (ADJP (CD (800)) (NN (mg)))) (NN (t.i.d.))) (-RRB- (<RB>))))) (VP (VBN (co-administered)) (PP (IN (with)) (drug_ENTITY (NP (NP (NN (Vardenafil))) (ADJP (CD (10)) (NN (mg)))))))) (VP (VBD (resulted)) (PP (IN (in)) (NP (NP (NP (DT (a)) (JJ (16-fold)) (NN (increase))) (PP (IN (in)) (drug_ENTITY (NP (NN (vardenafil)) (NN (AUC)))))) (, (,)) (NP (NP (DT (a)) (JJ (7-fold)) (NN (increase))) (PP (IN (in)) (drug_ENTITY (NP (NN (vardenafil)) (NN (Cmax)))))) (CC (and)) (NP (NP (DT (a)) (JJ (2-fold)) (NN (increase))) (PP (IN (in)) (NE-Type-2-drug (NP (NN (vardenafil)))))))))) |ET|
-1  |BT|  (S (NP (VP (PP (NE-Type-1-drug (NP (NP (NN (Vardenafil))) (ADJP (CD (10)) (NN (mg)))))))) (VP (VBD (resulted)) (PP (IN (in)) (NP (NP (NP (DT (a)) (JJ (16-fold)) (NN (increase))) (PP (IN (in)) (NE-Type-2-drug (NP (NN (vardenafil)))))))))) |ET|
-1  |BT|  (S (NP (VP (PP (NE-Type-1-drug (NP (NP (NN (Vardenafil))) (ADJP (CD (10)) (NN (mg)))))))) (VP (VBD (resulted)) (PP (IN (in)) (NP (NP (NP (DT (a)) (JJ (16-fold)) (NN (increase))) (PP (IN (in)) (drug_ENTITY (NP (NN (vardenafil)) (NN (AUC)))))) (, (,)) (NP (NP (DT (a)) (JJ (7-fold)) (NN (increase))) (PP (IN (in)) (NE-Type-2-drug (NP (NN (vardenafil)))))))))) |ET|
-1  |BT|  (S (NP (VP (PP (NE-Type-1-drug (NP (NP (NN (Vardenafil))) (ADJP (CD (10)) (NN (mg)))))))) (VP (VBD (resulted)) (PP (IN (in)) (NP (NP (NP (DT (a)) (JJ (16-fold)) (NN (increase))) (PP (IN (in)) (drug_ENTITY (NP (NN (vardenafil)) (NN (AUC)))))) (, (,)) (NP (NP (DT (a)) (JJ (7-fold)) (NN (increase))) (PP (IN (in)) (drug_ENTITY (NP (NN (vardenafil)) (NN (Cmax)))))) (CC (and)) (NP (NP (DT (a)) (JJ (2-fold)) (NN (increase))) (PP (IN (in)) (NE-Type-2-drug (NP (NN (vardenafil)))))))))) |ET|
-1  |BT|  (NP (NP (PP (NE-Type-1-drug (NP (NN (vardenafil)) (NN (AUC)))))) (, (,)) (NP (NP (DT (a)) (JJ (7-fold)) (NN (increase))) (PP (IN (in)) (NE-Type-2-drug (NP (NN (vardenafil))))))) |ET|
-1  |BT|  (NP (NP (PP (NE-Type-1-drug (NP (NN (vardenafil)) (NN (AUC)))))) (, (,)) (NP (NP (DT (a)) (JJ (7-fold)) (NN (increase))) (PP (IN (in)) (drug_ENTITY (NP (NN (vardenafil)) (NN (Cmax)))))) (CC (and)) (NP (NP (DT (a)) (JJ (2-fold)) (NN (increase))) (PP (IN (in)) (NE-Type-2-drug (NP (NN (vardenafil))))))) |ET|
-1  |BT|  (NP (NP (PP (NE-Type-1-drug (NP (NN (vardenafil)) (NN (Cmax)))))) (CC (and)) (NP (NP (DT (a)) (JJ (2-fold)) (NN (increase))) (PP (IN (in)) (NE-Type-2-drug (NP (NN (vardenafil))))))) |ET|
1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (Ritonavir)))) (PRN (-LRB- (<LB>)) (NP (ADJP (CD (600)) (NN (mg))) (NN (b.i.d.))) (-RRB- (<RB>)))) (VP (VBN (co-administered)) (PP (IN (with)) (NE-Type-2-drug (NP (NN (Vardenafil)) (CD (5)) (NN (mg))))))) |ET|
-1  |BT|  (S (NP (NP (NE-Type-1-drug (NP (NN (Ritonavir)))) (PRN (-LRB- (<LB>)) (NP (ADJP (CD (600)) (NN (mg))) (NN (b.i.d.))) (-RRB- (<RB>)))) (VP (VBN (co-administered)) (PP (IN (with)) (drug_ENTITY (NP (NN (Vardenafil)) (CD (5)) (NN (mg))))))) (VP (VBD (resulted)) (PP (IN (in)) (NP (NP (NP (DT (a)) (JJ (49-fold)) (NN (increase))) (PP (IN (in)) (NE-Type-2-drug (NP (NN (vardenafil)))))))))) |ET|
-1  |BT|  (S (NP (NP (NE-Type-1-drug (NP (NN (Ritonavir)))) (PRN (-LRB- (<LB>)) (NP (ADJP (CD (600)) (NN (mg))) (NN (b.i.d.))) (-RRB- (<RB>)))) (VP (VBN (co-administered)) (PP (IN (with)) (drug_ENTITY (NP (NN (Vardenafil)) (CD (5)) (NN (mg))))))) (VP (VBD (resulted)) (PP (IN (in)) (NP (NP (NP (DT (a)) (JJ (49-fold)) (NN (increase))) (PP (IN (in)) (drug_ENTITY (NP (NN (vardenafil)) (NN (AUC)))))) (CC (and)) (NP (NP (DT (a)) (ADJP (RB (13-fold))) (NN (increase))) (PP (IN (in)) (NE-Type-2-drug (NP (NN (vardenafil)))))))))) |ET|
-1  |BT|  (S (NP (VP (PP (NE-Type-1-drug (NP (NN (Vardenafil)) (CD (5)) (NN (mg))))))) (VP (VBD (resulted)) (PP (IN (in)) (NP (NP (NP (DT (a)) (JJ (49-fold)) (NN (increase))) (PP (IN (in)) (NE-Type-2-drug (NP (NN (vardenafil)))))))))) |ET|
-1  |BT|  (S (NP (VP (PP (NE-Type-1-drug (NP (NN (Vardenafil)) (CD (5)) (NN (mg))))))) (VP (VBD (resulted)) (PP (IN (in)) (NP (NP (NP (DT (a)) (JJ (49-fold)) (NN (increase))) (PP (IN (in)) (drug_ENTITY (NP (NN (vardenafil)) (NN (AUC)))))) (CC (and)) (NP (NP (DT (a)) (ADJP (RB (13-fold))) (NN (increase))) (PP (IN (in)) (NE-Type-2-drug (NP (NN (vardenafil)))))))))) |ET|
-1  |BT|  (NP (NP (PP (NE-Type-1-drug (NP (NN (vardenafil)) (NN (AUC)))))) (CC (and)) (NP (NP (DT (a)) (ADJP (RB (13-fold))) (NN (increase))) (PP (IN (in)) (NE-Type-2-drug (NP (NN (vardenafil))))))) |ET|
1  |BT|  (VP (NP (PP (NE-Type-1-drug (NP (NN (vardenafil)))))) (PP (IN (by)) (NP (NE-Type-2-drug (NP (NN (ritonavir))))))) |ET|
-1  |BT|  (VP (NP (PP (NE-Type-1-drug (NP (NN (vardenafil)))))) (PP (IN (by)) (NP (drug_ENTITY (NP (NN (ritonavir)))) (, (,)) (NP (NE-Type-2-drug (NP (DT (a)) (ADJP (RB (highly)) (JJ (potent))) (NN (CYP3A4)))))))) |ET|
-1  |BT|  (VP (NP (PP (NE-Type-1-drug (NP (NN (vardenafil)))))) (PP (IN (by)) (NP (drug_ENTITY (NP (NN (ritonavir)))) (, (,)) (NP (drug_ENTITY (NP (DT (a)) (ADJP (RB (highly)) (JJ (potent))) (NN (CYP3A4)) (NN (inhibitor)))) (, (,)) (SBAR (WHNP (WDT (which))) (S (ADVP (RB (also))) (VP (VBZ (inhibits)) (NE-Type-2-drug (NP (NN (CYP2C9))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (ritonavir)))) (, (,)) (NP (NE-Type-2-drug (NP (DT (a)) (ADJP (RB (highly)) (JJ (potent))) (NN (CYP3A4)))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (ritonavir)))) (, (,)) (NP (drug_ENTITY (NP (DT (a)) (ADJP (RB (highly)) (JJ (potent))) (NN (CYP3A4)) (NN (inhibitor)))) (, (,)) (SBAR (WHNP (WDT (which))) (S (ADVP (RB (also))) (VP (VBZ (inhibits)) (NE-Type-2-drug (NP (NN (CYP2C9))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (CYP3A4)) (NN (inhibitor)))) (, (,)) (SBAR (WHNP (WDT (which))) (S (ADVP (RB (also))) (VP (VBZ (inhibits)) (NE-Type-2-drug (NP (NN (CYP2C9)))))))) |ET|
1  |BT|  (S (NE-Type-1-drug (NP (NN (Ritonavir)))) (ADVP (RB (significantly))) (VP (VBD (prolonged)) (NP (NP (DT (the)) (NN (half-life))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (vardenafil)))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (vardenafil)))) (CC (and)) (NE-Type-2-drug (NP (DT (the)) (JJ (following)) (NNS (drugs))))) |ET|
-1  |BT|  (NP (S (VP (VP (PP (NP (NE-Type-1-drug (NP (NN (vardenafil)))) (CC (and)) (drug_ENTITY (NP (DT (the)) (JJ (following)) (NNS (drugs))))))))) (: (:)) (NP (NE-Type-2-drug (NP (NN (glyburide)))))) |ET|
-1  |BT|  (NP (S (VP (VP (PP (NP (NE-Type-1-drug (NP (NN (vardenafil)))) (CC (and)) (drug_ENTITY (NP (DT (the)) (JJ (following)) (NNS (drugs))))))))) (: (:)) (NP (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (NE-Type-2-drug (NP (NN (warfarin)))))) |ET|
-1  |BT|  (NP (S (VP (VP (PP (NP (NE-Type-1-drug (NP (NN (vardenafil)))) (CC (and)) (drug_ENTITY (NP (DT (the)) (JJ (following)) (NNS (drugs))))))))) (: (:)) (NP (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (NE-Type-2-drug (NP (NN (digoxin)))))) |ET|
-1  |BT|  (NP (S (VP (VP (PP (NP (NE-Type-1-drug (NP (NN (vardenafil)))) (CC (and)) (drug_ENTITY (NP (DT (the)) (JJ (following)) (NNS (drugs))))))))) (: (:)) (NP (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (drug_ENTITY (NP (NN (digoxin)))) (, (,)) (NE-Type-2-drug (NP (NN (Maalox)))))) |ET|
-1  |BT|  (NP (S (VP (VP (PP (NP (NE-Type-1-drug (NP (NN (vardenafil)))) (CC (and)) (drug_ENTITY (NP (DT (the)) (JJ (following)) (NNS (drugs))))))))) (: (:)) (NP (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (drug_ENTITY (NP (NN (digoxin)))) (, (,)) (drug_ENTITY (NP (NN (Maalox)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NN (ranitidine)))))) |ET|
-1  |BT|  (NP (S (VP (VP (PP (NP (NE-Type-1-drug (NP (NNS (drugs))))))))) (: (:)) (NP (NE-Type-2-drug (NP (NN (glyburide)))))) |ET|
-1  |BT|  (NP (S (VP (VP (PP (NP (NE-Type-1-drug (NP (NNS (drugs))))))))) (: (:)) (NP (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (NE-Type-2-drug (NP (NN (warfarin)))))) |ET|
-1  |BT|  (NP (S (VP (VP (PP (NP (NE-Type-1-drug (NP (NNS (drugs))))))))) (: (:)) (NP (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (NE-Type-2-drug (NP (NN (digoxin)))))) |ET|
-1  |BT|  (NP (S (VP (VP (PP (NP (NE-Type-1-drug (NP (NNS (drugs))))))))) (: (:)) (NP (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (drug_ENTITY (NP (NN (digoxin)))) (, (,)) (NE-Type-2-drug (NP (NN (Maalox)))))) |ET|
-1  |BT|  (NP (S (VP (VP (PP (NP (NE-Type-1-drug (NP (NNS (drugs))))))))) (: (:)) (NP (drug_ENTITY (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (drug_ENTITY (NP (NN (digoxin)))) (, (,)) (drug_ENTITY (NP (NN (Maalox)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NN (ranitidine)))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (glyburide)))) (, (,)) (NE-Type-2-drug (NP (NN (warfarin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (NE-Type-2-drug (NP (NN (digoxin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (drug_ENTITY (NP (NN (digoxin)))) (, (,)) (NE-Type-2-drug (NP (NN (Maalox))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (glyburide)))) (, (,)) (drug_ENTITY (NP (NN (warfarin)))) (, (,)) (drug_ENTITY (NP (NN (digoxin)))) (, (,)) (drug_ENTITY (NP (NN (Maalox)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NN (ranitidine))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (warfarin)))) (, (,)) (NE-Type-2-drug (NP (NN (digoxin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (warfarin)))) (, (,)) (drug_ENTITY (NP (NN (digoxin)))) (, (,)) (NE-Type-2-drug (NP (NN (Maalox))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (warfarin)))) (, (,)) (drug_ENTITY (NP (NN (digoxin)))) (, (,)) (drug_ENTITY (NP (NN (Maalox)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NN (ranitidine))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (digoxin)))) (, (,)) (NE-Type-2-drug (NP (NN (Maalox))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (digoxin)))) (, (,)) (drug_ENTITY (NP (NN (Maalox)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NN (ranitidine))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Maalox)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NN (ranitidine))))) |ET|
-1  |BT|  (S (PP (NE-Type-1-drug (NP (JJ (warfarin)) (NN (study))))) (, (,)) (NE-Type-2-drug (NP (NN (vardenafil))))) |ET|
-1  |BT|  (NP (PP (NE-Type-1-drug (NP (NN (Vardenafil))))) (PP (IN (on)) (NE-Type-2-drug (NP (JJ (other)) (NNS (drugs)))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Vardenafil)))) (CC (and)) (NE-Type-2-drug (NP (PRP$ (its)) (NNS (metabolites))))) |ET|
-1  |BT|  (S (NP (NE-Type-1-drug (NP (NN (Vardenafil)))) (CC (and)) (drug_ENTITY (NP (PRP$ (its)) (NNS (metabolites))))) (VP (VBD (had)) (NP (DT (no)) (NN (effect))) (PP (IN (on)) (NP (NE-Type-2-drug (NP (NN (CYP1A2)))))))) |ET|
-1  |BT|  (S (NP (NE-Type-1-drug (NP (NN (Vardenafil)))) (CC (and)) (drug_ENTITY (NP (PRP$ (its)) (NNS (metabolites))))) (VP (VBD (had)) (NP (DT (no)) (NN (effect))) (PP (IN (on)) (NP (drug_ENTITY (NP (NN (CYP1A2)))) (, (,)) (NP (NN (2A6))) (, (,)) (CC (and)) (NP (NP (NN (2E1))) (PRN (-LRB- (<LB>)) (NE-Type-2-drug (NP (NN (Ki)) (NN (100uM)))))))))) |ET|
-1  |BT|  (S (NP (NE-Type-1-drug (NP (NNS (metabolites))))) (VP (VBD (had)) (NP (DT (no)) (NN (effect))) (PP (IN (on)) (NP (NE-Type-2-drug (NP (NN (CYP1A2)))))))) |ET|
-1  |BT|  (S (NP (NE-Type-1-drug (NP (NNS (metabolites))))) (VP (VBD (had)) (NP (DT (no)) (NN (effect))) (PP (IN (on)) (NP (drug_ENTITY (NP (NN (CYP1A2)))) (, (,)) (NP (NN (2A6))) (, (,)) (CC (and)) (NP (NP (NN (2E1))) (PRN (-LRB- (<LB>)) (NE-Type-2-drug (NP (NN (Ki)) (NN (100uM)))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (CYP1A2)))) (, (,)) (NP (NN (2A6))) (, (,)) (CC (and)) (NP (NP (NN (2E1))) (PRN (-LRB- (<LB>)) (NE-Type-2-drug (NP (NN (Ki)) (NN (100uM))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (isoforms)))) (PRN (-LRB- (<LB>)) (NP (NE-Type-2-drug (NP (NN (CYP2C8))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (vardenafil)) (NN (metabolite)) (NN (M1)))) (, (,)) (SBAR (WHNP (WDT (which))) (S (VP (VBD (had)) (NP (NP (DT (a)) (NN (Ki))) (PP (IN (of)) (NP (NP (CD (1.4)) (NN (uM))) (PP (IN (toward)) (NE-Type-2-drug (NP (NN (CYP3A4)))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (vardenafil)) (NN (metabolite)) (NN (M1)))) (, (,)) (SBAR (WHNP (WDT (which))) (S (VP (VBD (had)) (NP (NP (DT (a)) (NN (Ki))) (PP (IN (of)) (NP (NP (CD (1.4)) (NN (uM))) (PP (IN (toward)) (drug_ENTITY (NP (NN (CYP3A4))))))) (, (,)) (SBAR (WHNP (WDT (which))) (S (VP (VBZ (is)) (ADJP (ADJP (QP (RB (about)) (CD (20)) (NNS (times))) (JJR (higher))) (PP (IN (than)) (NP (NP (DT (the)) (NN (M1)) (NN (Cmax)) (NNS (values))) (PP (IN (after)) (NE-Type-2-drug (NP (DT (an)) (ADJP (CD (80)) (NN (mg))) (NN (Vardenafil)))))))))))))))) |ET|
-1  |BT|  (NP (PP (NP (PP (NE-Type-1-drug (NP (NN (CYP3A4))))))) (, (,)) (SBAR (WHNP (WDT (which))) (S (VP (VBZ (is)) (ADJP (ADJP (QP (RB (about)) (CD (20)) (NNS (times))) (JJR (higher))) (PP (IN (than)) (NP (NP (DT (the)) (NN (M1)) (NN (Cmax)) (NNS (values))) (PP (IN (after)) (NE-Type-2-drug (NP (DT (an)) (ADJP (CD (80)) (NN (mg))) (NN (Vardenafil)))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (Nitrates)))) (: (:)) (NP (NP (DT (The)) (NN (blood)) (NN (pressure)) (JJ (lowering)) (NNS (effects))) (PP (IN (of)) (NP (NP (NE-Type-2-drug (NP (JJ (sublingual)) (NNS (nitrates))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (Nitrates)))) (: (:)) (NP (NP (DT (The)) (NN (blood)) (NN (pressure)) (JJ (lowering)) (NNS (effects))) (PP (IN (of)) (NP (NP (drug_ENTITY (NP (JJ (sublingual)) (NNS (nitrates)))) (PRN (-LRB- (<LB>)) (NP (CD (0.4)) (NN (mg))) (-RRB- (<RB>)))) (VP (VBN (taken)) (PP (NP (QP (CD (1)) (CC (and)) (CD (4))) (NNS (hours))) (IN (after)) (NE-Type-2-drug (NP (NN (vardenafil)))))))))) |ET|
-1  |BT|  (S (NP (NE-Type-1-drug (NP (NNS (Nitrates)))) (: (:)) (NP (NP (DT (The)) (NN (blood)) (NN (pressure)) (JJ (lowering)) (NNS (effects))) (PP (IN (of)) (NP (NP (drug_ENTITY (NP (JJ (sublingual)) (NNS (nitrates)))) (PRN (-LRB- (<LB>)) (NP (CD (0.4)) (NN (mg))) (-RRB- (<RB>)))) (VP (VBN (taken)) (PP (NP (QP (CD (1)) (CC (and)) (CD (4))) (NNS (hours))) (IN (after)) (drug_ENTITY (NP (NN (vardenafil))))))))) (CC (and)) (NP (NP (NNS (increases))) (PP (IN (in)) (NP (NP (NN (heart)) (NN (rate))) (SBAR (WHADVP (WRB (when))) (S (VP (VBN (taken)) (PP (IN (at)) (NP (QP (CD (1)) (, (,)) (CD (4)) (CC (and)) (CD (8))) (NNS (hours))))))))))) (VP (VBD (were)) (VP (VBN (potentiated)) (PP (IN (by)) (NP (NP (DT (a)) (ADJP (CD (20)) (NN (mg))) (NN (dose))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (NN (Vardenafil))))))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NNS (nitrates)))) (PRN (-LRB- (<LB>)) (NP (CD (0.4)) (NN (mg))) (-RRB- (<RB>)))) (VP (VBN (taken)) (PP (NP (QP (CD (1)) (CC (and)) (CD (4))) (NNS (hours))) (IN (after)) (NE-Type-2-drug (NP (NN (vardenafil))))))) |ET|
-1  |BT|  (S (NP (NP (PP (NP (NP (NE-Type-1-drug (NP (NNS (nitrates)))) (PRN (-LRB- (<LB>)) (NP (CD (0.4)) (NN (mg))) (-RRB- (<RB>)))) (VP (VBN (taken)) (PP (NP (QP (CD (1)) (CC (and)) (CD (4))) (NNS (hours))) (IN (after)) (drug_ENTITY (NP (NN (vardenafil))))))))) (CC (and)) (NP (NP (NNS (increases))) (PP (IN (in)) (NP (NP (NN (heart)) (NN (rate))) (SBAR (WHADVP (WRB (when))) (S (VP (VBN (taken)) (PP (IN (at)) (NP (QP (CD (1)) (, (,)) (CD (4)) (CC (and)) (CD (8))) (NNS (hours))))))))))) (VP (VBD (were)) (VP (VBN (potentiated)) (PP (IN (by)) (NP (NP (DT (a)) (ADJP (CD (20)) (NN (mg))) (NN (dose))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (NN (Vardenafil))))))))))) |ET|
-1  |BT|  (S (NP (NP (PP (NP (VP (PP (NE-Type-1-drug (NP (NN (vardenafil))))))))) (CC (and)) (NP (NP (NNS (increases))) (PP (IN (in)) (NP (NP (NN (heart)) (NN (rate))) (SBAR (WHADVP (WRB (when))) (S (VP (VBN (taken)) (PP (IN (at)) (NP (QP (CD (1)) (, (,)) (CD (4)) (CC (and)) (CD (8))) (NNS (hours))))))))))) (VP (VBD (were)) (VP (VBN (potentiated)) (PP (IN (by)) (NP (NP (DT (a)) (ADJP (CD (20)) (NN (mg))) (NN (dose))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (NN (Vardenafil))))))))))) |ET|
-1  |BT|  (S (S (NP (PP (NP (PP (NE-Type-1-drug (NP (NNS (nitrates))))) (PP (IN (for)) (NP (NP (NNS (patients))) (PP (IN (with)) (DISO_ENTITY (NP (JJ (ischemic)) (NN (heart)) (NN (disease)))))))))) (VP (VBZ (has)) (RB (not)) (VP (VBN (been)) (VP (VBN (evaluated)))))) (, (,)) (CC (and)) (S (NP (NP (JJ (concomitant)) (NN (use))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (NN (Vardenafil))))))))) |ET|
-1  |BT|  (S (S (NP (PP (NP (PP (NE-Type-1-drug (NP (NNS (nitrates))))) (PP (IN (for)) (NP (NP (NNS (patients))) (PP (IN (with)) (DISO_ENTITY (NP (JJ (ischemic)) (NN (heart)) (NN (disease)))))))))) (VP (VBZ (has)) (RB (not)) (VP (VBN (been)) (VP (VBN (evaluated)))))) (, (,)) (CC (and)) (S (NP (NP (JJ (concomitant)) (NN (use))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (Vardenafil)))) (CC (and)) (NE-Type-2-drug (NP (NNS (nitrates))))))))) |ET|
1  |BT|  (NP (NE-Type-1-drug (NP (NN (Vardenafil)))) (CC (and)) (NE-Type-2-drug (NP (NNS (nitrates))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Nifedipine)))) (: (:)) (NE-Type-2-drug (NP (NP (NN (Vardenafil))) (ADJP (CD (20)) (NN (mg)))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Nifedipine)))) (: (:)) (drug_ENTITY (NP (NP (NN (Vardenafil))) (ADJP (CD (20)) (NN (mg))))) (, (,)) (SBAR (WHADVP (WRB (when))) (S (VP (VBN (co-administered)) (PP (IN (with)) (NP (NE-Type-2-drug (NP (JJ (slow-release)) (NN (nifedipine)) (CD (30)) (NN (mg)))))))))) |ET|
-1  |BT|  (S (NP (NE-Type-1-drug (NP (NN (Nifedipine)))) (: (:)) (drug_ENTITY (NP (NP (NN (Vardenafil))) (ADJP (CD (20)) (NN (mg))))) (, (,)) (SBAR (WHADVP (WRB (when))) (S (VP (VBN (co-administered)) (PP (IN (with)) (NP (drug_ENTITY (NP (JJ (slow-release)) (NN (nifedipine)) (CD (30)) (NN (mg)))) (CC (or)) (NP (NP (CD (60)) (NN (mg))) (ADVP (RB (once)) (RB (daily))))))))) (, (,))) (VP (VBD (did)) (RB (not)) (VP (VB (affect)) (NP (NP (NP (DT (the)) (JJ (relative)) (NN (bioavailability))) (PRN (-LRB- (<LB>)) (NP (NN (AUC))) (-RRB- (<RB>)))) (CC (or)) (NP (NP (NP (JJ (maximum)) (NN (concentration))) (PRN (-LRB- (<LB>)) (NP (NN (Cmax))) (-RRB- (<RB>)))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (NN (nifedipine))))))))))) |ET|
-1  |BT|  (S (NP (NE-Type-1-drug (NP (NN (Nifedipine)))) (: (:)) (drug_ENTITY (NP (NP (NN (Vardenafil))) (ADJP (CD (20)) (NN (mg))))) (, (,)) (SBAR (WHADVP (WRB (when))) (S (VP (VBN (co-administered)) (PP (IN (with)) (NP (drug_ENTITY (NP (JJ (slow-release)) (NN (nifedipine)) (CD (30)) (NN (mg)))) (CC (or)) (NP (NP (CD (60)) (NN (mg))) (ADVP (RB (once)) (RB (daily))))))))) (, (,))) (VP (VBD (did)) (RB (not)) (VP (VB (affect)) (NP (NP (NP (DT (the)) (JJ (relative)) (NN (bioavailability))) (PRN (-LRB- (<LB>)) (NP (NN (AUC))) (-RRB- (<RB>)))) (CC (or)) (NP (NP (NP (JJ (maximum)) (NN (concentration))) (PRN (-LRB- (<LB>)) (NP (NN (Cmax))) (-RRB- (<RB>)))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (nifedipine)))) (, (,)) (NP (NE-Type-2-drug (NP (DT (a)) (NN (drug)))))))))))) |ET|
-1  |BT|  (S (NP (NE-Type-1-drug (NP (NN (Nifedipine)))) (: (:)) (drug_ENTITY (NP (NP (NN (Vardenafil))) (ADJP (CD (20)) (NN (mg))))) (, (,)) (SBAR (WHADVP (WRB (when))) (S (VP (VBN (co-administered)) (PP (IN (with)) (NP (drug_ENTITY (NP (JJ (slow-release)) (NN (nifedipine)) (CD (30)) (NN (mg)))) (CC (or)) (NP (NP (CD (60)) (NN (mg))) (ADVP (RB (once)) (RB (daily))))))))) (, (,))) (VP (VBD (did)) (RB (not)) (VP (VB (affect)) (NP (NP (NP (DT (the)) (JJ (relative)) (NN (bioavailability))) (PRN (-LRB- (<LB>)) (NP (NN (AUC))) (-RRB- (<RB>)))) (CC (or)) (NP (NP (NP (JJ (maximum)) (NN (concentration))) (PRN (-LRB- (<LB>)) (NP (NN (Cmax))) (-RRB- (<RB>)))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (nifedipine)))) (, (,)) (NP (drug_ENTITY (NP (DT (a)) (NN (drug)))) (SBAR (WHNP (WDT (that))) (S (VP (VBZ (is)) (VP (VBN (metabolized)) (PP (IN (via)) (NE-Type-2-drug (NP (NN (CYP3A4))))))))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NP (NN (Vardenafil))) (ADJP (CD (20)) (NN (mg))))) (, (,)) (SBAR (WHADVP (WRB (when))) (S (VP (VBN (co-administered)) (PP (IN (with)) (NP (NE-Type-2-drug (NP (JJ (slow-release)) (NN (nifedipine)) (CD (30)) (NN (mg)))))))))) |ET|
-1  |BT|  (S (NP (NE-Type-1-drug (NP (NP (NN (Vardenafil))) (ADJP (CD (20)) (NN (mg))))) (, (,)) (SBAR (WHADVP (WRB (when))) (S (VP (VBN (co-administered)) (PP (IN (with)) (NP (drug_ENTITY (NP (JJ (slow-release)) (NN (nifedipine)) (CD (30)) (NN (mg)))) (CC (or)) (NP (NP (CD (60)) (NN (mg))) (ADVP (RB (once)) (RB (daily))))))))) (, (,))) (VP (VBD (did)) (RB (not)) (VP (VB (affect)) (NP (NP (NP (DT (the)) (JJ (relative)) (NN (bioavailability))) (PRN (-LRB- (<LB>)) (NP (NN (AUC))) (-RRB- (<RB>)))) (CC (or)) (NP (NP (NP (JJ (maximum)) (NN (concentration))) (PRN (-LRB- (<LB>)) (NP (NN (Cmax))) (-RRB- (<RB>)))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (NN (nifedipine))))))))))) |ET|
-1  |BT|  (S (NP (NE-Type-1-drug (NP (NP (NN (Vardenafil))) (ADJP (CD (20)) (NN (mg))))) (, (,)) (SBAR (WHADVP (WRB (when))) (S (VP (VBN (co-administered)) (PP (IN (with)) (NP (drug_ENTITY (NP (JJ (slow-release)) (NN (nifedipine)) (CD (30)) (NN (mg)))) (CC (or)) (NP (NP (CD (60)) (NN (mg))) (ADVP (RB (once)) (RB (daily))))))))) (, (,))) (VP (VBD (did)) (RB (not)) (VP (VB (affect)) (NP (NP (NP (DT (the)) (JJ (relative)) (NN (bioavailability))) (PRN (-LRB- (<LB>)) (NP (NN (AUC))) (-RRB- (<RB>)))) (CC (or)) (NP (NP (NP (JJ (maximum)) (NN (concentration))) (PRN (-LRB- (<LB>)) (NP (NN (Cmax))) (-RRB- (<RB>)))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (nifedipine)))) (, (,)) (NP (NE-Type-2-drug (NP (DT (a)) (NN (drug)))))))))))) |ET|
-1  |BT|  (S (NP (NE-Type-1-drug (NP (NP (NN (Vardenafil))) (ADJP (CD (20)) (NN (mg))))) (, (,)) (SBAR (WHADVP (WRB (when))) (S (VP (VBN (co-administered)) (PP (IN (with)) (NP (drug_ENTITY (NP (JJ (slow-release)) (NN (nifedipine)) (CD (30)) (NN (mg)))) (CC (or)) (NP (NP (CD (60)) (NN (mg))) (ADVP (RB (once)) (RB (daily))))))))) (, (,))) (VP (VBD (did)) (RB (not)) (VP (VB (affect)) (NP (NP (NP (DT (the)) (JJ (relative)) (NN (bioavailability))) (PRN (-LRB- (<LB>)) (NP (NN (AUC))) (-RRB- (<RB>)))) (CC (or)) (NP (NP (NP (JJ (maximum)) (NN (concentration))) (PRN (-LRB- (<LB>)) (NP (NN (Cmax))) (-RRB- (<RB>)))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (nifedipine)))) (, (,)) (NP (drug_ENTITY (NP (DT (a)) (NN (drug)))) (SBAR (WHNP (WDT (that))) (S (VP (VBZ (is)) (VP (VBN (metabolized)) (PP (IN (via)) (NE-Type-2-drug (NP (NN (CYP3A4))))))))))))))))) |ET|
-1  |BT|  (S (NP (SBAR (S (VP (PP (NP (NE-Type-1-drug (NP (NN (nifedipine)) (CD (30)) (NN (mg)))) (CC (or)) (NP (NP (CD (60)) (NN (mg))) (ADVP (RB (once)) (RB (daily))))))))) (, (,))) (VP (VBD (did)) (RB (not)) (VP (VB (affect)) (NP (NP (NP (DT (the)) (JJ (relative)) (NN (bioavailability))) (PRN (-LRB- (<LB>)) (NP (NN (AUC))) (-RRB- (<RB>)))) (CC (or)) (NP (NP (NP (JJ (maximum)) (NN (concentration))) (PRN (-LRB- (<LB>)) (NP (NN (Cmax))) (-RRB- (<RB>)))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (NN (nifedipine))))))))))) |ET|
-1  |BT|  (S (NP (SBAR (S (VP (PP (NP (NE-Type-1-drug (NP (NN (nifedipine)) (CD (30)) (NN (mg)))) (CC (or)) (NP (NP (CD (60)) (NN (mg))) (ADVP (RB (once)) (RB (daily))))))))) (, (,))) (VP (VBD (did)) (RB (not)) (VP (VB (affect)) (NP (NP (NP (DT (the)) (JJ (relative)) (NN (bioavailability))) (PRN (-LRB- (<LB>)) (NP (NN (AUC))) (-RRB- (<RB>)))) (CC (or)) (NP (NP (NP (JJ (maximum)) (NN (concentration))) (PRN (-LRB- (<LB>)) (NP (NN (Cmax))) (-RRB- (<RB>)))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (nifedipine)))) (, (,)) (NP (NE-Type-2-drug (NP (DT (a)) (NN (drug)))))))))))) |ET|
-1  |BT|  (S (NP (SBAR (S (VP (PP (NP (NE-Type-1-drug (NP (NN (nifedipine)) (CD (30)) (NN (mg)))) (CC (or)) (NP (NP (CD (60)) (NN (mg))) (ADVP (RB (once)) (RB (daily))))))))) (, (,))) (VP (VBD (did)) (RB (not)) (VP (VB (affect)) (NP (NP (NP (DT (the)) (JJ (relative)) (NN (bioavailability))) (PRN (-LRB- (<LB>)) (NP (NN (AUC))) (-RRB- (<RB>)))) (CC (or)) (NP (NP (NP (JJ (maximum)) (NN (concentration))) (PRN (-LRB- (<LB>)) (NP (NN (Cmax))) (-RRB- (<RB>)))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (nifedipine)))) (, (,)) (NP (drug_ENTITY (NP (DT (a)) (NN (drug)))) (SBAR (WHNP (WDT (that))) (S (VP (VBZ (is)) (VP (VBN (metabolized)) (PP (IN (via)) (NE-Type-2-drug (NP (NN (CYP3A4))))))))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (nifedipine)))) (, (,)) (NP (NE-Type-2-drug (NP (DT (a)) (NN (drug)))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (nifedipine)))) (, (,)) (NP (drug_ENTITY (NP (DT (a)) (NN (drug)))) (SBAR (WHNP (WDT (that))) (S (VP (VBZ (is)) (VP (VBN (metabolized)) (PP (IN (via)) (NE-Type-2-drug (NP (NN (CYP3A4))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (drug)))) (SBAR (WHNP (WDT (that))) (S (VP (VBZ (is)) (VP (VBN (metabolized)) (PP (IN (via)) (NE-Type-2-drug (NP (NN (CYP3A4)))))))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NN (Nifedipine)))) (VP (VBD (did)) (RB (not)) (VP (VB (alter)) (NP (NP (DT (the)) (NN (plasma)) (NNS (levels))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (Vardenafil))))))))) |ET|
1  |BT|  (S (PP (NP (SBAR (S (VP (VP (PP (NE-Type-1-drug (NP (NN (nifedipine))))))))))) (, (,)) (NE-Type-2-drug (NP (NP (NN (Vardenafil))) (ADJP (CD (20)) (NN (mg)))))) |ET|
1  |BT|  (S (NE-Type-1-drug (NP (NN (Vardenafil)) (CD (10)) (CC (or)) (CD (20)) (NN (mg)))) (VP (VBD (was)) (UCP (VP (VBN (given)) (PP (TO (to)) (NP (JJ (healthy)) (NNS (volunteers))))) (CC (either)) (ADVP (RB (simultaneously))) (CC (or)) (PP (NP (CD (6)) (NNS (hours))) (IN (after)) (NP (NP (DT (a)) (ADJP (CD (10)) (NN (mg))) (NN (dose))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (terazosin)))))))))) |ET|
1  |BT|  (NP (NE-Type-1-drug (NP (NN (Vardenafil)) (CD (10)) (NN (mg)))) (CC (and)) (NE-Type-2-drug (NP (NN (terazosin)) (CD (10))))) |ET|
1  |BT|  (NP (NE-Type-1-drug (NP (NN (Vardenafil)) (CD (20)) (NN (mg)))) (CC (and)) (NE-Type-2-drug (NP (NN (terazosin)) (CD (10))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NN (Vardenafil)) (NN (dosing)))) (VP (VBD (was)) (VP (VBN (separated)) (PP (IN (from)) (NE-Type-2-drug (NP (NN (terazosin)) (CD (10)))))))) |ET|
-1  |BT|  (S (SBAR (S (NE-Type-1-drug (NP (NN (Vardenafil)) (NN (dosing)))) (VP (VBD (was)) (VP (VBN (separated)) (PP (IN (from)) (drug_ENTITY (NP (NN (terazosin)) (CD (10)) (NN (mg))))) (PP (IN (by)) (NP (CD (6)) (NNS (hours)))))))) (, (,)) (NP (NP (QP (CD (7)) (IN (of)) (CD (28))) (NNS (subjects))) (SBAR (WHNP (WP (who))) (S (VP (VBD (received)) (NP (NP (CD (20)) (NN (mg))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (Vardenafil))))))))))) |ET|
-1  |BT|  (S (SBAR (S (VP (VP (PP (NE-Type-1-drug (NP (NN (terazosin)) (CD (10)) (NN (mg))))) (PP (IN (by)) (NP (CD (6)) (NNS (hours)))))))) (, (,)) (NP (NP (QP (CD (7)) (IN (of)) (CD (28))) (NNS (subjects))) (SBAR (WHNP (WP (who))) (S (VP (VBD (received)) (NP (NP (CD (20)) (NN (mg))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (Vardenafil))))))))))) |ET|
-1  |BT|  (S (PP (NP (PP (NE-Type-1-drug (NP (NN (tamsulosin))))) (PP (IN (in)) (NP (JJ (healthy)) (NNS (volunteers)))))) (, (,)) (NP (NP (QP (CD (1)) (IN (of)) (CD (24))) (NNS (subjects))) (VP (VBN (dosed)) (PP (IN (with)) (NP (NP (NE-Type-2-drug (NP (NN (Vardenafil)) (CD (20)) (NN (mg)))))))))) |ET|
-1  |BT|  (S (PP (NP (PP (NE-Type-1-drug (NP (NN (tamsulosin))))) (PP (IN (in)) (NP (JJ (healthy)) (NNS (volunteers)))))) (, (,)) (NP (NP (QP (CD (1)) (IN (of)) (CD (24))) (NNS (subjects))) (VP (VBN (dosed)) (PP (IN (with)) (NP (NP (drug_ENTITY (NP (NN (Vardenafil)) (CD (20)) (NN (mg)))) (CC (and)) (NE-Type-2-drug (NP (NN (tamsulosin)) (CD (0.4)) (NN (mg)))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Vardenafil)) (CD (20)) (NN (mg)))) (CC (and)) (NE-Type-2-drug (NP (NN (tamsulosin)) (CD (0.4)) (NN (mg))))) |ET|
1  |BT|  (NP (NE-Type-1-drug (NP (NN (Vardenafil)) (CD (10)) (NN (mg)))) (CC (and)) (NE-Type-2-drug (NP (NN (tamsulosin)) (CD (0.4)) (NN (mg))))) |ET|
1  |BT|  (S (NE-Type-1-drug (NP (NN (Vardenafil)))) (VP (MD (should)) (RB (not)) (VP (VB (be)) (VP (VBN (used)) (PP (IN (in)) (NP (NP (NNS (patients))) (PP (IN (on)) (NE-Type-2-drug (NP (NN (alpha-blocker))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Ritonavir)))) (CC (and)) (NE-Type-2-drug (NP (NN (indinavir))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (Ritonavir)))) (CC (and)) (drug_ENTITY (NP (NN (indinavir))))) (: (:)) (S (PP (IN (Upon)) (NP (NP (JJ (concomitant)) (NN (administration))) (PP (IN (of)) (NP (NP (CD (5)) (NN (mg))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (Vardenafil))))))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (Ritonavir)))) (CC (and)) (drug_ENTITY (NP (NN (indinavir))))) (: (:)) (S (PP (IN (Upon)) (NP (NP (JJ (concomitant)) (NN (administration))) (PP (IN (of)) (NP (NP (CD (5)) (NN (mg))) (PP (IN (of)) (drug_ENTITY (NP (NN (Vardenafil))))) (PP (IN (with)) (NE-Type-2-drug (NP (ADJP (CD (600)) (NN (mg))) (NN (BID)) (NN (ritonavir))))))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (Ritonavir)))) (CC (and)) (drug_ENTITY (NP (NN (indinavir))))) (: (:)) (S (PP (IN (Upon)) (NP (NP (JJ (concomitant)) (NN (administration))) (PP (IN (of)) (NP (NP (CD (5)) (NN (mg))) (PP (IN (of)) (drug_ENTITY (NP (NN (Vardenafil))))) (PP (IN (with)) (drug_ENTITY (NP (ADJP (CD (600)) (NN (mg))) (NN (BID)) (NN (ritonavir))))))))) (, (,)) (NP (NP (DT (the)) (NP (NN (Cmax))) (CC (and)) (NP (NN (AUC)))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (ritonavir)))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (indinavir))))) (: (:)) (S (PP (IN (Upon)) (NP (NP (JJ (concomitant)) (NN (administration))) (PP (IN (of)) (NP (NP (CD (5)) (NN (mg))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (Vardenafil))))))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (indinavir))))) (: (:)) (S (PP (IN (Upon)) (NP (NP (JJ (concomitant)) (NN (administration))) (PP (IN (of)) (NP (NP (CD (5)) (NN (mg))) (PP (IN (of)) (drug_ENTITY (NP (NN (Vardenafil))))) (PP (IN (with)) (NE-Type-2-drug (NP (ADJP (CD (600)) (NN (mg))) (NN (BID)) (NN (ritonavir))))))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (indinavir))))) (: (:)) (S (PP (IN (Upon)) (NP (NP (JJ (concomitant)) (NN (administration))) (PP (IN (of)) (NP (NP (CD (5)) (NN (mg))) (PP (IN (of)) (drug_ENTITY (NP (NN (Vardenafil))))) (PP (IN (with)) (drug_ENTITY (NP (ADJP (CD (600)) (NN (mg))) (NN (BID)) (NN (ritonavir))))))))) (, (,)) (NP (NP (DT (the)) (NP (NN (Cmax))) (CC (and)) (NP (NN (AUC)))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (ritonavir)))))))) |ET|
1  |BT|  (NP (PP (NE-Type-1-drug (NP (NN (Vardenafil))))) (PP (IN (with)) (NE-Type-2-drug (NP (ADJP (CD (600)) (NN (mg))) (NN (BID)) (NN (ritonavir)))))) |ET|
-1  |BT|  (S (PP (NP (PP (NP (PP (NE-Type-1-drug (NP (NN (Vardenafil))))) (PP (IN (with)) (drug_ENTITY (NP (ADJP (CD (600)) (NN (mg))) (NN (BID)) (NN (ritonavir))))))))) (, (,)) (NP (NP (DT (the)) (NP (NN (Cmax))) (CC (and)) (NP (NN (AUC)))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (ritonavir))))))) |ET|
-1  |BT|  (S (PP (NP (PP (NP (PP (NE-Type-1-drug (NP (NN (ritonavir))))))))) (, (,)) (NP (NP (DT (the)) (NP (NN (Cmax))) (CC (and)) (NP (NN (AUC)))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (ritonavir))))))) |ET|
1  |BT|  (NP (PP (NE-Type-1-drug (NP (NN (Vardenafil))))) (PP (IN (with)) (NE-Type-2-drug (NP (ADJP (CD (800)) (NN (mg))) (NN (TID)) (NN (indinavir)))))) |ET|
-1  |BT|  (S (PP (NP (PP (NP (PP (NE-Type-1-drug (NP (NN (Vardenafil))))) (PP (IN (with)) (drug_ENTITY (NP (ADJP (CD (800)) (NN (mg))) (NN (TID)) (NN (indinavir))))))))) (, (,)) (NP (NP (DT (the)) (NP (NN (Cmax))) (CC (and)) (NP (NN (AUC)))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (indinavir))))))) |ET|
-1  |BT|  (S (PP (NP (PP (NP (PP (NE-Type-1-drug (NP (NN (indinavir))))))))) (, (,)) (NP (NP (DT (the)) (NP (NN (Cmax))) (CC (and)) (NP (NN (AUC)))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (indinavir))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Alcohol)))) (: (:)) (NP (NE-Type-2-drug (NP (NN (Alcohol)))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Alcohol)))) (: (:)) (NP (drug_ENTITY (NP (NN (Alcohol)))) (PRN (-LRB- (<LB>)) (NP (CD (0.5)) (NN (g/kg)) (NN (body)) (NN (weight))) (: (:)) (NP (NP (QP (RB (approximately)) (CD (40))) (NN (mL))) (PP (IN (of)) (NP (NP (JJ (absolute)) (NN (alcohol))) (PP (IN (in)) (NP (DT (a)) (CD (70)) (NN (kg)) (NN (person))))))) (-RRB- (<RB>)))) (CC (and)) (NE-Type-2-drug (NP (NN (vardenafil))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (Alcohol)))) (PRN (-LRB- (<LB>)) (NP (CD (0.5)) (NN (g/kg)) (NN (body)) (NN (weight))) (: (:)) (NP (NP (QP (RB (approximately)) (CD (40))) (NN (mL))) (PP (IN (of)) (NP (NP (JJ (absolute)) (NN (alcohol))) (PP (IN (in)) (NP (DT (a)) (CD (70)) (NN (kg)) (NN (person))))))) (-RRB- (<RB>)))) (CC (and)) (NE-Type-2-drug (NP (NN (vardenafil))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (Vardenafil)))) (PRN (-LRB- (<LB>)) (NP (CD (20)) (NN (mg))) (-RRB- (<RB>)))) (VP (VBD (did)) (RB (not)) (VP (VB (potentiate)) (NP (NP (DT (the)) (JJ (hypotensive)) (NNS (effects))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (alcohol))))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (Vardenafil)))) (PRN (-LRB- (<LB>)) (NP (CD (20)) (NN (mg))) (-RRB- (<RB>)))) (VP (VBD (did)) (RB (not)) (VP (VB (potentiate)) (NP (NP (DT (the)) (JJ (hypotensive)) (NNS (effects))) (PP (IN (of)) (drug_ENTITY (NP (NN (alcohol))))) (PP (IN (during)) (NP (NP (DT (the)) (JJ (4-hour)) (NN (observation)) (NN (period))) (PP (IN (in)) (NP (JJ (healthy)) (NNS (volunteers)))))))) (SBAR (WHADVP (WRB (when))) (S (VP (VBN (administered)) (PP (IN (with)) (NE-Type-2-drug (NP (NN (alcohol)))))))))) |ET|
-1  |BT|  (VP (VP (NP (PP (NE-Type-1-drug (NP (NN (alcohol))))) (PP (IN (during)) (NP (NP (DT (the)) (JJ (4-hour)) (NN (observation)) (NN (period))) (PP (IN (in)) (NP (JJ (healthy)) (NNS (volunteers)))))))) (SBAR (WHADVP (WRB (when))) (S (VP (VBN (administered)) (PP (IN (with)) (NE-Type-2-drug (NP (NN (alcohol))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Aspirin)))) (: (:)) (S (NP (NE-Type-2-drug (NP (NN (Vardenafil))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Aspirin)))) (: (:)) (S (NP (drug_ENTITY (NP (NN (Vardenafil)))) (PRN (-LRB- (<LB>)) (NP (NP (CD (10)) (NN (mg))) (CC (and)) (NP (CD (20)) (NN (mg)))) (-RRB- (<RB>)))) (VP (VBD (did)) (RB (not)) (VP (VB (potentiate)) (NP (NP (DT (the)) (NN (increase))) (PP (IN (in)) (NP (NP (JJ (bleeding)) (NN (time))) (VP (VBN (caused)) (PP (IN (by)) (NE-Type-2-drug (NP (NN (aspirin))))))))))))) |ET|
-1  |BT|  (S (NP (NE-Type-1-drug (NP (NN (Vardenafil)))) (PRN (-LRB- (<LB>)) (NP (NP (CD (10)) (NN (mg))) (CC (and)) (NP (CD (20)) (NN (mg)))) (-RRB- (<RB>)))) (VP (VBD (did)) (RB (not)) (VP (VB (potentiate)) (NP (NP (DT (the)) (NN (increase))) (PP (IN (in)) (NP (NP (JJ (bleeding)) (NN (time))) (VP (VBN (caused)) (PP (IN (by)) (NE-Type-2-drug (NP (NN (aspirin)))))))))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NN (Vardenafil)))) (VP (VBD (had)) (NP (DT (no)) (NN (effect))) (PP (IN (on)) (NP (NP (DT (the)) (NNS (pharmacodynamics))) (PP (IN (of)) (NP (NP (NE-Type-2-drug (NP (NN (glyburide))))))))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NN (Vardenafil)))) (VP (VBD (had)) (NP (DT (no)) (NN (effect))) (PP (IN (on)) (NP (NP (DT (the)) (NNS (pharmacodynamics))) (PP (IN (of)) (NP (NP (drug_ENTITY (NP (NN (glyburide)))) (PRN (-LRB- (<LB>)) (NP (NP (NE-Type-2-drug (NP (NN (glucose)))))))))))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NN (Vardenafil)))) (VP (VBD (had)) (NP (DT (no)) (NN (effect))) (PP (IN (on)) (NP (NP (DT (the)) (NNS (pharmacodynamics))) (PP (IN (of)) (NP (NP (drug_ENTITY (NP (NN (glyburide)))) (PRN (-LRB- (<LB>)) (NP (NP (drug_ENTITY (NP (NN (glucose)))) (CC (and)) (NE-Type-2-drug (NP (NN (insulin)))))))))))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NN (Vardenafil)))) (VP (VBD (had)) (NP (DT (no)) (NN (effect))) (PP (IN (on)) (NP (NP (DT (the)) (NNS (pharmacodynamics))) (PP (IN (of)) (NP (NP (drug_ENTITY (NP (NN (glyburide)))) (PRN (-LRB- (<LB>)) (NP (NP (drug_ENTITY (NP (NN (glucose)))) (CC (and)) (drug_ENTITY (NP (NN (insulin))))) (NNS (concentrations))) (-RRB- (<RB>)))) (CC (and)) (NE-Type-2-drug (NP (NN (warfarin)))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (glyburide)))) (PRN (-LRB- (<LB>)) (NP (NP (NE-Type-2-drug (NP (NN (glucose)))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (glyburide)))) (PRN (-LRB- (<LB>)) (NP (NP (drug_ENTITY (NP (NN (glucose)))) (CC (and)) (NE-Type-2-drug (NP (NN (insulin)))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (glyburide)))) (PRN (-LRB- (<LB>)) (NP (NP (drug_ENTITY (NP (NN (glucose)))) (CC (and)) (drug_ENTITY (NP (NN (insulin))))) (NNS (concentrations))) (-RRB- (<RB>)))) (CC (and)) (NE-Type-2-drug (NP (NN (warfarin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (glucose)))) (CC (and)) (NE-Type-2-drug (NP (NN (insulin))))) |ET|
-1  |BT|  (NP (NP (PRN (NP (NP (NE-Type-1-drug (NP (NN (glucose)))) (CC (and)) (drug_ENTITY (NP (NN (insulin))))) (NNS (concentrations))) (-RRB- (<RB>)))) (CC (and)) (NE-Type-2-drug (NP (NN (warfarin))))) |ET|
-1  |BT|  (NP (NP (PRN (NP (NP (NE-Type-1-drug (NP (NN (insulin))))) (NNS (concentrations))) (-RRB- (<RB>)))) (CC (and)) (NE-Type-2-drug (NP (NN (warfarin))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NN (Zidovudine)))) (: (:)) (S (NP (EX (There))) (VP (VBZ (is)) (NP (NP (DT (no)) (JJ (significant)) (JJ (pharmacokinetic)) (NN (interaction))) (PP (IN (between)) (NP (NE-Type-2-drug (NP (NN (ZDV)))))))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NN (Zidovudine)))) (: (:)) (S (NP (EX (There))) (VP (VBZ (is)) (NP (NP (DT (no)) (JJ (significant)) (JJ (pharmacokinetic)) (NN (interaction))) (PP (IN (between)) (NP (drug_ENTITY (NP (NN (ZDV)))) (CC (and)) (NE-Type-2-drug (NP (NN (zalcitabine)))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (ZDV)))) (CC (and)) (NE-Type-2-drug (NP (NN (zalcitabine))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NN (Zalcitabine)))) (ADVP (RB (also))) (VP (VBZ (has)) (NP (DT (no)) (JJ (significant)) (NN (effect))) (PP (IN (on)) (NP (NP (DT (the)) (JJ (intracellular)) (NN (phosphorylation))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (ZDV))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (didanosine)))) (CC (and)) (NE-Type-2-drug (NP (NN (stavudine))))) |ET|
-1  |BT|  (S (NP (NE-Type-1-drug (NP (NN (didanosine)))) (CC (and)) (drug_ENTITY (NP (NN (stavudine))))) (VP (VBD (had)) (NP (DT (no)) (JJ (significant)) (NN (effect))) (PP (IN (on)) (NP (NP (DT (the)) (JJ (intracellular)) (NN (phosphorylation))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (zalcitabine))))))))) |ET|
-1  |BT|  (S (NP (NE-Type-1-drug (NP (NN (stavudine))))) (VP (VBD (had)) (NP (DT (no)) (JJ (significant)) (NN (effect))) (PP (IN (on)) (NP (NP (DT (the)) (JJ (intracellular)) (NN (phosphorylation))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (zalcitabine))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Lamivudine)))) (: (:)) (S (NP (NP (ADJP (FW (In)) (FW (vitro))) (NNS (studies))) (PP (IN (in)) (NP (NP (JJ (peripheral)) (NN (blood)) (JJ (mononuclear)) (NNS (cells))) (, (,)) (NP (NN (U937))) (CC (and)) (NP (NN (Molt-4)) (NNS (cells)))))) (VP (VBD (revealed)) (SBAR (IN (that)) (S (NE-Type-2-drug (NP (NN (lamivudine))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Lamivudine)))) (: (:)) (S (NP (NP (ADJP (FW (In)) (FW (vitro))) (NNS (studies))) (PP (IN (in)) (NP (NP (JJ (peripheral)) (NN (blood)) (JJ (mononuclear)) (NNS (cells))) (, (,)) (NP (NN (U937))) (CC (and)) (NP (NN (Molt-4)) (NNS (cells)))))) (VP (VBD (revealed)) (SBAR (IN (that)) (S (drug_ENTITY (NP (NN (lamivudine)))) (ADVP (RB (significantly))) (VP (VBD (inhibited)) (NE-Type-2-drug (NP (NN (zalcitabine)))))))))) |ET|
1  |BT|  (S (NE-Type-1-drug (NP (NN (lamivudine)))) (ADVP (RB (significantly))) (VP (VBD (inhibited)) (NE-Type-2-drug (NP (NN (zalcitabine)))))) |ET|
-1  |BT|  (NP (PP (NE-Type-1-drug (NP (NN (zalcitabine))))) (PP (TO (to)) (NP (NE-Type-2-drug (NP (PRP$ (its)) (CD (three)) (NNS (metabolites))))))) |ET|
-1  |BT|  (NP (PP (NE-Type-1-drug (NP (NN (zalcitabine))))) (PP (TO (to)) (NP (drug_ENTITY (NP (PRP$ (its)) (CD (three)) (NNS (metabolites)))) (PRN (-LRB- (<LB>)) (VP (VBG (including)) (NE-Type-2-drug (NP (DT (the)) (JJ (active)) (NN (zalcitabine))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (metabolites)))) (PRN (-LRB- (<LB>)) (VP (VBG (including)) (NE-Type-2-drug (NP (DT (the)) (JJ (active)) (NN (zalcitabine))))))) |ET|
1  |BT|  (S (NE-Type-1-drug (NP (NN (Zalcitabine)))) (VP (VBD (inhibited)) (NE-Type-2-drug (NP (NN (lamivudine)))))) |ET|
-1  |BT|  (S (NP (PP (NE-Type-1-drug (NP (NN (lamivudine)) (NN (concentration)))))) (VP (VBZ (is)) (PP (IN (of)) (NP (JJ (clinical)) (NN (significance)))) (, (,)) (SBAR (IN (as)) (S (NE-Type-2-drug (NP (NN (lamivudine)))))))) |ET|
-1  |BT|  (S (NP (PP (NE-Type-1-drug (NP (NN (lamivudine)) (NN (concentration)))))) (VP (VBZ (is)) (PP (IN (of)) (NP (JJ (clinical)) (NN (significance)))) (, (,)) (SBAR (IN (as)) (S (drug_ENTITY (NP (NN (lamivudine)))) (VP (VBZ (is)) (NP (NP (DT (a)) (ADJP (RBR (more)) (JJ (efficient))) (NN (substrate))) (PP (IN (for)) (NE-Type-2-drug (NP (NN (deoxycytidine)) (NN (kinase))))))))))) |ET|
-1  |BT|  (S (NP (PP (NE-Type-1-drug (NP (NN (lamivudine)) (NN (concentration)))))) (VP (VBZ (is)) (PP (IN (of)) (NP (JJ (clinical)) (NN (significance)))) (, (,)) (SBAR (IN (as)) (S (drug_ENTITY (NP (NN (lamivudine)))) (VP (VBZ (is)) (NP (NP (DT (a)) (ADJP (RBR (more)) (JJ (efficient))) (NN (substrate))) (PP (IN (for)) (drug_ENTITY (NP (NN (deoxycytidine)) (NN (kinase))))) (PP (IN (than)) (NE-Type-2-drug (NP (NN (zalcitabine))))))))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NN (lamivudine)))) (VP (VBZ (is)) (NP (NP (DT (a)) (ADJP (RBR (more)) (JJ (efficient))) (NN (substrate))) (PP (IN (for)) (NE-Type-2-drug (NP (NN (deoxycytidine)) (NN (kinase)))))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NN (lamivudine)))) (VP (VBZ (is)) (NP (NP (DT (a)) (ADJP (RBR (more)) (JJ (efficient))) (NN (substrate))) (PP (IN (for)) (drug_ENTITY (NP (NN (deoxycytidine)) (NN (kinase))))) (PP (IN (than)) (NE-Type-2-drug (NP (NN (zalcitabine)))))))) |ET|
-1  |BT|  (NP (PP (NE-Type-1-drug (NP (NN (deoxycytidine)) (NN (kinase))))) (PP (IN (than)) (NE-Type-2-drug (NP (NN (zalcitabine)))))) |ET|
1  |BT|  (NP (NE-Type-1-drug (NP (NN (zalcitabine)))) (CC (and)) (NE-Type-2-drug (NP (NN (lamivudine))))) |ET|
-1  |BT|  (S (NP (PP (NP (NE-Type-1-drug (NP (NN (zalcitabine)))) (CC (and)) (drug_ENTITY (NP (NN (lamivudine)))))) (PP (IN (in)) (NP (NNS (humans))))) (VP (MD (may)) (VP (VB (result)) (PP (IN (in)) (NP (NP (JJ (sub-therapeutic)) (NNS (concentrations))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (JJ (active)) (JJ (phosphorylated)) (NN (zalcitabine))))))))))) |ET|
-1  |BT|  (S (NP (PP (NP (NE-Type-1-drug (NP (NN (zalcitabine)))) (CC (and)) (drug_ENTITY (NP (NN (lamivudine)))))) (PP (IN (in)) (NP (NNS (humans))))) (VP (MD (may)) (VP (VB (result)) (PP (IN (in)) (NP (NP (JJ (sub-therapeutic)) (NNS (concentrations))) (PP (IN (of)) (NP (drug_ENTITY (NP (JJ (active)) (JJ (phosphorylated)) (NN (zalcitabine)))) (, (,)) (SBAR (WHNP (WDT (which))) (S (VP (MD (may)) (VP (VB (lead)) (PP (TO (to)) (NP (NP (DT (a)) (VBN (decreased)) (JJ (antiretroviral)) (NN (effect))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (zalcitabine)))))))))))))))))) |ET|
-1  |BT|  (S (NP (PP (NP (NE-Type-1-drug (NP (NN (lamivudine)))))) (PP (IN (in)) (NP (NNS (humans))))) (VP (MD (may)) (VP (VB (result)) (PP (IN (in)) (NP (NP (JJ (sub-therapeutic)) (NNS (concentrations))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (JJ (active)) (JJ (phosphorylated)) (NN (zalcitabine))))))))))) |ET|
-1  |BT|  (S (NP (PP (NP (NE-Type-1-drug (NP (NN (lamivudine)))))) (PP (IN (in)) (NP (NNS (humans))))) (VP (MD (may)) (VP (VB (result)) (PP (IN (in)) (NP (NP (JJ (sub-therapeutic)) (NNS (concentrations))) (PP (IN (of)) (NP (drug_ENTITY (NP (JJ (active)) (JJ (phosphorylated)) (NN (zalcitabine)))) (, (,)) (SBAR (WHNP (WDT (which))) (S (VP (MD (may)) (VP (VB (lead)) (PP (TO (to)) (NP (NP (DT (a)) (VBN (decreased)) (JJ (antiretroviral)) (NN (effect))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (zalcitabine)))))))))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (zalcitabine)))) (, (,)) (SBAR (WHNP (WDT (which))) (S (VP (MD (may)) (VP (VB (lead)) (PP (TO (to)) (NP (NP (DT (a)) (VBN (decreased)) (JJ (antiretroviral)) (NN (effect))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (zalcitabine)))))))))))) |ET|
1  |BT|  (NP (NE-Type-1-drug (NP (NN (zalcitabine)))) (CC (and)) (NE-Type-2-drug (NP (NN (lamivudine))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Saquinavir)))) (: (:)) (S (NP (NP (DT (The)) (NN (combination))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (NN (HIVID))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Saquinavir)))) (: (:)) (S (NP (NP (DT (The)) (NN (combination))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (HIVID)))) (, (,)) (NE-Type-2-drug (NP (NN (saquinavir))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Saquinavir)))) (: (:)) (S (NP (NP (DT (The)) (NN (combination))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (HIVID)))) (, (,)) (drug_ENTITY (NP (NN (saquinavir)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NN (ZDV))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (HIVID)))) (, (,)) (NE-Type-2-drug (NP (NN (saquinavir))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (HIVID)))) (, (,)) (drug_ENTITY (NP (NN (saquinavir)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NN (ZDV))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (saquinavir)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NN (ZDV))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NNS (Drugs)))) (VP (VBN (Associated)) (PP (IN (With)) (DISO_ENTITY (NP (JJ (Peripheral)) (NN (Neuropathy))))))) (: (:)) (S (NP (NP (DT (The)) (JJ (concomitant)) (NN (use))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (HIVID)))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NNS (Drugs)))) (VP (VBN (Associated)) (PP (IN (With)) (DISO_ENTITY (NP (JJ (Peripheral)) (NN (Neuropathy))))))) (: (:)) (S (NP (NP (DT (The)) (JJ (concomitant)) (NN (use))) (PP (IN (of)) (drug_ENTITY (NP (NN (HIVID))))) (PP (IN (with)) (NP (NE-Type-2-drug (NP (NNS (drugs))))))))) |ET|
1  |BT|  (NP (PP (NE-Type-1-drug (NP (NN (HIVID))))) (PP (IN (with)) (NP (NE-Type-2-drug (NP (NNS (drugs))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (Drugs)))) (SBAR (WHNP (WDT (that))) (S (VP (VBP (have)) (VP (VBN (been)) (VP (VBN (associated)) (PP (IN (with)) (DISO_ENTITY (NP (JJ (peripheral)) (NN (neuropathy))))) (S (VP (VBP (include)) (NP (NP (NE-Type-2-drug (NP (JJ (antiretroviral)) (NN (nucleoside)) (NNS (analogues)))))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (Drugs)))) (SBAR (WHNP (WDT (that))) (S (VP (VBP (have)) (VP (VBN (been)) (VP (VBN (associated)) (PP (IN (with)) (DISO_ENTITY (NP (JJ (peripheral)) (NN (neuropathy))))) (S (VP (VBP (include)) (NP (NP (drug_ENTITY (NP (JJ (antiretroviral)) (NN (nucleoside)) (NNS (analogues)))) (, (,)) (NE-Type-2-drug (NP (NN (chloramphenicol)))))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (Drugs)))) (SBAR (WHNP (WDT (that))) (S (VP (VBP (have)) (VP (VBN (been)) (VP (VBN (associated)) (PP (IN (with)) (DISO_ENTITY (NP (JJ (peripheral)) (NN (neuropathy))))) (S (VP (VBP (include)) (NP (NP (drug_ENTITY (NP (JJ (antiretroviral)) (NN (nucleoside)) (NNS (analogues)))) (, (,)) (drug_ENTITY (NP (NN (chloramphenicol)))) (, (,)) (NE-Type-2-drug (NP (NN (cisplatin)))))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (Drugs)))) (SBAR (WHNP (WDT (that))) (S (VP (VBP (have)) (VP (VBN (been)) (VP (VBN (associated)) (PP (IN (with)) (DISO_ENTITY (NP (JJ (peripheral)) (NN (neuropathy))))) (S (VP (VBP (include)) (NP (NP (drug_ENTITY (NP (JJ (antiretroviral)) (NN (nucleoside)) (NNS (analogues)))) (, (,)) (drug_ENTITY (NP (NN (chloramphenicol)))) (, (,)) (drug_ENTITY (NP (NN (cisplatin))))) (, (,)) (NP (NE-Type-2-drug (NP (NN (dapsone)))))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (Drugs)))) (SBAR (WHNP (WDT (that))) (S (VP (VBP (have)) (VP (VBN (been)) (VP (VBN (associated)) (PP (IN (with)) (DISO_ENTITY (NP (JJ (peripheral)) (NN (neuropathy))))) (S (VP (VBP (include)) (NP (NP (drug_ENTITY (NP (JJ (antiretroviral)) (NN (nucleoside)) (NNS (analogues)))) (, (,)) (drug_ENTITY (NP (NN (chloramphenicol)))) (, (,)) (drug_ENTITY (NP (NN (cisplatin))))) (, (,)) (NP (drug_ENTITY (NP (NN (dapsone)))) (, (,)) (NE-Type-2-drug (NP (NN (disulfiram)))))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (Drugs)))) (SBAR (WHNP (WDT (that))) (S (VP (VBP (have)) (VP (VBN (been)) (VP (VBN (associated)) (PP (IN (with)) (DISO_ENTITY (NP (JJ (peripheral)) (NN (neuropathy))))) (S (VP (VBP (include)) (NP (NP (drug_ENTITY (NP (JJ (antiretroviral)) (NN (nucleoside)) (NNS (analogues)))) (, (,)) (drug_ENTITY (NP (NN (chloramphenicol)))) (, (,)) (drug_ENTITY (NP (NN (cisplatin))))) (, (,)) (NP (drug_ENTITY (NP (NN (dapsone)))) (, (,)) (drug_ENTITY (NP (NN (disulfiram)))) (, (,)) (NE-Type-2-drug (NP (NN (ethionamide)))))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (Drugs)))) (SBAR (WHNP (WDT (that))) (S (VP (VBP (have)) (VP (VBN (been)) (VP (VBN (associated)) (PP (IN (with)) (DISO_ENTITY (NP (JJ (peripheral)) (NN (neuropathy))))) (S (VP (VBP (include)) (NP (NP (drug_ENTITY (NP (JJ (antiretroviral)) (NN (nucleoside)) (NNS (analogues)))) (, (,)) (drug_ENTITY (NP (NN (chloramphenicol)))) (, (,)) (drug_ENTITY (NP (NN (cisplatin))))) (, (,)) (NP (drug_ENTITY (NP (NN (dapsone)))) (, (,)) (drug_ENTITY (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (NE-Type-2-drug (NP (NN (glutethimide)))))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (Drugs)))) (SBAR (WHNP (WDT (that))) (S (VP (VBP (have)) (VP (VBN (been)) (VP (VBN (associated)) (PP (IN (with)) (DISO_ENTITY (NP (JJ (peripheral)) (NN (neuropathy))))) (S (VP (VBP (include)) (NP (NP (drug_ENTITY (NP (JJ (antiretroviral)) (NN (nucleoside)) (NNS (analogues)))) (, (,)) (drug_ENTITY (NP (NN (chloramphenicol)))) (, (,)) (drug_ENTITY (NP (NN (cisplatin))))) (, (,)) (NP (drug_ENTITY (NP (NN (dapsone)))) (, (,)) (drug_ENTITY (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (NE-Type-2-drug (NP (NN (gold)))))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (Drugs)))) (SBAR (WHNP (WDT (that))) (S (VP (VBP (have)) (VP (VBN (been)) (VP (VBN (associated)) (PP (IN (with)) (DISO_ENTITY (NP (JJ (peripheral)) (NN (neuropathy))))) (S (VP (VBP (include)) (NP (NP (drug_ENTITY (NP (JJ (antiretroviral)) (NN (nucleoside)) (NNS (analogues)))) (, (,)) (drug_ENTITY (NP (NN (chloramphenicol)))) (, (,)) (drug_ENTITY (NP (NN (cisplatin))))) (, (,)) (NP (drug_ENTITY (NP (NN (dapsone)))) (, (,)) (drug_ENTITY (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (NE-Type-2-drug (NP (NN (hydralazine)))))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (Drugs)))) (SBAR (WHNP (WDT (that))) (S (VP (VBP (have)) (VP (VBN (been)) (VP (VBN (associated)) (PP (IN (with)) (DISO_ENTITY (NP (JJ (peripheral)) (NN (neuropathy))))) (S (VP (VBP (include)) (NP (NP (drug_ENTITY (NP (JJ (antiretroviral)) (NN (nucleoside)) (NNS (analogues)))) (, (,)) (drug_ENTITY (NP (NN (chloramphenicol)))) (, (,)) (drug_ENTITY (NP (NN (cisplatin))))) (, (,)) (NP (drug_ENTITY (NP (NN (dapsone)))) (, (,)) (drug_ENTITY (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (NE-Type-2-drug (NP (NN (iodoquinol)))))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (Drugs)))) (SBAR (WHNP (WDT (that))) (S (VP (VBP (have)) (VP (VBN (been)) (VP (VBN (associated)) (PP (IN (with)) (DISO_ENTITY (NP (JJ (peripheral)) (NN (neuropathy))))) (S (VP (VBP (include)) (NP (NP (drug_ENTITY (NP (JJ (antiretroviral)) (NN (nucleoside)) (NNS (analogues)))) (, (,)) (drug_ENTITY (NP (NN (chloramphenicol)))) (, (,)) (drug_ENTITY (NP (NN (cisplatin))))) (, (,)) (NP (drug_ENTITY (NP (NN (dapsone)))) (, (,)) (drug_ENTITY (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (NE-Type-2-drug (NP (NN (isoniazid)))))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (Drugs)))) (SBAR (WHNP (WDT (that))) (S (VP (VBP (have)) (VP (VBN (been)) (VP (VBN (associated)) (PP (IN (with)) (DISO_ENTITY (NP (JJ (peripheral)) (NN (neuropathy))))) (S (VP (VBP (include)) (NP (NP (drug_ENTITY (NP (JJ (antiretroviral)) (NN (nucleoside)) (NNS (analogues)))) (, (,)) (drug_ENTITY (NP (NN (chloramphenicol)))) (, (,)) (drug_ENTITY (NP (NN (cisplatin))))) (, (,)) (NP (drug_ENTITY (NP (NN (dapsone)))) (, (,)) (drug_ENTITY (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (drug_ENTITY (NP (NN (isoniazid)))) (, (,)) (NE-Type-2-drug (NP (NN (metronidazole)))))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (Drugs)))) (SBAR (WHNP (WDT (that))) (S (VP (VBP (have)) (VP (VBN (been)) (VP (VBN (associated)) (PP (IN (with)) (DISO_ENTITY (NP (JJ (peripheral)) (NN (neuropathy))))) (S (VP (VBP (include)) (NP (NP (drug_ENTITY (NP (JJ (antiretroviral)) (NN (nucleoside)) (NNS (analogues)))) (, (,)) (drug_ENTITY (NP (NN (chloramphenicol)))) (, (,)) (drug_ENTITY (NP (NN (cisplatin))))) (, (,)) (NP (drug_ENTITY (NP (NN (dapsone)))) (, (,)) (drug_ENTITY (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (drug_ENTITY (NP (NN (isoniazid)))) (, (,)) (drug_ENTITY (NP (NN (metronidazole)))) (, (,)) (NE-Type-2-drug (NP (NN (nitrofurantoin)))))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (Drugs)))) (SBAR (WHNP (WDT (that))) (S (VP (VBP (have)) (VP (VBN (been)) (VP (VBN (associated)) (PP (IN (with)) (DISO_ENTITY (NP (JJ (peripheral)) (NN (neuropathy))))) (S (VP (VBP (include)) (NP (NP (drug_ENTITY (NP (JJ (antiretroviral)) (NN (nucleoside)) (NNS (analogues)))) (, (,)) (drug_ENTITY (NP (NN (chloramphenicol)))) (, (,)) (drug_ENTITY (NP (NN (cisplatin))))) (, (,)) (NP (drug_ENTITY (NP (NN (dapsone)))) (, (,)) (drug_ENTITY (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (drug_ENTITY (NP (NN (isoniazid)))) (, (,)) (drug_ENTITY (NP (NN (metronidazole)))) (, (,)) (drug_ENTITY (NP (NN (nitrofurantoin)))) (, (,)) (NE-Type-2-drug (NP (NN (phenytoin)))))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (Drugs)))) (SBAR (WHNP (WDT (that))) (S (VP (VBP (have)) (VP (VBN (been)) (VP (VBN (associated)) (PP (IN (with)) (DISO_ENTITY (NP (JJ (peripheral)) (NN (neuropathy))))) (S (VP (VBP (include)) (NP (NP (drug_ENTITY (NP (JJ (antiretroviral)) (NN (nucleoside)) (NNS (analogues)))) (, (,)) (drug_ENTITY (NP (NN (chloramphenicol)))) (, (,)) (drug_ENTITY (NP (NN (cisplatin))))) (, (,)) (NP (drug_ENTITY (NP (NN (dapsone)))) (, (,)) (drug_ENTITY (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (drug_ENTITY (NP (NN (isoniazid)))) (, (,)) (drug_ENTITY (NP (NN (metronidazole)))) (, (,)) (drug_ENTITY (NP (NN (nitrofurantoin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (NE-Type-2-drug (NP (NN (ribavirin)))))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (Drugs)))) (SBAR (WHNP (WDT (that))) (S (VP (VBP (have)) (VP (VBN (been)) (VP (VBN (associated)) (PP (IN (with)) (DISO_ENTITY (NP (JJ (peripheral)) (NN (neuropathy))))) (S (VP (VBP (include)) (NP (NP (drug_ENTITY (NP (JJ (antiretroviral)) (NN (nucleoside)) (NNS (analogues)))) (, (,)) (drug_ENTITY (NP (NN (chloramphenicol)))) (, (,)) (drug_ENTITY (NP (NN (cisplatin))))) (, (,)) (NP (drug_ENTITY (NP (NN (dapsone)))) (, (,)) (drug_ENTITY (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (drug_ENTITY (NP (NN (isoniazid)))) (, (,)) (drug_ENTITY (NP (NN (metronidazole)))) (, (,)) (drug_ENTITY (NP (NN (nitrofurantoin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (drug_ENTITY (NP (NN (ribavirin)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NN (vincristine)))))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (JJ (antiretroviral)) (NN (nucleoside)) (NNS (analogues)))) (, (,)) (NE-Type-2-drug (NP (NN (chloramphenicol))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (JJ (antiretroviral)) (NN (nucleoside)) (NNS (analogues)))) (, (,)) (drug_ENTITY (NP (NN (chloramphenicol)))) (, (,)) (NE-Type-2-drug (NP (NN (cisplatin))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (JJ (antiretroviral)) (NN (nucleoside)) (NNS (analogues)))) (, (,)) (drug_ENTITY (NP (NN (chloramphenicol)))) (, (,)) (drug_ENTITY (NP (NN (cisplatin))))) (, (,)) (NP (NE-Type-2-drug (NP (NN (dapsone)))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (JJ (antiretroviral)) (NN (nucleoside)) (NNS (analogues)))) (, (,)) (drug_ENTITY (NP (NN (chloramphenicol)))) (, (,)) (drug_ENTITY (NP (NN (cisplatin))))) (, (,)) (NP (drug_ENTITY (NP (NN (dapsone)))) (, (,)) (NE-Type-2-drug (NP (NN (disulfiram)))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (JJ (antiretroviral)) (NN (nucleoside)) (NNS (analogues)))) (, (,)) (drug_ENTITY (NP (NN (chloramphenicol)))) (, (,)) (drug_ENTITY (NP (NN (cisplatin))))) (, (,)) (NP (drug_ENTITY (NP (NN (dapsone)))) (, (,)) (drug_ENTITY (NP (NN (disulfiram)))) (, (,)) (NE-Type-2-drug (NP (NN (ethionamide)))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (JJ (antiretroviral)) (NN (nucleoside)) (NNS (analogues)))) (, (,)) (drug_ENTITY (NP (NN (chloramphenicol)))) (, (,)) (drug_ENTITY (NP (NN (cisplatin))))) (, (,)) (NP (drug_ENTITY (NP (NN (dapsone)))) (, (,)) (drug_ENTITY (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (NE-Type-2-drug (NP (NN (glutethimide)))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (JJ (antiretroviral)) (NN (nucleoside)) (NNS (analogues)))) (, (,)) (drug_ENTITY (NP (NN (chloramphenicol)))) (, (,)) (drug_ENTITY (NP (NN (cisplatin))))) (, (,)) (NP (drug_ENTITY (NP (NN (dapsone)))) (, (,)) (drug_ENTITY (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (NE-Type-2-drug (NP (NN (gold)))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (JJ (antiretroviral)) (NN (nucleoside)) (NNS (analogues)))) (, (,)) (drug_ENTITY (NP (NN (chloramphenicol)))) (, (,)) (drug_ENTITY (NP (NN (cisplatin))))) (, (,)) (NP (drug_ENTITY (NP (NN (dapsone)))) (, (,)) (drug_ENTITY (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (NE-Type-2-drug (NP (NN (hydralazine)))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (JJ (antiretroviral)) (NN (nucleoside)) (NNS (analogues)))) (, (,)) (drug_ENTITY (NP (NN (chloramphenicol)))) (, (,)) (drug_ENTITY (NP (NN (cisplatin))))) (, (,)) (NP (drug_ENTITY (NP (NN (dapsone)))) (, (,)) (drug_ENTITY (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (NE-Type-2-drug (NP (NN (iodoquinol)))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (JJ (antiretroviral)) (NN (nucleoside)) (NNS (analogues)))) (, (,)) (drug_ENTITY (NP (NN (chloramphenicol)))) (, (,)) (drug_ENTITY (NP (NN (cisplatin))))) (, (,)) (NP (drug_ENTITY (NP (NN (dapsone)))) (, (,)) (drug_ENTITY (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (NE-Type-2-drug (NP (NN (isoniazid)))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (JJ (antiretroviral)) (NN (nucleoside)) (NNS (analogues)))) (, (,)) (drug_ENTITY (NP (NN (chloramphenicol)))) (, (,)) (drug_ENTITY (NP (NN (cisplatin))))) (, (,)) (NP (drug_ENTITY (NP (NN (dapsone)))) (, (,)) (drug_ENTITY (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (drug_ENTITY (NP (NN (isoniazid)))) (, (,)) (NE-Type-2-drug (NP (NN (metronidazole)))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (JJ (antiretroviral)) (NN (nucleoside)) (NNS (analogues)))) (, (,)) (drug_ENTITY (NP (NN (chloramphenicol)))) (, (,)) (drug_ENTITY (NP (NN (cisplatin))))) (, (,)) (NP (drug_ENTITY (NP (NN (dapsone)))) (, (,)) (drug_ENTITY (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (drug_ENTITY (NP (NN (isoniazid)))) (, (,)) (drug_ENTITY (NP (NN (metronidazole)))) (, (,)) (NE-Type-2-drug (NP (NN (nitrofurantoin)))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (JJ (antiretroviral)) (NN (nucleoside)) (NNS (analogues)))) (, (,)) (drug_ENTITY (NP (NN (chloramphenicol)))) (, (,)) (drug_ENTITY (NP (NN (cisplatin))))) (, (,)) (NP (drug_ENTITY (NP (NN (dapsone)))) (, (,)) (drug_ENTITY (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (drug_ENTITY (NP (NN (isoniazid)))) (, (,)) (drug_ENTITY (NP (NN (metronidazole)))) (, (,)) (drug_ENTITY (NP (NN (nitrofurantoin)))) (, (,)) (NE-Type-2-drug (NP (NN (phenytoin)))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (JJ (antiretroviral)) (NN (nucleoside)) (NNS (analogues)))) (, (,)) (drug_ENTITY (NP (NN (chloramphenicol)))) (, (,)) (drug_ENTITY (NP (NN (cisplatin))))) (, (,)) (NP (drug_ENTITY (NP (NN (dapsone)))) (, (,)) (drug_ENTITY (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (drug_ENTITY (NP (NN (isoniazid)))) (, (,)) (drug_ENTITY (NP (NN (metronidazole)))) (, (,)) (drug_ENTITY (NP (NN (nitrofurantoin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (NE-Type-2-drug (NP (NN (ribavirin)))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (JJ (antiretroviral)) (NN (nucleoside)) (NNS (analogues)))) (, (,)) (drug_ENTITY (NP (NN (chloramphenicol)))) (, (,)) (drug_ENTITY (NP (NN (cisplatin))))) (, (,)) (NP (drug_ENTITY (NP (NN (dapsone)))) (, (,)) (drug_ENTITY (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (drug_ENTITY (NP (NN (isoniazid)))) (, (,)) (drug_ENTITY (NP (NN (metronidazole)))) (, (,)) (drug_ENTITY (NP (NN (nitrofurantoin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (drug_ENTITY (NP (NN (ribavirin)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NN (vincristine)))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (chloramphenicol)))) (, (,)) (NE-Type-2-drug (NP (NN (cisplatin))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (chloramphenicol)))) (, (,)) (drug_ENTITY (NP (NN (cisplatin))))) (, (,)) (NP (NE-Type-2-drug (NP (NN (dapsone)))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (chloramphenicol)))) (, (,)) (drug_ENTITY (NP (NN (cisplatin))))) (, (,)) (NP (drug_ENTITY (NP (NN (dapsone)))) (, (,)) (NE-Type-2-drug (NP (NN (disulfiram)))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (chloramphenicol)))) (, (,)) (drug_ENTITY (NP (NN (cisplatin))))) (, (,)) (NP (drug_ENTITY (NP (NN (dapsone)))) (, (,)) (drug_ENTITY (NP (NN (disulfiram)))) (, (,)) (NE-Type-2-drug (NP (NN (ethionamide)))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (chloramphenicol)))) (, (,)) (drug_ENTITY (NP (NN (cisplatin))))) (, (,)) (NP (drug_ENTITY (NP (NN (dapsone)))) (, (,)) (drug_ENTITY (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (NE-Type-2-drug (NP (NN (glutethimide)))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (chloramphenicol)))) (, (,)) (drug_ENTITY (NP (NN (cisplatin))))) (, (,)) (NP (drug_ENTITY (NP (NN (dapsone)))) (, (,)) (drug_ENTITY (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (NE-Type-2-drug (NP (NN (gold)))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (chloramphenicol)))) (, (,)) (drug_ENTITY (NP (NN (cisplatin))))) (, (,)) (NP (drug_ENTITY (NP (NN (dapsone)))) (, (,)) (drug_ENTITY (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (NE-Type-2-drug (NP (NN (hydralazine)))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (chloramphenicol)))) (, (,)) (drug_ENTITY (NP (NN (cisplatin))))) (, (,)) (NP (drug_ENTITY (NP (NN (dapsone)))) (, (,)) (drug_ENTITY (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (NE-Type-2-drug (NP (NN (iodoquinol)))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (chloramphenicol)))) (, (,)) (drug_ENTITY (NP (NN (cisplatin))))) (, (,)) (NP (drug_ENTITY (NP (NN (dapsone)))) (, (,)) (drug_ENTITY (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (NE-Type-2-drug (NP (NN (isoniazid)))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (chloramphenicol)))) (, (,)) (drug_ENTITY (NP (NN (cisplatin))))) (, (,)) (NP (drug_ENTITY (NP (NN (dapsone)))) (, (,)) (drug_ENTITY (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (drug_ENTITY (NP (NN (isoniazid)))) (, (,)) (NE-Type-2-drug (NP (NN (metronidazole)))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (chloramphenicol)))) (, (,)) (drug_ENTITY (NP (NN (cisplatin))))) (, (,)) (NP (drug_ENTITY (NP (NN (dapsone)))) (, (,)) (drug_ENTITY (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (drug_ENTITY (NP (NN (isoniazid)))) (, (,)) (drug_ENTITY (NP (NN (metronidazole)))) (, (,)) (NE-Type-2-drug (NP (NN (nitrofurantoin)))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (chloramphenicol)))) (, (,)) (drug_ENTITY (NP (NN (cisplatin))))) (, (,)) (NP (drug_ENTITY (NP (NN (dapsone)))) (, (,)) (drug_ENTITY (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (drug_ENTITY (NP (NN (isoniazid)))) (, (,)) (drug_ENTITY (NP (NN (metronidazole)))) (, (,)) (drug_ENTITY (NP (NN (nitrofurantoin)))) (, (,)) (NE-Type-2-drug (NP (NN (phenytoin)))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (chloramphenicol)))) (, (,)) (drug_ENTITY (NP (NN (cisplatin))))) (, (,)) (NP (drug_ENTITY (NP (NN (dapsone)))) (, (,)) (drug_ENTITY (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (drug_ENTITY (NP (NN (isoniazid)))) (, (,)) (drug_ENTITY (NP (NN (metronidazole)))) (, (,)) (drug_ENTITY (NP (NN (nitrofurantoin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (NE-Type-2-drug (NP (NN (ribavirin)))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (chloramphenicol)))) (, (,)) (drug_ENTITY (NP (NN (cisplatin))))) (, (,)) (NP (drug_ENTITY (NP (NN (dapsone)))) (, (,)) (drug_ENTITY (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (drug_ENTITY (NP (NN (isoniazid)))) (, (,)) (drug_ENTITY (NP (NN (metronidazole)))) (, (,)) (drug_ENTITY (NP (NN (nitrofurantoin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (drug_ENTITY (NP (NN (ribavirin)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NN (vincristine)))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (cisplatin))))) (, (,)) (NP (NE-Type-2-drug (NP (NN (dapsone)))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (cisplatin))))) (, (,)) (NP (drug_ENTITY (NP (NN (dapsone)))) (, (,)) (NE-Type-2-drug (NP (NN (disulfiram)))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (cisplatin))))) (, (,)) (NP (drug_ENTITY (NP (NN (dapsone)))) (, (,)) (drug_ENTITY (NP (NN (disulfiram)))) (, (,)) (NE-Type-2-drug (NP (NN (ethionamide)))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (cisplatin))))) (, (,)) (NP (drug_ENTITY (NP (NN (dapsone)))) (, (,)) (drug_ENTITY (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (NE-Type-2-drug (NP (NN (glutethimide)))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (cisplatin))))) (, (,)) (NP (drug_ENTITY (NP (NN (dapsone)))) (, (,)) (drug_ENTITY (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (NE-Type-2-drug (NP (NN (gold)))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (cisplatin))))) (, (,)) (NP (drug_ENTITY (NP (NN (dapsone)))) (, (,)) (drug_ENTITY (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (NE-Type-2-drug (NP (NN (hydralazine)))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (cisplatin))))) (, (,)) (NP (drug_ENTITY (NP (NN (dapsone)))) (, (,)) (drug_ENTITY (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (NE-Type-2-drug (NP (NN (iodoquinol)))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (cisplatin))))) (, (,)) (NP (drug_ENTITY (NP (NN (dapsone)))) (, (,)) (drug_ENTITY (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (NE-Type-2-drug (NP (NN (isoniazid)))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (cisplatin))))) (, (,)) (NP (drug_ENTITY (NP (NN (dapsone)))) (, (,)) (drug_ENTITY (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (drug_ENTITY (NP (NN (isoniazid)))) (, (,)) (NE-Type-2-drug (NP (NN (metronidazole)))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (cisplatin))))) (, (,)) (NP (drug_ENTITY (NP (NN (dapsone)))) (, (,)) (drug_ENTITY (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (drug_ENTITY (NP (NN (isoniazid)))) (, (,)) (drug_ENTITY (NP (NN (metronidazole)))) (, (,)) (NE-Type-2-drug (NP (NN (nitrofurantoin)))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (cisplatin))))) (, (,)) (NP (drug_ENTITY (NP (NN (dapsone)))) (, (,)) (drug_ENTITY (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (drug_ENTITY (NP (NN (isoniazid)))) (, (,)) (drug_ENTITY (NP (NN (metronidazole)))) (, (,)) (drug_ENTITY (NP (NN (nitrofurantoin)))) (, (,)) (NE-Type-2-drug (NP (NN (phenytoin)))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (cisplatin))))) (, (,)) (NP (drug_ENTITY (NP (NN (dapsone)))) (, (,)) (drug_ENTITY (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (drug_ENTITY (NP (NN (isoniazid)))) (, (,)) (drug_ENTITY (NP (NN (metronidazole)))) (, (,)) (drug_ENTITY (NP (NN (nitrofurantoin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (NE-Type-2-drug (NP (NN (ribavirin)))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (cisplatin))))) (, (,)) (NP (drug_ENTITY (NP (NN (dapsone)))) (, (,)) (drug_ENTITY (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (drug_ENTITY (NP (NN (isoniazid)))) (, (,)) (drug_ENTITY (NP (NN (metronidazole)))) (, (,)) (drug_ENTITY (NP (NN (nitrofurantoin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (drug_ENTITY (NP (NN (ribavirin)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NN (vincristine)))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (dapsone)))) (, (,)) (NE-Type-2-drug (NP (NN (disulfiram))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (dapsone)))) (, (,)) (drug_ENTITY (NP (NN (disulfiram)))) (, (,)) (NE-Type-2-drug (NP (NN (ethionamide))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (dapsone)))) (, (,)) (drug_ENTITY (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (NE-Type-2-drug (NP (NN (glutethimide))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (dapsone)))) (, (,)) (drug_ENTITY (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (NE-Type-2-drug (NP (NN (gold))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (dapsone)))) (, (,)) (drug_ENTITY (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (NE-Type-2-drug (NP (NN (hydralazine))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (dapsone)))) (, (,)) (drug_ENTITY (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (NE-Type-2-drug (NP (NN (iodoquinol))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (dapsone)))) (, (,)) (drug_ENTITY (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (NE-Type-2-drug (NP (NN (isoniazid))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (dapsone)))) (, (,)) (drug_ENTITY (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (drug_ENTITY (NP (NN (isoniazid)))) (, (,)) (NE-Type-2-drug (NP (NN (metronidazole))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (dapsone)))) (, (,)) (drug_ENTITY (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (drug_ENTITY (NP (NN (isoniazid)))) (, (,)) (drug_ENTITY (NP (NN (metronidazole)))) (, (,)) (NE-Type-2-drug (NP (NN (nitrofurantoin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (dapsone)))) (, (,)) (drug_ENTITY (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (drug_ENTITY (NP (NN (isoniazid)))) (, (,)) (drug_ENTITY (NP (NN (metronidazole)))) (, (,)) (drug_ENTITY (NP (NN (nitrofurantoin)))) (, (,)) (NE-Type-2-drug (NP (NN (phenytoin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (dapsone)))) (, (,)) (drug_ENTITY (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (drug_ENTITY (NP (NN (isoniazid)))) (, (,)) (drug_ENTITY (NP (NN (metronidazole)))) (, (,)) (drug_ENTITY (NP (NN (nitrofurantoin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (NE-Type-2-drug (NP (NN (ribavirin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (dapsone)))) (, (,)) (drug_ENTITY (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (drug_ENTITY (NP (NN (isoniazid)))) (, (,)) (drug_ENTITY (NP (NN (metronidazole)))) (, (,)) (drug_ENTITY (NP (NN (nitrofurantoin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (drug_ENTITY (NP (NN (ribavirin)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NN (vincristine))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (disulfiram)))) (, (,)) (NE-Type-2-drug (NP (NN (ethionamide))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (NE-Type-2-drug (NP (NN (glutethimide))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (NE-Type-2-drug (NP (NN (gold))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (NE-Type-2-drug (NP (NN (hydralazine))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (NE-Type-2-drug (NP (NN (iodoquinol))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (NE-Type-2-drug (NP (NN (isoniazid))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (drug_ENTITY (NP (NN (isoniazid)))) (, (,)) (NE-Type-2-drug (NP (NN (metronidazole))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (drug_ENTITY (NP (NN (isoniazid)))) (, (,)) (drug_ENTITY (NP (NN (metronidazole)))) (, (,)) (NE-Type-2-drug (NP (NN (nitrofurantoin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (drug_ENTITY (NP (NN (isoniazid)))) (, (,)) (drug_ENTITY (NP (NN (metronidazole)))) (, (,)) (drug_ENTITY (NP (NN (nitrofurantoin)))) (, (,)) (NE-Type-2-drug (NP (NN (phenytoin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (drug_ENTITY (NP (NN (isoniazid)))) (, (,)) (drug_ENTITY (NP (NN (metronidazole)))) (, (,)) (drug_ENTITY (NP (NN (nitrofurantoin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (NE-Type-2-drug (NP (NN (ribavirin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (disulfiram)))) (, (,)) (drug_ENTITY (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (drug_ENTITY (NP (NN (isoniazid)))) (, (,)) (drug_ENTITY (NP (NN (metronidazole)))) (, (,)) (drug_ENTITY (NP (NN (nitrofurantoin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (drug_ENTITY (NP (NN (ribavirin)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NN (vincristine))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (ethionamide)))) (, (,)) (NE-Type-2-drug (NP (NN (glutethimide))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (NE-Type-2-drug (NP (NN (gold))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (NE-Type-2-drug (NP (NN (hydralazine))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (NE-Type-2-drug (NP (NN (iodoquinol))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (NE-Type-2-drug (NP (NN (isoniazid))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (drug_ENTITY (NP (NN (isoniazid)))) (, (,)) (NE-Type-2-drug (NP (NN (metronidazole))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (drug_ENTITY (NP (NN (isoniazid)))) (, (,)) (drug_ENTITY (NP (NN (metronidazole)))) (, (,)) (NE-Type-2-drug (NP (NN (nitrofurantoin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (drug_ENTITY (NP (NN (isoniazid)))) (, (,)) (drug_ENTITY (NP (NN (metronidazole)))) (, (,)) (drug_ENTITY (NP (NN (nitrofurantoin)))) (, (,)) (NE-Type-2-drug (NP (NN (phenytoin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (drug_ENTITY (NP (NN (isoniazid)))) (, (,)) (drug_ENTITY (NP (NN (metronidazole)))) (, (,)) (drug_ENTITY (NP (NN (nitrofurantoin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (NE-Type-2-drug (NP (NN (ribavirin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (ethionamide)))) (, (,)) (drug_ENTITY (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (drug_ENTITY (NP (NN (isoniazid)))) (, (,)) (drug_ENTITY (NP (NN (metronidazole)))) (, (,)) (drug_ENTITY (NP (NN (nitrofurantoin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (drug_ENTITY (NP (NN (ribavirin)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NN (vincristine))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (glutethimide)))) (, (,)) (NE-Type-2-drug (NP (NN (gold))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (NE-Type-2-drug (NP (NN (hydralazine))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (NE-Type-2-drug (NP (NN (iodoquinol))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (NE-Type-2-drug (NP (NN (isoniazid))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (drug_ENTITY (NP (NN (isoniazid)))) (, (,)) (NE-Type-2-drug (NP (NN (metronidazole))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (drug_ENTITY (NP (NN (isoniazid)))) (, (,)) (drug_ENTITY (NP (NN (metronidazole)))) (, (,)) (NE-Type-2-drug (NP (NN (nitrofurantoin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (drug_ENTITY (NP (NN (isoniazid)))) (, (,)) (drug_ENTITY (NP (NN (metronidazole)))) (, (,)) (drug_ENTITY (NP (NN (nitrofurantoin)))) (, (,)) (NE-Type-2-drug (NP (NN (phenytoin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (drug_ENTITY (NP (NN (isoniazid)))) (, (,)) (drug_ENTITY (NP (NN (metronidazole)))) (, (,)) (drug_ENTITY (NP (NN (nitrofurantoin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (NE-Type-2-drug (NP (NN (ribavirin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (glutethimide)))) (, (,)) (drug_ENTITY (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (drug_ENTITY (NP (NN (isoniazid)))) (, (,)) (drug_ENTITY (NP (NN (metronidazole)))) (, (,)) (drug_ENTITY (NP (NN (nitrofurantoin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (drug_ENTITY (NP (NN (ribavirin)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NN (vincristine))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (gold)))) (, (,)) (NE-Type-2-drug (NP (NN (hydralazine))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (NE-Type-2-drug (NP (NN (iodoquinol))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (NE-Type-2-drug (NP (NN (isoniazid))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (drug_ENTITY (NP (NN (isoniazid)))) (, (,)) (NE-Type-2-drug (NP (NN (metronidazole))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (drug_ENTITY (NP (NN (isoniazid)))) (, (,)) (drug_ENTITY (NP (NN (metronidazole)))) (, (,)) (NE-Type-2-drug (NP (NN (nitrofurantoin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (drug_ENTITY (NP (NN (isoniazid)))) (, (,)) (drug_ENTITY (NP (NN (metronidazole)))) (, (,)) (drug_ENTITY (NP (NN (nitrofurantoin)))) (, (,)) (NE-Type-2-drug (NP (NN (phenytoin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (drug_ENTITY (NP (NN (isoniazid)))) (, (,)) (drug_ENTITY (NP (NN (metronidazole)))) (, (,)) (drug_ENTITY (NP (NN (nitrofurantoin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (NE-Type-2-drug (NP (NN (ribavirin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (gold)))) (, (,)) (drug_ENTITY (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (drug_ENTITY (NP (NN (isoniazid)))) (, (,)) (drug_ENTITY (NP (NN (metronidazole)))) (, (,)) (drug_ENTITY (NP (NN (nitrofurantoin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (drug_ENTITY (NP (NN (ribavirin)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NN (vincristine))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (hydralazine)))) (, (,)) (NE-Type-2-drug (NP (NN (iodoquinol))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (NE-Type-2-drug (NP (NN (isoniazid))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (drug_ENTITY (NP (NN (isoniazid)))) (, (,)) (NE-Type-2-drug (NP (NN (metronidazole))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (drug_ENTITY (NP (NN (isoniazid)))) (, (,)) (drug_ENTITY (NP (NN (metronidazole)))) (, (,)) (NE-Type-2-drug (NP (NN (nitrofurantoin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (drug_ENTITY (NP (NN (isoniazid)))) (, (,)) (drug_ENTITY (NP (NN (metronidazole)))) (, (,)) (drug_ENTITY (NP (NN (nitrofurantoin)))) (, (,)) (NE-Type-2-drug (NP (NN (phenytoin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (drug_ENTITY (NP (NN (isoniazid)))) (, (,)) (drug_ENTITY (NP (NN (metronidazole)))) (, (,)) (drug_ENTITY (NP (NN (nitrofurantoin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (NE-Type-2-drug (NP (NN (ribavirin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (hydralazine)))) (, (,)) (drug_ENTITY (NP (NN (iodoquinol)))) (, (,)) (drug_ENTITY (NP (NN (isoniazid)))) (, (,)) (drug_ENTITY (NP (NN (metronidazole)))) (, (,)) (drug_ENTITY (NP (NN (nitrofurantoin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (drug_ENTITY (NP (NN (ribavirin)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NN (vincristine))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (iodoquinol)))) (, (,)) (NE-Type-2-drug (NP (NN (isoniazid))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (iodoquinol)))) (, (,)) (drug_ENTITY (NP (NN (isoniazid)))) (, (,)) (NE-Type-2-drug (NP (NN (metronidazole))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (iodoquinol)))) (, (,)) (drug_ENTITY (NP (NN (isoniazid)))) (, (,)) (drug_ENTITY (NP (NN (metronidazole)))) (, (,)) (NE-Type-2-drug (NP (NN (nitrofurantoin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (iodoquinol)))) (, (,)) (drug_ENTITY (NP (NN (isoniazid)))) (, (,)) (drug_ENTITY (NP (NN (metronidazole)))) (, (,)) (drug_ENTITY (NP (NN (nitrofurantoin)))) (, (,)) (NE-Type-2-drug (NP (NN (phenytoin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (iodoquinol)))) (, (,)) (drug_ENTITY (NP (NN (isoniazid)))) (, (,)) (drug_ENTITY (NP (NN (metronidazole)))) (, (,)) (drug_ENTITY (NP (NN (nitrofurantoin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (NE-Type-2-drug (NP (NN (ribavirin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (iodoquinol)))) (, (,)) (drug_ENTITY (NP (NN (isoniazid)))) (, (,)) (drug_ENTITY (NP (NN (metronidazole)))) (, (,)) (drug_ENTITY (NP (NN (nitrofurantoin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (drug_ENTITY (NP (NN (ribavirin)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NN (vincristine))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (isoniazid)))) (, (,)) (NE-Type-2-drug (NP (NN (metronidazole))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (isoniazid)))) (, (,)) (drug_ENTITY (NP (NN (metronidazole)))) (, (,)) (NE-Type-2-drug (NP (NN (nitrofurantoin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (isoniazid)))) (, (,)) (drug_ENTITY (NP (NN (metronidazole)))) (, (,)) (drug_ENTITY (NP (NN (nitrofurantoin)))) (, (,)) (NE-Type-2-drug (NP (NN (phenytoin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (isoniazid)))) (, (,)) (drug_ENTITY (NP (NN (metronidazole)))) (, (,)) (drug_ENTITY (NP (NN (nitrofurantoin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (NE-Type-2-drug (NP (NN (ribavirin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (isoniazid)))) (, (,)) (drug_ENTITY (NP (NN (metronidazole)))) (, (,)) (drug_ENTITY (NP (NN (nitrofurantoin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (drug_ENTITY (NP (NN (ribavirin)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NN (vincristine))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (metronidazole)))) (, (,)) (NE-Type-2-drug (NP (NN (nitrofurantoin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (metronidazole)))) (, (,)) (drug_ENTITY (NP (NN (nitrofurantoin)))) (, (,)) (NE-Type-2-drug (NP (NN (phenytoin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (metronidazole)))) (, (,)) (drug_ENTITY (NP (NN (nitrofurantoin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (NE-Type-2-drug (NP (NN (ribavirin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (metronidazole)))) (, (,)) (drug_ENTITY (NP (NN (nitrofurantoin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (drug_ENTITY (NP (NN (ribavirin)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NN (vincristine))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (nitrofurantoin)))) (, (,)) (NE-Type-2-drug (NP (NN (phenytoin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (nitrofurantoin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (NE-Type-2-drug (NP (NN (ribavirin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (nitrofurantoin)))) (, (,)) (drug_ENTITY (NP (NN (phenytoin)))) (, (,)) (drug_ENTITY (NP (NN (ribavirin)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NN (vincristine))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (phenytoin)))) (, (,)) (NE-Type-2-drug (NP (NN (ribavirin))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (phenytoin)))) (, (,)) (drug_ENTITY (NP (NN (ribavirin)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NN (vincristine))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (ribavirin)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NN (vincristine))))) |ET|
1  |BT|  (NP (PP (NE-Type-1-drug (NP (NN (HIVID))))) (PP (IN (with)) (NE-Type-2-drug (NP (NN (didanosine)))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Pentamidin)) (NN (e)))) (: (:)) (S (NP (NP (NN (Treatment))) (PP (IN (with)) (NE-Type-2-drug (NP (NN (HIVID)))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Pentamidin)) (NN (e)))) (: (:)) (S (NP (NP (NN (Treatment))) (PP (IN (with)) (drug_ENTITY (NP (NN (HIVID)))))) (VP (MD (should)) (VP (VB (be)) (VP (VBN (interrupted)))) (SBAR (WHADVP (WRB (when))) (S (NP (NP (DT (the)) (NN (use))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (DT (a)) (NN (drug)))))))))))) |ET|
1  |BT|  (S (NP (PP (NE-Type-1-drug (NP (NN (HIVID)))))) (VP (MD (should)) (VP (VB (be)) (VP (VBN (interrupted)))) (SBAR (WHADVP (WRB (when))) (S (NP (NP (DT (the)) (NN (use))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (DT (a)) (NN (drug))))))))))) |ET|
1  |BT|  (NP (NE-Type-1-drug (NP (NN (pentamidin)) (NN (e)))) (CC (and)) (NE-Type-2-drug (NP (NN (HIVID))))) |ET|
1  |BT|  (S (SBAR (S (NE-Type-1-drug (NP (NN (pentamidin)) (NN (e)))) (VP (VBZ (is)) (VP (VBN (required)) (S (VP (TO (to)) (VP (VB (treat)) (DISO_ENTITY (NP (NN (Pneumocystis)) (NN (carinii)) (NNS (pneumonia))))))))))) (, (,)) (NP (NP (NN (treatment))) (PP (IN (with)) (NE-Type-2-drug (NP (NN (HIVID))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Amphotericin)))) (, (,)) (NE-Type-2-drug (NP (NN (Foscarnet))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Amphotericin)))) (, (,)) (drug_ENTITY (NP (NN (Foscarnet)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NN (Aminoglycosides))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (Amphotericin)))) (, (,)) (drug_ENTITY (NP (NN (Foscarnet)))) (, (,)) (CC (and)) (drug_ENTITY (NP (NN (Aminoglycosides))))) (: (:)) (S (NP (NE-Type-2-drug (NP (NNS (Drugs))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (Amphotericin)))) (, (,)) (drug_ENTITY (NP (NN (Foscarnet)))) (, (,)) (CC (and)) (drug_ENTITY (NP (NN (Aminoglycosides))))) (: (:)) (S (NP (drug_ENTITY (NP (NNS (Drugs)))) (PP (JJ (such)) (IN (as)) (NP (NE-Type-2-drug (NP (NN (amphotericin))))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (Amphotericin)))) (, (,)) (drug_ENTITY (NP (NN (Foscarnet)))) (, (,)) (CC (and)) (drug_ENTITY (NP (NN (Aminoglycosides))))) (: (:)) (S (NP (drug_ENTITY (NP (NNS (Drugs)))) (PP (JJ (such)) (IN (as)) (NP (drug_ENTITY (NP (NN (amphotericin)))) (, (,)) (NE-Type-2-drug (NP (NN (foscarnet))))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (Amphotericin)))) (, (,)) (drug_ENTITY (NP (NN (Foscarnet)))) (, (,)) (CC (and)) (drug_ENTITY (NP (NN (Aminoglycosides))))) (: (:)) (S (NP (drug_ENTITY (NP (NNS (Drugs)))) (PP (JJ (such)) (IN (as)) (NP (drug_ENTITY (NP (NN (amphotericin)))) (, (,)) (drug_ENTITY (NP (NN (foscarnet)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NNS (aminoglycosides))))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (Amphotericin)))) (, (,)) (drug_ENTITY (NP (NN (Foscarnet)))) (, (,)) (CC (and)) (drug_ENTITY (NP (NN (Aminoglycosides))))) (: (:)) (S (NP (drug_ENTITY (NP (NNS (Drugs)))) (PP (JJ (such)) (IN (as)) (NP (drug_ENTITY (NP (NN (amphotericin)))) (, (,)) (drug_ENTITY (NP (NN (foscarnet)))) (, (,)) (CC (and)) (drug_ENTITY (NP (NNS (aminoglycosides))))))) (VP (VP (MD (may)) (VP (VB (increase)) (NP (NP (DT (the)) (NN (risk))) (PP (IN (of)) (NP (VBG (developing)) (ADJP (NP (DISO_ENTITY (NP (JJ (peripheral)) (NN (neuropathy)))) (CC (or)) (NE-Type-2-drug (NP (JJ (other)) (NN (HIVID)))))))))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (Amphotericin)))) (, (,)) (drug_ENTITY (NP (NN (Foscarnet)))) (, (,)) (CC (and)) (drug_ENTITY (NP (NN (Aminoglycosides))))) (: (:)) (S (NP (drug_ENTITY (NP (NNS (Drugs)))) (PP (JJ (such)) (IN (as)) (NP (drug_ENTITY (NP (NN (amphotericin)))) (, (,)) (drug_ENTITY (NP (NN (foscarnet)))) (, (,)) (CC (and)) (drug_ENTITY (NP (NNS (aminoglycosides))))))) (VP (VP (MD (may)) (VP (VB (increase)) (NP (NP (DT (the)) (NN (risk))) (PP (IN (of)) (NP (VBG (developing)) (ADJP (NP (DISO_ENTITY (NP (JJ (peripheral)) (NN (neuropathy)))) (CC (or)) (drug_ENTITY (NP (JJ (other)) (NN (HIVID))))) (JJ (-associated))) (JJ (adverse)) (NNS (events))))) (PP (IN (by)) (S (VP (VBG (interfering)) (PP (IN (with)) (NP (NP (DT (the)) (JJ (renal)) (NN (clearance))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (zalcitabine))))))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Foscarnet)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NN (Aminoglycosides))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (Foscarnet)))) (, (,)) (CC (and)) (drug_ENTITY (NP (NN (Aminoglycosides))))) (: (:)) (S (NP (NE-Type-2-drug (NP (NNS (Drugs))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (Foscarnet)))) (, (,)) (CC (and)) (drug_ENTITY (NP (NN (Aminoglycosides))))) (: (:)) (S (NP (drug_ENTITY (NP (NNS (Drugs)))) (PP (JJ (such)) (IN (as)) (NP (NE-Type-2-drug (NP (NN (amphotericin))))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (Foscarnet)))) (, (,)) (CC (and)) (drug_ENTITY (NP (NN (Aminoglycosides))))) (: (:)) (S (NP (drug_ENTITY (NP (NNS (Drugs)))) (PP (JJ (such)) (IN (as)) (NP (drug_ENTITY (NP (NN (amphotericin)))) (, (,)) (NE-Type-2-drug (NP (NN (foscarnet))))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (Foscarnet)))) (, (,)) (CC (and)) (drug_ENTITY (NP (NN (Aminoglycosides))))) (: (:)) (S (NP (drug_ENTITY (NP (NNS (Drugs)))) (PP (JJ (such)) (IN (as)) (NP (drug_ENTITY (NP (NN (amphotericin)))) (, (,)) (drug_ENTITY (NP (NN (foscarnet)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NNS (aminoglycosides))))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (Foscarnet)))) (, (,)) (CC (and)) (drug_ENTITY (NP (NN (Aminoglycosides))))) (: (:)) (S (NP (drug_ENTITY (NP (NNS (Drugs)))) (PP (JJ (such)) (IN (as)) (NP (drug_ENTITY (NP (NN (amphotericin)))) (, (,)) (drug_ENTITY (NP (NN (foscarnet)))) (, (,)) (CC (and)) (drug_ENTITY (NP (NNS (aminoglycosides))))))) (VP (VP (MD (may)) (VP (VB (increase)) (NP (NP (DT (the)) (NN (risk))) (PP (IN (of)) (NP (VBG (developing)) (ADJP (NP (DISO_ENTITY (NP (JJ (peripheral)) (NN (neuropathy)))) (CC (or)) (NE-Type-2-drug (NP (JJ (other)) (NN (HIVID)))))))))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (Foscarnet)))) (, (,)) (CC (and)) (drug_ENTITY (NP (NN (Aminoglycosides))))) (: (:)) (S (NP (drug_ENTITY (NP (NNS (Drugs)))) (PP (JJ (such)) (IN (as)) (NP (drug_ENTITY (NP (NN (amphotericin)))) (, (,)) (drug_ENTITY (NP (NN (foscarnet)))) (, (,)) (CC (and)) (drug_ENTITY (NP (NNS (aminoglycosides))))))) (VP (VP (MD (may)) (VP (VB (increase)) (NP (NP (DT (the)) (NN (risk))) (PP (IN (of)) (NP (VBG (developing)) (ADJP (NP (DISO_ENTITY (NP (JJ (peripheral)) (NN (neuropathy)))) (CC (or)) (drug_ENTITY (NP (JJ (other)) (NN (HIVID))))) (JJ (-associated))) (JJ (adverse)) (NNS (events))))) (PP (IN (by)) (S (VP (VBG (interfering)) (PP (IN (with)) (NP (NP (DT (the)) (JJ (renal)) (NN (clearance))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (zalcitabine))))))))))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (Aminoglycosides))))) (: (:)) (S (NP (NE-Type-2-drug (NP (NNS (Drugs))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (Aminoglycosides))))) (: (:)) (S (NP (drug_ENTITY (NP (NNS (Drugs)))) (PP (JJ (such)) (IN (as)) (NP (NE-Type-2-drug (NP (NN (amphotericin))))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (Aminoglycosides))))) (: (:)) (S (NP (drug_ENTITY (NP (NNS (Drugs)))) (PP (JJ (such)) (IN (as)) (NP (drug_ENTITY (NP (NN (amphotericin)))) (, (,)) (NE-Type-2-drug (NP (NN (foscarnet))))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (Aminoglycosides))))) (: (:)) (S (NP (drug_ENTITY (NP (NNS (Drugs)))) (PP (JJ (such)) (IN (as)) (NP (drug_ENTITY (NP (NN (amphotericin)))) (, (,)) (drug_ENTITY (NP (NN (foscarnet)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NNS (aminoglycosides))))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (Aminoglycosides))))) (: (:)) (S (NP (drug_ENTITY (NP (NNS (Drugs)))) (PP (JJ (such)) (IN (as)) (NP (drug_ENTITY (NP (NN (amphotericin)))) (, (,)) (drug_ENTITY (NP (NN (foscarnet)))) (, (,)) (CC (and)) (drug_ENTITY (NP (NNS (aminoglycosides))))))) (VP (VP (MD (may)) (VP (VB (increase)) (NP (NP (DT (the)) (NN (risk))) (PP (IN (of)) (NP (VBG (developing)) (ADJP (NP (DISO_ENTITY (NP (JJ (peripheral)) (NN (neuropathy)))) (CC (or)) (NE-Type-2-drug (NP (JJ (other)) (NN (HIVID)))))))))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (Aminoglycosides))))) (: (:)) (S (NP (drug_ENTITY (NP (NNS (Drugs)))) (PP (JJ (such)) (IN (as)) (NP (drug_ENTITY (NP (NN (amphotericin)))) (, (,)) (drug_ENTITY (NP (NN (foscarnet)))) (, (,)) (CC (and)) (drug_ENTITY (NP (NNS (aminoglycosides))))))) (VP (VP (MD (may)) (VP (VB (increase)) (NP (NP (DT (the)) (NN (risk))) (PP (IN (of)) (NP (VBG (developing)) (ADJP (NP (DISO_ENTITY (NP (JJ (peripheral)) (NN (neuropathy)))) (CC (or)) (drug_ENTITY (NP (JJ (other)) (NN (HIVID))))) (JJ (-associated))) (JJ (adverse)) (NNS (events))))) (PP (IN (by)) (S (VP (VBG (interfering)) (PP (IN (with)) (NP (NP (DT (the)) (JJ (renal)) (NN (clearance))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (zalcitabine))))))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (Drugs)))) (PP (JJ (such)) (IN (as)) (NP (NE-Type-2-drug (NP (NN (amphotericin))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (Drugs)))) (PP (JJ (such)) (IN (as)) (NP (drug_ENTITY (NP (NN (amphotericin)))) (, (,)) (NE-Type-2-drug (NP (NN (foscarnet))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NNS (Drugs)))) (PP (JJ (such)) (IN (as)) (NP (drug_ENTITY (NP (NN (amphotericin)))) (, (,)) (drug_ENTITY (NP (NN (foscarnet)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NNS (aminoglycosides))))))) |ET|
-1  |BT|  (S (NP (NE-Type-1-drug (NP (NNS (Drugs)))) (PP (JJ (such)) (IN (as)) (NP (drug_ENTITY (NP (NN (amphotericin)))) (, (,)) (drug_ENTITY (NP (NN (foscarnet)))) (, (,)) (CC (and)) (drug_ENTITY (NP (NNS (aminoglycosides))))))) (VP (VP (MD (may)) (VP (VB (increase)) (NP (NP (DT (the)) (NN (risk))) (PP (IN (of)) (NP (VBG (developing)) (ADJP (NP (DISO_ENTITY (NP (JJ (peripheral)) (NN (neuropathy)))) (CC (or)) (NE-Type-2-drug (NP (JJ (other)) (NN (HIVID))))))))))))) |ET|
1  |BT|  (S (NP (NE-Type-1-drug (NP (NNS (Drugs)))) (PP (JJ (such)) (IN (as)) (NP (drug_ENTITY (NP (NN (amphotericin)))) (, (,)) (drug_ENTITY (NP (NN (foscarnet)))) (, (,)) (CC (and)) (drug_ENTITY (NP (NNS (aminoglycosides))))))) (VP (VP (MD (may)) (VP (VB (increase)) (NP (NP (DT (the)) (NN (risk))) (PP (IN (of)) (NP (VBG (developing)) (ADJP (NP (DISO_ENTITY (NP (JJ (peripheral)) (NN (neuropathy)))) (CC (or)) (drug_ENTITY (NP (JJ (other)) (NN (HIVID))))) (JJ (-associated))) (JJ (adverse)) (NNS (events))))) (PP (IN (by)) (S (VP (VBG (interfering)) (PP (IN (with)) (NP (NP (DT (the)) (JJ (renal)) (NN (clearance))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (zalcitabine)))))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (amphotericin)))) (, (,)) (NE-Type-2-drug (NP (NN (foscarnet))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (amphotericin)))) (, (,)) (drug_ENTITY (NP (NN (foscarnet)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NNS (aminoglycosides))))) |ET|
-1  |BT|  (S (NP (PP (NP (NE-Type-1-drug (NP (NN (amphotericin)))) (, (,)) (drug_ENTITY (NP (NN (foscarnet)))) (, (,)) (CC (and)) (drug_ENTITY (NP (NNS (aminoglycosides))))))) (VP (VP (MD (may)) (VP (VB (increase)) (NP (NP (DT (the)) (NN (risk))) (PP (IN (of)) (NP (VBG (developing)) (ADJP (NP (DISO_ENTITY (NP (JJ (peripheral)) (NN (neuropathy)))) (CC (or)) (NE-Type-2-drug (NP (JJ (other)) (NN (HIVID))))))))))))) |ET|
1  |BT|  (S (NP (PP (NP (NE-Type-1-drug (NP (NN (amphotericin)))) (, (,)) (drug_ENTITY (NP (NN (foscarnet)))) (, (,)) (CC (and)) (drug_ENTITY (NP (NNS (aminoglycosides))))))) (VP (VP (MD (may)) (VP (VB (increase)) (NP (NP (DT (the)) (NN (risk))) (PP (IN (of)) (NP (VBG (developing)) (ADJP (NP (DISO_ENTITY (NP (JJ (peripheral)) (NN (neuropathy)))) (CC (or)) (drug_ENTITY (NP (JJ (other)) (NN (HIVID))))) (JJ (-associated))) (JJ (adverse)) (NNS (events))))) (PP (IN (by)) (S (VP (VBG (interfering)) (PP (IN (with)) (NP (NP (DT (the)) (JJ (renal)) (NN (clearance))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (zalcitabine)))))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (foscarnet)))) (, (,)) (CC (and)) (NE-Type-2-drug (NP (NNS (aminoglycosides))))) |ET|
-1  |BT|  (S (NP (PP (NP (NE-Type-1-drug (NP (NN (foscarnet)))) (, (,)) (CC (and)) (drug_ENTITY (NP (NNS (aminoglycosides))))))) (VP (VP (MD (may)) (VP (VB (increase)) (NP (NP (DT (the)) (NN (risk))) (PP (IN (of)) (NP (VBG (developing)) (ADJP (NP (DISO_ENTITY (NP (JJ (peripheral)) (NN (neuropathy)))) (CC (or)) (NE-Type-2-drug (NP (JJ (other)) (NN (HIVID))))))))))))) |ET|
1  |BT|  (S (NP (PP (NP (NE-Type-1-drug (NP (NN (foscarnet)))) (, (,)) (CC (and)) (drug_ENTITY (NP (NNS (aminoglycosides))))))) (VP (VP (MD (may)) (VP (VB (increase)) (NP (NP (DT (the)) (NN (risk))) (PP (IN (of)) (NP (VBG (developing)) (ADJP (NP (DISO_ENTITY (NP (JJ (peripheral)) (NN (neuropathy)))) (CC (or)) (drug_ENTITY (NP (JJ (other)) (NN (HIVID))))) (JJ (-associated))) (JJ (adverse)) (NNS (events))))) (PP (IN (by)) (S (VP (VBG (interfering)) (PP (IN (with)) (NP (NP (DT (the)) (JJ (renal)) (NN (clearance))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (zalcitabine)))))))))))))) |ET|
-1  |BT|  (S (NP (PP (NP (NE-Type-1-drug (NP (NNS (aminoglycosides))))))) (VP (VP (MD (may)) (VP (VB (increase)) (NP (NP (DT (the)) (NN (risk))) (PP (IN (of)) (NP (VBG (developing)) (ADJP (NP (DISO_ENTITY (NP (JJ (peripheral)) (NN (neuropathy)))) (CC (or)) (NE-Type-2-drug (NP (JJ (other)) (NN (HIVID))))))))))))) |ET|
1  |BT|  (S (NP (PP (NP (NE-Type-1-drug (NP (NNS (aminoglycosides))))))) (VP (VP (MD (may)) (VP (VB (increase)) (NP (NP (DT (the)) (NN (risk))) (PP (IN (of)) (NP (VBG (developing)) (ADJP (NP (DISO_ENTITY (NP (JJ (peripheral)) (NN (neuropathy)))) (CC (or)) (drug_ENTITY (NP (JJ (other)) (NN (HIVID))))) (JJ (-associated))) (JJ (adverse)) (NNS (events))))) (PP (IN (by)) (S (VP (VBG (interfering)) (PP (IN (with)) (NP (NP (DT (the)) (JJ (renal)) (NN (clearance))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (zalcitabine)))))))))))))) |ET|
1  |BT|  (VP (NP (PP (NP (ADJP (NP (NE-Type-1-drug (NP (NN (HIVID))))) (JJ (-associated))) (JJ (adverse)) (NNS (events))))) (PP (IN (by)) (S (VP (VBG (interfering)) (PP (IN (with)) (NP (NP (DT (the)) (JJ (renal)) (NN (clearance))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (zalcitabine))))))))))) |ET|
1  |BT|  (NP (PP (NP (PP (NE-Type-1-drug (NP (NNS (drugs))))))) (PP (IN (with)) (NE-Type-2-drug (NP (NN (HIVID)))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Probenecid)))) (CC (or)) (NE-Type-2-drug (NP (NN (Cimetidine))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (Probenecid)))) (CC (or)) (drug_ENTITY (NP (NN (Cimetidine))))) (: (:)) (S (NP (NP (JJ (Concomitant)) (NN (administration))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (NN (probenecid))))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (Probenecid)))) (CC (or)) (drug_ENTITY (NP (NN (Cimetidine))))) (: (:)) (S (NP (NP (JJ (Concomitant)) (NN (administration))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (probenecid)))) (CC (or)) (NE-Type-2-drug (NP (NN (cimetidine))))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (Probenecid)))) (CC (or)) (drug_ENTITY (NP (NN (Cimetidine))))) (: (:)) (S (NP (NP (JJ (Concomitant)) (NN (administration))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (probenecid)))) (CC (or)) (drug_ENTITY (NP (NN (cimetidine))))))) (VP (VBZ (decreases)) (NP (NP (DT (the)) (NN (elimination))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (zalcitabine))))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (Probenecid)))) (CC (or)) (drug_ENTITY (NP (NN (Cimetidine))))) (: (:)) (S (NP (NP (JJ (Concomitant)) (NN (administration))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (probenecid)))) (CC (or)) (drug_ENTITY (NP (NN (cimetidine))))))) (VP (VBZ (decreases)) (NP (NP (DT (the)) (NN (elimination))) (PP (IN (of)) (drug_ENTITY (NP (NN (zalcitabine)))))) (, (,)) (PP (ADVP (RBS (most)) (RB (likely))) (IN (by)) (NP (NP (NN (inhibition))) (PP (IN (of)) (NP (NP (JJ (renal)) (JJ (tubular)) (NN (secretion))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (zalcitabine)))))))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (Cimetidine))))) (: (:)) (S (NP (NP (JJ (Concomitant)) (NN (administration))) (PP (IN (of)) (NP (NE-Type-2-drug (NP (NN (probenecid))))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (Cimetidine))))) (: (:)) (S (NP (NP (JJ (Concomitant)) (NN (administration))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (probenecid)))) (CC (or)) (NE-Type-2-drug (NP (NN (cimetidine))))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (Cimetidine))))) (: (:)) (S (NP (NP (JJ (Concomitant)) (NN (administration))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (probenecid)))) (CC (or)) (drug_ENTITY (NP (NN (cimetidine))))))) (VP (VBZ (decreases)) (NP (NP (DT (the)) (NN (elimination))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (zalcitabine))))))))) |ET|
-1  |BT|  (NP (NP (NE-Type-1-drug (NP (NN (Cimetidine))))) (: (:)) (S (NP (NP (JJ (Concomitant)) (NN (administration))) (PP (IN (of)) (NP (drug_ENTITY (NP (NN (probenecid)))) (CC (or)) (drug_ENTITY (NP (NN (cimetidine))))))) (VP (VBZ (decreases)) (NP (NP (DT (the)) (NN (elimination))) (PP (IN (of)) (drug_ENTITY (NP (NN (zalcitabine)))))) (, (,)) (PP (ADVP (RBS (most)) (RB (likely))) (IN (by)) (NP (NP (NN (inhibition))) (PP (IN (of)) (NP (NP (JJ (renal)) (JJ (tubular)) (NN (secretion))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (zalcitabine)))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (probenecid)))) (CC (or)) (NE-Type-2-drug (NP (NN (cimetidine))))) |ET|
1  |BT|  (S (NP (PP (NP (NE-Type-1-drug (NP (NN (probenecid)))) (CC (or)) (drug_ENTITY (NP (NN (cimetidine))))))) (VP (VBZ (decreases)) (NP (NP (DT (the)) (NN (elimination))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (zalcitabine)))))))) |ET|
-1  |BT|  (S (NP (PP (NP (NE-Type-1-drug (NP (NN (probenecid)))) (CC (or)) (drug_ENTITY (NP (NN (cimetidine))))))) (VP (VBZ (decreases)) (NP (NP (DT (the)) (NN (elimination))) (PP (IN (of)) (drug_ENTITY (NP (NN (zalcitabine)))))) (, (,)) (PP (ADVP (RBS (most)) (RB (likely))) (IN (by)) (NP (NP (NN (inhibition))) (PP (IN (of)) (NP (NP (JJ (renal)) (JJ (tubular)) (NN (secretion))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (zalcitabine))))))))))) |ET|
1  |BT|  (S (NP (PP (NP (NE-Type-1-drug (NP (NN (cimetidine))))))) (VP (VBZ (decreases)) (NP (NP (DT (the)) (NN (elimination))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (zalcitabine)))))))) |ET|
-1  |BT|  (S (NP (PP (NP (NE-Type-1-drug (NP (NN (cimetidine))))))) (VP (VBZ (decreases)) (NP (NP (DT (the)) (NN (elimination))) (PP (IN (of)) (drug_ENTITY (NP (NN (zalcitabine)))))) (, (,)) (PP (ADVP (RBS (most)) (RB (likely))) (IN (by)) (NP (NP (NN (inhibition))) (PP (IN (of)) (NP (NP (JJ (renal)) (JJ (tubular)) (NN (secretion))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (zalcitabine))))))))))) |ET|
-1  |BT|  (VP (NP (PP (NE-Type-1-drug (NP (NN (zalcitabine)))))) (, (,)) (PP (ADVP (RBS (most)) (RB (likely))) (IN (by)) (NP (NP (NN (inhibition))) (PP (IN (of)) (NP (NP (JJ (renal)) (JJ (tubular)) (NN (secretion))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (zalcitabine)))))))))) |ET|
1  |BT|  (VP (NE-Type-1-drug (NP (NNS (drugs)))) (PP (IN (in)) (NP (NP (NN (combination))) (PP (IN (with)) (NE-Type-2-drug (NP (NN (zalcitabine)))))))) |ET|
-1  |BT|  (S (S (NP (VP (NE-Type-1-drug (NP (NNS (drugs)))) (PP (IN (in)) (NP (NP (NN (combination))) (PP (IN (with)) (drug_ENTITY (NP (NN (zalcitabine))))))))) (VP (MD (should)) (VP (VB (be)) (VP (VBN (monitored)) (PP (IN (for)) (NP (NP (NNS (signs))) (PP (IN (of)) (NP (NN (toxicity)))))))))) (CC (and)) (S (NP (NP (DT (the)) (NN (dose))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (zalcitabine)))))))) |ET|
-1  |BT|  (S (S (NP (VP (PP (NP (PP (NE-Type-1-drug (NP (NN (zalcitabine))))))))) (VP (MD (should)) (VP (VB (be)) (VP (VBN (monitored)) (PP (IN (for)) (NP (NP (NNS (signs))) (PP (IN (of)) (NP (NN (toxicity)))))))))) (CC (and)) (S (NP (NP (DT (the)) (NN (dose))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (zalcitabine)))))))) |ET|
-1  |BT|  (NE-Type-2-drug (NP (NN (Magnesium)) (JJ (/Aluminum-containing)) (JJ (Antacid)))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Magnesium)) (JJ (/Aluminum-containing)) (JJ (Antacid)) (NNS (Products)))) (: (:)) (S (NP (NP (NN (Absorption))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (zalcitabine)))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Magnesium)) (JJ (/Aluminum-containing)) (JJ (Antacid)) (NNS (Products)))) (: (:)) (S (NP (NP (NN (Absorption))) (PP (IN (of)) (drug_ENTITY (NP (NN (zalcitabine)))))) (VP (VBZ (is)) (ADVP (RB (moderately))) (VP (VBN (reduced)) (PRN (-LRB- (<LB>)) (NP (QP (RB (approximately)) (CD (25))) (NN (%))) (-RRB- (<RB>))) (SBAR (WHADVP (WRB (when))) (S (VP (VBN (coadministered)) (PP (IN (with)) (NE-Type-2-drug (NP (NN (magnesium)))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Magnesium)) (JJ (/Aluminum-containing)) (JJ (Antacid)) (NNS (Products)))) (: (:)) (S (NP (NP (NN (Absorption))) (PP (IN (of)) (drug_ENTITY (NP (NN (zalcitabine)))))) (VP (VBZ (is)) (ADVP (RB (moderately))) (VP (VBN (reduced)) (PRN (-LRB- (<LB>)) (NP (QP (RB (approximately)) (CD (25))) (NN (%))) (-RRB- (<RB>))) (SBAR (WHADVP (WRB (when))) (S (VP (VBN (coadministered)) (PP (IN (with)) (NE-Type-2-drug (NP (NN (magnesium)) (NN (/aluminum-containing)) (JJ (antacid)))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (JJ (/Aluminum-containing)) (JJ (Antacid)) (NNS (Products)))) (: (:)) (S (NP (NP (NN (Absorption))) (PP (IN (of)) (NE-Type-2-drug (NP (NN (zalcitabine)))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (JJ (/Aluminum-containing)) (JJ (Antacid)) (NNS (Products)))) (: (:)) (S (NP (NP (NN (Absorption))) (PP (IN (of)) (drug_ENTITY (NP (NN (zalcitabine)))))) (VP (VBZ (is)) (ADVP (RB (moderately))) (VP (VBN (reduced)) (PRN (-LRB- (<LB>)) (NP (QP (RB (approximately)) (CD (25))) (NN (%))) (-RRB- (<RB>))) (SBAR (WHADVP (WRB (when))) (S (VP (VBN (coadministered)) (PP (IN (with)) (NE-Type-2-drug (NP (NN (magnesium)))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (JJ (/Aluminum-containing)) (JJ (Antacid)) (NNS (Products)))) (: (:)) (S (NP (NP (NN (Absorption))) (PP (IN (of)) (drug_ENTITY (NP (NN (zalcitabine)))))) (VP (VBZ (is)) (ADVP (RB (moderately))) (VP (VBN (reduced)) (PRN (-LRB- (<LB>)) (NP (QP (RB (approximately)) (CD (25))) (NN (%))) (-RRB- (<RB>))) (SBAR (WHADVP (WRB (when))) (S (VP (VBN (coadministered)) (PP (IN (with)) (NE-Type-2-drug (NP (NN (magnesium)) (NN (/aluminum-containing)) (JJ (antacid)))))))))))) |ET|
1  |BT|  (S (NP (PP (NE-Type-1-drug (NP (NN (zalcitabine)))))) (VP (VBZ (is)) (ADVP (RB (moderately))) (VP (VBN (reduced)) (PRN (-LRB- (<LB>)) (NP (QP (RB (approximately)) (CD (25))) (NN (%))) (-RRB- (<RB>))) (SBAR (WHADVP (WRB (when))) (S (VP (VBN (coadministered)) (PP (IN (with)) (NE-Type-2-drug (NP (NN (magnesium))))))))))) |ET|
1  |BT|  (S (NP (PP (NE-Type-1-drug (NP (NN (zalcitabine)))))) (VP (VBZ (is)) (ADVP (RB (moderately))) (VP (VBN (reduced)) (PRN (-LRB- (<LB>)) (NP (QP (RB (approximately)) (CD (25))) (NN (%))) (-RRB- (<RB>))) (SBAR (WHADVP (WRB (when))) (S (VP (VBN (coadministered)) (PP (IN (with)) (NE-Type-2-drug (NP (NN (magnesium)) (NN (/aluminum-containing)) (JJ (antacid))))))))))) |ET|
-1  |BT|  (NE-Type-2-drug (NP (NN (magnesium)) (NN (/aluminum-containing)) (JJ (antacid)))) |ET|
1  |BT|  (S (NE-Type-1-drug (NP (NN (zalcitabine)))) (VP (VBZ (is)) (RB (not)) (VP (VBN (recommended)) (S (VP (TO (to)) (VP (VB (be)) (VP (VBN (ingested)) (ADVP (RB (simultaneously))) (PP (IN (with)) (NP (NE-Type-2-drug (NP (NN (magnesium))))))))))))) |ET|
1  |BT|  (S (NE-Type-1-drug (NP (NN (zalcitabine)))) (VP (VBZ (is)) (RB (not)) (VP (VBN (recommended)) (S (VP (TO (to)) (VP (VB (be)) (VP (VBN (ingested)) (ADVP (RB (simultaneously))) (PP (IN (with)) (NP (drug_ENTITY (NP (NN (magnesium)))) (: (/)) (NE-Type-2-drug (NP (JJ (aluminum-containing)) (NNS (antacids))))))))))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (magnesium)))) (: (/)) (NE-Type-2-drug (NP (JJ (aluminum-containing)) (NNS (antacids))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NN (Metoclopramide)) (: (:)) (NN (Bioavailability)))) (VP (VBZ (is)) (ADVP (RB (mildly))) (VP (VBN (reduced)) (PRN (-LRB- (<LB>)) (NP (QP (RB (approximately)) (CD (10))) (NN (%))) (-RRB- (<RB>))) (SBAR (WHADVP (WRB (when))) (S (NP (NE-Type-2-drug (NP (NN (zalcitabine)))))))))) |ET|
-1  |BT|  (S (NE-Type-1-drug (NP (NN (Metoclopramide)) (: (:)) (NN (Bioavailability)))) (VP (VBZ (is)) (ADVP (RB (mildly))) (VP (VBN (reduced)) (PRN (-LRB- (<LB>)) (NP (QP (RB (approximately)) (CD (10))) (NN (%))) (-RRB- (<RB>))) (SBAR (WHADVP (WRB (when))) (S (NP (drug_ENTITY (NP (NN (zalcitabine)))) (CC (and)) (NE-Type-2-drug (NP (NN (metoclopramide)))))))))) |ET|
1  |BT|  (NP (NE-Type-1-drug (NP (NN (zalcitabine)))) (CC (and)) (NE-Type-2-drug (NP (NN (metoclopramide))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Doxorubicin)))) (: (:)) (S (NE-Type-2-drug (NP (NN (Doxorubicin)))))) |ET|
-1  |BT|  (NP (NE-Type-1-drug (NP (NN (Doxorubicin)))) (: (:)) (S (drug_ENTITY (NP (NN (Doxorubicin)))) (VP (VBD (caused)) (NP (NP (NP (DT (a)) (NN (decrease))) (PP (IN (in)) (NE-Type-2-drug (NP (NN (zalcitabine)))))))))) |ET|
1  |BT|  (S (NE-Type-1-drug (NP (NN (Doxorubicin)))) (VP (VBD (caused)) (NP (NP (NP (DT (a)) (NN (decrease))) (PP (IN (in)) (NE-Type-2-drug (NP (NN (zalcitabine))))))))) |ET|
-1  |BT|  (VP (NE-Type-1-drug (NP (NN (zalcitabine)) (NN (activity)))) (PP (IN (because)) (IN (of)) (NE-Type-2-drug (NP (JJ (lessened)) (JJ (active)) (NN (metabolite)))))) |ET|
